References - iarc

References 

1 . Anon. (1982). The World Health 

Organization Histological Typing of Breast 

Tumors-Second Edition. The World Health 

Organization. Am J Clin Pathol 78: 806-816. 

2. Anon. (1987). The reduction in risk of 

ovarian cancer associated with oral-contraceptive 

use. The Cancer and Steroid 

Hormone Study of the Centers for Disease 

Control and the National Institute of Child 

Health and Human Development. N Engl J 

Med 316: 650-655. 

3. Anon. (1990). Surgical-procedure terminology 

for the vulva and vagina. Report of 

an International Society for the Study of 

Vulvar Disease Task Force. J Reprod Med 

35: 1033-1034. 

4. Anon. (1992). Systemic treatment of early 

breast cancer by hormonal, cytotoxic, or 

immune therapy. 133 randomised trials 

involving 31,000 recurrences and 24,000 

deaths among 75,000 women. Early Breast 

Cancer Trialists' Collaborative Group. 

Lancet 339: 1-15. 

5. Anon. (1996). Clinical practice guidelines 

for the use of tumor markers in breast and 

colorectal cancer. Adopted on May 17, 

1996 by the American Society of Clinical 

Oncology. J Clin Oncol 14: 2843-2877. 

6. Anon. (1997). Consensus conference on 

the classification of ductal carcinoma in 

situ. Hum Pathol 28: 1221-1225. 

7. Anon. (1997). Consensus Conference on 

the classification of ductal carcinoma in 

situ. The Consensus Conference 

Committee. Cancer 80: 1798-1802. 

8 . Anon. (1997). Pathology of familial 

breast cancer: differences between breast 

cancers in carriers of BRCA1 or BRCA2 

mutations and sporadic cases. Breast 

Cancer Linkage Consortium. Lancet 349: 

1505-1510. 

9. Anon. (1998). 1997 update of recommendations 

for the use of tumor markers in 

breast and colorectal cancer. Adopted on 

November 7, 1997 by the American Society 

of Clinical Oncology. J Clin Oncol 16: 793- 

795. 

10. Anon. (1998). Tamoxifen for early breast 

cancer: an overview of the randomised trials. 

Early Breast Cancer Trialists' 

Collaborative Group. Lancet 351: 1451- 

1467. 

11. Anon. (1999). Cancer risks in BRCA2 

mutation carriers. The Breast Cancer 

Linkage Consortium. J Natl Cancer Inst 91: 

1310-1316. 

1 2 .Aaltonen LA, Salovaara R, Kristo P, Canzian 

F, Hemminki A, Peltomaki P, Chadwick RB, 

Kaariainen H, Eskelinen M, Jarvinen H, 

Mecklin JP, de la CA (1998). Incidence of 

hereditary nonpolyposis colorectal cancer and 

the feasibility of molecular screening for the 

disease. N Engl J Med 338: 1481-1487. 

372 References 

13. Aarnio M, Mecklin JP, Aaltonen LA, 

Nystrom-Lahti M, Jarvinen HJ (1995). Lifetime 

risk of different cancers in hereditary 

non-polyposis colorectal cancer (HNPCC) 

syndrome. Int J Cancer 64: 430-433. 

1 4 . Aarnio M, Sankila R, Pukkala E, 

Salovaara R, Aaltonen LA, de la CA, 

Peltomaki P, Mecklin JP, Jarvinen HJ 

(1999). Cancer risk in mutation carriers of 

DNA-mismatch-repair genes. Int J Cancer 

81: 214-218. 

15. Aaro CA, Jacobson LJ, Soule EH (1963). 

Endocervical polyps. Obstet Gynecol 21: 

659-665. 

16. Aas T, Borresen AL, Geisler S, Smith- 

Sorensen B, Johnsen H, Varhaug JE, 

Akslen LA, Lonning PE (1996). Specific P53 

mutations are associated with de novo 

resistance to doxorubicin in breast cancer 

patients. Nat Med 2: 811-814. 

1 7 . Abati AD, Kimmel M, Rosen PP (1990). 

Apocrine mammary carcinoma. A clinicopathologic 

study of 72 cases. Am J Clin 

Pathol 94: 371-377. 

18. Abbondanzo SL, Seidman JD, Lefkowitz 

M, Tavassoli FA, Krishnan J (1996). Primary 

diffuse large B-cell lymphoma of the 

breast. A clinicopathologic study of 31 

cases. Pathol Res Pract 192: 37-43. 

19. Abbott TM, Hermann WJJr., Scully RE 

(1984). Ovarian fetiform teratoma 

(homunculus) in a 9-year-old girl. Int J 

Gynecol Pathol 2: 392-402. 

20. Abdul-Karim FW, Bazi TM, Sorensen K, 

Nasr MF (1987). Sarcoma of the uterine 

cervix: clinicopathologic findings in three 

cases. Gynecol Oncol 26: 103-111. 

21. Abeler V, Nesland JM (1989). Alveolar 

soft-part sarcoma in the uterine cervix. 

Arch Pathol Lab Med 113: 1179-1183. 

2 2 . Abeler VM, Holm R, Nesland JM, 

Kjorstad KE (1994). Small cell carcinoma of 

the cervix. A clinicopathologic study of 26 

patients. Cancer 73: 672-677. 

23. Abeler VM, Kjorstad KE, Nesland JM 

(1991). Undifferentiated carcinoma of the 

endometrium. A histopathologic and clinical 

study of 31 cases. Cancer 68: 98-105. 

24. Abeler VM, Vergote IB, Kjorstad KE, 

Trope CG (1996). Clear cell carcinoma of 

the endometrium. Prognosis and metastatic 

pattern. Cancer 78: 1740-1747. 

25. Abell MR, Ramirez JA (1973). Sarcomas 

and carcinosarcomas of the uterine cervix. 

Cancer 31: 1176-1192. 

26. Abeln EC, Smit VT, Wessels JW, de 

Leeuw WJ, Cornelisse CJ, Fleuren GJ 

(1997). Molecular genetic evidence for the 

conversion hypothesis of the origin of 

malignant mixed mullerian tumours. J 

Pathol 183: 424-431. 

2 7 . Abner AL, Collins L, Peiro G, Recht A, 

Come S, Shulman LN, Silver B, Nixon A, Harris 

JR, Schnitt SJ, Connolly JL (1998). Correlation 

of tumor size and axillary lymph node involvement 

with prognosis in patients with T1 breast 

c a r c i n o m a .Cancer 83: 2502-2508. 

28. Aboumrad MH, Horn RC, Fine G (1963). 

Lipid-secreting mammary carcinoma. 

Cancer 16: 521-525. 

29. Abrams J, Talcott J, Corson JM (1989). 

Pulmonary metastases in patients with 

low-grade endometrial stromal sarcoma. 

Clinicopathologic findings with immunohistochemical 

characterization. Am J Surg 

Pathol 13: 133-140. 

30. Acharya S, Wilson T, Gradia S, Kane 

MF, Guerrette S, Marsischky GT, Kolodner 

R, Fishel R (1996). hMSH2 forms specific 

mispair-binding complexes with hMSH3 

and hMSH6. Proc Natl Acad Sci USA 93: 

13629-13634. 

3 1 . Ackerman AB, Mihara I (1985). 

Dysplasia, dysplastic melanocytes, dysplastic 

nevi, the dysplastic nevus syndrome, 

and the relation between dysplastic 

nevi and malignant melanomas. Hum 

Pathol 16: 87-91. 

32. Ackerman LV, Katzenstein AL (1977). 

The concept of minimal breast cancer and 

the pathologist's role in the diagnosis of 

"early carcinoma". Cancer 39: 2755-2763. 

33. Acosta-Sison H (1970). Chorioadenoma 

destruens. A report of 41 case. Am J 

Obstet Gynecol 80: 176. 

34. Acs G, Lawton TJ, Rebbeck TR, LiVolsi 

VA, Zhang PJ (2001). Differential expression 

of E-cadherin in lobular and ductal 

neoplasms of the breast and its biologic 

and diagnostic implications. Am J Clin 

Pathol 115: 85-98. 

3 5 . Adami HO, Bergstrom R, Hansen J 

(1985). Age at first primary as a determinant 

of the incidence of bilateral breast 

cancer. Cumulative and relative risks in a 

population-based case-control study. 

Cancer 55: 643-647. 

36. Adami HO, Signorello LB, Trichopoulos 

D (1998). Towards an understanding of 

breast cancer etiology. Semin Cancer Biol 

8: 255-262. 

37. Adami HO, Sparen P, Bergstrom R, 

Holmberg L, Krusemo UB, Ponten J (1989). 

Increasing survival trend after cancer 

diagnosis in Sweden: 1960-1984. J Natl 

Cancer Inst 81: 1640-1647. 

38. Adashi EY, Rosenshein NB, Parmley TH, 

Woodruff JD (1980). Histogenesis of the 

broad ligament adrenal rest. Int J 

Gynaecol Obstet 18: 102-104. 

39. Adeniji KA, Adelusola KA, Odesanmi 

WO, Fadiran OA (1997). Histopathological 

analysis of carcinoma of the male breast in 

Ile-Ife, Nigeria. East Afr Med J 74: 455-457. 

4 0 . Adeyinka A, Mertens F, Idvall I, 

Bondeson L, Ingvar C, Heim S, Mitelman F, 

Pandis N (1998). Cytogenetic findings in 

invasive breast carcinomas with prognostically 

favourable histology: a less complex 

karyotypic pattern? Int J Cancer 79: 361- 

364. 

41. Adnane J, Gaudray P, Dionne CA, 

Crumley G, Jaye M, Schlessinger J, Jeanteur 

P, Birnbaum D, Theillet C (1991). BEK and 

FLG, two receptors to members of the FGF 

family, are amplified in subsets of human 

breast cancers. Oncogene 6: 659-663. 

4 2 . Agathanggelou A, Honorio S, 

Macartney DP, Martinez A, Dallol A, Rader 

J, Fullwood P, Chauhan A, Walker R, Shaw 

JA, Hosoe S, Lerman MI, Minna JD, Maher 

ER, Latif F (2001). Methylation associated 

inactivation of RASSF1A from region 

3p21.3 in lung, breast and ovarian tumours. 

Oncogene 20: 1509-1518. 

4 3 . Agnarsson BA, Jonasson JG, 

Bjornsdottir IB, Barkardottir RB, Egilsson 

V, Sigurdsson H (1998). Inherited BRCA2 

mutation associated with high grade 

breast cancer. Breast Cancer Res Treat 47: 

121-127. 

44. Agoff SN, Grieco VS, Garcia R, Gown 

AM (2001). Immunohistochemical distinction 

of endometrial stromal sarcoma and 

cellular leiomyoma. Appl Immunohistochem 

Mol Morphol 9: 164-169. 

45. Aguirre P, Scully RE, Wolfe HJ, DeLellis 

RA (1986). Argyrophil cells in Brenner 

tumors: histochemical and immunohistochemical 

analysis. Int J Gynecol Pathol 5: 

223-234. 

46. Aguirre P, Thor AD, Scully RE (1989). 

Ovarian small cell carcinoma. Histogenetic 

considerations based on immunohistochemical 

and other findings. Am J Clin 

Pathol 92: 140-149. 

47. Ahern JK, Allen NH (1978). Cervical 

hemangioma: a case report and review of 

the literature. J Reprod Med 21: 228-231. 

48. Ahmed AA, Swan RW, Owen A, Kraus 

FT, Patrick F (1997). Uterus-like mass arising 

in the broad ligament: a metaplasia or 

mullerian duct anomaly? Int J Gynecol 

Pathol 16: 279-281. 

49. Aho M, Vesterinen E, Meyer B, Purola 

E, Paavonen J (1991). Natural history of 

vaginal intraepithelial neoplasia. Cancer 

68: 195-197. 

50. Aida H, Takakuwa K, Nagata H, Tsuneki 

I, Takano M, Tsuji S, Takahashi T, Sonoda 

T, Hatae M, Takahashi K, Hasegawa K, 

Mizunuma H, Toyoda N, Kamata H, Torii Y, 

Saito N, Tanaka K, Yakushiji M, Araki T, 

Tanaka K (1998). Clinical features of ovarian 

cancer in Japanese women with germline 

mutations of BRCA1. Clin Cancer Res 

4: 235-240. 

5 1 . AJCC (2002). AJCC Cancer Staging 

Manual. Sixth ed. Springer Verlag: New 

York.

52. Akhtar M, Robinson C, Ashraf Ali M, 

Godwin JT (1983). Secretory carcinoma of 

the breast in adults. Cancer 51: 2245-2254. 

53. Akiyama Y, Sato H, Yamada T, Nagasaki 

H, Tsuchiya A, Abe R, Yuasa Y (1997). 

Germ-line mutation of the hMSH6/GTBP 

gene in an atypical hereditary nonpolyposis 

colorectal cancer kindred. Cancer Res 

57: 3920-3923. 

54. Al Jafari MS, Panton HM, Gradwell E 

(1985). Phaeochromocytoma of the broad 

ligament. Case report. Br J Obstet 

Gynaecol 92: 649-651. 

5 5 . Al Kurdi M, Monaghan JM (1981). 

Thirty-two years experience in management 

of primary tumours of the vagina. Br 

J Obstet Gynaecol 88: 1145-1150. 

56. Al Nafussi AI, Al Yusif R (1998). Papillary 

squamotransitional cell carcinoma of the 

uterine cervix: an advanced stage disease 

despite superficial location: report of two 

cases and review of the literature. Eur J 

Gynaecol Oncol 19: 455-457. 

5 7 . Al Nafussi AI, Hughes DE (1994). 

Histological features of CIN3 and their 

value in predicting invasive microinvasive 

squamous carcinoma. J Clin Pathol 47: 

799-804. 

5 8 . Alamowitch B, Mausset V, Ruiz A, 

Tissier F, Fourmestraux J, Bouillot JL, 

Bethoux JP (1999). [Non-secreting 

pheochromocytoma of the broad ligament 

revealed by appendicular peritonitis]. 

Presse Med 28: 225-228. 

59. Albain KS, Allred DC, Clark GM (1994). 

Breast cancer outcome and predictors of 

outcome: are there age differentials? J 

Natl Cancer Inst Monogr 35-42. 

60. Albertson DG, Ylstra B, Segraves R, 

Collins C, Dairkee SH, Kowbel D, Kuo WL, 

Gray JW, Pinkel D (2000). Quantitative 

mapping of amplicon structure by array 

CGH identifies CYP24 as a candidate oncogene. 

Nat Genet 25: 144-146. 

6 1 . Albonico G, Querzoli P, Ferretti S, 

Rinaldi R, Nenci I (1996). Biological heterogeneity 

of breast carcinoma in situ. Ann N 

Y Acad Sci 784: 458-461. 

6 2 . Albonico G, Querzoli P, Ferretti S, 

Rinaldi R, Nenci I (1998). Biological profile 

of in situ breast cancer investigated by 

immunohistochemical technique. Cancer 

Detect Prev 22: 313-318. 

6 3 . Albores-Saavedra J, Gersell D, Gilks 

CB, Henson DE, Lindberg G, Santiago H, 

Scully RE, Silva E, Sobin LH, Tavassoli FJ, 

Travis WD, Woodruff JM (1997). 

Terminology of endocrine tumors of the 

uterine cervix: results of a workshop 

sponsored by the College of American 

Pathologists and the National Cancer 

I n s t i t u t e . Arch Pathol Lab Med 121: 34-39. 

6 4 . Albores-Saavedra J, Gilcrease M 

(1999). Glomus tumor of the uterine cervix. 

Int J Gynecol Pathol 18: 69-72. 

65. Albores-Saavedra J, Manivel C, Mora 

A, Vuitch F, Milchgrub S, Gould E (1992). 

The solid variant of adenoid cystic carcinoma 

of the cervix.Int J Gynecol Pathol11: 

2-10. 

66. Albores-Saavedra J, Young RH (1995). 

Transitional cell neoplasms (carcinomas 

and inverted papillomas) of the uterine 

cervix. A report of five cases. Am J Surg 

Pathol 19: 1138-1145. 

67. Alderson MR, Hamlin I, Staunton MD 

(1971). The relative significance of prognostic 

factors in breast carcinoma. Br J 

Cancer 25: 646-656. 

68. Alfsen GC, Kristensen GB, Skovlund E, 

Pettersen EO, Abeler VM (2001). Histologic 

subtype has minor importance for overall 

survival in patients with adenocarcinoma 

of the uterine cervix: a population-based 

study of prognostic factors in 505 patients 

with nonsquamous cell carcinomas of the 

cervix. Cancer 92: 2471-2483. 

6 9 . Alizadeh AA, Ross DT, Perou CM, van de 

Rijn M (2001). Towards a novel classification 

of human malignancies based on gene 

expression patterns. J Pathol 195: 41-52. 

7 0 . Allaire AD, Majmudar B (1993). 

Dracunculosis of the broad ligament. A 

case of a "parasitic leiomyoma". Am J Surg 

Pathol 17: 937-940. 

71. Allred DC, Elledge RM (1999). Caution 

concerning micrometastatic breast carcinoma 

in sentinel lymph nodes. Cancer 86: 

905-907. 

72. Allred DC, Mohsin SK, Fuqua SA (2001). 

Histological and biological evolution of 

human premalignant breast disease. 

Endocr Relat Cancer 8: 47-61. 

7 3 . Altaras MM, Jaffe R, Corduba M, 

Holtzinger M, Bahary C (1990). Primary 

paraovarian cystadenocarcinoma: clinical 

and management aspects and literature 

review. Gynecol Oncol 38: 268-272. 

7 4 . Alvarado-Cabrero I, Navani SS, Young 

RH, Scully RE (1997). Tumors of the fimbriated 

end of the fallopian tube: a clinicopathologic 

analysis of 20 cases, including nine carcinom 

a s .Int J Gynecol Pathol 16: 189-196. 

7 5 . Alvarado-Cabrero I, Young RH, 

Vamvakas EC, Scully RE (1999). Carcinoma 

of the fallopian tube: a clinicopathological 

study of 105 cases with observations on 

staging and prognostic factors. Gynecol 

Oncol 72: 367-379. 

7 6 . Alvarez-Fernandez E, Salinero- 

Paniagua E (1981). Vascular tumors of the 

mammary gland. A histochemical and 

ultrastructural study. Virchows Arch A 

Pathol Anat Histol 394: 31-47. 

77. Amant F, Moerman P, Davel GH, De Vos 

R, Vergote I, Lindeque BG, de Jonge E 

(2001). Uterine carcinosarcoma with 

melanocytic differentiation. Int J Gynecol 

Pathol 20: 186-190. 

7 8 . Ambros RA, Kurman RJ (1992). 

Combined assessment of vascular and 

myometrial invasion as a model to predict 

prognosis in stage I endometrioid adenocarcinoma 

of the uterine corpus. Cancer 

69: 1424-1431. 

79. Ambros RA, Sherman ME, Zahn CM, 

Bitterman P, Kurman RJ (1995). 

Endometrial intraepithelial carcinoma: a 

distinctive lesion specifically associated 

with tumors displaying serous differentiation. 

Hum Pathol 26: 1260-1267. 

80. American Joint Committee on Cancer 

(1997). AJCC Cancer Staging Manual. 5th 

ed. Lippincott-Raven: Philadelphia. 

81. Amr SS, Elmallah KO (1995). Agressive 

angiomyxoma of the vagina. Int J 


8 2 . Anan K, Mitsuyama S, Tamae K, 

Nishihara K, Iwashita T, Abe Y, Ihara T, 

Nakahara S, Katsumoto F, Toyoshima S 

(2001). Pathological features of mucinous 

carcinoma of the breast are favourable for 

breast-conserving therapy. Eur J Surg 

Oncol 27: 459-463. 

8 3 . Anand S, Penrhyn-Lowe S, 

Venkitaraman AR (2003). AURORA-A amplification 

overrides the mitotic spindle 

assembly checkpoint, inducing resistance 

to Taxol. Cancer Cell 3: 51-62. 

8 4 . Anastassiades OT, Bouropoulou V, 

Kontogeorgos G, Tsakraklides EV (1979). 

Duct elastosis in infiltrating carcinoma of 

the breast. Pathol Res Pract 165: 411-421. 

85. Anbazhagan R, Fujii H, Gabrielson E 

(1999). Microsatellite instability is uncommon 

in breast cancer. Clin Cancer Res 5: 

839-844. 

86. Andersen JA (1974). Lobular carcinoma 

in situ of the breast with ductal involvement. 

Frequency and possible influence on 

prognosis. Acta Pathol Microbiol Scand 

[A] 82: 655-662. 87. Andersen JA (1974). 

Lobular carcinoma in situ. A histologic 

study of 52 cases. Acta Pathol Microbiol 

Scand [A] 82: 735-741. 

88. Andersen JA (1974). Lobular carcinoma 

in situ. A long-term follow-up in 52 cases. 

Acta Pathol Microbiol Scand [A] 82: 519- 

533. 

89. Andersen JA, Vendelboe ML (1981). 

Cytoplasmic mucous globules in lobular 

carcinoma in situ. Diagnosis and prognosis. 

Am J Surg Pathol 5: 251-255. 

9 0 . Anderson B, Turner DA, Benda J (1987). 

Ovarian sarcoma. Gynecol Oncol 26: 183-192. 

9 1 . Anderson BO, Petrek JA, Byrd DR, 

Senie RT, Borgen PI (1996). Pregnancy 

influences breast cancer stage at diagnosis 

in women 30 years of age and younger. 

Ann Surg Oncol 3: 204-211. 

92. Anderson C, Ricci A Jr., Pedersen CA, 

Cartun RW (1991). Immunocytochemical 

analysis of estrogen and progesterone 

receptors in benign stromal lesions of the 

breast. Evidence for hormonal etiology in 

pseudoangiomatous hyperplasia of mammary 

stroma. Am J Surg Pathol 15: 145-149. 

92a. Anderson DE (1971). Some characteristics 

of familial breast cancer. Cancer 28: 

1500-1504. 

93. Anderson DE (1974). Genetic study of 

breast cancer: identification of a high risk 

group. Cancer 34: 1090-1097. 

9 4 . Anderson DE, Badzioch MD (1992). 

Breast cancer risks in relatives of male 

breast cancer patients. J Natl Cancer Inst 

84: 1114-1117. 

9 5 . Anderson DE, Badzioch MD (1993). 

Familial effects of prostate and other cancers 

on lifetime breast cancer risk. Breast 

Cancer Res Treat 28: 107-113. 

9 6 . Anderson MC, Rees DA (1975). 

Gynandroblastoma of the ovary. Br J 

Obstet Gynaecol 82: 68-73. 

9 7 . Anderson TJ, Lamb J, Donnan P, 

Alexander FE, Huggins A, Muir BB, 

Kirkpatrick AE, Chetty U, Hepburn W, Smith 

A, Prescott RJ, Forrest P. (1991). 

Comparative pathology of breast cancer in 

a randomised trial of screening. Br J 

Cancer 64: 108-113. 

98. Andrac-Meyer L, Solere K, Sappa P, 

Garcia S, Charpin C (2000). [Infiltrating 

syringoadenoma of the nipple: a new 

case]. Ann Pathol 20: 142-144. 

99. Andrassy RJ, Wiener ES, Raney RB, 

Hays DM, Arndt CA, Lobe TE, Lawrence W, 

Anderson JR, Qualman SJ, Crist WM 

(1999). Progress in the surgical management 

of vaginal rhabdomyosarcoma: a 25year 

review from the Intergroup 

Rhabdomyosarcoma Study Group. J 

Pediatr Surg 34: 731-734. 

100. Andreasson B, Bock JE, Strom KV, 

Visfeldt J (1983). Verrucous carcinoma of 

the vulval region. Acta Obstet Gynecol 

Scand 62: 183-186. 

1 0 1 . Angele S, Lauge A, Fernet M, Moullan 

N, Beauvais P, Couturier J, Stoppa-Lyonnet 

D, Hall J (2003). Phenotypic cellular characterization 

of an ataxia telangiectasia 

patient carrying a causal homozygous missense 

mutation. Hum Mutat 21: 169-170. 

1 0 2 . Angele S, Treilleux I, Taniere P, 

Martel-Planche G, Vuillaume M, Bailly C, 

Bremond A, Montesano R, Hall J (2000). 

Abnormal expression of the ATM and TP53 

genes in sporadic breast carcinomas. Clin 

Cancer Res 6: 3536-3544. 

103. Ansah-Boateng Y, Wells M, Poole DR 

(1985). Coexistent immature teratoma of 

the uterus and endometrial adenocarcino - 

ma complicated by gliomatosis peritonei. 

Gynecol Oncol 21: 106-110. 

1 0 4 . Anteby EY, Ron M, Revel A, 

Shimonovitz S, Ariel I, Hurwitz A (1994). 

Germ cell tumors of the ovary arising after 

dermoid cyst resection: a long-term follow-up 

study. Obstet Gynecol 83: 605-608. 

1 0 5 . Anthony PP, James PD (1975). 

Adenoid cystic carcinoma of the breast: 

prevalence, diagnostic criteria, and histogenesis. 

J Clin Pathol 28: 647-655. 

106. Antoniou A, Pharoah PD, Narod S, 

Risch HA, Eyfjord JE, Hopper JL, Loman N, 

Olsson H, Johannsson O, Borg A, Pasini B, 

Radice P, Manoukian S, Eccles DM, Tang 

N, Olah E, Anton-Culver H, Warner E, 

Lubinski J, Gronwald J, Gorski B, Tulinius 

H, Thorlacius S, Eerola H, Nevanlinna H, 

Syrjakoski K, Kallioniemi OP, Thompson D, 

Evans C, Peto J, Lalloo F, Evans DG, Easton 

DF (2003). Average risks of breast and 

ovarian cancer associated with BRCA1 or 

BRCA2 mutations detected in case series 

unselected for family history: a combined 

analysis of 22 studies. Am J Hum Genet 72: 

1117-1130. 

107. Antoniou AC, Pharoah PD, McMullan 

G, Day NE, Ponder BA, Easton D (2001). 

Evidence for further breast cancer susceptibility 

genes in addition to BRCA1 and 

BRCA2 in a population-based study. Genet 

Epidemiol 21: 1-18. 

108. Anttila T, Saikku P, Koskela P, Bloigu 

A, Dillner J, Ikaheimo I, Jellum E, Lehtinen 

M, Lenner P, Hakulinen T, Narvanen A, 

Pukkala E, Thoresen S, Youngman L, 

Paavonen J (2001). Serotypes of Chlamydia 

trachomatis and risk for development of 

cervical squamous cell carcinoma. JAMA 

285: 47-51. 

109. Anzick SL, Kononen J, Walker RL, 

Azorsa DO, Tanner MM, Guan XY, Sauter 

G, Kallioniemi OP, Trent JM, Meltzer PS 

(1997). AIB1, a steroid receptor coactivator 

amplified in breast and ovarian cancer. 

Science 277: 965-968. 

110. Aoyama C, Peters J, Senadheera S, 

Liu P, Shimada H (1998). Uterine cervical 

dysplasia and cancer: identification of cmyc 

status by quantitative polymerase 

chain reaction. Diagn Mol Pathol 7: 324- 

330. 

111. Aoyama T, Mizuno T, Andoh K, Takagi 

T, Mizuno T, Eimoto T (1996). alpha- 

Fetoprotein-producing (hepatoid) carcinoma 

of the fallopian tube. Gynecol Oncol 63: 

261-266. 

1 1 2 . Aozasa K, Ito H, Kohro T, Ha K, 

Nakamura M, Okada A (1981). Chorio-carcinoma 

in infant and mother. Acta Pathol 

Jpn 31: 317-322. 

1 1 3 . Aozasa K, Ohsawa M, Saeki K, 

Horiuchi K, Kawano K, Taguchi T (1992). 

Malignant lymphoma of the breast. 

Immunologic type and association with 

lymphocytic mastopathy. Am J Clin Pathol 

97: 699-704. 

References 373

1 1 4 . Aozasa K, Saeki K, Ohsawa M, 

Horiuchi K, Mishima K, Tsujimoto M (1993). 

Malignant lymphoma of the uterus. Report 

of seven cases with immunohistochemical 

study. Cancer 72: 1959-1964. 

115. Appleby JM, Barber JB, Levine E, 

Varley JM, Taylor AM, Stankovic T, 

Heighway J, Warren C, Scott D (1997). 

Absence of mutations in the ATM gene in 

breast cancer patients with severe 

responses to radiotherapy. Br J Cancer 76: 

1546-1549. 

1 1 6 . Arbabi L, Warhol MJ (1982). 

Pleomorphic liposarcoma following radiotherapy 

for breast carcinoma. Cancer 49: 

878-880. 

117. Arber DA, Simpson JF, Weiss LM, 

Rappaport H (1994). Non-Hodgkin's lymphoma 

involving the breast. Am J Surg 

Pathol 18: 288-295. 

118. Arias-Stella J Jr., Rosen PP (1988). 

Hemangiopericytoma of the breast. Mod 

Pathol 1: 98-103. 

119. Ariel IM, Kempner R (1989). The prognosis 

of patients who become pregnant 

after mastectomy for breast cancer. Int 

Surg 74: 185-187. 

1 2 0 . Ariyoshi K, Kawauchi S, Kaku T, 

Nakano H, Tsuneyoshi M (2000). 

Prognostic factors in ovarian carcinosarcoma: 

a clinicopathological and immunohistochemical 

analysis of 23 cases. 

Histopathology 37: 427-436. 

121. Armes JE, Egan AJ, Southey MC, Dite 

GS, McCredie MR, Giles GG, Hopper JL, 

Venter DJ (1998). The histologic phenotypes 

of breast carcinoma occurring 

before age 40 years in women with and 

without BRCA1 or BRCA2 germline mutations: 

a population-based study. Cancer 83: 

2335-2345. 

122. Aron DC, Marks WM, Alper PR, Karam 

JH (1980). Pheochromocytoma of the 

broad ligament. Localization by computerized 

tomography and ultrasonography. 

Arch Intern Med 140: 550-552. 

1 2 3 . Arora DS, Haldane S (1996). 

Carcinosarcoma arising in a dermoid cyst 

of the ovary. J Clin Pathol 49: 519-521. 

124. Arroyo JG, Harris W, Laden SA (1998). 

Recurrent mixed germ cell-sex cord-stromal 

tumor of the ovary in an adult. Int J 


1 2 5 . Asgeirsson KS, Jonasson JG, 

Tryggvadottir L, Olafsdottir K, 

Sigurgeirsdottir JR, Ingvarsson S, 

Ogmundsdottir HM (2000). Altered expression 

of E-cadherin in breast cancer: patterns, 

mechanisms and clinical significance. 

Eur J Cancer 36: 1098-1106. 

1 2 6 . Ashikari R, Huvos AG, Urban JA, 

Robbins GF (1973). Infiltrating lobular carcinoma 

of the breast. Cancer 31: 110-116. 

127. Aslani M, Ahn GH, Scully RE (1988). 

Serous papillary cystadenoma of borderline 

malignancy of broad ligament. A report 

of 25 cases. Int J Gynecol Pathol 7: 131- 

138. 

127a. Aslani M, Scully RE (1989). Primary 

carcinoma of the broad ligament. Report of 

four cases and review of the literature. 

Cancer 64: 1540-1545. 

128. Athale UH, Shurtleff SA, Jenkins JJ, 

Poquette CA, Tan M, Downing JR, Pappo 

AS (2001). Use of reverse transcriptase 

polymerase chain reaction for diagnosis 

and staging of alveolar rhabdomyosarcoma, 

Ewing sarcoma family of tumors, and 

desmoplastic small round cell tumor. Am J 

Pediatr Hematol Oncol 23: 99-104. 


129. Athma P, Rappaport R, Swift M (1996). 

Molecular genotyping shows that ataxiatelangiectasia 

heterozygotes are predisposed 

to breast cancer. Cancer Genet 

Cytogenet 92: 130-134. 

1 3 0 . Atkins K, Bell S, Kempson R, 

Hendrickson M (2001). Epithelioid smooth 

muscle tumors of the uterus. M o d e r n 

Pathol 14: 132A. 

1 3 1 . Atkins K, Bell S, Kempson R, 

Hendrickson M (2001). Myxoid smooth 

muscle tumors of the uterus. M o d e r n 

Pathol 14: 132A. 

132. Atlas I, Gajewski W, Falkenberry S, 

Granai CO, Steinhoff MM (1998). Absence 

of estrogen and progesterone receptors in 

glassy cell carcinoma of the cervix. Obstet 

Gynecol 91: 136-138. 

133. Atri M, Nazarnia S, Aldis AE, Reinhold 

C, Bret PM, Kintzen G (1994). Transvaginal 

US appearance of endometrial abnormalities. 

Radiographics 14: 483-492. 

134. Aubele M, Mattis A, Zitzelsberger H, 

Walch A, Kremer M, Welzl G, Hofler H, 

Werner M (2000). Extensive ductal carcinoma 

In situ with small foci of invasive 

ductal carcinoma: evidence of genetic 

resemblance by CGH. Int J Cancer 85: 82- 

86. 

1 3 5 . Aubele M, Werner M (1999). 

Heterogeneity in breast cancer and the 

problem of relevance of findings. Anal Cell 

Pathol 19: 53-58. 

136. Aubele MM, Cummings MC, Mattis 

AE, Zitzelsberger HF, Walch AK, Kremer M, 

Hofler H, Werner M (2000). Accumulation 

of chromosomal imbalances from intraductal 

proliferative lesions to adjacent in 

situ and invasive ductal breast cancer. 

Diagn Mol Pathol 9: 14-19. 

137. Aure JC, Høeg K, Kolstad P (1971). 

Clinical and histologic studies of ovarian 

carcinoma. Long-term follow-up of 990 

cases. Obstet Gynecol 37: 1-9. 

1 3 8 . Austin RM, Dupree WB (1986). 

Liposarcoma of the breast: a clinicopatho - 

logic study of 20 cases. Hum Pathol 17: 

906-913. 

1 3 9 . Austin RM, Norris HJ (1987). 

Malignant Brenner tumor and transitional 

cell carcinoma of the ovary: a comparison. 


140. Avinoach I, Zirkin HJ, Glezerman M 

(1989). Proliferating trichilemmal tumor of 

the vulva. Case report and review of the literature. 


1 4 1 . Axe S, Parmley T, Woodruff JD, 

Hlopak B (1986). Adenomas in minor 

vestibular glands. Obstet Gynecol 68: 16- 

18. 

142. Axe SR, Klein VR, Woodruff JD (1985). 

Choriocarcinoma of the ovary. O b s t e t 

Gynecol 66: 111-114. 

143. Axiotis CA, Lippes HA, Merino MJ, 

deLanerolle NC, Stewart AF, Kinder B 

(1987). Corticotroph cell pituitary adenoma 

within an ovarian teratoma. A new cause 

of Cushing's syndrome. Am J Surg Pathol 

11: 218-224. 

144. Aziz S, Kuperstein G, Rosen B, Cole D, 

Nedelcu R, McLaughlin J, Narod SA (2001). 

A genetic epidemiological study of carcinoma 

of the fallopian tube. Gynecol Oncol 

80: 341-345. 

1 4 5 . Azoury RS, Woodruff JD (1971). 

Primary ovarian sarcomas. Report of 43 

cases from the Emil Novak Ovarian Tumor 

Registry. Obstet Gynecol 37: 920-941. 

146. Azuma C, Saji F, Tokugawa Y, Kimura 

T, Nobunaga T, Takemura M, Kameda T, 

Tanizawa O (1991). Application of gene 

amplification by polymerase chain reaction 

to genetic analysis of molar mitochondrial 

DNA: the detection of anuclear empty 

ovum as the cause of complete mole. 


1 4 7 . Azzopardi AG (1979). Problems in 

Breast Pathology. Classification of Primary 

Breast Carcinoma. AG Azzopardi (Ed.) WB 

Saunders: Philadelphia. 

148. Azzopardi JG (1979). Papilloma and 

papillary carcinoma. In: Problems in 

Breast Pathology. JG Azzopardi (Ed.) WB 

Saunders: London, pp. 150-166. 

149. Azzopardi JG, Ahmed A, Millis RR 

(1979). Problems in Breast Pathology. AG 

Azzopardi (Ed.) WB Saunders: 

London/Philadelphia. 

1 5 0 . Azzopardi JG, Eusebi V (1977). 

Melanocyte colonization and pigmentation 

of breast carcinoma. Histopathology 1: 21- 

30. 

151. Azzopardi JG, Salm R (1984). Ductal 

adenoma of the breast: a lesion which can 

mimic carcinoma. J Pathol 144: 15-23. 

1 5 2 . Azzopardi JG, Smith, OD (1959). 

Salivary gland tumours and their mucins. 

J Pathol Bacteriol 77: 131-140. 

1 5 3 . Baak JP, Nauta JJ, Wisse- 

Brekelmans EC, Bezemer PD (1988). 

Architectural and nuclear morphometrical 

features together are more important 

prognosticators in endometrial hyperplasias 

than nuclear morphometrical features 

alone. J Pathol 154: 335-341. 

154. Baak JP, Orbo A, van Diest PJ, Jiwa 

M, de Bruin P, Broeckaert M, Snijders W, 

Boodt PJ, Fons G, Burger C, Verheijen RH, 

Houben PW, The HS, Kenemans P (2001). 

Prospective multicenter evaluation of the 

morphometric D-score for prediction of the 

outcome of endometrial hyperplasias. Am 

J Surg Pathol 25: 930-935. 

155. Babin EA, Davis JR, Hatch KD, Hallum 

AV III (2000). Wilms' tumor of the cervix: a 

case report and review of the literature. 


1 5 6 . Bacus SS, Zelnick CR, Chin DM, 

Yarden Y, Kaminsky DB, Bennington J, 

Wen D, Marcus JN, Page DL (1994). 

Medullary carcinoma is associated with 

expression of intercellular adhesion molecule-1. 

Implication to its morphology and 

its clinical behavior. Am J Pathol 145: 1337- 

1348. 

1 5 7 . Badve S, Sloane JP (1995). 

Pseudoangiomatous hyperplasia of male 

breast. Histopathology 26: 463-466. 

158. Baekelandt M, Jorunn NA, Kristensen 

GB, Trope CG, Abeler VM (2000). 

Carcinoma of the fallopian tube. Cancer 89: 

2076-2084. 

1 5 9 . Baer R, Ludwig T (2002). The 

BRCA1/BARD1 heterodimer, a tumor suppressor 

complex with ubiquitin E3 ligase 

activity. Curr Opin Genet Dev 12: 86-91. 

160. Baergen RN, Warren CD, Isacson C, 

Ellenson LH (2001). Early uterine serous 

carcinoma: clonal origin of extrauterine 

disease. Int J Gynecol Pathol 20: 214-219. 

161. Bagshawe KD, Dent J, Webb J (1986). 

Hydatidiform mole in England and Wales 

1973-83. Lancet 2: 673-677. 

162. Bagshawe KD, Rawlins G, Pike MC, 

Lawler SD (1971). ABO blood-groups in trophoblastic 

neoplasia. Lancet 1: 553-556. 

163. Bague S, Rodriguez IM, Prat J (2002). 

Sarcoma-like mural nodules in mucinous 

cystic tumors of the ovary revisited: a clinicopathologic 

analysis of 10 additional 

cases. Am J Surg Pathol 26: 1467-1476. 

164. Bailey MJ, Royce C, Sloane JP, Ford 

HT, Powles TJ, Gazet JC (1980). Bilateral 

carcinoma of the breast. Br J Surg 67: 514- 

516. 

165. Baker BA, Frickey L, Yu IT, Hawkins 

EP, Cushing B, Perlman EJ (1998). DNA 

content of ovarian immature teratomas 

and malignant germ cell tumors. Gynecol 

Oncol 71: 14-18. 

1 6 6 . Baker PM, Oliva E, Young RH, 

Talerman A, Scully RE (2001). Ovarian 

mucinous carcinoids including some with 

a carcinomatous component: a report of 17 


167. Baker RJ, Hildebrandt RH, Rouse RV, 

Hendrickson MR, Longacre TA (1999). 

Inhibin and CD99 (MIC2) expression in 

uterine stromal neoplasms with sex-cordlike 

elements. Hum Pathol 30: 671-679. 

168. Bakri Y, Berkowitz RS, Goldstein DP, 

Subhi J, Senoussi M, von Sinner W, 

Jabbar FA (1994). Brain metastases of gestational 

trophoblastic tumor. J Reprod 

Med 39: 179-184. 

1 6 9 . Balasa RW, Adcock LL, Prem KA, 

Dehner LP (1977). The Brenner tumor: a 

clinicopathologic review. Obstet Gynecol 

50: 120-128. 

170. Balat O, Balat A, Verschraegen C, 

Tornos C, Edwards CL (1996). Sarcoma 

botryoides of the uterine endocervix: longterm 

results of conservative surgery. Eur J 


1 7 1 . Ball HG, Berman ML (1982). 

Management of primary vaginal carcinoma. 


172. Ballance WA, Ro JY, el Naggar AK, 

Grignon DJ, Ayala AG, Romsdahl MG 

(1990). Pleomorphic adenoma (benign 

mixed tumor) of the breast. An immunohistochemical, 

flow cytometric, and ultrastructural 

study and review of the literature. 

Am J Clin Pathol 93: 795-801. 

173. Ballerini P, Recchione C, Cavalleri A, 

Moneta R, Saccozzi R, Secreto G (1990). 

Hormones in male breast cancer. Tumori 

76: 26-28. 

174. Balzi D, Buiatti E, Geddes M, Khlat M, 

Masuyer E, Parkin DM (1993). Summary of 

the results by site. In: Cancer in Italian 

Migrant Populations, IARC Scientific 

Publication No 123, International Agency 

for Research on Cancer: Lyon, pp. 193-292. 

175. Bandera CA, Muto MG, Schorge JO, 

Berkowitz RS, Rubin SC, Mok SC (1998). 

BRCA1 gene mutations in women with 

papillary serous carcinoma of the peritoneum. 

Obstet Gynecol 92: 596-600. 

176. Bandera CA, Muto MG, Welch WR, 

Berkowitz RS, Mok SC (1998). Genetic 

imbalance on chromosome 17 in papillary 

serous carcinoma of the peritoneum. 

Oncogene 16: 3455-3459. 

177. Banik S, Bishop PW, Ormerod LP, 

O'Brien TE (1986). Sarcoidosis of the 

breast. J Clin Pathol 39: 446-448. 

178. Bannatyne P, Russell P (1981). Early 

adenocarcinoma of the fallopian tubes. A 

case for multifocal tumorigenesis. Diagn 

Gynecol Obstet 3: 49-60. 

179. Bapat B, Xia L, Madlensky L, Mitri A, 

Tonin P, Narod SA, Gallinger S (1996). The 

genetic basis of Muir-Torre syndrome 

includes the hMLH1 locus. Am J Hum 

Genet 59: 736-739.

180. Bapat K, Brustein S (1989). Uterine 

sarcoma with liposarcomatous differentiation: 

report of a case and review of the literature. 

Int J Gynaecol Obstet 28: 71-75. 

1 8 1 . Barlund M, Monni O, Kononen J, 

Cornelison R, Torhorst J, Sauter G, 

Kallioniemi OLLI, Kallioniemi A (2000). 

Multiple genes at 17q23 undergo amplification 

and overexpression in breast cancer. 

Cancer Res 60: 5340-5344. 

182. Baron JA (1984). Smoking and estrogen-related 

disease. Am J Epidemiol 119: 

9-22. 

183. Barrett TL, Smith KJ, Hodge JJ, Butler 

R, Hall FW, Skelton HG (1997). Immunohistochemical 

nuclear staining for p53, PCNA, 

and Ki-67 in different histologic variants of 

basal cell carcinoma. J Am Acad Dermatol 

37: 430-437. 

184. Barry TS, Schnitt SJ, Ellis I, Eusebi V, 

Gown AM (1999). Absence of myoepithelium 

in microglandular adenosis of the 

breast confirmed with new myoepithelial 

markers. Lab Invest 79: 16A. 

1 8 5 . Barter JF, Smith EB, Szpak CA, 

Hinshaw W, Clarke-Pearson DL, Creasman 

WT (1985). Leiomyosarcoma of the uterus: 

clinicopathologic study of 21 cases. 


186. Barth RJ Jr. (1999). Histologic features 

predict local recurrence after breast conserving 

therapy of phyllodes tumors. 

Breast Cancer Res Treat 57: 291-295. 

186a. Barth A, Craig PH, Silverstein MJ 

(1997). Predictors of axillary lymph node 

metastases in patients with T1 breast carcinoma. 

Cancer 79: 1918-1922. 

187. Bartnik J, Powell WS, Moriber-Katz S, 

Amenta PS (1989). Metaplastic papillary 

tumor of the fallopian tube. Case report, 

immunohistochemical features, and 

review of the literature. Arch Pathol Lab 

Med 113: 545-547. 

1 8 8 . Barwick KW, LiVolsi VA (1979). 

Heterologous mixed mullerian tumor confined 

to an endometrial polyp. O b s t e t 

Gynecol 53: 512-514. 

189. Barzilai A, Rotman G, Shiloh Y (2002). 

ATM deficiency and oxidative stress: a 

new dimension of defective response to 

DNA damage. DNA Repair (Amst) 1: 3-25. 

190. Baschinsky DY, Niemann TH, Eaton 

LA, Frankel WL (1999). Malignant mixed 

Mullerian tumor with rhabdoid features: a 

report of two cases and a review of the literature. 


1 9 1 . Bassler R, Katzer B (1992). 

Histopathology of myoepithelial (basocellular) 

hyperplasias in adenosis and epitheliosis 

of the breast demonstrated by the 

reactivity of cytokeratins and S100 protein. 

An analysis of heterogenic cell proliferations 

in 90 cases of benign and malignant 

breast diseases. Virchows Arch A Pathol 

Anat Histopathol 421: 435-442. 

192. Bauer RD, McCoy CP, Roberts DK, Fritz 

G (1984). Malignant melanoma metastatic 

to the endometrium. Obstet Gynecol 63: 

264-268. 

193. Bayo S, Bosch FX, de Sanjose S, 

Munoz N, Combita AL, Coursaget P, Diaz 

M, Dolo A, van den Brule AJ, Meijer CJ 

(2002). Risk factors of invasive cervical 

cancer in Mali. Int J Epidemiol 31: 202-209. 

194. Bebb DG, Yu Z, Chen J, Telatar M, 

Gelmon K, Phillips N, Gatti RA, Glickman 

BW (1999). Absence of mutations in the 

ATM gene in forty-seven cases of sporadic 

breast cancer. Br J Cancer 80: 1979-1981. 

195. Becker JL, Papenhausen PR, Widen 

RH (1997). Cytogenetic, morphologic and 

oncogene analysis of a cell line derived 

from a heterologous mixed mullerian tumor 

of the ovary. In Vitro Cell Dev Biol Anim 33: 

325-331. 

1 9 6 . Beckmann MW, Niederacher D, 

Schnurch HG, Gusterson BA, Bender HG 

(1997). Multistep carcinogenesis of breast 

cancer and tumour heterogeneity. J Mol 

Med 75: 429-439. 197. Beerman H, Smit VT, 

Kluin PM, Bonsing BA, Hermans J, 

Cornelisse CJ (1991). Flow cytometric 

analysis of DNA stemline heterogeneity in 

primary and metastatic breast cancer. 

Cytometry 12: 147-154. 

198. Begin LR, Clement PB, Kirk ME, Jothy 

S, McCaughey WT, Ferenczy A (1985). 

Aggressive angiomyxoma of pelvic soft 

parts: a clinicopathologic study of nine 

cases. Hum Pathol 16: 621-628. 

1 9 9 . Beilby JO, Parkinson C (1975). 

Features of prognostic significance in solid 

ovarian teratoma. Cancer 36: 2147-2154. 

200. Bell DA (1991). Mucinous adenofibromas 

of the ovary. A report of 10 cases. Am 


201. Bell DA, Scully RE (1985). Atypical and 

borderline endometrioid adenofibromas of 

the ovary. A report of 27 cases. Am J Surg 

Pathol 9: 205-214. 

202. Bell DA, Scully RE (1985). Benign and 

borderline clear cell adenofibromas of the 

ovary. Cancer 56: 2922-2931. 

203. Bell DA, Scully RE (1990). Ovarian 

serous borderline tumors with stromal 

microinvasion: a report of 21 cases. Hum 

Pathol 21: 397-403. 

204. Bell DA, Scully RE (1990). Serous borderline 

tumors of the peritoneum. Am J 

Surg Pathol 14: 230-239. 

205. Bell DA, Scully RE (1994). Early de 

novo ovarian carcinoma. A study of fourteen 

cases. Cancer 73: 1859-1864. 

206. Bell DA, Shimm DS, Gang DL (1985). 

Wilms' tumor of the endocervix. A r c h 

Pathol Lab Med 109: 371-373. 

207. Bell DA, Weinstock MA, Scully RE 

(1988). Peritoneal implants of ovarian 

serous borderline tumors. Histologic features 

and prognosis. Cancer 62: 2212-2222. 

2 0 8 . Bell DA, Woodruff JM, Scully RE 

(1984). Ependymoma of the broad ligament. 

A report of two cases. Am J Surg Pathol 8: 

203-209. 

209. Bell DW, Varley JM, Szydlo TE, Kang 

DH, Wahrer DC, Shannon KE, Lubratovich 

M, Verselis SJ, Isselbacher KJ, Fraumeni 

JF, Birch JM, Li FP, Garber JE, Haber DA 

(1999). Heterozygous germ line hCHK2 

mutations in Li-Fraumeni syndrome. 

Science 286: 2528-2531. 

210. Bell KA, Smith Sehdev AE, Kurman RJ 

(2001). Refined diagnostic criteria for 

implants associated with ovarian atypical 

proliferative serous tumors (borderline) 

and micropapillary serous carcinomas. 


211. Bell SW, Kempson RL, Hendrickson 

MR (1994). Problematic uterine smooth 

muscle neoplasms. A clinicopathologic 

study of 213 cases. Am J Surg Pathol 18: 

535-558. 

212. Ben David M, Dekel A, Gal R, Dicker D, 

Feldberg D, Goldman JA (1988). Prolapsed 

cervical leiomyosarcoma. Obstet Gynecol 

Surv 43: 642-644. 

2 1 3 . Ben David Y, Chetrit A, Hirsh- 

Yechezkel G, Friedman E, Beck BD, Beller 

U, Ben Baruch G, Fishman A, Levavi H, 

Lubin F, Menczer J, Piura B, Struewing JP, 

Modan B (2002). Effect of BRCA mutations 

on the length of survival in epithelial ovari - 

an tumors. J Clin Oncol 20: 463-466. 

2 1 4 . Ben Ezra J, Sheibani K (1987). 

Antigenic phenotype of the lymphocytic 

component of medullary carcinoma of the 

breast. Cancer 59: 2037-2041. 

2 1 5 . Benatar B, Wright C, Freinkel AL, 

Cooper K (1998). Primary extrarenal Wilms' 

tumor of the uterus presenting as a cervical 

polyp. Int J Gynecol Pathol 17: 277-280. 

2 1 6 . Benda JA, Platz CE, Anderson B 

(1986). Malignant melanoma of the vulva: a 

clinical-pathologic review of 16 cases. Int 

J Gynecol Pathol 5: 202-216. 

217. Benedet JL, Bender H, Jones H III, 

Ngan HY, Pecorelli S (2000). FIGO staging 

classifications and clinical practice guidelines 

in the management of gynecologic 

cancers. FIGO Committee on Gynecologic 

Oncology. Int J Gynaecol Obstet 70: 209- 

262. 

218. Benedet JL, Ehlen TG (2001). Vulvar 

Cancer In: Prognostic Factors in Cancer. 

MK Gospodarowicz, DE Henson, RV Hutter, 

B O'Sullivan, LH Oblin, CH Wittekink (Eds.) 

2nd ed. Willey- Liss: New York, pp. 489-500. 

2 1 9 . Benedet JL, Miller DM, Ehlen TG, 

Bertrand MA (1997). Basal cell carcinoma 

of the vulva: clinical features and treatment 

results in 28 patients. Obstet Gynecol 

90: 765-768. 

220. Benedet JL, Murphy KJ, Fairey RN, 

Boyes DA (1983). Primary invasive carcinoma 

of the vagina. Obstet Gynecol 62: 715- 

719. 

2 2 1 . Benedetti-Panici P, Maneschi F, 

D'Andrea G, Cutillo G, Rabitti C, Congiu M, 

Coronetta F, Capelli A (2000). Early cervical 

carcinoma: the natural history of lymph 

node involvement redefined on the basis of 

thorough parametrectomy and giant section 

study. Cancer 88: 2267-2274. 

2 2 2 . Bennett HGJ, Ehrlich MM (1941). 

Myoma of the vagina. Am J Obstet 

Gynecol 42: 314-320. 

223. Bentz JS, Yassa N, Clayton F (1998). 

Pleomorphic lobular carcinoma of the 

breast: clinicopathologic features of 12 

cases. Mod Pathol 11: 814-822. 

224. Beral V (2002). Breast cancer and 

breastfeeding: collaborative reanalysis of 

individual data from 47 epidemiological 

studies in 30 countries, including 50302 

women with breast cancer and 96973 

women without the disease. Lancet 360: 

187-195. 

225. Beral V, Banks E, Reeves G, Appleby P 

(1999). Use of HRT and the subsequent risk 

of cancer. J Epidemiol Biostat 4: 191-210. 

226. Beral V, Hermon C, Munoz N, Devesa 

SS (1994). Cervical cancer. Cancer surv 19- 

20: 265-285. 

227. Beral V, Reeves G (1993). Childbearing, 

oral contraceptive use, and breast cancer. 

Lancet 341: 1102. 

228. Berchuck A, Boyd J (1995). Molecular 

basis of endometrial cancer. Cancer 76: 

2034-2040. 

229. Berchuck A, Heron KA, Carney ME, 

Lancaster JM, Fraser EG, Vinson VL, 

Deffenbaugh AM, Miron A, Marks JR, 

Futreal PA, Frank TS (1998). Frequency of 

germline and somatic BRCA1 mutations in 

ovarian cancer. Clin Cancer Res 4: 2433- 

2437. 

230. Berchuck A, Kohler MF, Marks JR, 

Wiseman R, Boyd J, Bast RC Jr. (1994). The 

p53 tumor suppressor gene frequently is 

altered in gynecologic cancers. Am J 


231. Berchuck A, Rubin SC, Hoskins WJ, 

Saigo PE, Pierce VK, Lewis JL Jr. (1988). 

Treatment of uterine leiomyosarcoma. 


232. Berchuck A, Rubin SC, Hoskins WJ, 

Saigo PE, Pierce VK, Lewis JL Jr. (1990). 

Treatment of endometrial stromal tumors. 


233. Berean K, Tron VA, Churg A, Clement 

PB (1986). Mammary fibroadenoma with 

multinucleated stromal giant cells. Am J 


234. Berek J, Adashi PA, Hillart PA (1996). 

Novak's Gynaecology. XII ed. Williams & 

Wilkins: Baltimore, Maryland. 

235. Berends MJ, Hollema H, Wu Y, Van 

der Sluis T, Mensink RG, ten Hoor KA, 

Sijmons RH, de Vries EG, Pras E, Mourits 

MJ, Hofstra RM, Buys CH, Kleibeuker JH, 

Der Zee AG (2001). MLH1 and MSH2 protein 

expression as a pre-screening marker 

in hereditary and non-hereditary endometrial 

hyperplasia and cancer. Int J Cancer 

92: 398-403. 

236. Berends MJ, Wu Y, Sijmons RH, 

Mensink RG, Van Der Sluis T, Hordijk-Hos 

JM, de Vries EG, Hollema H, Karrenbeld A, 

Buys CH, van der Zee AG, Hofstra RM, 

Kleibeuker JH (2002). Molecular and clinical 

characteristics of MSH6 variants: an 

analysis of 25 index carriers of a germline 

variant. Am J Hum Genet 70: 26-37. 

237. Berezowski K, Stastny JF, Kornstein 

MJ (1996). Cytokeratins 7 and 20 and carcinoembryonic 

antigen in ovarian and 

colonic carcinoma. Mod Pathol 9: 426-429. 

238. Bergeron C, Ferenczy A, Richart RM, 

Guralnick M (1990). Micropapillomatosis 

labialis appears unrelated to human papillomavirus. 


239. Bergeron C, Ferenczy A, Shah KV, 

Naghashfar Z (1987). Multicentric human 

papillomavirus infections of the female 

genital tract: correlation of viral types with 

abnormal mitotic figures, colposcopic 

presentation, and location. Obstet Gynecol 

69: 736-742. 

240. Bergeron C, Nogales FF, Masseroli M, 

Abeler V, Duvillard P, Muller-Holzner E, 

Pickartz H, Wells M (1999). A multicentric 

European study testing the reproducibility 

of the WHO classification of endometrial 

hyperplasia with a proposal of a simplified 

working classification for biopsy and 

curettage specimens. Am J Surg Pathol 23: 

1102-1108. 

241. Bergh J, Norberg T, Sjogren S, 

Lindgren A, Holmberg L (1995). Complete 

sequencing of the p53 gene provides prognostic 

information in breast cancer 

patients, particularly in relation to adjuvant 

systemic therapy and radiotherapy. Nat 

Med 1: 1029-1034. 

241a. Bergstrom A, Pisani P, Tenet V, Wolk 

A, Adami HO (2001). Overweight as an 

avoidable cause of cancer in Europe. Int J 

Cancer 91: 421-430. 

242. Berkey CS, Frazier AL, Gardner JD, 

Colditz GA (1999). Adolescence and breast 

carcinoma risk. Cancer 85: 2400-2409. 

243. Berkowitz RS, Bernstein MR, Laborde 

O, Goldstein DP (1994). Subsequent pregnancy 

experience in patients with gestational 

trophoblastic disease. New England 

Trophoblastic Disease Center, 1965-1992. 

J Reprod Med 39: 228-232. 


244. Berkowitz RS, Cramer DW, Bernstein 

MR, Cassells S, Driscoll SG, Goldstein DP 

(1985). Risk factors for complete molar 

pregnancy from a case-control study. Am 

J Obstet Gynecol 152: 1016-1020. 

245. Berkowitz RS, Ehrmann RL, Knapp RC 

(1978). Endometrial stromal sarcoma arising 

from vaginal endometriosis. O b s t e t 

Gynecol 51: 34s-37s. 

246. Berliant II (1970). [Neurofibroma of the 

broad ligament of the uterus]. A k u s h 

Ginekol (Mosk) 46: 70-71. 

247. Berman ML, Soper JT, Creasman WT, 

Olt GT, Disaia PJ (1989). Conservative surgical 

management of superficially invasive 

stage I vulvar carcinoma. Gynecol Oncol 

35: 352-357. 

248. Bermudez A, Vighi S, Garcia A, Sardi J 

(2001). Neuroendocrine cervical carcinoma: 

a diagnostic and therapeutic challenge. 


249. Berns EM, Foekens JA, Vossen R, 

Look MP, Devilee P, Henzen-Logmans SC, 

van Staveren IL, van Putten WL, Inganas 

M, Meijer-van Gelder ME, Cornelisse C, 

Claassen CJ, Portengen H, Bakker B, Klijn 

JG (2000). Complete sequencing of TP53 

predicts poor response to systemic therapy 

of advanced breast cancer. Cancer Res 

60: 2155-2162. 

250. Berns EM, Klijn JG, van Putten WL, 

van Staveren IL, Portengen H, Foekens JA 

(1992). c-myc amplification is a better 

prognostic factor than HER2/neu amplification 

in primary breast cancer. Cancer 

Res 52: 1107-1113. 

251. Berns EM, van Staveren IL, Look MP, 

Smid M, Klijn JG, Foekens JA (1998). 

Mutations in residues of TP53 that directly 

contact DNA predict poor outcome in 

human primary breast cancer. Br J Cancer 

77: 1130-1136. 

252. Bernstein JL, Thompson WD, Risch N, 

Holford TR (1992). Risk factors predicting 

the incidence of second primary breast 

cancer among women diagnosed with a 

first primary breast cancer. Am J 

Epidemiol 136: 925-936. 

253. Bernstein JL, Thompson WD, Risch N, 

Holford TR (1992). The genetic epidemiolo - 

gy of second primary breast cancer. Am J 

Epidemiol 136: 937-948. 

254. Bernstein L, Deapen D, Ross RK (1993). 

The descriptive epidemiology of malignant 

cystosarcoma phyllodes tumors of the 


255. Bernstein L, Ross RK (1993). 

Endogenous hormones and breast cancer 

risk. Epidemiol Rev 15: 48-65. 

256. Berrino F, Capocaccia R, Esteve J, 

Gatta G, Hakulinen T, Micheli A, Sant M, 

Verdecchia A (1999). Survival of Cancer 

patients in Europe: The EUROCARE-2 

Study. IARC Scientific Publication No 151. 

International Agency for Research on 

Cancer: Lyon. 

257. Bertucci F, Nasser V, Granjeaud S, 

Eisinger F, Adelaide J, Tagett R, Loriod B, 

Giaconia A, Benziane A, Devilard E, 

Jacquemier J, Viens P, Nguyen C, 

Birnbaum D, Houlgatte R (2002). Gene 

expression profiles of poor-prognosis primary 

breast cancer correlate with survival. 

Hum Mol Genet 11: 863-872. 

258. Bertwistle D, Swift S, Marston NJ, 

Jackson LE, Crossland S, Crompton MR, 

Marshall CJ, Ashworth A (1997). Nuclear 

location and cell cycle regulation of the 

BRCA2 protein. Cancer Res 57: 5485-5488. 

259. Berx G, Becker KF, Hofler H, van Roy F 

(1998). Mutations of the human E-cadherin 

(CDH1) gene. Hum Mutat 12: 226-237. 


260. Berx G, Cleton-Jansen AM, Nollet F, 

de Leeuw WJ, van de Vijvert M, Cornelisse 

C, van Roy F (1995). E-cadherin is a 

tumour/invasion suppressor gene mutated 

in human lobular breast cancers. EMBO J 

14: 6107-6115. 

261. Berx G, Cleton-Jansen AM, Strumane 

K, de Leeuw WJ, Nollet F, van Roy F, 

Cornelisse C (1996). E-cadherin is inactivated 

in a majority of invasive human lobular 

breast cancers by truncation mutations 

throughout its extracellular domain. 

Oncogene 13: 1919-1925. 

262. Bethwaite PB, Holloway LJ, Yeong 

ML, Thornton A (1993). Effect of tumour 

associated tissue eosinophilia on survival 

of women with stage IB carcinoma of the 

uterine cervix. J Clin Pathol 46: 1016-1020. 

263. Bethwaite PB, Koreth J, Herrington 

CS, McGee JO (1995). Loss of heterozygosity 

occurs at the D11S29 locus on chromosome 

11q23 in invasive cervical carcinoma. 

Br J Cancer 71: 814-818. 

264. Biankin SA, O’Toole VE, Fung C, 

Russell P (2000). Bizarre leimyoma of the 

vagina: Report of a case. Int J Gynecol 

Pathol 19: 186-187. 

265. Bieche I, Lidereau R (1995). Genetic 

alterations in breast cancer. G e n e s 

Chromosomes Cancer 14: 227-251. 

266. Bieche I, Lidereau R (1999). Increased 

level of exon 12 alternatively spliced 

BRCA2 transcripts in tumor breast tissue 

compared with normal tissue. Cancer Res 

59: 2546-2550. 

267. Bieche I, Nogues C, Lidereau R (1999). 

Overexpression of BRCA2 gene in sporadic 

breast tumours. Oncogene 18: 5232-5238. 

268. Bienenstock J, Befus AD (1980). 

Mucosal immunology. Immunology 41: 249- 

270. 

269. Biernat W, Jablkowski W (2000). 

Syringomatous adenoma of the nipple. Pol 

J Pathol 51: 201-202. 

270. Bijker N, Peterse JL, Duchateau L, 

Robanus-Maandag EC, Bosch CA, Duval C, 

Pilotti S, Van de Vijver MJ (2001). 

Histological type and marker expression of 

the primary tumour compared with its local 

recurrence after breast-conserving therapy 

for ductal carcinoma in situ. Br J 

Cancer 84: 539-544. 

271. Bijker N, Rutgers EJ, Peterse JL, 

Fentiman IS, Julien JP, Duchateau L, van 

Dongen JA (2001). Variations in diagnostic 

and therapeutic procedures in a multicentre, 

randomized clinical trial (EORTC 10853) 

investigating breast-conserving treatment 

for DCIS. Eur J Surg Oncol 27: 135-140. 

272. Bingham C, Roberts D, Hamilton TC 

(2001). The role of molecular biology in 

understanding ovarian cancer initiation 

and progression. Int J Gynecol Cancer 11 

Suppl 1: 7-11. 

273. Birch JM, Hartley AL, Blair V, Kelsey 

AM, Harris M, Teare MD, Jones PH (1990). 

Cancer in the families of children with soft 

tissue sarcoma. Cancer 66: 2239-2248. 

274. Birkeland SA, Storm HH, Lamm LU, 

Barlow L, Blohme I, Forsberg B, Eklund B, 

Fjeldborg O, Friedberg M, Frodin L, Glattre 

E, Halvorsen S, Holm NV, Jakobsen A, 

Jorgensen HE, Ladefoged J, Lindholm T, 

Lundgren G, Pukkala E. (1995). Cancer risk 

after renal transplantation in the Nordic 

countries, 1964-1986. Int J Cancer 60: 183- 

189. 

275. Bisceglia M, Attino V, D'Addetta C, 

Murgo R, Fletcher CD (1996). [Early stage 

Stewart-Treves syndrome: report of 2 

cases and review of the literature]. 

Pathologica 88: 483-490. 

276. Bisceglia M, Fusilli S, Zaffarano L, 

Fiorentino F, Tardio B (1995). [Inflammatory 

pseudotumor of the breast. Report of a 

case and review of the literature]. 


277. Biscotti CV, Hart WR (1989). Juvenile 

granulosa cell tumors of the ovary. Arch 


278. Biscotti CV, Hart WR (1992). Peritoneal 

serous micropapillomatosis of low malignant 

potential (serous borderline tumors of 

the peritoneum). A clinicopathologic study 

of 17 cases. Am J Surg Pathol 16: 467-475. 

279. Biscotti CV, Hart WR (1998). Apoptotic 

bodies: a consistent morphologic feature 

of endocervical adenocarcinoma in situ. 


2 8 0 . Bishara M, Scapa E (1997). [Stromal 

uterine sarcoma arising from intestinal 

endometriosis after abdominal hysterectomy 

and salpingo-oophorectomy]. H a r e f u a h 

133: 353-355. 

281. Bishop DT, Hopper J (1997). AT-tributable 

risks? Nat Genet 15: 226. 

2 8 2 . Bitterman P, Chun B, Kurman RJ 

(1990). The significance of epithelial differentiation 

in mixed mesodermal tumors of 

the uterus. A clinicopathologic and 

immunohistochemical study. Am J Surg 

Pathol 14: 317-328. 

283. Bjorkholm E, Silfversward C (1980). 

Theca-cell tumors. Clinical features and 

prognosis. Acta Radiol Oncol 19: 241-244. 

284. Bjorkholm E, Silfversward C (1981). 

Prognostic factors in granulosa-cell 

tumors. Gynecol Oncol 11: 261-274. 

285. Black CL, Morris DM, Goldman LI, 

McDonald JC (1983). The significance of 

lymph node involvement in patients with 

medullary carcinoma of the breast. Surg 


286. Black MM, Barclay TH, Hankey BF 

(1975). Prognosis in breast cancer utilizing 

histologic characteristics of the primary 

tumor. Cancer 36: 2048-2055. 

287. Blaker H, Graf M, Rieker RJ, Otto HF 

(1999). Comparison of losses of heterozygosity 

and replication errors in primary 

colorectal carcinomas and corresponding 

liver metastases. J Pathol 188: 258-262. 

288. Blamey RW (1998). Clinical aspects of 

malignant breast lesions In: Systemic 

Pathology, CW Elston, IO Ellis (Eds.). 3rd 

ed. Churchill Livingstone: Edinburgh, pp. 

501-513. 

289. Bloch T, Roth LM, Stehman FB, Hull 

MT, Schwenk GR Jr. (1988). Osteosarcoma 

of the uterine cervix associated with 

hyperplastic and atypical mesonephric 

rests. Cancer 62: 1594-1600. 

290. Block E (1947). Squamous cell carcinoma 

of the fallopian tube. Acta Radiol 28: 

49-68. 

291. Blom R, Guerrieri C, Stal O, Malmstrom 

H, Simonsen E (1998). Leiomyosarcoma of 

the uterus: A clinicopathologic, DNA flow 

cytometric, p53, and mdm-2 analysis of 49 


292. Blom R, Malmstrom H, Guerrieri C 

(1999). Endometrial stromal sarcoma of the 

uterus: a clinicopathologic, DNA flow cytometric, 

p53, and mdm-2 analysis of 17 

cases. Int J Gynecol Cancer 9: 98-104. 

293. Bloom HJ, Richardson WW (1957). 

Histological grading and prognosis in 

breast cancer. Br J Cancer 11: 359-377. 

294. Bloom HJ, Richardson WW, Field JR 

(1970). Host resistance and survival in car - 

cinoma of breast: a study of 104 cases of 

medullary carcinoma in a series of 1,411 

cases of breast cancer followed for 20 

years. Br Med J 3: 181-188. 

295. Boardman CH, Webb MJ, Jefferies JA 

(2000). Low-grade endometrial stromal sarcoma 

of the ectocervix after therapy for 

breast cancer. Gynecol Oncol 79: 120-123. 

296. Bobrow LG, Richards MA, Happerfield 

LC, Diss TC, Isaacson PG, Lammie GA, 

Millis RR (1993). Breast lymphomas: a clin - 

icopathologic review. Hum Pathol 24: 274- 

278. 

297. Bochar DA, Wang L, Beniya H, Kinev 

A, Xue Y, Lane WS, Wang W, Kashanchi F, 

Shiekhattar R (2000). BRCA1 is associated 

with a human SWI/SNF-related complex: 

linking chromatin remodeling to breast 

cancer. Cell 102: 257-265. 

298. Bodian CA, Perzin KH, Lattes R (1996). 

Lobular neoplasia. Long term risk of breast 

cancer and relation to other factors. 

Cancer 78: 1024-1034. 

2 9 9 . Bodian CA, Perzin KH, Lattes R, 

Hoffmann P, Abernathy TG (1993). 

Prognostic significance of benign proliferative 

breast disease. Cancer 71: 3896-3907. 

300. Bodner K, Bodner-Adler B, Obermair 

A, Windbichler G, Petru E, Mayerhofer S, 

Czerwenka K, Leodolter S, Kainz C, 

Mayerhofer K (2001). Prognostic parameters 

in endometrial stromal sarcoma: a 

clinicopathologic study in 31 patients. 


301. Boecker W, Buerger H, Schmitz K, Ellis 

IA, van Diest PJ, Sinn H-P, Geradts J, 

Diallo R, Poremba C, Herbst H (2001). 

Ductal epithelial proliferations of the 

breast: a biological continuum? Comparative 

genomic hybridization an highmolecular-weight 

cytokeratin expression 

patterns. J Pathol 195: 415-421. 

302. Bohm J, Roder-Weber M, Hofler H, 

Kolben M (1991). Bilateral stromal Leydig 

cell tumour of the ovary. Case report and 

literature review. Pathol Res Pract 187: 

348-352. 

303. Boice JD Jr., Engholm G, Kleinerman 

RA, Blettner M, Stovall M, Lisco H, 

Moloney WC, Austin DF, Bosch A, Cookfair 

DL, Krementz ET, Latourettte HB, Merrill 

JA, Peters LJ, Schultz MD, Strom HH, 

Bjorkholm E, Pettersson F, Bell CMJ, 

Coleman MP, Fraser P, Neal FE, Prior P, 

Choi NW, Hislop TG, Koch M, Kreiger N, 

Robb D, Robson D, Thomson DH, 

Lochmuller H, Vonfournier D, Frischkorn R, 

Kjorstad KE, Rimpela A, Pejovic MH, Kirn 

VP, Stankusova H, Berrino F, Sigurdsson K, 

Hutchinson GB, Macmahon B (1988). 

Radiation dose and second cancer risk in 

patients treated for cancer of the cervix. 

Radiat Res 116: 3-55. 

304. Boice JD Jr., Preston D, Davis FG, 

Monson RR (1991). Frequent chest X-ray 

fluoroscopy and breast cancer incidence 

among tuberculosis patients in 

Massachusetts. Radiat Res 125: 214-222. 

305. Boks D.E., Trujillo A.P., Voogd AC, 

Morreau H, Kenter GG, Vasen HF (2002). 

Survival analysis of endometrial carcinoma 

asociated with hereditary nonpolyposis 

colorectal cancer. Int J Cancer 102: 198- 

200. 

306. Boland CR, Thibodeau SN, Hamilton 

SR, Sidransky D, Eshleman JR, Burt RW, 

Meltzer SJ, Rodriguez-Bigas MA, Fodde R, 

Ranzani GN, Srivastava S (1998). A 

National Cancer Institute Workshop on 

Microsatellite Instability for cancer detection 

and familial predisposition: development 

of international criteria for the deter - 

mination of microsatellite instability in 

colorectal cancer. Cancer Res 58: 5248- 

5257.

307. Bolis GB, Maccio T (2000). Clear cell 

adenocarcinoma of the vulva arising in 

endometriosis. A case report. Eur J 


3 0 8 . Bonfiglio TA, Patten SF Jr., 

Woodworth FE (1976). Fibroxanthosarcoma 

of the uterine cervix: cytopathologic and 

histopathologic manifestations. Acta Cytol 

20: 501-504. 

309. Bonneau D, Longy M (2000). Mutations 

of the human PTEN gene. Hum Mutat 16: 

109-122. 

3 1 0 . Bonnet M, Guinebretiere JM, 

Kremmer E, Grunewald V, Benhamou E, 

Contesso G, Joab I (1999). Detection of 

Epstein-Barr virus in invasive breast cancers. 

J Natl Cancer Inst 91: 1376-1381. 

311. Bonnier P, Romain S, Dilhuydy JM, 

Bonichon F, Julien JP, Charpin C, Lejeune 

C, Martin PM, Piana L (1997). Influence of 

pregnancy on the outcome of breast cancer: 

a case-control study. Societe 

Francaise de Senologie et de Pathologie 

Mammaire Study Group. Int J Cancer 72: 

720-727. 

312. Bonnier P, Romain S, Giacalone PL, 

Laffargue F, Martin PM, Piana L (1995). 

Clinical and biologic prognostic factors in 

breast cancer diagnosed during postmenopausal 

hormone replacement therapy. 


313. Bonsing BA, Corver WE, Fleuren GJ, 

Cleton-Jansen AM, Devilee P, Cornelisse 

CJ (2000). Allelotype analysis of flow-sorted 

breast cancer cells demonstrates 

genetically related diploid and aneuploid 

subpopulations in primary tumors and 

lymph node metastases. Genes Chromosomes 

Cancer 28: 173-183. 

3 1 4 . Borazjani G, Prem KA, Okagaki T, 

Twiggs LB, Adcock LL (1990). Primary 

malignant melanoma of the vagina: a clinicopathological 

analysis of 10 cases. 


315. Borgen PI, Senie RT, McKinnon WM, 

Rosen PP (1997). Carcinoma of the male 

breast: analysis of prognosis compared 

with matched female patients. Ann Surg 

Oncol 4: 385-388. 

3 1 6 . Bork P, Hofmann K, Bucher P, 

Neuwald AF, Altschul SF, Koonin EV (1997). 

A superfamily of conserved domains in 

DNA damage-responsive cell cycle checkpoint 

proteins. FASEB J 11: 68-76. 

317. Borresen AL, Andersen TI, Eyfjord JE, 

Cornelis RS, Thorlacius S, Borg A, 

Johansson U, Theillet C, Scherneck S, 

Hartman S, Cornelisse CJ, Hovig E, Devilee 

P (1995). TP53 mutations and breast cancer 

prognosis: particularly poor survival rates 

for cases with mutations in the zinc-binding 

domains. Genes Chromosomes Cancer 

14: 71-75. 

318. Borresen AL, Andersen TI, Tretli S, 

Heiberg A, Moller P (1990). Breast cancer 

and other cancers in Norwegian families 

with ataxia-telangiectasia. Genes Chromosomes 

Cancer 2: 339-340. 

319. Borst MJ, Ingold JA (1993). Metastatic 

patterns of invasive lobular versus invasive 

ductal carcinoma of the breast. 

Surgery 114: 637-641. 

320. Bosch FX, Lorincz A, Munoz N, Meijer 

CJ, Shah KV (2002). The causal relation 

between human papillomavirus and cervical 

cancer. J Clin Pathol 55: 244-265. 

321. Bose S, Derosa CM, Ozzello L (1999). 

Immunostaining of type IV collagen and 

smooth muscle actin as an aid in the diagnosis 

of breast lesions. Breast J 5: 194-201. 

322. Bostwick DG, Tazelaar HD, Ballon SC, 

Hendrickson MR, Kempson RL (1986). 

Ovarian epithelial tumors of borderline 

malignancy. A clinical and pathologic 


3 2 3 . Botta G, Fessia L, Ghiringhello B 

(1982). Juvenile milk protein secreting carcinoma. 

Virchows Arch A Pathol Anat 

Histol 395: 145-152. 

3 2 4 . Bottles K, Lacey CG, Goldberg J, 

Lanner-Cusin K, Hom J, Miller TR (1984). 

Merkel cell carcinoma of the vulva. Obstet 

Gynecol 63: 61S-65S. 

325. Boulat J, Mathoulin MP, Vacheret H, 

Andrac L, Habib MC, Pellissier JF, Piana L, 

Charpin C (1994). [Granular cell tumors of 

the breast]. Ann Pathol 14: 93-100. 

326. Boussen H, Kochbati L, Besbes M, 

Dhiab T, Makhlouf R, Jerbi G, Gamoudi A, 

Benna F, Rahal K, Maalej M, Ben Ayed F 

(2000). [Male secondary breast cancer 

after treatment for Hodgkin's disease. 

Case report and review of the literature]. 

Cancer Radiother 4: 465-468. 

327. Bouvet M, Ollila DW, Hunt KK, Babiera 

GV, Spitz FR, Giuliano AE, Strom EA, Ames 

FC, Ross MI, Singletary SE (1997). Role of 

conservation therapy for invasive lobular 

carcinoma of the breast. Ann Surg Oncol 4: 

650-654. 

328. Bower JF, Erickson ER (1967). Bilateral 

ovarian fibromas in a 5-year-old. Am J 


3 2 9 . Boyd J, Sonoda Y, Federici MG, 

Bogomolniy F, Rhei E, Maresco DL, Saigo 

PE, Almadrones LA, Barakat RR, Brown CL, 

Chi DS, Curtin JP, Poynor EA, Hoskins WJ 

(2000). Clinicopathologic features of BRCAlinked 

and sporadic ovarian cancer. JAMA 

283: 2260-2265. 

330. Boyd J, Takahashi H, Waggoner SE, 

Jones LA, Hajek RA, Wharton JT, Liu FS, 

Fujino T, Barrett JC, McLachlan JA (1996). 

Molecular genetic analysis of clear cell 

adenocarcinomas of the vagina and cervix 

associated and unassociated with diethyl - 

stilbestrol exposure in utero. Cancer 77: 

507-513. 

3 3 1 . Boyer CV, Navin JJ (1965). 

Extraskeletal osteogenic sarcoma. A late 

complication of radiation therapy. Cancer 

18: 628-633. 

332. Brainard JA, Hart WR (1998). Adenoid 

basal epitheliomas of the uterine cervix: a 

reevaluation of distinctive cervical basaloid 

lesions currently classified as adenoid 

basal carcinoma and adenoid basal hyperplasia. 


3 3 3 . Brand E, Berek JS, Nieberg RK, 

Hacker NF (1987). Rhabdomyosarcoma of 

the uterine cervix. Sarcoma botryoides. 

Cancer 60: 1552-1560. 

3 3 4 . Brandfass RJ, Everts-Suarez EA 

(1955). Lipomatous tumors of the uterus: a 

review of the world's literature with a case 

report of true lipoma. Am J Obstet Gynecol 

70: 359-367. 

3 3 5 . Branton PA, Tavassoli FA (1993). 

Spindle cell epithelioma, the so-called 

mixed tumor of the vagina. A clinicopatho - 

logic, immunohistochemical, and ultrastructural 

analysis of 28 cases. Am J Surg 

Pathol 17: 509-515. 

336. Bratthauer GL, Lininger RA, Man YG, 

Tavassoli FA (2002). Androgen and estrogen 

receptor mRNA status in apocrine carcinomas. 

Diagn Mol Pathol 11: 113-118. 

337. Bratthauer GL, Moinfar F, Stamatakos 

MD, Mezzetti TP, Shekitka KM, Man Y-G, 

Tavassoli FA (2002). Combined E-cadherin 

and high molecular weight cytokeratin 

immunoprofile differentiates lobular, ductal 

and hybrid mammary intraepithelial 

neoplasia. Hum Pathol 33: 620-627. 

338. Bratthauer GL, Tavassoli FA (2002). 

Lobular neoplasia: previously unexplored 

aspects assessed in 775 cases and their 

clinical implications. Virchows Arch 440: 

134-138. 

339. Braun S, Pantel K, Muller P, Janni W, 

Hepp F, Kentenich CR, Gastroph S, 

Wischnik A, Dimpfl T, Kindermann G, 

Riethmuller G, Schlimok G (2000). 

Cytokeratin-positive cells in the bone mar - 

row and survival of patients with stage I, II, 

or III breast cancer. N Engl J Med 342: 525- 

533. 

3 4 0 . Breen JL, Neubecker RD (1962). 

Tumors of the round ligament. A review of 

the literature and a report of 25 cases. 


341. Brescia RJ, Dubin N, Demopoulos RI 

(1989). Endometrioid and clear cell carcinoma 

of the ovary. Factors affecting survival. 


3 4 2 . Bret AJ, Grepinet J (1967). 

[Endometrial polyps of the intramural portion 

of the Fallopian tube. Their relation to 

sterility and endometriosis]. Sem Hop 43: 

183-192. 

3 4 3 . Brewer JI, Mazur MT (1981). 

Gestational choriocarcinoma. Its origin in 

the placenta during seemingly normal 

pregnancy. Am J Surg Pathol 5: 267-277. 

344. Briest S, Horn LC, Haupt R, Schneider 

JP, Schneider U, Hockel M (1999). 

Metastasizing signet ring cell carcinoma 

of the stomach-mimicking bilateral inflammatory 

breast cancer. Gynecol Oncol 74: 

491-494. 

345. Brinck U, Jakob C, Bau O, Fuzesi L 

(2000). Papillary squamous cell carcinoma 

of the uterine cervix: report of three cases 

and a review of its classification. Int J 


346. Brinkmann U (1998). CAS, the human 

homologue of the yeast chromosome-seg - 

regation gene CSE1, in proliferation, apop - 

tosis, and cancer. Am J Hum Genet 62: 509- 

513. 

346 a. Brinton LA, Hoover R, Fraumeni JF 

Jr. (1982). Interaction of familial and hormonal 

risk factors for breast cancer. J 

Natl Cancer Inst 69: 817-822. 

3 4 7 . Brinton LA, Nasca PC, Mallin K, 

Schairer C, Rosenthal J, Rothenberg R, 

Yordan E Jr., Richart RM (1990). Case-con - 

trol study of in situ and invasive carcinoma 

of the vagina. Gynecol Oncol 38: 49-54. 

348. Brisigotti M, Moreno A, Murcia C, 

Matias-Guiu X, Prat J (1989). Verrucous 

carcinoma of the vulva. A clinicopatholog - 

ic and immunohistochemical study of five 

cases. Int J Gynecol Pathol 8: 1-7. 

349. Brocca PP (1866). Traité des Tumeurs. 

3 5 0 . Broders AC (2002). Squamous cell 

epithelioma of the skin. A study of 256 

cases. Ann Surg 73: 141-160. 

351. Broeks A, Urbanus JH, Floore AN, 

Dahler EC, Klijn JG, Rutgers EJ, Devilee P, 

Russell NS, van Leeuwen FE, van't Veer LJ 

(2000). ATM-heterozygous germline mutations 

contribute to breast cancer-susceptibility. 

Am J Hum Genet 66: 494-500. 

352. Brogi E, Harris NL (1999). Lymphomas 

of the breast: pathology and clinical 

behavior. Semin Oncol 26: 357-364. 

353. Bronner CE, Baker SM, Morrison PT, 

Warren G, Smith LG, Lescoe MK, Kane M, 

Earabino C, Lipford J, Lindblom A, 

Tannergard P, Bollag AG, Godwin AR, 

Ward DC, Nordenskjold M, Fishel R, 

Kolodner R, Liskay RM. (1994). Mutation in 

the DNA mismatch repair gene homologue 

hMLH1 is associated with hereditary nonpolyposis 

colon cancer. Nature 368: 258- 

261. 

3 5 4 . Brooks JJ, LiVolsi VA (1987). 

Liposarcoma presenting on the vulva. Am 

J Obstet Gynecol 156: 73-75. 

355. Brown H, Vlastos G, Newman LA, 

Benderly M, Singletary E, Sahin A (2000). 

Histopathological features of bilateral and 

unilateral breast carcinoma: a comparative 

study. Mod Pathol 13: 18A. 

356. Brown MA, Xu CF, Nicolai H, Griffiths 

B, Chambers JA, Black D, Solomon E 

(1996). The 5' end of the BRCA1 gene lies 

within a duplicated region of human chromosome 

17q21. Oncogene 12: 2507-2513. 

357. Brown RS, Marley JL, Cassoni AM 

(1998). Pseudo-Meigs' syndrome due to 

broad ligament leiomyoma: a mimic of 

metastatic ovarian carcinoma. Clin Oncol 

(R Coll Radiol ) 10: 198-201. 

358. Brown VL, Proby CM, Barnes DM, 

Kelsell DP (2002). Lack of mutations within 

ST7 gene in tumour-derived cell lines and 

primary epithelial tumours. Br J Cancer 87: 

208-211. 

359. Brustein S, Filippa DA, Kimmel M, 

Lieberman PH, Rosen PP (1987). Malignant 

lymphoma of the breast. A study of 53 

patients. Ann Surg 205: 144-150. 

360. Bryson SC, Colgan TJ, Vernon CP 

(1986). Invasive squamous cell carcinoma 

of the vulva: Delineation of high-risk group 

requiring adjuvant radiotherapy. J Reprod 

Med 31: 976-978. 

361. Buchwalter CL, Jenison EL, Fromm M, 

Mehta VT, Hart WR (1997). Pure embryonal 

rhabdomyosarcoma of the fallopian tube. 


362. Buckley CH (2000). Tumours of the 

cervix - tumours of the female genital tract. 

In: Diagnostic Histopathology of Tumours, 

CDM Fletcher (Ed.) Churchill Livingstone: 

London. pp. 685-705. 

363. Buckley JD (1984). The epidemiology 

of molar pregnancy and choriocarcinoma. 

Clin Obstet Gynecol 27: 153-159. 

364. Buckshee K, Dhond AJ, Mittal S, Bose 

S (1990). Pseudo-Meigs' syndrome secondary 

to broad ligament leiomyoma: a 

case report. Asia Oceania J Obstet 

Gynaecol 16: 201-205. 

365. Buerger H, Mommers EC, Littmann R, 

Simon R, Diallo R, Poremba C, Dockhorn- 

Dworniczak B, van Diest PJ, Boecker W 

(2001). Ductal invasive G2 and G3 carcinomas 

of the breast are the end stages of at 

least two different lines of genetic evolution. 

J Pathol 194: 165-170. 

3 6 6 . Buerger H, Otterbach F, Simon R, 

Poremba C, Diallo R, Decker T, Riethdorf L, 

Brinkschmidt C, Dockhorn-Dworniczak B, 

Boecker W (1999). Comparative genomic 

hybridization of ductal carcinoma in situ of 

the breast-evidence of multiple genetic 

pathways. J Pathol 187: 396-402. 

367. Bullón A, Arseneau J, Prat J, Young 

RH, Scully RE (1981). Tubular Krukenberg 

tumor. A problem in histopathologic diagnosis. 


368. Bundred NJ (2001). Prognostic and 

predictive factors in breast cancer. 

Cancer Treat Rev 27: 137-142. 


369. Bur ME, Zimarowski MJ, Schnitt SJ, 

Baker S, Lew R (1992). Estrogen receptor 

immunohistochemistry in carcinoma in situ 


370. Burghardt E, Baltzer J, Tulusan AH, 

Haas J (1992). Results of surgical treatment 

of 1028 cervical cancers studied with 

volumetry. Cancer 70: 648-655. 

371. Burghardt E, Östör AG, Fox H (1997). 

The new FIGO definition of cervical cancer 

stage IA: a critique. Gynecol Oncol 65: 1-5. 

372. Burghardt E, Pickel H, Girardi F (1998). 

Colposcopy-Cervical Pathology Textbook 

and Atlas. 3rd ed. Thieme: New York. 

373. Burke TW, Eifel PJ, McGuire P, et al. 

(2000). Vulva. In: Principles and Practice of 

Gynecologic Oncology. WJ Hoskins, CA 

Perez, RC Young (Eds.). 3rd ed. pp. 775- 

810.Williams & Wilkins: Philadelphia, 

374. Burke TW, Stringer CA, Gershenson 

DM, Edwards CL, Morris M, Wharton JT 

(1990). Radical wide excision and selective 

inguinal node dissection for squamous cell 

carcinoma of the vulva. Gynecol Oncol 38: 

328-332. 

375. Burki N, Buser M, Emmons LR, Gencik 

A, Haner M, Torhorst JK, Weber W, Muller 

H (1990). Malignancies in families of 

women with medullary, tubular and invasive 

ductal breast cancer. Eur J Cancer 26: 

295-303. 

376. Burks RT, Sherman ME, Kurman RJ 

(1996). Micropapillary serous carcinoma of 

the ovary. A distinctive low-grade carcinoma 

related to serous borderline tumors. 


377. Burns B, Curry RH, Bell ME (1979). 

Morphologic features of prognostic signif - 

icance in uterine smooth muscle tumors: a 

review of eighty-four cases. Am J Obstet 

Gynecol 135: 109-114. 

378. Burrell HC, Sibbering DM, Wilson AR 

(1995). Case report: fibromatosis of the 

breast in a male patient. Br J Radiol 68: 

1128-1129. 

379. Burt EC, McGown G, Thorncroft M, 

James LA, Birch JM, Varley JM (1999). 

Exclusion of the genes CDKN2 and PTEN 

as causative gene defects in Li-Fraumeni 

syndrome. Br J Cancer 80: 9-10. 

380. Burt RL, Prichard RW, Kim BS (1976). 

Fibroepithelial polyp of the vagina. A report 

of five cases. Obstet Gynecol 47: 52S-54S. 

381. Busby JG (1952). Neurofibromatosis of 

the cervix. Am J Obstet Gynecol 63: 674- 

675. 

382. Bussolati G, Gugliotta P, Sapino A, 

Eusebi V, Lloyd RV (1985). Chromograninreactive 

endocrine cells in argyrophilic 

carcinomas ("carcinoids") and normal tissue 

of the breast. Am J Pathol 120: 186-192. 

383. Butnor KJ, Sporn TA, Hammar SP, 

Roggli VL (2001). Well-differentiated papillary 

mesothelioma. Am J Surg Pathol 25: 

1304-1309. 

3 8 4 . Byrne P, Vella EJ, Rollason T, 

Frampton J (1989). Ovarian fibromatosis 

with minor sex cord elements. Case report. 

Br J Obstet Gynaecol 96: 245-248. 

385. Byskov AG, Skakkebaek NE, Stafanger 

G, Peters H (1977). Influence of ovarian 

surface epithelium and rete ovarii on follicle 

formation. J Anat 123: 77-86. 

386. Calabresi E, De Giuli G, Becciolini A, 

Giannotti P, Lombardi G, Serio M (1976). 

Plasma estrogens and androgens in male 

breast cancer. J Steroid Biochem 7: 605- 

609. 


387. Calle EE, Murphy TK, Rodriguez C, 

Thun MJ, Heath CWJ (1998). Occupation 

and breast cancer mortality in a prospective 

cohort of US women. Am J Epidemiol 

148: 191-197. 

3 8 8 . Calle EE, Rodriguez C, Walker- 

Thurmond K, Thun MJ (2003). Overweight, 

obesity, and mortality from cancer in a 

prospectively studied cohort of U.S. adults. 

N Engl J Med 348: 1625-1638. 

389. Calonje E, Guerin D, McCormick D, 

Fletcher CD (1999). Superficial angiomyxo - 

ma: clinicopathologic analysis of a series 

of distinctive but poorly recognized cutaneous 

tumors with tendency for recurrence. 


390. Cameron CT, Adair FE (1965). The clin - 

ical features and diagnosis of the common 

breast tumours. Med J Aust 2: 651-654. 

391. Campello TR, Fittipaldi H, O'Valle F, 

Carvia RE, Nogales FF (1998). Extrauterine 

(tubal) placental site nodule. 


392. Cancellieri A, Eusebi V, Mambelli V, 

Ricotti G, Gardini G, Pasquinelli G (1991). 

Well-differentiated angiosarcoma of the 

skin following radiotherapy. Report of two 


393. Cangiarella J, Symmans WF, Cohen 

JM, Goldenberg A, Shapiro RL, Waisman J 

(1998). Malignant melanoma metastatic to 

the breast: a report of seven cases diagnosed 

by fine-needle aspiration cytology. 

Cancer 84: 160-162. 

394. Cannistra SA (1993). Cancer of the 

ovary. N Engl J Med 329: 1550-1559. 

395. Canola T, Kirkis EJ, Meckes PF, Pitts 

SB (1994). Interdisciplinary group 

approach to occupational safety and 

health administration standard: reductions 

in cost and duplication of effort. Am J 

Infect Control 22: 182-187. 

396. Cantuaria G, Angioli R, Nahmias J, 

Estape R, Penalver M (1999). Primary 

malignant melanoma of the uterine cervix: 



397. Capella C, Usellini L, Papotti M, Macri 

L, Finzi G, Eusebi V, Bussolati G (1990). 

Ultrastructural features of neuroendocrine 

differentiated carcinomas of the breast. 

Ultrastruct Pathol 14: 321-334. 

398. Cappello F, Barbato F, Tomasino RM 

(2000). Mature teratoma of the uterine corpus 

with thyroid differentiation. Pathol Int 

50: 546-548. 

399. Carapeto R, Nogales FF Jr., Matilla A 

(1978). Ectopic pregnancy coexisting with 

a primary carcinoma of the Fallopian tube: 

a case report. Int J Gynaecol Obstet 16: 

263-264. 

400. Carcangiu ML, Chambers JT (1995). 

Early pathologic stage clear cell carcinoma 

and uterine papillary serous carcinoma 

of the endometrium: comparison of clinicopathologic 

features and survival. Int J 


4 0 1 . Cardenosa G, Eklund GW (1991). 

Benign papillary neoplasms of the breast: 

mammographic findings. Radiology 1 8 1 : 

751-755. 

402. Carinelli SG, Giudici MN, Brioschi D, 

Cefis F (1990). Alveolar soft part sarcoma of 

the vagina. Tumori 76: 77-80. 

403. Carlson JA, Ambros R, Malfetano J, 

Ross J, Grabowski R, Lamb P, Figge H, 

Mihm MC Jr. (1998). Vulvar lichen sclerosus 

and squamous cell carcinoma: a 

cohort, case control, and investigational 

study with historical perspective; implications 

for chronic inflammation and sclerosis 

in the development of neoplasia. Hum 

Pathol 29: 932-948. 

404. Carlson JA Jr., Wheeler JE (1993). 

Primary ovarian melanoma arising in a dermoid 

stage IIIc: long-term disease-free 

survival with aggressive surgery and platinum 

therapy. Gynecol Oncol 48: 397-401. 

405. Carlson JW, McGlennen RC, Gomez R, 

Longbella C, Carter J, Carson LF (1996). 

Sebaceous carcinoma of the vulva: a case 

report and review of the literature. 


4 0 6 . Carlson RW, Favret AM (1999). 

Multidisciplinary management of locally 

advanced breast cancer. Breast J 5: 303- 

307. 

4 0 7 . Carney JA, Young WF Jr. (1992). 

Primary pigmented nodular adrenocortical 

disease and its associated conditions. 

Endocrinologist 2: 6-21. 

408. Carpenter R, Gibbs N, Matthews J, 

Cooke T (1987). Importance of cellular DNA 

content in pre-malignant breast disease 

and pre-invasive carcinoma of the female 

breast. Br J Surg 74: 905-906. 

409. Carstens PH, Greenberg RA, Francis 

D, Lyon H (1985). Tubular carcinoma of the 

breast. A long term follow-up. H i s t o - 

pathology 9: 271-280. 

410. Carstens PH, Huvos AG, Foote FW Jr., 

Ashikari R (1972). Tubular carcinoma of the 

breast: a clinicopathologic study of 35 

cases. Am J Clin Pathol 58: 231-238. 

411. Carter BA, Page DL, Schuyler P, Parl 

FF, Simpson JF, Jensen RA, Dupont WD 

(2001). No elevation in long-term breast 

carcinoma risk for women with fibroadenomas 

that contain atypical hyperplasia. 

Cancer 92: 30-36. 

4 1 2 . Carter CL, Corle DK, Micozzi MS, 

Schatzkin A, Taylor PR (1988). A prospective 

study of the development of breast 

cancer in 16,692 women with benign 

breast disease. Am J Epidemiol 128: 467- 

477. 

412a. Carter CL, Jones DY, Schatzkin A, 

Brinton LA (1989). A prospective study of 

reproductive, familial and socioeconomic 

risk factors for breast cancer using 

NHANES I data. Public Health Rep 104: 45- 

50. 

413. Carter D, Orr SL, Merino MJ (1983). 

Intracystic papillary carcinoma of the 

breast. After mastectomy, radiotherapy or 

excisional biopsy alone. Cancer 52: 14-19. 

414. Carter D, Pipkin RD, Shepard RH, 

Elkins RC, Abbey H (1978). Relationship of 

necrosis and tumor border to lymph node 

metastases and 10-year survival in carcinoma 

of the breast. Am J Surg Pathol 2: 39- 

46. 

415. Carter J, Elliott P (1990). Syringoma-an 

unusual cause of pruritus vulvae. Aust 

NZ J Obstet Gynaecol 30: 382-383. 

416. Carter J, Elliott P, Russell P (1992). 

Bilateral fibroepithelial polypi of labium 

minus with atypical stromal cells. 

Pathology 24: 37-39. 

417. Cartier R, Cartier I (1993). Practical 

Colposcopy. 3rd ed. Laboratoire Cartier: 

Paris. 

418. Casagrande JT, Hanisch R, Pike MC, 

Ross RK, Brown JB, Henderson BE (1988). 

A case-control study of male breast cancer. 

Cancer Res 48: 1326-1330. 

419. Cashell AW, Cohen ML (1991). 

Masculinizing sclerosing stromal tumor of 

the ovary during pregnancy. G y n e c o l 

Oncol 43: 281-285. 

420. Casper GR, Östör AG, Quinn MA (1997). 

A clinicopathologic study of glandular dysplasia 

of the cervix. Gynecol Oncol 64: 166- 

170. 

421. Cass I, Baldwin RL, Fasylova E, Fields 

AL, Klinger HP, Runowicz CD, Karlan BY 

(2001). Allelotype of papillary serous peritoneal 

carcinomas. Gynecol Oncol 82: 69- 

76. 

422. Cass I, Baldwin RL, Varkey T, Moslehi 

R, Narod SA, Karlan BY (2003). Improved 

survival in women with BRCA-associated 

ovarian carcinoma. Cancer 97: 2187-2195. 

423. Castellsague X, Bosch FX, Munoz N, 

Meijer CJ, Shah KV, de Sanjose S, Eluf- 

Neto J, Ngelangel CA, Chichareon S, Smith 

JS, Herrero R, Moreno V, Franceschi S 

(2002). Male circumcision, penile human 

papillomavirus infection, and cervical cancer 

in female partners. N Engl J Med 346: 

1105-1112. 

424. Castrillon DH, Lee KR, Nucci MR 

(2002). Distinction between endometrial 

and endocervical adenocarcinoma: an 

immunohistochemical study. Int J Gynecol 

Pathol 21: 4-10. 

425. Castrillon DH, Sun D, Weremowicz S, 

Fisher RA, Crum CP, Genest DR (2001). 

Discrimination of complete hydatidiform 

mole from its mimics by immunohistochemistry 

of the paternally imprinted gene 

product p57KIP2. Am J Surg Pathol 25: 

1225-1230. 

426. Catteau A, Harris WH, Xu CF, Solomon 

E (1999). Methylation of the BRCA1 promoter 

region in sporadic breast and ovarian 

cancer: correlation with disease characteristics. 

Oncogene 18: 1957-1965. 

427. Cavalli LR, Rogatto SR, Rainho CA, dos 

Santos MJ, Cavalli IJ, Grimaldi DM (1995). 

Cytogenetic report of a male breast cancer. 

Cancer Genet Cytogenet 81: 66-71. 

428. Cecalupo AJ, Frankel LS, Sullivan MP 

(1982). Pelvic and ovarian extramedullary 

leukemic relapse in young girls: a report of 

four cases and review of the literature. 

Cancer 50: 587-593. 

429. Cerhan JR, Kushi LH, Olson JE, Rich 

SS, Zheng W, Folsom AR, Sellers TA (2000). 

Twinship and risk of postmenopausal 

breast cancer. J Natl Cancer Inst 92: 261- 

265. 

430. Chachlani N, Yue CT, Gerardo LT 

(1997). Granular cell tumor of the breast in 

a male. A case report. Acta Cytol 41: 1807- 

1810. 

431. Chafe W, Richards A, Morgan L, 

Wilkinson E (1988). Unrecognized invasive 

carcinoma in vulvar intraepithelial neopla - 

sia (VIN). Gynecol Oncol 31: 154-165. 

432. Chalvardjian A, Derzko C (1982). 

Gynandroblastoma: its ultrastructure. 

Cancer 50: 710-721. 

433. Chalvardjian A, Scully RE (1973). 

Sclerosing stromal tumors of the ovary. 

Cancer 31: 664-670. 

434. Chandraratnam E, Leong AS (1983). 

Papillary serous cystadenoma of borderline 

malignancy arising in a parovarian 

paramesonephric cyst. Light microscopic 

and ultrastructural observations. 


435. Chang-Claude J, Eby N, Kiechle M, 

Bastert G, Becher H (2000). Breastfeeding 

and breast cancer risk by age 50 among 

women in Germany. Cancer Causes 

Control 11: 687-695.

436. Chang J, Sharpe JC, A'Hern RP, Fisher 

C, Blake P, Shepherd J, Gore ME (1995). 

Carcinosarcoma of the ovary: incidence, 

prognosis, treatment and survival of 

patients. Ann Oncol 6: 755-758. 

437. Chang KL, Crabtree GS, Lim-Tan SK, 

Kempson RL, Hendrickson MR (1990). 

Primary uterine endometrial stromal neoplasms. 

A clinicopathologic study of 117 


438. Chang KL, Crabtree GS, Lim-Tan SK, 

Kempson RL, Hendrickson MR (1993). 

Primary extrauterine endometrial stromal 

neoplasms: a clinicopathologic study of 20 

cases and a review of the literature. Int J 


439. Chang YC, Hricak H, Thurnher S, Lacey 

CG (1988). Vagina: evaluation with MR 

imaging. Part II. Neoplasms. Radiology 169: 

175-179. 

4 4 0 . Chano T, Kontani K, Teramoto K, 

Okabe H, Ikegawa S (2002). Truncating 

mutations of RB1CC1 in human breast cancer. 

Nat Genet 31: 285-288. 

441. Chappuis PO, Rosenblatt J, Foulkes 

WD (1999). The influence of familial and 

hereditary factors on the prognosis of 

breast cancer. Ann Oncol 10: 1163-1170. 

442. Charbonnier F, Olschwang S, Wang Q, 

Boisson C, Martin C, Buisine MP, Puisieux 

A, Frebourg T (2002). MSH2 in contrast to 

MLH1 and MSH6 is frequently inactivated 

by exonic and promoter rearrangements in 

hereditary nonpolyposis colorectal cancer. 

Cancer Res 62: 848-853. 

4 4 3 . Charbonnier F, Raux G, Wang Q, 

Drouot N, Cordier F, Limacher JM, Saurin 

JC, Puisieux A, Olschwang S, Frebourg T 

(2000). Detection of exon deletions and 

duplications of the mismatch repair genes 

in hereditary nonpolyposis colorectal cancer 

families using multiplex polymerase 

chain reaction of short fluorescent fragments. 

Cancer Res 60: 2760-2763. 

4 4 4 . Charpin C, Bonnier P, Garcia S, 

Andrac L, Crebassa B, Dorel M, Lavaut 

MN, Allasia C (1999). E-cadherin and betacatenin 

expression in breast medullary 

carcinomas. Int J Oncol 15: 285-292. 

445. Charpin C, Bonnier P, Khouzami A, 

Vacheret H, Andrac L, Lavaut MN, Allasia 

C, Piana L (1992). Inflammatory breast carcinoma: 

an immunohistochemical study 

using monoclonal anti-pHER-2/neu, pS2, 

cathepsin, ER and PR. Anticancer Res 12: 

591-597. 

446. Charpin C, Mathoulin MP, Andrac L, 

Barberis J, Boulat J, Sarradour B, Bonnier 

P, Piana L (1994). Reappraisal of breast 

hamartomas. A morphological study of 41 


4 4 7 . Chatterjee A, Pulido HA, Koul S, 

Beleno N, Perilla A, Posso H, Manusukhani 

M, Murty VV (2001). Mapping the sites of 

putative tumor suppressor genes at 6p25 

and 6p21.3 in cervical carcinoma: occurrence 

of allelic deletions in precancerous 

lesions. Cancer Res 61: 2119-2123. 

448. Chaudary MA, Millis RR, Hoskins EO, 

Halder M, Bulbrook RD, Cuzick J, Hayward 

JL (1984). Bilateral primary breast cancer: 

a prospective study of disease incidence. 

Br J Surg 71: 711-714. 

449. Chehab NH, Malikzay A, Appel M, 

Halazonetis TD (2000). Chk2/hCds1 functions 

as a DNA damage checkpoint in G(1) 

by stabilizing p53. Genes Dev 14: 278-288. 

450. Chen J, Silver DP, Walpita D, Cantor 

SB, Gazdar AF, Tomlinson G, Couch FJ, 

Weber BL, Ashley T, Livingston DM, Scully 

R (1998). Stable interaction between the 

products of the BRCA1 and BRCA2 tumor 

suppressor genes in mitotic and meiotic 

cells. Mol Cell 2: 317-328. 

451. Chen KT (1981). Bilateral papillary adenofibroma 

of the fallopian tube. Am J Clin 

Pathol 75: 229-231. 

452. Chen KT (1984). Bilateral malignant 

Brenner tumor of the ovary. J Surg Oncol 

26: 194-197. 

453. Chen KT (1986). Female genital tract 

tumors in Peutz-Jeghers syndrome. Hum 

Pathol 17: 858-861. 

454. Chen KT (1990). Pleomorphic adenoma 

of the breast. Am J Clin Pathol 93: 792-794. 

455. Chen KT (2000). Composite Large-Cell 

Neuroendocrine Carcinoma and Surface 

Epithelial-Stromal Neoplasm of the Ovary. 

Int J Surg Pathol 8: 169-174. 

456. Chen KT, Hafez GR, Gilbert EF (1980). 

Myxoid variant of epithelioid smooth muscle 

tumor. Am J Clin Pathol 74: 350-353. 

457. Chen KT, Kirkegaard DD, Bocian JJ 

(1980). Angiosarcoma of the breast. 

Cancer 46: 368-371. 

458. Chen KT, Kuo TT, Hoffmann KD (1981). 

Leiomyosarcoma of the breast: a case of 

long survival and late hepatic metastasis. 

Cancer 47: 1883-1886. 

4 5 9 . Chen KT, Vergon JM (1981). 

Carcinomesenchymoma of the uterus. Am 


460. Chen T, Sahin A, Aldaz CM (1996). 

Deletion map of chromosome 16q in ductal 

carcinoma in situ of the breast: refining a 

putative tumor suppressor gene region. 

Cancer Res 56: 5605-5609. 461. Chen YY, 

Schnitt SJ (1998). Prognostic factors for 

patients with breast cancers 1cm and 

smaller. Breast Cancer Res Treat 51: 209- 

225. 

462. Chenevix-Trench G, Spurdle AB, Gatei 

M, Kelly H, Marsh A, Chen X, Donn K, 

Cummings M, Nyholt D, Jenkins MA, Scott 

C, Pupo GM, Dork T, Bendix R, Kirk J, 

Tucker K, McCredie MR, Hopper JL, 

Sambrook J, Mann GJ, Khanna KK (2002). 

Dominant negative ATM mutations in 

breast cancer families. J Natl Cancer Inst 

94: 205-215. 

463. Cheng J, Saku T, Okabe H, Furthmayr 

H (1992). Basement membranes in adenoid 

cystic carcinoma. An immunohistochemical 

study. Cancer 69: 2631-2640. 

464. Cheng PC, Gosewehr JA, Kim TM, 

Velicescu M, Wan M, Zheng J, Felix JC, 

Cofer KF, Luo P, Biela BH, Godorov G, 

Dubeau L (1996). Potential role of the inac - 

tivated X chromosome in ovarian epithelial 

tumor development. J Natl Cancer Inst 88: 

510-518. 

465. Cheng WF, Lin HH, Chen CK, Chang 

DY, Huang SC (1995). Leiomyosarcoma of 

the broad ligament: a case report and literature 

review. Gynecol Oncol 56: 85-89. 

466. Chestnut DH, Szpak CA, Fortier KJ, 

Hammond CB (1988). Uterine hemangioma 

associated with infertility. South Med J 81: 

926-928. 

4 6 7 . Chetty R, Govender D (1997). 

Inflammatory pseudotumor of the breast. 

Pathology 29: 270-271. 

468. Chetty R, Kalan MR (1992). Malignant 

granular cell tumor of the breast. J Surg 

Oncol 49: 135-137. 

469. Cheung AN, Shen DH, Khoo US, Wong 

LC, Ngan HY (1998). p21WAF1/CIP1 expression 

in gestational trophoblastic disease: 

correlation with clinicopathological 

parameters, and Ki67 and p53 gene 

expression. J Clin Pathol 51: 159-162. 

470. Cheung AN, So KF, Ngan HY, Wong LC 

(1994). Primary squamous cell carcinoma 

of fallopian tube. Int J Gynecol Pathol 13: 

92-95. 

471. Cheung AN, Srivastava G, Chung LP, 

Ngan HY, Man TK, Liu YT, Chen WZ, Collins 

RJ, Wong LC, Ma HK (1994). Expression of 

the p53 gene in trophoblastic cells in hydatidiform 

moles and normal human placentas. 

J Reprod Med 39: 223-227. 

4 7 2 . Cheung AN, Young RH, Scully RE 

(1994). Pseudocarcinomatous hyperplasia 

of the fallopian tube associated with salpingitis. 

A report of 14 cases. Am J Surg 

Pathol 18: 1125-1130. 

473. Chevallier B, Asselain B, Kunlin A, 

Veyret C, Bastit P, Graic Y (1987). 

Inflammatory breast cancer.Determination 

of prognostic factors by univariate 

and multivariate analysis. Cancer 60: 897- 

902. 

4 7 4 . Chhieng C, Cranor M, Lesser ME, 

Rosen PP (1998). Metaplastic carcinoma of 

the breast with osteocartilaginous heterologous 

elements. Am J Surg Pathol 22: 188- 

194. 

475. Chiarle R, Godio L, Fusi D, Soldati T, 

Palestro G (1997). Pure alveolar rhabdomyosarcoma 

of the corpus uteri: 

description of a case with increased 

serum level of CA-125. Gynecol Oncol 66: 

320-323. 

4 7 6 . Chiba N, Parvin JD (2001). 

Redistribution of BRCA1 among four different 

protein complexes following replication 

blockage. J Biol Chem 276: 38549- 

38554. 

477. Chico A, Garcia JL, Matias-Guiu X, 

Webb SM, Rodriguez J, Prat J, Calaf J 

(1995). A gonadotrophin dependent stromal 

luteoma: a rare cause of post-menopausal 

virilization. Clin Endocrinol (Oxf) 43: 645- 

649. 

4 7 8 . Cho D, Woodruff JD (1988). 

Trichoepithelioma of the vulva. A report of 

two cases. J Reprod Med 33: 317-319. 

479. Cho SB, Park CM, Park SW, Kim SH, 

Kim KA, Cha SH, Chung IJ, Kim YW, Yoon 

YK, Kim JS (2001). Malignant mixed mullerian 

tumor of the ovary: imaging findings. 

Eur Radiol 11: 1147-1150. 

4 8 0 . Chodosh LA (1998). Expression of 

BRCA1 and BRCA2 in normal and neoplas - 

tic cells. J Mammary Gland Biol Neoplasia 

3: 389-402. 

481. Choi-Hong SR, Genest DR, Crum CP, 

Berkowitz R, Goldstein DP, Schofield DE 

(1995). Twin pregnancies with complete 

hydatidiform mole and coexisting fetus: 

use of fluorescent in situ hybridization to 

evaluate placental X- and Y-chromosomal 

content. Hum Pathol 26: 1175-1180. 

4 8 2 . Choi YL, Kim HS, Ahn G (2000). 

Immunoexpression of inhibin alpha subunit, 

inhibin/activin betaA subunit and 

CD99 in ovarian tumors. Arch Pathol Lab 

Med 124: 563-569. 

483. Chorlton I, Norris HJ, King FM (1974). 

Malignant reticuloendothelial disease 

involving the ovary as a primary manifestation: 

a series of 19 lymphomas and 1 granulocytic 

sarcoma. Cancer 34: 397-407. 

4 8 4 . Christman JE, Ballon SC (1990). 

Ovarian fibrosarcoma associated with 

Maffucci's syndrome. Gynecol Oncol 37: 

290-291. 

485. Chu KC, Tarone RE, Kessler LG, Ries 

LA, Hankey BF, Miller BA, Edwards BK 

(1996). Recent trends in U.S. breast cancer 

incidence, survival, and mortality rates. J 


486. Chu PG, Arber DA, Weiss LM, Chang 

KL (2001). Utility of CD10 in distinguishing 

between endometrial stromal sarcoma and 

uterine smooth muscle tumors: an 

immunohistochemical comparison of 34 

cases. Mod Pathol 14: 465-471. 

487. Chua CL, Thomas A, Ng BK (1988). 

Cystosarcoma phyllodes--Asian variations. 

Aust N Z J Surg 58: 301-305. 

488. Chuang SS, Lin CN, Li CY, Wu CH 

(2001). Uterine leiomyoma with massive 

lymphocytic infiltration simulating malignant 

lymphoma. A case report with 

immunohistochemical study showing that 

the infiltrating lymphocytes are cytotoxic T 

cells. Pathol Res Pract 197: 135-138. 

489. Chuaqui R, Silva M, Emmert-Buck M 

(2001). Allelic deletion mapping on chromosome 

6q and X chromosome inactivation 

clonality patterns in cervical intraepithelial 

neoplasia and invasive carcinoma. 


490. Chuaqui RF, Sanz-Ortega J, Vocke C, 

Linehan WM, Sanz-Esponera J, Zhuang Z, 

Emmert-Buck MR, Merino MJ (1995). Loss 

of heterozygosity on the short arm of chromosome 

8 in male breast carcinomas. 

Cancer Res 55: 4995-4998. 

491. Chumas JC, Scully RE (1991). 

Sebaceous tumors arising in ovarian dermoid 

cysts. Int J Gynecol Pathol 10: 356- 

363. 

492. Chung AF, Casey MJ, Flannery JT, 

Woodruff JM, Lewis JL Jr. (1980). 

Malignant melanoma of the vagina--report 

of 19 cases. Obstet Gynecol 55: 720-727. 

493. Churg A, Colby TV, Cagle P, Corson J, 

Gibbs AR, Gilks B, Grimes M, Hammar S, 

Roggli V, Travis WD (2000). The separation 

of benign and malignant mesothelial proliferations. 


494. Ciano PS, Antonioli DA, Critchlow J, 

Burke L, Goldman H (1987). Villous adenoma 

presenting as a vaginal polyp in a rectovaginal 

tract. Hum Pathol 18: 863-866. 

495. Cina SJ, Richardson MS, Austin RM, 

Kurman RJ (1997). Immunohistochemical 

staining for Ki-67 antigen, carcinoembryonic 

antigen, and p53 in the differential 

diagnosis of glandular lesions of the 

cervix. Mod Pathol 10: 176-180. 

496. Cinel L, Taner D, Nabaei SM, Dogan M 

(2000). Aggressive angiomyxoma of the 

vagina. Report of a distinctive type gynecologic 

soft tissue neoplasm. Acta Obstet 

Gynecol Scand 79: 232-233. 

497. Cirisano FD Jr., Robboy SJ, Dodge RK, 

Bentley RC, Krigman HR, Synan IS, Soper 

JT, Clarke-Pearson DL (2000). The outcome 

of stage I-II clinically and surgically staged 

papillary serous and clear cell endometrial 

cancers when compared with endometrioid 

carcinoma. Gynecol Oncol 77: 55-65. 

498. Clark WH Jr., Hood AF, Tucker MA, 

Jampel RM (1998). Atypical melanocytic 

nevi of the genital type with a discussion of 

reciprocal parenchymal-stromal interactions 

in the biology of neoplasia. H u m 

Pathol 29: S1-24. 

499. Claus EB, Risch N, Thompson WD 

(1994). Autosomal dominant inheritance of 

early-onset breast cancer. Implications for 

risk prediction. Cancer 73: 643-651. 

500. Claus EB, Risch N, Thompson WD, 

Carter D (1993). Relationship between 

breast histopathology and family history of 

breast cancer. Cancer 71: 147-153. 


501. Claus EB, Risch NJ, Thompson WD 

(1990). Age at onset as an indicator of 

familial risk of breast cancer. Am J 

Epidemiol 131: 961-972. 

502. Clayton F (1986). Pure mucinous carcinomas 

of breast: morphologic features and 

prognostic correlates. Hum Pathol 17: 34- 

38. 

503. Clayton F, Bodian CA, Banogon P, 

Goetz H, Kancherla P, Lazarovic B. (1992). 

Reproducibility of diagnosis in noninvasive 

breast disease. Lab Invest 66: 12A. 

504. Clement PB (1988). Postoperative 

spindle-cell nodule of the endometrium. 


505. Clement PB (1993). Tumor-like lesions 

of the ovary associated with pregnancy. 


506. Clement PB (1994). Diseases of the 

peritoneum (including endometriosis). In: 

Blaustein's Pathology of the Female 

Genital Tract, RJ Kurman (Ed.) 4th ed. 

Springer-Verlag: New York. pp. 647-703. 

507. Clement PB, Azzopardi JG (1983). 

Microglandular adenosis of the breast--a 

lesion simulating tubular carcinoma. 


508. Clement PB, Dimmick JE (1979). 

Endodermal variant of mature cystic teratoma 

of the ovary: report of a case. 

Cancer 43: 383-385. 

509. Clement PB, Oliva E, Young RH (1996). 

Mullerian adenosarcoma of the uterine 

corpus associated with tamoxifen therapy: 

a report of six cases and a review of 

tamoxifen-associated endometrial lesions. 


510. Clement PB, Scully RE (1974). 

Mullerian adenosarcoma of the uterus. A 

clinicopathologic analysis of ten cases of a 

distinctive type of mullerian mixed tumor. 

Cancer 34: 1138-1149. 

511. Clement PB, Scully RE (1976). Uterine 

tumors resembling ovarian sex-cord 

tumors. A clinicopathologic analysis of 

fourteen cases. Am J Clin Pathol 66: 512- 

525. 


Extrauterine mesodermal (mullerian) 

adenosarcoma: a clinicopathologic analysis 

of five cases. Am J Clin Pathol 69: 276- 

283. 

513. Clement PB, Scully RE (1980). Large 

solitary luteinized follicle cyst of pregnancy 

and puerperium: A clinicopathological 

analysis of eight cases. Am J Surg Pathol 

4: 431-438. 


Mullerian adenofibroma of the uterus with 

invasion of myometrium and pelvic veins. 



Mullerian adenosarcoma of the uterus: a 

clinicopathologic analysis of 100 cases 

with a review of the literature. Hum Pathol 

21: 363-381. 


Endometrial stromal sarcomas of the 

uterus with extensive endometrioid glandular 

differentiation: a report of three 

cases that caused problems in differential 

diagnosis. Int J Gynecol Pathol 11: 163-173. 

517. Clement PB, Young RH (1987). Atypical 

polypoid adenomyoma of the uterus associated 

with Turner's syndrome. A report of 

three cases, including a review of "estrogen-associated" 

endometrial neoplasms 

and neoplasms associated with Turner's 

syndrome. Int J Gynecol Pathol 6: 104-113. 

518. Clement PB, Young RH (1987). Diffuse 

leiomyomatosis of the uterus: a report of 

four cases. Int J Gynecol Pathol 6: 322-330. 


518 a. Clement PB, Young RH (1999). Florid 

cystic endosalpingiosis with tumor-like 

manifestations: a report of four cases 

including the first reported cases of transmural 

endosalpingiosis of the uterus. Am J 


519. Clement PB, Young RH, Azzopardi JG 

(1987). Collagenous spherulosis of the 

breast. Am J Surg Pathol 11: 411-417. 

520. Clement PB, Young RH, Hanna W, 

Scully RE (1994). Sclerosing peritonitis 

associated with luteinized thecomas of the 

ovary. A clinicopathological analysis of six 


521. Clement PB, Young RH, Keh P, Östör 

AG, Scully RE (1995). Malignant 

mesonephric neoplasms of the uterine 

cervix. A report of eight cases, including 

four with a malignant spindle cell component. 


522. Clement PB, Young RH, Scully RE 

(1987). Endometrioid-like variant of ovarian 

yolk sac tumor. A clinicopathological 

analysis of eight cases. Am J Surg Pathol 

11: 767-778. 


(1988). Intravenous leiomyomatosis of the 

uterus. A clinicopathological analysis of 16 

cases with unusual histologic features. 



(1988). Ovarian granulosa cell proliferations 

of pregnancy: a report of nine cases. 

Hum Pathol 19: 657-662. 


(1992). Diffuse, perinodular, and other patterns 

of hydropic degeneration within and 

adjacent to uterine leiomyomas. Problems 

in differential diagnosis. Am J Surg Pathol 

16: 26-32. 


(1996). Malignant mesotheliomas presenting 

as ovarian masses. A report of nine 

cases, including two primary ovarian 

mesotheliomas. Am J Surg Pathol 20: 1067- 

1080. 

527. Clement PB, Zubovits JT, Young RH, 

Scully RE (1998). Malignant mullerian 

mixed tumors of the uterine cervix: a report 

of nine cases of a neoplasm with morphol - 

ogy often different from its counterpart in 

the corpus. Int J Gynecol Pathol 17: 211- 

222. 

528. Clifford GM, Smith JS, Plummer M, 

Munoz N, Franceschi S (2003). Human 

papillomavirus types in invasive cervical 

cancer worldwide: a meta-analysis. Br J 

Cancer 88: 63-73. 

529. Cobleigh MA, Vogel CL, Tripathy D, 

Robert NJ, Scholl S, Fehrenbacher L, 

Wolter JM, Paton V, Shak S, Lieberman G, 

Slamon DJ (1999). Multinational study of 

the efficacy and safety of humanized anti- 

HER2 monoclonal antibody in women who 

have HER2-overexpressing metastatic 

breast cancer that has progressed after 

chemotherapy for metastatic disease. J 

Clin Oncol 17: 2639-2648. 

530. Cohen C, Guarner J, DeRose PB (1993). 

Mammary Paget's disease and associated 

carcinoma. An immunohistochemical 

study. Arch Pathol Lab Med 117: 291-294. 

531. Cohen I, Altaras MM, Shapira J, 

Tepper R, Rosen DJ, Cordoba M, Zalel Y, 

Figer A, Yigael D, Beyth Y (1996). Timedependent 

effect of tamoxifen therapy on 

endometrial pathology in asymptomatic 

postmenopausal breast cancer patients. 


532. Cohen MA, Morris EA, Rosen PP, 

Dershaw DD, Liberman L, Abramson AF 

(1996). Pseudoangiomatous stromal hyperplasia: 

mammographic, sonographic, and 

clinical patterns. Radiology 198: 117-120. 

533. Cohen MB, Mulchahey KM, Molnar JJ 

(1986). Ovarian endodermal sinus tumor 

with intestinal differentiation. Cancer 57: 

1580-1583. 

534. Cohen PL, Brooks JJ (1991). 

Lymphomas of the breast. A clinicopathologic 

and immunohistochemical study of 

primary and secondary cases. Cancer 67: 

1359-1369. 

535. Cohen PR, Kohn SR, Kurzrock R (1991). 

Association of sebaceous gland tumors 

and internal malignancy: the Muir-Torre 

syndrome. Am J Med 90: 606-613. 

536. Cohn-Cedermark G, Rutqvist LE, 

Rosendahl I, Silfversward C (1991). 

Prognostic factors in cystosarcoma phyllodes. 

A clinicopathologic study of 77 

patients. Cancer 68: 2017-2022. 

537. Cokelaere K, Michielsen P, De Vos R, 

Sciot R (2001). Primary mesenteric malignant 

mixed mesodermal (mullerian) tumor 

with neuroendocrine differentiation. Mod 

Pathol 14: 515-520. 

538. Colgan TJ (1998). Vulvar intraepithelial 

neoplasia: a synopsis of recent developments. 

J Lower Genital Tract Disease 2: 31- 

36. 

539. Collaborative Group on Hormonal 

Factors in Breast Cancer (1996). Breast 

cancer and hormonal contraceptives: collaborative 

reanalysis of individual data on 

53 297 women with breast cancer and 100 

239 women without breast cancer from 54 

epidemiological studies. Lancet 347: 1713- 

1727. 

540. Collaborative Group on Hormonal 

Factors in Breast Cancer (1997). Breast 

cancer and hormone replacement therapy: 

collaborative reanalysis of data from 51 

epidemiological studies of 52,705 women 

with breast cancer and 108,411 women 

without breast cancer. Lancet 350: 1047- 

1059. 

541. Collins N, Wooster R, Stratton MR 

(1997). Absence of methylation of CpG din - 

ucleotides within the promoter of the 

breast cancer susceptibility gene BRCA2 

in normal tissues and in breast and ovarian 

cancers. Br J Cancer 76: 1150-1156. 

542. Collins RJ, Cheung A, Ngan HY, Wong 

LC, Chan SY, Ma HK (1991). Primary mixed 

neuroendocrine and mucinous carcinoma 

of the ovary. Arch Gynecol Obstet 248: 139- 

143. 

543. Colombat M, Sevestre H, Gontier MF 

(2001). Epithelioid leiomyosarcoma of the 

uterine cervix. Report of a case. A n n 

Pathol 21: 48-50. 

544. Colome MI, Ro JY, Ayala AG, El- 

Nagger A, Siddiqui RT, Ordonez NG (1996). 

Adenoid cystic carcinoma of the breast 

metastatic tio the kidney. J Pathol 

Bacteriol 4: 69-78. 

545. Colpaert C, Vermeulen P, Jeuris W, 

van Beest P, Goovaerts G, Weyler J, Van 

Dam P, Dirix L, Van Marck E (2001). Early 

distant relapse in "node-negative" breast 

cancer patients is not predicted by occult 

axillary lymph node metastases, but by the 

features of the primary tumour. J Pathol 

193: 442-449. 

546. Comerci JT Jr., Licciardi F, Bergh PA, 

Gregori C, Breen JL (1994). Mature cystic 

teratoma: a clinicopathologic evaluation of 

517 cases and review of the literature. 


547. Conant EF, Dillon RL, Palazzo J, Ehrlich 

SM, Feig SA (1994). Imaging findings in 

mucin-containing carcinomas of the 

breast: correlation with pathologic features. 

AJR Am J Roentgenol 163: 821-824. 

548. Connolly DC, Katabuchi H, Cliby WA, 

Cho KR (2000). Somatic mutations in the 

STK11/LKB1 gene are uncommon in rare 

gynecological tumor types associated with 

Peutz-Jegher's syndrome. Am J Pathol 

156: 339-345. 

549. Conran RM, Hitchcock CL, Popek EJ, 

Norris HJ, Griffin JL, Geissel A, McCarthy 

WF (1993). Diagnostic considerations in 

molar gestations. Hum Pathol 24: 41-48. 

550. Contesso G, Mouriesse H, Friedman S, 

Genin J, Sarrazin D, Rouesse J (1987). The 

importance of histologic grade in longterm 

prognosis of breast cancer: a study of 

1,010 patients, uniformly treated at the 

Institut Gustave-Roussy. J Clin Oncol 5: 

1378-1386. 

551. Cook DL, Weaver DL (1995). 

Comparison of DNA content, S-phase fraction, 

and survival between medullary and 

ductal carcinoma of the breast. Am J Clin 

Pathol 104: 17-22. 

552. Cooper HS, Patchefsky AS, Krall RA 

(1978). Tubular carcinoma of the breast. 

Cancer 42: 2334-2342. 

553. Copas P, Dyer M, Hall DJ, Diddle AW 

(1981). Granular cell myoblastoma of the 

uterine cervix. Diagn Gynecol Obstet 3: 

251-254. 

554. Copeland LJ, Cleary K, Sneige N, 

Edwards CL (1985). Neuroendocrine 

(Merkel cell) carcinoma of the vulva: a 



555. Copeland LJ, Gershenson DM, Saul 

PB, Sneige N, Stringer CA, Edwards CL 

(1985). Sarcoma botryoides of the female 

genital tract. Obstet Gynecol 66: 262-266. 

556. Copeland LJ, Sneige N, Gershenson 

DM, Saul PB, Stringer CA, Seski JC (1986). 

Adenoid cystic carcinoma of Bartholin 

gland. Obstet Gynecol 67: 115-120. 

557. Copeland LJ, Sneige N, Ordonez NG, 

Hancock KC, Gershenson DM, Saul PB, 

Kavanagh JJ (1985). Endodermal sinus 

tumor of the vagina and cervix. Cancer 55: 

2558-2565. 

558. Copeland LJ, Sneige N, Stringer CA, 

Gershenson DM, Saul PB, Kavanagh JJ 

(1985). Alveolar rhabdomyosarcoma of the 

female genitalia. Cancer 56: 849-855. 

559. Cornelis RS, Devilee P, van Vliet M, 

Kuipers-Dijkshoorn N, Kersenmaeker A, 

Bardoel A, Khan PM, Cornelisse CJ (1993). 

Allele loss patterns on chromosome 17q in 

109 breast carcinomas indicate at least 

two distinct target regions. Oncogene 8: 

781-785. 

560. Cornelis RS, Neuhausen SL, 

Johansson O, Arason A, Kelsell D, Ponder 

BA, Tonin P, Hamann U, Lindblom A, Lalle 

P, Longy M, Olah E, Scherneck S, Bignon 

YJ, Sobol H, Changclaude J, Larsson C, 

Spurr N, Borg A, Barkardottir RB, Narod S, 

Devilee P. (1995). High allele loss rates at 

17q12-q21 in breast and ovarian tumors 

from BRCAl-linked families. The Breast 

Cancer Linkage Consortium. G e n e s 


561. Costa A (1974). [A little known variant 

of pure adenoma of the breast: pure apoc - 

rine cell adenoma (with a classification of 

breast adenomas)]. Arch De Vecchi Anat 

Patol 60: 393-401.

562. Costa MJ, Ames PF, Walls J, Roth LM 

(1997). Inhibin immunohistochemistry 

applied to ovarian neoplasms: a novel, 

effective, diagnostic tool. Hum Pathol 28: 

1247-1254. 

563. Costa MJ, DeRose PB, Roth LM, 

Brescia RJ, Zaloudek CJ, Cohen C (1994). 

Immunohistochemical phenotype of ovarian 

granulosa cell tumors: absence of 

epithelial membrane antigen has diagnostic 

value. Hum Pathol 25: 60-66. 

564. Costa MJ, Hansen C, Dickerman A, 

Scudder SA (1998). Clinicopathologic significance 

of transitional cell carcinoma 

pattern in nonlocalized ovarian epithelial 

tumors (stages 2-4). Am J Clin Pathol 109: 

173-180. 

565. Costa MJ, McIlnay KR, Trelford J 

(1995). Cervical carcinoma with glandular 

differentiation: histological evaluation predicts 

disease recurrence in clinical stage I 

or II patients. Hum Pathol 26: 829-837. 

566. Costa MJ, Silverberg SG (1989). 

Oncocytic carcinoma of the male breast. 


567. Costa MJ, Thomas W, Majmudar B, 

Hewan-Lowe K (1992). Ovarian myxoma: 

ultrastructural and immunohistochemical 

findings. Ultrastruct Pathol 16: 429-438. 

568. Coukos G, Makrigiannakis A, Chung J, 

Randall TC, Rubin SC, Benjamin I (1999). 

Complete hydatidiform mole. A disease 

with a changing profile. J Reprod Med 44: 

698-704. 

569. Coyne J.D. (2001). Apocrine ductal 

carcinoma in-situ with an unusual morphological 

presentation. Histopathology 3 8 : 

277-280. 

570. Cozen W, Bernstein L, Wang F, Press 

MF, Mack TM (1999). The risk of angiosarcoma 

following primary breast cancer. Br 

J Cancer 81: 532-536. 

571. Craig JR, Hart WR (1979). Extragenital 

adenomatoid tumor: Evidence for the 

mesothelial theory of origin. Cancer 43: 

1678-1681. 

572. Cramer SF, Roth LM, Ulbright TM, 

Mazur MT, Nunez CA, Gersell DJ, Mills SE, 

Kraus FT (1987). Evaluation of the reproducibility 

of the World Health Organization 

classification of common ovarian cancers. 

With emphasis on methodology. A r c h 


573. Crawford D, Nimmo M, Clement PB, 

Thomson T, Benedet JL, Miller D, Gilks CB 

(1999). Prognostic factors in Paget's disease 

of the vulva: a study of 21 cases.Int J 


5 7 4 . Creasman W, Ondicino F, 

Maisonneuve P, Benefet J, Shepherd J 

(1998). Carcinoma of the corpus uteri: 

Annual report on the results of treatment in 

gynaecological cancer. J Epidemiol 

Biostat 3: 46-47. 

575. Creasman WT (1993). Prognostic significance 

of hormone receptors in 

endometrial cancer. Cancer 71: 1467-1470. 

5 7 6 . Creasman WT, Odicino F, 

Maisonneuve P, Beller U, Benedet JL, 

Heintz AP, Ngan HY, Sideri M, Pecorelli S 

(2001). Carcinoma of the corpus uteri. J 

Epidemiol Biostat 6: 47-86. 

577. Creasman WT, Phillips JL, Menck HR 

(1998). The National Cancer Data Base 

report on cancer of the vagina. Cancer 83: 

1033-1040. 

578. Crichlow RW, Galt SW (1990). Male 

breast cancer. Surg Clin North Am 70: 

1165-1177. 

579. Crissman JD, Visscher DW, Kubus J 

(1990). Image cytophotometric DNA analy - 

sis of atypical hyperplasias and intraductal 

carcinomas of the breast. Arch Pathol Lab 

Med 114: 1249-1253. 

580. Crook T, Brooks LA, Crossland S, Osin 

P, Barker KT, Waller J, Philp E, Smith PD, 

Yulug I, Peto J, Parker G, Allday MJ, 

Crompton MR, Gusterson BA (1998). p53 

mutation with frequent novel condons but 

not a mutator phenotype in B. Oncogene 

17: 1681-1689. 

581. Crook T, Crossland S, Crompton MR, 

Osin P, Gusterson BA (1997). p53 mutations 

in BRCA1-associated familial breast cancer. 

Lancet 350: 638-639. 

582. Crowe J, Hakes T, Rosen PP, Rosen 

PP, Kinne DW, Robbins GF. (1985). 

Changing trends in the management of 

inflammatory breast cancer: a clinicalpathological 

review of 69 patients. Am J 

Clin Oncol 8: 21. 

583. Crozier MA, Copeland LJ, Silva EG, 

Gershenson DM, Stringer CA (1989). Clear 

cell carcinoma of the ovary: a study of 59 


584. Crum CP (1992). Carcinoma of the 

vulva: epidemiology and pathogenesis. 


585. Crum CP, Fu YS, Levine RU, Richart 

RM, Townsend DE, Fenoglio CM (1982). 

Intraepithelial squamous lesions of the 

vulva: biologic and histologic criteria for 

the distinction of condylomas from vulvar 

intraepithelial neoplasia. Am J Obstet 

Gynecol 144: 77-83. 

586. Crum CP, Ikenberg H, Richart RM, 

Gissman L (1984). Human papillomavirus 

type 16 and early cervical neoplasia. N 

Engl J Med 310: 880-883. 

587. Crum CP, Mitao M, Levine RU, 

Silverstein S (1985). Cervical papillomaviruses 

segregate within morphologically 

distinct precancerous lesions. J Virol 

54: 675-681. 

588. Crum CP, Rogers BH, Andersen W 

(1980). Osteosarcoma of the uterus: case 



589. Cuatrecasas M, Erill N, Musulen E, 

Costa I, Matias-Guiu X, Prat J (1998). K-ras 

mutations in nonmucinous ovarian epithelial 

tumors: a molecular analysis and clinicopathologic 

study of 144 patients. Cancer 

82: 1088-1095. 

590. Cuatrecasas M, Matias-Guiu X, Prat J 

(1996). Synchronous mucinous tumors of 

the appendix and the ovary associated 

with pseudomyxoma peritonei. A clinicopathologic 

study of six cases with comparative 

analysis of c-Ki-ras mutations. Am J 


591. Cuatrecasas M, Villanueva A, Matias- 

Guiu X, Prat J (1997). K-ras mutations in 

mucinous ovarian tumors: a clinicopathologic 

and molecular study of 95 cases. 

Cancer 79: 1581-1586. 

592. Cui J, Antoniou AC, Dite GS, Southey 

MC, Venter DJ, Easton DF, Giles GG, 

McCredie MR, Hopper JL (2001). After 

BRCA1 and BRCA2-what next? 

Multifactorial segregation analyses of 

three-generation, population-based 

Australian families affected by female 

breast cancer. Am J Hum Genet 68: 420- 

431. 

592a. Cui S, Lespinasse P, Cracchiolo B, 

Sama J, Kreitzer MS, Heller DS (2001). 

Large cell neuroendocrine carcinoma of 

the cervix associated with adenocarcinoma 

in situ: evidence of a common origin. 


593. Cummings MC, Aubele M, Mattis A, 

Purdie D, Hutzler P, Hofler H, Werner M 

(2000). Increasing chromosome 1 copy 

number parallels histological progression 

in breast carcinogenesis. Br J Cancer 82: 

1204-1210. 

594. Cunha TM, Felix A, Cabral I (2001). 

Preoperative assessment of deep myometrial 

and cervical invasion in endometrial 

carcinoma: comparison of magnetic resonance 

imaging and gross visual inspection. 

Int J Gynecol Cancer 11: 130-136. 

595. Cunningham JM, Kim CY, Christensen 

ER, Tester DJ, Parc Y, Burgart LJ, Halling 

KC, McDonnell SK, Schaid DJ, Walsh VC, 

Kubly V, Nelson H, Michels VV, Thibodeau 

SN (2001). The frequency of hereditary 

defective mismatch repair in a prospective 

series of unselected colorectal carcinomas. 

Am J Hum Genet 69: 780-790. 

596. Cuny M, Kramar A, Courjal F, 

Johannsdottir V, Iacopetta B, Fontaine H, 

Grenier J, Culine S, Theillet C (2000). 

Relating genotype and phenotype in breast 

cancer: an analysis of the prognostic significance 

of amplification at eight different 

genes or loci and of p53 mutations. Cancer 

Res 60: 1077-1083. 

597. Curry JL, Olejnik JL, Wojcik EM (2001). 

Cellular angiofibroma of the vulva with 

DNA ploidy analysis. Int J Gynecol Pathol 

20: 200-203. 

598. Curtin JP, Rubin SC, Hoskins WJ, 

Hakes TB, Lewis JL Jr. (1989). Second-look 

laparotomy in endodermal sinus tumor: a 

report of two patients with normal levels of 

alpha-fetoprotein and residual tumor at 

reexploration. Obstet Gynecol 73: 893-895. 

599. Curtin JP, Saigo P, Slucher B, 

Venkatraman ES, Mychalczak B, Hoskins 

WJ (1995). Soft-tissue sarcoma of the vagina 

and vulva: a clinicopathologic study. 


600. Cushing B, Giller R, Ablin A, Cohen L, 

Cullen J, Hawkins E, Heifetz SA, Krailo M, 

Lauer SJ, Marina N, Rao PV, Rescorla F, 

Vinocur CD, Weetman RM, Castleberry RP 

(1999). Surgical resection alone is effective 

treatment for ovarian immature teratoma 

in children and adolescents: a report of the 

pediatric oncology group and the children's 

cancer group. Am J Obstet Gynecol 

181: 353-358. 

601. Cutuli B, Borel C, Dhermain F, Magrini 

SM, Wasserman TH, Bogart JA, Provencio 

M, de Lafontan B, de la RA, Cellai E, Graic 

Y, Kerbrat P, Alzieu C, Teissier E, Dilhuydy 

JM, Mignotte H, Velten M (2001). Breast 

cancer occurred after treatment for 

Hodgkin's disease: analysis of 133 cases. 

Radiother Oncol 59: 247-255. 

602. Cutuli B, Dilhuydy JM, de Lafontan B, 

Berlie J, Lacroze M, Lesaunier F, Graic Y, 

Tortochaux J, Resbeut M, Lesimple T, 

Gamelin E, Campana F, Reme-Saumon M, 

Moncho-Bernier V, Cuilliere JC, Marchal 

C, De Gislain G, N'Guyen TD, Teissier E, 

Velten M (1997). Ductal carcinoma in situ 

of the male breast. Analysis of 31 cases. 

Eur J Cancer 33: 35-38. 

603. Czernobilsky B (1967). Intracystic carcinoma 

of the female breast. Surg Gynecol 

Obstet 124: 93-98. 

604. Czernobilsky B, Gillespie JJ, Roth LM 

(1982). Adenosarcoma of the ovary. A lightand 

electron-microscopic study with 

review of the literature. Diagn Gynecol 

Obstet 4: 25-36. 

604a. Czernobilsky B, Lancet M (1972). 

Broad ligament adenocarcinoma of 

Mullerian origin. Obstet Gynecol 40: 238- 

242. 

605. Czernobilsky B, Moll R, Levy R, Franke 

WW (1985). Co-expression of cytokeratin 

and vimentin filaments in mesothelial, 

granulosa and rete ovarii cells of the 

human ovary. Eur J Cell Biol 37: 175-190. 

606. d'Ablaing G III, Klatt EC, DiRocco G, 

Hibbard LT (1983). Broad ligament serous 

tumor of low malignant potential. Int J 


607. D'Avanzo B, La Vecchia C (1995). Risk 

factors for male breast cancer. Br J 

Cancer 71: 1359-1362. 

608. D'Orsi CJ, Feldhaus L, Sonnenfeld M 

(1983). Unusual lesions of the breast. 

Radiol Clin North Am 21: 67-80. 

609. Dal Cin P, Timmerman D, Van den 

Berghe H, Wanschura S, Kazmierczak B, 

Vergote I, Deprest J, Neven P, Moerman P, 

Bullerdiek J, Van den Berghe H (1998). 

Genomic changes in endometrial polyps 

associated with tamoxifen show no evidence 

for its action as an external carcinogen. 

Cancer Res 58: 2278-2281. 

610. Dalal P, Shousha S (1995). Keratin 19 in 

paraffin sections of medullary carcinoma 

and other benign and malignant breast 

lesions. Mod Pathol 8: 413-416. 

611. Daling JR, Sherman KJ, Hislop TG, 

Maden C, Mandelson MT, Beckmann AM, 

Weiss NS (1992). Cigarette smoking and 

the risk of anogenital cancer. Am J 

Epidemiol 135: 180-189. 

612. Dalton LW, Page DL, Dupont WD 

(1994). Histologic grading of breast carcinoma. 

A reproducibility study. Cancer 73: 

2765-2770. 

6 1 3 . Daly MB (1992). Ovarian Cancer. 

Hematology/oncology clinics of North 

America. The epidemiology of ovarian 

cancer. WB Saunders: Philadelphia. 

614. Damajanov I, Drobnjak P, Grizelj V, 

Longhino N (1975). Sclerosing stromal 

tumor of the ovary: A hormonal and ultrastructural 

analysis. Obstet Gynecol 45: 675- 

679. 

615. Damiani S, Dina R, Eusebi V (1999). 

Eosinophilic and granular cell tumors of 

the breast. Semin Diagn Pathol 16: 117-125. 

616. Damiani S, Eusebi V, Losi L, D'Adda T, 

Rosai J (1998). Oncocytic carcinoma 

(malignant oncocytoma) of the breast. Am 


617. Damiani S, Koerner FC, Dickersin GR, 

Cook MG, Eusebi V (1992). Granular cell 

tumour of the breast. Virchows Arch A 

Pathol Anat Histopathol 420: 219-226. 

618. Damiani S, Panarelli M (1996). 

Mammary adenohibernoma. H i s t o p a t h o l o g y 

28: 554-555. 

619. Damiani S, Pasquinelli G, Lamovec J, 

Peterse JL, Eusebi V (2000). Acinic cell carcinoma 

of the breast: an immunohistochemical 

and ultrastructural study. 

Virchows Arch 437: 74-81. 

620. Damjanov I, Amenta PS, Zarghami F 

(1984). Transformation of an AFP-positive 

yolk sac carcinoma into an AFP-negative 

neoplasm. Evidence for in vivo cloning of 

the human parietal yolk sac carcinoma. 

Cancer 53: 1902-1907. 

621. Dammann R, Li C, Yoon JH, Chin PL, 

Bates S, Pfeifer GP (2000). Epigenetic inactivation 

of a RAS association domain fami - 

ly protein from the lung tumour suppressor 

locus 3p21.3. Nat Genet 25: 315-319. 

622. Dammann R, Yang G, Pfeifer GP (2001). 

Hypermethylation of the cpG island of Ras 

association domain family 1A (RASSF1A), a 

putative tumor suppressor gene from the 

3p21.3 locus, occurs in a large percentage 

of human breast cancers. Cancer Res 61: 

3105-3109. 


623. Daroca PJ Jr. (1987). Medullary carcinoma 

of the breast with granulomatous 

stroma. Hum Pathol 18: 761-763. 

624. Daroca PJ Jr., Reed RJ, Love GL, 

Kraus SD (1985). Myoid hamartomas of the 

breast. Hum Pathol 16: 212-219. 

625. Dasouki M, Ishmael H, Eng C (2001). 

Macrocephaly, macrosomia and autistic 

behavior due to a de novo PTEN germline 

mutation. Am J Hum Genet 69S: 280. 

626. Davies JD, Mera SL (1987). Elastosis in 

breast carcinoma: II. Association of protease 

inhibitors with immature elastic 

fibres. J Pathol 153: 317-324. 

627. Davis BW, Gelber R, Goldhirsch A, 

Hartmann WH, Hollaway L, Russell I, 

Rudenstam CM (1985). Prognostic significance 

of peritumoral vessel invasion in 

clinical trials of adjuvant therapy for breast 

cancer with axillary lymph node metastasis. 

Hum Pathol 16: 1212-1218. 

628. Davis DL, Bradlow HL, Wolff M, 

Woodruff T, Hoel DG, Anton-Culver H 

(1993). Medical hypothesis: xenoestrogens 

as preventable causes of breast cancer. 

Environ Health Perspect 101: 372-377. 

629. Davis GD, Patton WS (1983). Capillary 

hemangioma of the cervix and vagina: 

management with carbon dioxide laser. 

Obstet Gynecol 62: 95s-96s. 

630. Davis GL (1996). Malignant melanoma 

arising in mature ovarian cystic teratoma 

(dermoid cyst). Report of two cases and literature 

analysis. Int J Gynecol Pathol 15: 

356-362. 

631. Davis KP, Hartmann LK, Keeney GL, 

Shapiro H (1996). Primary ovarian carcinoid 

tumors. Gynecol Oncol 61: 259-265. 

632. Davis S, Mirick DK, Stevens RG (2001). 

Night shift work, light at night, and risk of 


1562. 

633. Davos I, Abell MR (1976). Sarcomas of 

the vagina. Obstet Gynecol 47: 342-350. 

634. Daw E (1971). Primary carcinoma of 

the vagina. J Obstet Gynaecol Br 

Commonw 78: 853-856. 

635. Dawson PJ, Ferguson DJ, Karrison T 

(1982). The pathological findings of breast 

cancer in patients surviving 25 years after 

radical mastectomy. Cancer 50: 2131-2138. 

636. Dawson PJ, Schroer KR, Wolman SR 

(1996). ras and p53 genes in male breast 

cancer. Mod Pathol 9: 367-370. 

637. Daya D (1994). Malignant female 

adnexal tumor of probable wolffian origin 

with review of the literature. Arch Pathol 

Lab Med 118: 310-312. 

638. Daya D, Lukka H, Clement PB (1992). 

Primitive neuroectodermal tumors of the 

uterus: a report of four cases. Hum Pathol 

23: 1120-1129. 

639. Daya D, Nazerali L, Frank GL (1992). 

Metastatic ovarian carcinoma of large 

intestinal origin simulating primary ovarian 

carcinoma. A clinicopathologic study of 25 

cases. Am J Clin Pathol 97: 751-758. 

640. Daya D, Sabet L (1991). The use of 

cytokeratin as a sensitive and reliable 

marker for trophoblastic tissue. Am J Clin 

Pathol 95: 137-141. 

641. Daya D, Young RH, Scully RE (1992). 

Endometrioid carcinoma of the fallopian 

tube resembling an adnexal tumor of probable 

wolffian origin: a report of six cases. 


642. Daya DA, Scully RE (1988). Sarcoma 

botryoides of the uterine cervix in young 

women: a clinicopathological study of 13 



643. de Cremoux P, Salomon AV, Liva S, 

Dendale R, Bouchind'homme B, Martin E, 

Sastre-Garau X, Magdelenat H, Fourquet 

A, Soussi T (1999). p53 mutation as a genetic 

trait of typical medullary breast carcinoma. 


644. de Deus JM, Focchi J, Stavale JN, de 

Lima GR (1995). Histologic and biomolecular 

aspects of papillomatosis of the vulvar 

vestibule in relation to human papillomavirus. 


645. de Fusco PA, Gaffey TA, Malkasian GD 

Jr., Long HJ, Cha SS (1989). Endometrial 

stromal sarcoma: review of Mayo Clinic 

experience, 1945-1980. Gynecol Oncol 35: 

8-14. 

646. de Hullu JA, Doting E, Piers DA, 

Hollema H, Aalders JG, Koops HS, 

Boonstra H, van der Zee AG (1998). 

Sentinel lymph node identification with 

technetium-99m-labeled nanocolloid in 

squamous cell cancer of the vulva. J Nucl 

Med 39: 1381-1385. 

647. de la Fuente AA (1982). Benign mixed 

Mullerian tumour--adenofibroma of the fallopian 

tube. Histopathology 6: 661-666. 

648. de la Rochefordiere A, Asselain B, 

Scholl S, Campana F, Ucla L, Vilcoq JR, 

Durand JC, Pouillart P, Fourquet A (1994). 

Simultaneous bilateral breast carcinomas: 

a retrospective review of 149 cases. Int J 

Radiat Oncol Biol Phys 30: 35-41. 

6 4 9 . de Leeuw WJ, Berx G, Vos CB, 

Peterse JL, Van de Vijver MJ, Litvinov S, 

van Roy F, Cornelisse CJ, Cleton-Jansen 

AM (1997). Simultaneous loss of E-cadherin 

and catenins in invasive lobular 

breast cancer and lobular carcinoma in 

situ. J Pathol 183: 404-411. 

650. de Leeuw WJ, Dierssen J, Vasen HF, 

Wijnen JT, Kenter GG, Meijers-Heijboer H, 

Brocker-Vriends A, Stormorken A, Moller 

P, Menko F, Cornelisse CJ, Morreau H 

(2000). Prediction of a mismatch repair 

gene defect by microsatellite instability 

and immunohistochemical analysis in 

endometrial tumours from HNPCC patients. 

J Pathol 192: 328-335. 

651. de Nictolis M, Curatola A, Tommasoni 

S, Magiera G (1994). High-grade endometrial 

stromal sarcoma: clinicopathologic 

and immunohistochemical study of a case. 


652. de Nictolis M, Montironi R, 

Tommasoni S, Carinelli S, Ojeda B, Matias- 

Guiu X, Prat J (1992). Serous borderline 

tumors of the ovary. A clinicopathologic, 

immunohistochemical, and quantitative 


653. de Nictolis M, Montironi R, 

Tommasoni S, Valli M, Pisani E, Fabris G, 

Prat J (1994). Benign, borderline, and welldifferentiated 

malignant intestinal mucinous 

tumors of the ovary: a clinicopathologic, 

histochemical, immunohistochemical, 

and nuclear quantitative study 

of 57 cases. Int J Gynecol Pathol 13: 10-21. 

654. de Rosa G, Boscaino A, Terracciano 

LM, Giordano G (1992). Giant adenomatoid 

tumors of the uterus. Int J Gynecol Pathol 

11: 156-160. 

655. de Wind N, Dekker M, van Rossum A, 

van der Valk M, te Riele H (1998). Mouse 

models for hereditary nonpolyposis colorectal 

cancer. Cancer Res 58: 248-255. 

6 5 6 . de Mascarel I, MacGrogan G, 

Mathoulin-Pelissier S, Soubeyran I, Picot 

V, Coindre JM (2002). Breast ductal carcinoma 

in situ with microinvasion: a definition 

supported by a long-term study of 1248 

serially sectioned ductal carcinomas. 

Cancer 94: 2134-2142. 

657. de Vivo I, Gertig DM, Nagase S, 

Hankinson SE, O'Brien R, Speizer FE, 

Parsons R, Hunter DJ (2000). Novel 

germline mutations in the PTEN tumour 

suppressor gene found in women with 

multiple cancers. J Med Genet 37: 336-341. 

658. Deavers MT, Gershenson DM, 

Tortolero-Luna G, Malpica A, Lu KH, Silva 

EG (2002). Micropapillary and cribriform 

patterns in ovarian serous tumors of low 

malignant potential: a study of 99 

advanced stage cases. Am J Surg Pathol 

26: 1129-1141. 

659. de Hoop TA, Mira J, Thomas MA 

(1997). Endosalpingiosis and chronic pelvic 

pain. J Reprod Med 42: 613-616. 

660. Dekel A, van Iddekinge B, Isaacson C, 

Dicker D, Feldberg D, Goldman J (1986). 

Primary choriocarcinoma of the fallopian 

tube. Report of a case with survival and 

postoperative delivery. Review of the liter - 

ature. Obstet Gynecol Surv 41: 142-148. 

661. Del Giudice ME, Fantus IG, Ezzat S, 

McKeown-Eyssen G, Page D, Goodwin PJ 

(1998). Insulin and related factors in premenopausal 

breast cancer risk. B r e a s t 


662. Delaloye JF, Ruzicka J, de Grandi P 

(1993). An ovarian tumor of probable 

Wolffian origin. Acta Obstet Gynecol 

Scand 72: 314-316. 

663. Delgado G, Bundy B, Zaino R, Sevin 

BU, Creasman WT, Major F (1990). 

Prospective surgical-pathological study of 

disease-free interval in patients with stage 

IB squamous cell carcinoma of the cervix: 

a Gynecologic Oncology Group study. 


664. Deligdisch L, Hirschmann S, Altchek A 

(1997). Pathologic changes in 

gonadotropin releasing hormone agonist 

analogue treated uterine leiomyomata. 

Fertil Steril 67: 837-841. 

665. Deligdisch L, Kalir T, Cohen CJ, de 

Latour M, Le Bouedec G, Penault-Llorca F 

(2000). Endometrial histopathology in 700 

patients treated with tamoxifen for breast 

cancer. Gynecol Oncol 78: 181-186. 

666. Dellas A, Schultheiss E, Holzgreve W, 

Oberholzer M, Torhorst J, Gudat F (1997). 

Investigation of the Bcl-2 and C-myc 

expression in relationship to the Ki-67 

labelling index in cervical intraepithelial 

neoplasia. Int J Gynecol Pathol 16: 212-218. 

667. de Matos P, Tyler D, Seigler HF (1998). 

Mucosal melanoma of the female genitalia: 

a clinicopathologic study of fortythree 

cases at Duke University Medical 

Center. Surgery 124: 38-48. 

668. de May RM, Kay S (1984). Granular cell 

tumor of the breast. Pathol Annu 19 Pt 2: 

121-148. 

669. Demers PA, Thomas DB, Rosenblatt 

KA, Jimenez LM, McTiernan A, Stalsberg 

H, Stemhagen A, Thompson WD, Curnen 

MG, Satariano W, Austin DF, Isacson P, 

Greenberg RS, Key C, Kolonel LN, West 

DW. (1991). Occupational exposure to 

electromagnetic fields and breast cancer 

in men. Am J Epidemiol 134: 340-347. 

670. Demopoulos RI, Sitelman A, Flotte T, 

Bigelow B (1980). Ultrastructural study of a 

female adnexal tumor of probable wolffian 

origin. Cancer 46: 2273-2280. 

671. Deng G, Lu Y, Zlotnikov G, Thor AD, 

Smith HS (1996). Loss of heterozygosity in 

normal tissue adjacent to breast carcinomas. 

Science 274: 2057-2059. 

672. Denley H, Pinder SE, Tan PH, Sim CS, 

Brown R, Barker T, Gearty J, Elston CW, 

Ellis IO (2000). Metaplastic carcinoma of 

the breast arising within complex sclerosing 

lesion: a report of five cases. 


673. Denton AS, Bond SJ, Matthews S, 

Bentzen SM, Maher EJ (2000). National 

audit of the management and outcome of 

carcinoma of the cervix treated with radiotherapy 

in 1993. Clin Oncol (R Coll Radiol) 

12: 347-353. 

674. Department of Health (1998). Report on 

health and social subjects No. 48. 

Nutritional aspects of the development of 

cancer. The Stationery Office: Norwich. 

675. DePasquale SE, McGuinness TB, 

Mangan CE, Husson M, Woodland MB 

(1996). Adenoid cystic carcinoma of 

Bartholin's gland: a review of the literature 

and report of a patient. Gynecol Oncol 61: 

122-125. 

676. DePriest PD, Banks ER, Powell DE, van 

Nagell JR Jr., Gallion HH, Puls LE, Hunter 

JE, Kryscio RJ, Royalty MB (1992). 

Endometrioid carcinoma of the ovary and 

endometriosis: the association in postmenopausal 

women. Gynecol Oncol 47: 71- 

75. 

677. Devaney K, Snyder R, Norris HJ, 

Tavassoli FA (1993). Proliferative and histologically 

malignant struma ovarii: a clinicopathologic 

study of 54 cases. Int J Gynecol 

Pathol 12: 333-343. 

678. Devaney K, Tavassoli FA (1991). 

Immunohistochemistry as a diagnostic aid 

in the interpretation of unusual mesenchymal 

tumors of the uterus. Mod Pathol 4: 

225-231. 

679. Devilee P, Cleton-Jansen A, 

Cornelisse CJ (2001). Ever since Knudson. 

Trends Genet 17: 569-573. 

680. Devilee P, Cornelisse CJ (1994). 

Somatic genetic changes in human breast 

cancer. Biochim Biophys Acta 1198: 113- 

130. 

681. Devouassoux-Shisheboran M, 

Schammel MD, Man YG, Tavassoli FA 

(2000). Fibromatosis of the breast: age-correlated 

morphofunctional features of 33 

cases. Arch Pathol Lab Med 124: 276-280. 

682. Devouassoux-Shisheboran M, Silver 

SA, Tavassoli FA (1999). Wolffian adnexal 

tumor, so-called female adnexal tumor of 

probable Wolffian origin (FATWO): 

immunohistochemical evidence in support 

of a Wolffian origin. Hum Pathol 30: 856- 

863. 

683. Devouassoux-Shisheboran M, 

Vortmeyer AO, Silver SA, Zhuang Z, 

Tavassoli FA (2000). Teratomatous genotype 

detected in malignancies of a nongerm 

cell phenotype. Lab Invest 80: 81-86. 

684. Dgani R, Shoham Z, Czernobilsky B, 

Singer D, Shani A, Lancet M (1989). 

Endolymphatic stromal myosis (endometrial 

low-grade stromal sarcoma) presenting 

with hematuria: a diagnostic challenge. 


685. Dhaliwal LK, Das I, Gopalan S (1992). 

Recurrent leiomyoma of the vagina. Int J 


686. Dharkar DD, Kraft JR, Gangadharam D 

(1981). Uterine lipomas. Arch Pathol Lab 

Med 105: 43-45. 

687. Di Bonito L, Patriarca S, Falconieri G 

(1992). Aggressive "breast-like" adenocarcinoma 

of vulva. Pathol Res Pract 188: 211-214. 

688. Di Cristofano A, Pesce B, Cordon- 

Cardo C, Pandolfi PP (1998). Pten is essential 

for embryonic development and tumour 

suppression. Nat Genet 19: 348-355.

689. Di Domenico A, Stangl F, Bennington J 

(1982). Leiomyosarcoma of the broad ligament. 

Gynecol Oncol 13: 412-415. 690. Di 

Sant'Agnese PA, Knowles DM (1980). 

Extracardiac rhabdomyoma: a clinicopathologic 

study and review of the literature. 

Cancer 46: 780-789. 

691. Diab SG, Clark GM, Osborne CK, Libby 

A, Allred DC, Elledge RM (1999). Tumor 

characteristics and clinical outcome of 

tubular and mucinous breast carcinomas. 

J Clin Oncol 17: 1442-1448. 

692. Diaz NM, McDivitt RW, Wick MR 

(1991). Microglandular adenosis of the 

breast. An immunohistochemical comparison 

with tubular carcinoma. Arch Pathol 

Lab Med 115: 578-582. 

693. Diaz NM, Palmer JO, McDivitt RW 

(1991). Carcinoma arising within fibroadenomas 

of the breast. A clinicopathologic 

study of 105 patients. Am J Clin Pathol 95: 

614-622. 

694. Dickersin GR, Maluf HM, Koerner FC 

(1997). Solid papillary carcinoma of breast: 

an ultrastructural study. Ultrastruct Pathol 

21: 153-161. 

695. Dickersin GR, Scully RE (1993). An 

update on the electron microscopy of 

small cell carcinoma of the ovary with 

hypercalcemia. Ultrastruct Pathol 17: 411- 

422. 

696. Dickersin GR, Scully RE (1998). Ovarian 

small cell tumors: an electron microscopic 

review. Ultrastruct Pathol 22: 199-226. 

697. Dickersin GR, Young RH, Scully RE 

(1995). Signet-ring stromal and related 

tumors of the ovary. Ultrastruct Pathol 19: 

401-419. 

698. Dickson JM, Mansel RE (2000). ABC of 

Breast Diseases. Symptoms, Assessment 

and Guidelines for Referral. 2nd ed. BMJ 

Books: London, pp. 1-5. 

699. DiCostanzo D, Rosen PP, Gareen I, 

Franklin S, Lesser M (1990). Prognosis in 

infiltrating lobular carcinoma. An analysis 

of "classical" and variant tumors. Am J 


700. Dietl J, Horny HP, Ruck P, Kaiserling E 

(1993). Dysgerminoma of the ovary. An 

immunohistochemical study of tumor-infiltrating 

lymphoreticular cells and tumor 

cells. Cancer 71: 2562-2568. 

701. Dietrich CU, Pandis N, Teixeira MR, 

Bardi G, Gerdes AM, Andersen JA, Heim S 

(1995). Chromosome abnormalities in 

benign hyperproliferative disorders of 

epithelial and stromal breast tissue. Int J 

Cancer 60: 49-53. 

702. Dina R, Eusebi V (1997). Clear cell 

tumors of the breast. Semin Diagn Pathol 

14: 175-182. 

703. Dinh TV, Slavin RE, Bhagavan BS, 

Hannigan EV, Tiamson EM, Yandell RB 

(1989). Mixed mullerian tumors of the 

uterus: a clinicopathologic study. Obstet 

Gynecol 74: 388-392. 

704. Dixon AR, Ellis IO, Elston CW, Blamey 

RW (1991). A comparison of the clinical 

metastatic patterns of invasive lobular and 

ductal carcinomas of the breast. Br J 

Cancer 63: 634-635. 

705. Dixon JM, Anderson TJ, Page DL, Lee 

D, Duffy SW (1982). Infiltrating lobular carcinoma 

of the breast. Histopathology 6: 

149-161. 

706. Dixon JM, Lumsden AB, Krajewski A, 

Elton RA, Anderson TJ (1987). Primary lymphoma 

of the breast. Br J Surg 74: 214-216. 

707. Dixon JM, Sainsbury JRC (1998). 

Handbook of Diseases of the Breast. 2nd 

ed. Churchill Livingstone: Edinburgh. 

708. Dobbs SP, Shaw PA, Brown LJ, 

Ireland D (1998). Borderline malignant 

change in recurrent mullerian papilloma of 

the vagina. J Clin Pathol 51: 875-877. 

709. Dockerty MB, Masson JC (1944). 

Ovarian fibromas: a clinical and pathologi - 

cal study of two hundred-and eighty-three 

cases. Am J Obstet Gynecol 47: 741-752. 

710. Dodge JA, Eltabbakh GH, Mount SL, 

Walker RP, Morgan A (2001). Clinical features 

and risk of recurrence among 

patients with vaginal intraepithelial neoplasia. 


711. Domagala W, Harezga B, Szadowska 

A, Markiewski M, Weber K, Osborn M 

(1993). Nuclear p53 protein accumulates 

preferentially in medullary and high-grade 

ductal but rarely in lobular breast carcino - 

mas. Am J Pathol 142: 669-674. 

712. Done SJ, Eskandarian S, Bull S, 

Redston M, Andrulis IL (2001). p53 missense 

mutations in microdissected highgrade 

ductal carcinoma in situ of the 

breast. J Natl Cancer Inst 93: 700-704. 

713. Donegan WL, Redlich PN, Lang PJ, 

Gall MT (1998). Carcinoma of the breast in 

males: a multiinstitutional survey. Cancer 

83: 498-509. 

714. Donehower LA, Harvey M, Slagle BL, 

McArthur MJ, Montgomery CA Jr., Butel 

JS, Bradley A (1992). Mice deficient for p53 

are developmentally normal but susceptible 

to spontaneous tumours. Nature 356: 

215-221. 

715. Dong C, Hemminki K (2001). 

Modification of cancer risks in offspring by 

sibling and parental cancers from 

2,112,616 nuclear families. Int J Cancer 92: 

144-150. 

715 a. Dong HJ, Li JG, Zeng JH, Huang SZ 

(1986). Papillary adenocarcinoma of the 

broad ligament. Report of a case and 

review of literature. Chin Med J (Engl) 99: 

431-432. 

716. Donkers B, Kazzaz BA, Meijering JH 

(1972). Rhabdomyosarcoma of the corpus 

uteri. Report of two cases with review of 

the literature. Am J Obstet Gynecol 114: 

1025-1030. 

717. Donnell RM, Rosen PP, Lieberman PH, 

Kaufman RJ, Kay S, Braun DW Jr., Kinne 

DW (1981). Angiosarcoma and other vascular 

tumors of the breast. Am J Surg 

Pathol 5: 629-642. 

718. Dougherty CM, Cunningham C, Mickal 

A (1978). Choriocarcinoma with metastasis 

in a postmenopausal woman. Am J Obstet 

Gynecol 132: 700-701. 

719. Douglas-Jones AG, Pace DP (1997). 

Pathology of R4 spiculated lesions in the 

breast screening programme. 


720. Downey GO, Okagaki T, Ostrow RS, 

Clark BA, Twiggs LB, Faras AJ (1988). 

Condylomatous carcinoma of the vulva 

with special reference to human papillomavirus 

DNA. Obstet Gynecol 72: 68-73. 

721. Drew PA, al Abbadi MA, Orlando CA, 

Hendricks JB, Kubilis PS, Wilkinson EJ 

(1996). Prognostic factors in carcinoma of 

the vulva: a clinicopathologic and DNA 

flow cytometric study. Int J Gynecol 

Pathol 15: 235-241. 

722. Driscoll SG (1963). Choriocarcinoma. 

An "incidental finding" within a term placenta. 


723. Droufakou S, Deshmane V, Roylance 

R, Hanby A, Tomlinson I, Hart IR (2001). 

Multiple ways of silencing E-cadherin 

gene expression in lobular carcinoma of 

the breast. Int J Cancer 92: 404-408. 

724. Droulias CA, Sewell CW, McSweeney 

MB, Powell RW (1976). Inflammatory carcinoma 

of the breast: A correlation of clinical, 

radiologic and pathogic findings. Ann 

Surg 184: 217-222. 

725. du Toit RS, Locker AP, Ellis IO, Elston 

CW, Nicholson RI, Blamey RW (1989). 

Invasive lobular carcinomas of the breast- 

-the prognosis of histopathological subtypes. 

Br J Cancer 60: 605-609. 

726. Dubeau L (1999). The cell of origin of 

ovarian epithelial tumors and the ovarian 

surface epithelium dogma: does the 

emperor have no clothes? Gynecol Oncol 

72: 437-442. 

727. Duggan MA, Hugh J, Nation JG, 

Robertson DI, Stuart GC (1989). 

Ependymoma of the uterosacral ligament. 

Cancer 64: 2565-2571. 

728. Dumont-Herskowitz RA, Safaii HS, 

Senior B (1978). Ovarian fibromata in four 

successive generations. J Pediatr 93: 621- 

624. 

729. Dunaif A, Hoffman AR, Scully RE, Flier 

JS, Longcope C, Levy LJ, Crowley WF Jr. 

(1985). Clinical, biochemical, and ovarian 

morphologic features in women with acanthosis 

nigricans and masculinization. 


7 3 0 . Dungar CF, Wilkinson EJ (1995). 

Vaginal columnar cell metaplasia. An 

acquired adenosis associated with topical 

5-fluorouracil therapy. J Reprod Med 40: 

361-366. 

731. Dunlop MG, Farrington SM, Carothers 

AD, Wyllie AH, Sharp L, Burn J, Liu B, 

Kinzler KW, Vogelstein B (1997). Cancer 

risk associated with germline DNA mismatch 

repair gene mutations. Hum Mol 

Genet 6: 105-110. 

732. Dupont WD, Page DL (1985). Risk factors 

for breast cancer in women with proliferative 

breast disease. N Engl J Med 312: 

146-151. 

733. Dupont WD, Page DL (1987). Breast 

cancer risk associated with proliferative 

disease, age at first birth, and a family his - 

tory of breast cancer. Am J Epidemiol 125: 

769-779. 

734. Dupont WD, Page DL, Parl FF, 

Vnencak-Jones CL, Plummer WD Jr., 

Rados MS, Schuyler PA (1994). Long-term 

risk of breast cancer in women with 

fibroadenoma. N Engl J Med 331: 10-15. 

735. Dupont WD, Parl FF, Hartmann WH, 

Brinton LA, Winfield AC, Worrell JA, 

Schuyler PA, Plummer WD (1993). Breast 

cancer risk associated with proliferative 

breast disease and atypical hyperplasia. 

Cancer 71: 1258-1265. 

7 3 6 . Durkop H, Foss HD, Eitelbach F, 

Anagnostopoulos I, Latza U, Pileri S, Stein 

H (2000). Expression of the CD30 antigen in 

non-lymphoid tissues and cells. J Pathol 

190: 613-618. 

737. Durst M, Gissmann L, Ikenberg H, zur 

Hausen H (1983). A papillomavirus DNA 

from a cervical carcinoma and its prevalence 

in cancer biopsy samples from different 

geographic regions. Proc Natl Acad 

Sci USA 80: 3812-3815. 

738. Duska LR, Flynn C, Goodman A (1998). 

Masculinizing sclerosing stromal cell 

tumor in pregnancy: report of a case and 

review of the literature. Eur J Gynaecol 

Oncol 19: 441-443. 

739. Duun S (1994). Bilateral virilizing hilus 

(Leydig) cell tumors of the ovary. Acta 

Obstet Gynecol Scand 73: 76-77. 

740. Duvall E, Survis JA (1983). Borderline 

tumour of the broad ligament. Case report. 

Br J Obstet Gynaecol 90: 372-375. 

741. Easton DF (1994). Cancer risks in A-T 

heterozygotes. Int J Radiat Biol 66: S177- 

S182. 

742. Easton DF, Ford D, Bishop DT (1995). 

Breast and ovarian cancer incidence in 

BRCA1-mutation carriers. Breast Cancer 

Linkage Consortium. Am J Hum Genet 56: 

265-271. 

743. Easton DF, Matthews FE, Ford D, 

Swerdlow AJ, Peto J (1996). Cancer mortality 

in relatives of women with ovarian 

cancer: the OPCS Study. Office of 

Population Censuses and Surveys. Int J 

Cancer 65: 284-294. 

744. Easton DF, Steele L, Fields P, Ormiston 

W, Averill D, Daly PA, McManus R, 

Neuhausen SL, Ford D, Wooster R, 

Cannon-Albright LA, Stratton MR, Goldgar 

DE (1997). Cancer risks in two large breast 

cancer families linked to BRCA2 on chromosome 

13q12-13. Am J Hum Genet 61: 

120-128. 

745. Ebrahim S, Daponte A, Smith TH, 

Tiltman A, Guidozzi F (2001). Primary mucinous 

adenocarcinoma of the vagina. 


746. Eckstein RP, Paradinas FJ, Bagshawe 

KD (1982). Placental site trophoblastic 

tumour (trophoblastic pseudotumour): a 

study of four cases requiring hysterectomy 

including one fatal case. Histopathology 6: 

211-226. 747. Eckstein RP, Russell P, 

Friedlander ML, Tattersall MH, Bradfield A 

(1985). Metastasizing placental site trophoblastic 

tumor: a case study. H u m 

Pathol 16: 632-636. 

748. Eddy GL, Marks RD Jr., Miller MC III, 

Underwood PB Jr. (1991). Primary invasive 

vaginal carcinoma. Am J Obstet Gynecol 

165: 292-296. 

749. Eeles RA (1999). Screening for heredi - 

tary cancer and genetic testing, epitomized 

by breast cancer. Eur J Cancer 35: 

1954-1962. 

7 5 0 . Egan AJ, Russell P (1996). Transitional 

(urothelial) cell metaplasia of the fallopian 

tube mucosa: morphological assessment of 

three cases. Int J Gynecol Pathol 15: 72-76. 

751. Egan RL (1976). Bilateral breast carcinomas: 

Role of mammography. Cancer 38: 

931-938. 

752. Eggers JW, Chesney TM (1984). 

Squamous cell carcinoma of the breast: a 

clinicopathologic analysis of eight cases 

and review of the literature.Hum Pathol 15: 

526-531. 

753. Ehrlich CE, Roth LM (1971). The 

Brenner tumor. A clinicopathologic study 

of 57 cases. Cancer 27: 332-342. 

754. Eichhorn JH, Bell DA, Young RH, 

Scully RE (1999). Ovarian serous borderline 

tumors with micropapillary and cribriform 

patterns: a study of 40 cases and comparison 

with 44 cases without these patterns. 


755. Eichhorn JH, Bell DA, Young RH, 

Swymer CM, Flotte TJ, Preffer RI, Scully RE 

(1992). DNA content and proliferative 

activity in ovarian small cell carcinomas of 

the hypercalcemic type. Implications for 

diagnosis, prognosis, and histogenesis. 


756. Eichhorn JH, Lawrence WD, Young 

RH, Scully RE (1996). Ovarian neuroendocrine 

carcinomas of non-small-cell type 

associated with surface epithelial adenocarcinomas. 

A study of five cases and 

review of the literature. Int J Gynecol 

Pathol 15: 303-314. 


757. Eichhorn JH, Scully RE (1991). Ovarian 

myxoma: clinicopathologic and immunocytologic 

analysis of five cases and a review 

of the literature. Int J Gynecol Pathol 10: 

156-169. 

7 5 8 . Eichhorn JH, Scully RE (1995). 

"Adenoid cystic" and basaloid carcinomas 

of the ovary: evidence for a surface epithelial 

lineage. A report of 12 cases. Mod 

Pathol 8: 731-740. 

7 5 9 . Eichhorn JH, Scully RE (1996). 

Endometrioid ciliated-cell tumors of the 

ovary: a report of five cases. Int J Gynecol 

Pathol 15: 248-256. 

760. Eichhorn JH, Young RH, Clement PB, 

Scully RE (2002). Mesodermal (mullerian) 

adenosarcoma of the ovary: a clinicopathologic 

analysis of 40 cases and a 

review of the literature. Am J Surg Pathol 

26: 1243-1258. 

761. Eichhorn JH, Young RH, Scully RE 

(1992). Primary ovarian small cell carcinoma 

of pulmonary type. A clinicopathologic, 

immunohistologic, and flow cytometric 

analysis of 11 cases. Am J Surg Pathol 16: 

926-938. 

762. Eifel P, Hendrickson M, Ross J, Ballon 

S, Martinez A, Kempson R (1982). 

Simultaneous presentation of carcinoma 

involving the ovary and the uterine corpus. 

Cancer 50: 163-170. 

7 6 3 . Eisen A, Rebbeck TR, Lynch HT, 

Lerman C, Ghadirian P, Dube MP (2000). 

Reduction in Breast Cancer Risk following 

Bilateral Prophylactic Oophorectomy in 

BRCA1 and BRCA2 Mutation Carriers. Am 

J Hum Genet 67: 58. 

764. Eisinger F, Jacquemier J, Charpin C, 

Stoppa-Lyonnet D, Bressac-de Paillerets 

B, Peyrat JP, Longy M, Guinebretiere JM, 

Sauvan R, Noguchi T, Birnbaum D, Sobol H 

(1998). Mutations at BRCA1: the medullary 

breast carcinoma revisited. Cancer Res 58: 

1588-1592. 

765. Eisinger F, Jacquemier J, 

Guinebretiere JM, Birnbaum D, Sobol H 

(1997). p53 involvement in BRCA1-associated 

breast cancer. Lancet 350: 1101. 

766. Eisinger F, Jacquemier J, Nogues C, 

Birnbaum D, Sobol H (1999). Steroid receptors 

in hereditary breast carcinomas associated 

with BRCA1 or BRCA2 mutations or 

unknown susceptibility genes. Cancer 85: 

2291-2295. 

767. Eisner RF, Nieberg RK, Berek JS 

(1989). Synchronous primary neoplasms of 

the female reproductive tract. G y n e c o l 

Oncol 33: 335-339. 

768. Elliott P, Coppleson M, Russell P, 

Liouros P, Carter J, MacLeod C, Jones M 

(2000). Early invasive (FIGO stage IA) carcinoma 

of the cervix: a clinico-pathologic 

study of 476 cases. Int J Gynecol Cancer 

10: 42-52. 

769. Ellis DL, Teitelbaum SL (1974). 

Inflammatory carcinoma of the breast. A 

pathologic definition. Cancer 33: 1045-1047. 

770. Ellis IO, Elston CW, Goulding H, et al. 

(1998). Miscellaneous benign lesions. In: 

The Breast. CW Elston and IO Ellis (Ed.) 1st 

ed. Churchill Livingstone: Edinburgh, p. 224. 

771. Ellis IO, Galea M, Broughton N, Locker 

A, Blamey RW, Elston CW (1992). 

Pathological prognostic factors in breast 

cancer. II. Histological type. Relationship 

with survival in a large study with longterm 

follow-up. Histopathology 20: 479-489. 


772. Ellis IO, Galea MH, Locker A, Roebuck 

EJ, Elston CW, Blamey RW, Wilson ARM 

(1993). Early experience in breast cancer 

screening: Emphasis on development of 

protocols for triple assessment. Breast 2: 

148-153. 

773. Elsheikh A, Keramopoulos A, Lazaris 

D, Ambela C, Louvrou N, Michalas S (2000). 

Breast tumors during adolescence. Eur J 


774. Elston C.W, Ellis I.O. (1998). 

Classification of malignant breast disease. 

In: The Breast. Systemic Pathology. CW 

Elston and IO Ellis (Eds.) 3rd ed. Churchill 

Livingstone: Edinburgh, pp. 239-247. 

775. Elston C.W, Ellis I.O. (1998). 

Fibroadenoma and related conditions. In: 

The Breast. CW Elston and IO Ellis (Ed.) 

Churchill Livingstone: Edinburgh. 

775a. Elston CW, Bagshawe KD (1972). The 

diagnosis of trophoblastic tumours from 

uterine curettings. J Clin Pathol 25: 111- 

118. 

776. Elston CW, Bagshawe KD (1972). The 

value of histological grading in the management 

of hydatidiform mole. J Obstet 

Gynaecol Br Commonw 79: 717-724. 

777. Elston CW, Ellis IO (1991). Pathological 

prognostic factors in breast cancer. I. The 

value of histological grade in breast cancer: 

experience from a large study with 

long-term follow-up. Histopathology 1 9 : 

403-410. 

778. Elston CW, Ellis IO (1998). Metastases 

within the breast. In: The Breast. C W 

Elston and IO Ellis (Eds.) Churchill 

Livingstone: Edinburgh. 

779. Elston CW, Ellis IO (1998). Systemic 

pathology 3E. In: The Breast. CW Elston 

and IO Ellis (Eds.) Churchill Livingstone: 

Edinburgh. 

780. Elston CW, Sloane JP, Amendoeira I, 

Apostolikas N, Bellocq JP, Bianchi S, 

Boecker W, Bussolati G, Coleman D, 

Connolly CE, Dervan P, Drijkoningen M, 

Eusebi V, Faverly D, Holland R, Jacquemier 

J, Lacerda M, Martinez-Penuela J, De 

Miguel C, Mossi S, Munt C, Peterse JL, 

Rank F, Reiner A, Sylvan M, Wells CA, 

Zafrani B (2000). Causes of inconsistency 

in diagnosing and classifying intraductal 

proliferations of the breast. European 

Commission Working Group on Breast 

Screening Pathology. Eur J Cancer 3 6 : 

1769-1772. 

781. Emerich J, Senkus E, Konefka T (1996). 

Alveolar rhabdomyosarcoma of the uterine 

cervix. Gynecol Oncol 63: 398-403. 

782. Emery JD, Kennedy AW, Tubbs RR, 

Castellani WJ, Hussein MA (1999). 

Plasmacytoma of the ovary: a case report 

and literature review. Gynecol Oncol 73: 

151-154. 

783. Emmert-Buck MR, Chuaqui R, Zhuang 

Z, Nogales F, Liotta LA, Merino MJ (1997). 

Molecular analysis of synchronous uterine 

and ovarian endometrioid tumors. Int J 


784. Emoto M, Iwasaki H, Kawarabayashi 

T, Egami D, Yoshitake H, Kikuchi M, 

Shirakawa K (1994). Primary osteosarcoma 

of the uterus: report of a case with 

immunohistochemical analysis. G y n e c o l 

Oncol 54: 385-388. 

785. Eng C (1997). Cowden syndrome. J 

Genet Counsel 6: 181-191. 

786. Eng C (2000). Will the real Cowden 

syndrome please stand up: revised diagnostic 

criteria. J Med Genet 37: 828-830. 

787. Eng C, Parsons R (1998). Cowden syndrome. 

In: The Genetic Basis of Human 

Cancer. B Vogelstein, K Kinzler (Eds.) New 

York: McGraw-Hill, pp. 519-526. 

788. Eng C, Parsons R (2001). Cowden syndrome. 

In: Metabolic and Molecular Bases 

of Inherited Disease. C Scriver, AL 

Beaudet, WS Sly, D Valle (Eds.) 8th ed. 

McGraw-Hill: New York , pp. 979-988. 

789. Enomoto T, Haba T, Fujita M, Hamada 

T, Yoshino K, Nakashima R, Wada H, 

Kurachi H, Wakasa K, Sakurai M, Murata 

Y, Shroyer KR (1997). Clonal analysis of 

high-grade squamous intra-epithelial 

lesions of the uterine cervix. Int J Cancer 

73: 339-344. 

790. Enzinger FM, Shiraki M (1967). 

Musculo-aponeurotic fibromatosis of the 

shoulder girdle (extra-abdominal 

desmoid). Analysis of thirty cases followed 

up for ten or more years. Cancer 20: 1131- 

1140. 

791. Erdreich LS, Asal NR, Hoge AF (1980). 

Morphologic types of breast cancer: age, 

bilaterality, and family history. South Med 

J 73: 28-32. 

792. Eriksson ET, Schimmelpenning H, 

Aspenblad U, Zetterberg A, Auer GU (1994). 

Immunohistochemical expression of the 

mutant p53 protein and nuclear DNA content 

during the transition from benign to 

malignant breast disease. Hum Pathol 25: 

1228-1233. 

7 9 3 . Erlandson RA, Rosen PP (1982). 

Infiltrating myoepithelioma of the breast. 


794. Ernster VL, Barclay J, Kerlikowske K, 

Wilkie H, Ballard-Barbash R (2000). 

Mortality among women with ductal carcinoma 

in situ of the breast in the population-based 

surveillance, epidemiology and 

end results program. Arch Intern Med 160: 

953-958. 

795. Escalonilla P, Grilli R, Canamero M, 

Soriano ML, Farina MC, Manzarbeitia F, 

Sainz R, Matsukura T, Requena L (1999). 

Sebaceous carcinoma of the vulva. Am J 

Dermatopathol 21: 468-472. 

796. Esche C, Kruse R, Lamberti C, Friedl W, 

Propping P, Lehmann P, Ruzicka T (1997). 

Muir-Torre syndrome: clinical features and 

molecular genetic analysis. Br J Dermatol 

136: 913-917. 

797. Essary LR, Kaarami M, Page DL, Wick 

MR (1999). Immunohistology of variant 

adenosis & pseudoinvasive epithelial proliferations 

of the breast: helpful or not? Lab 

Invest 79. 

798. Esteban JM, Allen WM, Schaerf RH 

(1999). Benign metastasizing leiomyoma of 

the uterus: histologic and immunohistochemical 

characterization of primary and 

metastatic lesions. Arch Pathol Lab Med 

123: 960-962. 

799. Esteller M, Levine R, Baylin SB, 

Ellenson LH, Herman JG (1998). MLH1 promoter 

hypermethylation is associated with 

the microsatellite instability phenotype in 

sporadic endometrial carcinomas. 

Oncogene 17: 2413-2417. 

800. Etzell JE, Devries S, Chew K, Florendo 

C, Molinaro A, Ljung BM, Waldman FM 

(2001). Loss of chromosome 16q in lobular 

carcinoma in situ. Hum Pathol 32: 292-296. 

801. Eusebi V, Azzopardi JG (1980). Lobular 

endocrine neoplasia in fibroadenoma of 

the breast. Histopathology 4: 413-428. 

802. Eusebi V, Betts CM, Haagensen DE, 

Gugliotta P, Bussolati G, Azzopardi JG 

(1984). Apocrine differentiation in lobular 

carcinoma of the breast. Hum Pathol 15: 

134-140. 

803. Eusebi V, Casadei GP, Bussolati G, 

Azzopardi JG (1986). Adenomyoepithelioma 

of the breast with a distinctive type 

of apocrine adenosis. Histopathology 11: 

305-315. 

804. Eusebi V, Damiani S, Losi L., Millis RR 

(1997). Apocrine differentiation in breast 

epithelium. Advances Anat Pathol 4: 139-155. 

805. Eusebi V, Damiani S, Losi L, Millis RR 

(1997). Apocrine differentiation in breast 

e p i t h e l i u m . Advances in Anatomic 


806. Eusebi V, Foschini MP, Bussolati G, 

Rosen PP (1995). Myoblastomatoid (histiocytoid) 

carcinoma of the breast. A type of 

apocrine carcinoma. Am J Surg Pathol 19: 

553-562. 

807. Eusebi V, Lamovec J, Cattani MG, 

Fedeli F, Millis RR (1986). Acantholytic variant 

of squamous-cell carcinoma of the 


808. Eusebi V, Magalhaes F, Azzopardi AG 

(1992). Pleomorphic lobular carcinoma of 

the breast: an aggressive tumour showing 

apocrine differentiation. Hum Pathol 23: 

655-662. 

809. Eusebi V, Millis RR, Cattani MG, 

Bussolati G, Azzopardi JG (1986). Apocrine 

carcinoma of the breast. A morphologic 

and immunocytochemical study. Am J 

Pathol 123: 532-541. 

810. Evans AJ, Pinder SE, Ellis IO, Wilson 

AR (2001). Screen detected ductal carcinoma 

in situ (DCIS): overdiagnosis or an obligate 

precursor of invasive disease? J Med 

Screen 8: 149-151. 811. Evans HL (1982). 

Endometrial stromal sarcoma and poorly 

differentiated endometrial sarcoma. 

Cancer 50: 2170-2182. 

812. Evans HL, Chawla SP, Simpson C, Finn 

KP (1988). Smooth muscle neoplasms of 

the uterus other than ordinary leiomyoma. 

A study of 46 cases, with emphasis on 

diagnostic criteria and prognostic factors. 

Cancer 62: 2239-2247. 

813. Evans MJ, Langlois NE, Kitchener HC, 

Miller ID (1995). Is there an association 

between long-term tamoxifen treatment 

and the development of carcinosarcoma 

(malignant mixed Mullerian tumor) of the 

uterus? Int J Gynecol Cancer 5: 310-313. 

814. Ewertz M, Holmberg L, Karjalainen S, 

Tretli S, Adami HO (1989). Incidence of 

male breast cancer in Scandinavia, 1943- 

1982. Int J Cancer 43: 27-31. 

815. Ewertz M, Holmberg L, Tretli S, 

Pedersen BV, Kristensen A (2001). Risk 

factors for male breast cancer - a casecontrol 

study from Scandinavia. A c t a 

Oncol 40: 467-471. 

816. Fackenthal JD, Cartegni L, Krainer AR, 

Olopade OI (2002). BRCA2 T2722R is a deleterious 

allele that causes exon skipping. 

Am J Hum Genet 71: 625-631. 

817. Fackenthal JD, Marsh DJ, Richardson 

AL, Cummings SA, Eng C, Robinson BG, 

Olopade OI (2001). Male breast cancer in 

Cowden syndrome patients with germline 

PTEN mutations. J Med Genet 38: 159-164. 

818. Fagundes H, Perez CA, Grigsby PW, 

Lockett MA (1992). Distant metastases 

after irradiation alone in carcinoma of the 

uterine cervix. Int J Radiat Oncol Biol Phys 

24: 197-204. 

819. Fairfield KM, Hankinson SE, Rosner 

BA, Hunter DJ, Colditz GA, Willett WC 

(2001). Risk of ovarian carcinoma and consumption 

of vitamins A, C, and E and specific 

carotenoids: a prospective analysis. 

Cancer 92: 2318-2326.

820. Falck J, Petrini JH, Williams BR, Lukas 

J, Bartek J (2002). The DNA damagedependent 

intra-S phase checkpoint is 

regulated by parallel pathways. Nat Genet 

30: 290-294. 

821. Falconieri G, Della LD, Zanconati F, 

Bittesini L (1997). Leiomyosarcoma of the 

female breast: report of two new cases 

and a review of the literature. Am J Clin 

Pathol 108: 19-25. 

822. Falkenberry SS, Steinhoff MM, 

Gordinier M, Rappoport S, Gajewski W, 

Granai CO (1996). Synchronous endometrioid 

tumors of the ovary and endometrium. 

A clinicopathologic study of 22 cases. J 

Reprod Med 41: 713-718. 

823. Fan LD, Zang HY, Zhang XS (1996). 

Ovarian epidermoid cyst: report of eight 


824. Fanburg-Smith JC, Meis-Kindblom 

JM, Fante R, Kindblom LG (1998). 

Malignant granular cell tumor of soft tissue: 

diagnostic criteria and clinicopathologic 

correlation. Am J Surg Pathol 22: 779- 

794. 

825. Fanning J, Lambert HC, Hale TM, 

Morris PC, Schuerch C (1999). Paget's disease 

of the vulva: prevalence of associated 

vulvar adenocarcinoma, invasive 

Paget's disease, and recurrence after surgical 

excision. Am J Obstet Gynecol 180: 

24-27. 

826. Faquin WC, Fitzgerald JT, Lin MC, 

Boynton KA, Muto MG, Mutter GL (2000). 

Sporadic microsatellite instability is specific 

to neoplastic and preneoplastic 

endometrial tissues. Am J Clin Pathol 113: 

576-582. 

827. Farshid G, Moinfar F, Meredith DJ, 

Peiterse S, Tavassoli FA (2001). Spindle 

cell ductal carcinoma in situ. An unusual 

variant of ductal intra-epithelial neoplasia 

that simulates ductal hyperplasia or a 

myoepithelial proliferation. Virchows Arch 

439: 70-77. 

828. Fastenberg NA, Martin RG, Buzdar AU, 

Hortobagyi GN, Montague ED, 

Blumenschein GR, Jessup JM (1985). 

Management of inflammatory carcinoma 

of the breast. A combined modality 

approach. Am J Clin Oncol 8: 134-141. 

829. Fathalla MF (1967). The occurrence of 

granulosa and theca tumours in clinically 

normal ovaries. A study of 25 cases. J 

Obstet Gynaecol Br Commonw 74: 278-282. 

830. Faul C, Kounelis S, Karasek K, 

Papadaki H, Greeenberger J, Jones MW 

(1996). Small cell carcinoma of the uterine 

cervix: Overespression of p53, Bcl2, and 

CD 44. Int J Gynecol Cancer 6: 369-375. 

831. Faverly DR, Burgers L, Bult P, Holland 

R (1994). Three dimensional imaging of 

mammary ductal carcinoma in situ: clinical 

implications. Semin Diagn Pathol 11: 193- 

198. 

832. Fawcett FJ, Kimbell NK (1971). 

Phaeochromocytoma of the ovary. J 

Obstet Gynaecol Br Commonw 78: 458-459. 

833. Feakins RM, Lowe DG (1997). Basal 

cell carcinoma of the vulva: a clinicopathologic 

study of 45 cases. Int J Gynecol 

Pathol 16: 319-324. 

834. Fechner RE (1972). Infiltrating lobular 

carcinoma without lobular carcinoma in 

situ. Cancer 29: 1539-1545. 

835. Fechner RE (1975). Histologic variants 

of infiltrating lobular carcinoma of the 

breast. Hum Pathol 6: 373-378. 

836. Fechner RE, Mills SE (1990). Breast 

Pathology Benign Proliferations, Atypias In 

Situ Carcinomas. ASCP Press - American 

Society of Clinical Pathologist: Chicago. 

837. Feczko JD, Jentz DL, Roth LM (1996). 

Adenoid cystic ovarian carcinoma compared 

with other adenoid cystic carcinomas 

of the female genital tract. M o d 

Pathol 9: 413-417. 

838. Feeley KM, Wells M (2001). Precursor 

lesions of ovarian epithelial malignancy. 


839. Fein DA, Fowble BL, Hanlon AL, Hooks 

MA, Hoffman JP, Sigurdson ER, Jardines 

LA, Eisenberg BL (1997). Identification of 

women with T1-T2 breast cancer at low 

risk of positive axillary nodes. J Surg 

Oncol 65: 34-39. 

840. Feinmesser M, Sulkes A, Morgenstern 

S, Sulkes J, Stern S, Okon E (2000). HLA-DR 

and beta 2 microglobulin expression in 

medullary and atypical medullary carcinoma 

of the breast: histopathologically similar 

but biologically distinct entities. J Clin 

Pathol 53: 286-291. 

841. Feldman LD, Hortobagyi GN, Buzdar 

AU, Ames FC, Blumenschein GR (1986). 

Pathological assessment of response to 

induction chemotherapy in breast cancer. 

Cancer Res 46: 2578-2581. 

842. Feltmate CM, Genest DR, Wise L, 

Bernstein MR, Goldstein DP, Berkowitz RS 

(2001). Placental site trophoblastic tumor: 

a 17-year experience at the New England 

Trophoblastic Disease Center. G y n e c o l 

Oncol 82: 415-419. 

843. Fenoglio C, Lattes R (1974). Sclerosing 

papillary proliferations in the female 

breast. A benign lesion often mistaken for 

carcinoma. Cancer 33: 691-700. 

844. Fentiman IS, Millis RR, Smith P, Ellul 

JP, Lampejo O (1997). Mucoid breast carcinomas: 

histology and prognosis. Br J 

Cancer 75: 1061-1065. 

845. Ferguson AW, Katabuchi H, Ronnett 

BM, Cho KR (2001). Glial implants in 

gliomatosis peritonei arise from normal tissue, 

not from the associated teratoma. Am 

J Pathol 159: 51-55. 

846. Ferlay J, Bray F, Pisani P, Parkin DM 

(2001). Globocan 2000. Cancer Incidence, 

Mortality and Prevalence Worlwide. 

IARCPress: Lyon. 

847. Fernandez FA, Val-Bernal F, Garijo- 

Ayensa F (1989). Mixed lipomas of the 

uterus and the broad ligament. Appl Pathol 

7: 70-71. 

848. Feroze M, Aravindan KP, Thomas M 

(1997). Mullerian adenosarcoma of the 

uterine cervix. Indian J Cancer 34: 68-72. 

849. Ferry JA, Scully RE (1988). "Adenoid 

cystic" carcinoma and adenoid basal carcinoma 

of the uterine cervix. A study of 28 


850. Ferry JA, Scully RE (1990). 

Mesonephric remnants, hyperplasia, and 

neoplasia in the uterine cervix. A study of 

49 cases. Am J Surg Pathol 14: 1100-1111. 

851. Ferry JA, Young RH (1991). Malignant 

lymphoma, pseudolymphoma, and 

hematopoietic disorders of the female 

genital tract. Pathol Annu 26 Pt 1: 227-263. 

852. Ferry JA, Young RH, Engel G, Scully RE 

(1994). Oxyphilic Sertoli cell tumor of the 

ovary: a report of three cases, two in 

patients with the Peutz-Jeghers syndrome. 


853. Fetsch JF, Laskin WB, Lefkowitz M, 

Kindblom LG, Meis-Kindblom JM (1996). 

Aggressive angiomyxoma: a clinicopathologic 

study of 29 female patients. Cancer 

78: 79-90. 

854. Fetsch JF, Laskin WB, Tavassoli FA 

(1997). Superficial angiomyxoma (cutaneous 

myxoma): a clinicopathologic study 

of 17 cases arising in the genital region. Int 


855. Feyrter F, Hartmann G (1963). Uber die 

carcinoide Wuchsform des Carcinoma 

mammae, insbesondere das Carcinoma 

solidum (gelatinosum) mamma. Fradf Z 

Pathol 73: 24-30. 

856. Fiche M, Avet-Loiseau H, Maugard 

CM, Sagan C, Heymann MF, Leblanc M, 

Classe JM, Fumoleau P, Dravet F, Mahe M, 

Dutrillaux B (2000). Gene amplifications 

detected by fluorescence in situ hybridization 

in pure intraductal breast carcinomas: 

relation to morphology, cell proliferation 

and expression of breast cancer-related 

genes. Int J Cancer 89: 403-410. 

857. Fina F, Romain S, Ouafik L, Palmari J, 

Ben Ayed F, Benharkat S, Bonnier P, 

Spyratos F, Foekens JA, Rose C, Buisson 

M, Gerard H, Reymond MO, Seigneurin 

JM, Martin PM (2001). Frequency and 

genome load of Epstein-Barr virus in 509 

breast cancers from different geographical 

areas. Br J Cancer 84: 783-790. 

858. Fingerland A (1938). Ganglioneuroma 

of the cervix uteri. J Pathol Bacteriol 47: 

631-634. 

859. Fink D, Kubik-Huch RA, Wildermuth S 

(2001). Juvenile granulosa cell tumor. 

Abdom Imaging 26: 550-552. 

860. Fink D, Nebel S, Aebi S, Zheng H, Kim 

HK, Christen RD, Howell SB (1997). 

Expression of the DNA mismatch repair 

proteins hMLH1 and hPMS2 in normal 

human tissues. Br J Cancer 76: 890-893. 

861. Finkler NJ, Berkowitz RS, Driscoll SG, 

Goldstein DP, Bernstein MR (1988). Clinical 

experience with placental site trophoblas - 

tic tumors at the New England 

Trophoblastic Disease Center. O b s t e t 

Gynecol 71: 854-857. 

862. Finn WF, Javert CT (1949). Primary and 

metastatic cancer of the fallopian tube. 

Cancer 2: 803-814. 

863. Fishel R (2001). The selection for mismatch 

repair defects in hereditary nonpolyposis 

colorectal cancer: revising the 

mutator hypothesis. Cancer Res 61: 7369- 

7374. 

8 6 4 . Fishel R, Lescoe MK, Rao MR, 

Copeland NG, Jenkins NA, Garber J, Kane 

M, Kolodner R (1993). The human mutator 

gene homolog MSH2 and its association 

with hereditary nonpolyposis colon cancer. 

Cell 75: 1027-1038. 

865. Fisher B, Costantino JP, Wickerham 

DL, Redmond CK, Kavanah M, Cronin WM, 

Vogel V, Robidoux A, Dimitrov N, Atkins J, 

Daly M, Wieand S, Tan-Chiu E, Ford L, 

Wolmark N (1998). Tamoxifen for prevention 

of breast cancer: report of the 

National Surgical Adjuvant Breast and 

Bowel Project P-1 Study. J Natl Cancer 

Inst 90: 1371-1388. 

8 6 6 . Fisher B, Dignam J, Wolmark N, 

Wickerham DL, Fisher ER, Mamounas E, 

Smith R, Begovic M, Dimitrov NV, 

Margolese RG, Kardinal CG, Kavanah MT, 

Fehrenbacher L, Oishi RH (1999). 

Tamoxifen in treatment of intraductal 

breast cancer: National Surgical Adjuvant 

Breast and Bowel Project B-24 randomised 

controlled trial. Lancet 353: 1993- 

2000. 

867. Fisher CJ, Hanby AM, Robinson L, 

Millis RR (1992). Mammary hamartoma--a 

review of 35 cases. Histopathology 20: 99- 

106. 

868. Fisher ER, Anderson S, Redmond C, 

Fisher B (1993). Pathologic findings from 

the National Surgical Adjuvant Breast 

Project protocol B-06. 10-year pathologic 

and clinical prognostic discriminants. 

Cancer 71: 2507-2514. 

8 6 9 . Fisher ER, Costantino J, Fisher B, 

Palekar AS, Paik SM, Suarez CM, Wolmark 

N (1996). Pathologic findings from the 

National Surgical Adjuvant Breast Project 

(NSABP) Protocol B-17. Five-year observations 

concerning lobular carcinoma in situ. 

Cancer 78: 1403-1416. 


Palekar AS, Redmond C, Mamounas E 

(1995). Pathologic findings from the 


(NSABP) Protocol B-17. Intraductal carcinoma 

(ductal carcinoma in situ). The 


Bowel Project Collaborating Investigators. 

Cancer 75: 1310-1319. 


Redmond C (1993). Pathologic findings 

from the National Surgical Adjuvant Breast 

Project (Protocol 4). Discriminants for 15year 

survival. National Surgical Adjuvant 

Breast and Bowel Project Investigators. 

Cancer 71: 2141-2150. 

8 7 2 . Fisher ER, Fisher B, Sass R, 

Wickerham L (1984). Pathologic findings 

from the National Surgical Adjuvant Breast 

Project (Protocol No. 4). XI. Bilateral breast 

cancer. Cancer 54: 3002-3011. 

8 7 3 . Fisher ER, Gregorio R, Kim WS, 

Redmond C (1977). Lipid in invasive cancer 

of the breast. Am J Clin Pathol 68: 558-561. 

8 7 4 . Fisher ER, Gregorio RM, Fisher B, 

Redmond C, Vellios F, Sommers SC (1975). 

The pathology of invasive breast cancer. A 

syllabus derived from findings of the 


(protocol no. 4). Cancer 36: 1-85. 

875. Fisher ER, Gregorio RM, Redmond C, 

Fisher B (1977). Tubulolobular invasive 

breast cancer: a variant of lobular invasive 

cancer. Hum Pathol 8: 679-683. 

876. Fisher ER, Kenny JP, Sass R, Dimitrov 

NV, Siderits RH, Fisher B (1990). Medullary 

cancer of the breast revisited. B r e a s t 


877. Fisher ER, Palekar AS, Gregorio RM, 

Redmond C, Fisher B (1978). Pathological 

findings from the National Surgical 

Adjuvant Breast Project (Protocol No 4) IV. 

Significance of tumour necrosis. H u m 

Pathol 9: 523-530. 

878. Fisher ER, Palekar AS, Gregorio RM, 

Paulson JD (1983). Mucoepidermoid and 

squamous cell carcinomas of breast with 

reference to squamous metaplasia and 

giant cell tumors. Am J Surg Pathol 7: 15- 

27. 

879. Fisher ER, Palekar AS, Redmond C, 

Barton B, Fisher B (1980). Pathologic findings 

from the National Surgical Adjuvant 

Breast Project (protocol no. 4). VI. Invasive 

papillary cancer. Am J Clin Pathol 73: 313- 

322. 

880. Fisher ER, Tavares J, Bulatao IS, Sass 

R, Fisher B (1985). Glycogen-rich, clear cell 

breast cancer: with comments concerning 

other clear cell variants. Hum Pathol 16: 

1085-1090. 

881. Fisher PE, Estabrook A, Cohen MB 

(1990). Fine needle aspiration biopsy of 

intramammary neurilemoma. Acta Cytol 34: 

35-37. 


882. Fisher RA, Lawler SD, Ormerod MG, 

Imrie PR, Povey S (1987). Flow cytometry 

used to distinguish between complete and 

partial hydatidiform moles. Placenta 8: 249- 

256. 

883. Fishman DA, Schwartz PE (1994). 

Current approaches to diagnosis and 

treatment of ovarian germ cell malignancies. 

Curr Opin Obstet Gynecol 6: 98-104. 

884. FitzGerald MG, Bean JM, Hegde SR, 

Unsal H, MacDonald DJ, Harkin DP, 

Finkelstein DM, Isselbacher KJ, Haber DA 

(1997). Heterozygous ATM mutations do 

not contribute to early onset of breast cancer. 

Nat Genet 15: 307-310. 

885. Fitzgibbons PL, Henson DE, Hutter RV 

(1998). Benign breast changes and the risk 

for subsequent breast cancer: an update 

of the 1985 consensus statement. Cancer 

Committee of the College of American 

Pathologists. Arch Pathol Lab Med 122: 

1053-1055. 

886. Fitzgibbons PL, Page DL, Weaver D, 

Thor AD, Allred DC, Clark GM, Ruby SG, 

O'Malley F, Simpson JF, Connolly JL, 

Hayes DF, Edge SB, Lichter A, Schnitt SJ 

(2000). Prognostic factors in breast cancer. 

College of American Pathologists 

Consensus Statement 1999. Arch Pathol 

Lab Med 124: 966-978. 

887. Flagiello D, Gerbault-Seureau M, 

Sastre-Garau X, Padoy E, Vielh P, 

Dutrillaux B (1998). Highly recurrent 

der(1;16)(q10;p10) and other 16q arm alterations 

in lobular breast cancer. G e n e s 


888. Flanagan CW, Parker JR, Mannel RS, 

Min KW, Kida M (1997). Primary endodermal 

sinus tumor of the vulva: a case report 

and review of the literature. G y n e c o l 

Oncol 66: 515-518. 

889. Flemming P, Wellmann A, Maschek H, 

Lang H, Georgii A (1995). Monoclonal antibodies 

against inhibin represent key markers 

of adult granulosa cell tumors of the 

ovary even in their metastases. A report of 

three cases with late metastasis, being 

previously misinterpreted as hemangiopericytoma. 

Am J Surg Pathol 19: 927- 

933. 

890. Fletcher CD, Tsang WY, Fisher C, Lee 

KC, Chan JK (1992). Angiomyofibroblastoma 

of the vulva. A benign neoplasm distinct 

from aggressive angiomyxoma. Am J Surg 

Pathol 16: 373-382. 

891. Fletcher JA, Pinkus JL, Lage JM, 

Morton CC, Pinkus GS (1992). Clonal 6p21 

rearrangement is restricted to the mesenchymal 

component of an endometrial 

polyp. Genes Chromosomes Cancer 5: 260- 

263. 

892. Flint A, Gikas PW, Roberts JA (1985). 

Alveolar soft part sarcoma of the uterine 


893. Flint A, Oberman HA (1984). Infarction 

and squamous metaplasia of intraductal 

papilloma: a benign breast lesion that may 

simulate carcinoma. Hum Pathol 15: 764- 

767. 

894. Fogt F, Vortmeyer AO, Ahn G, De 

Girolami U, Hunt RB, Daly T, Loda M (1994). 

Neural cyst of the ovary with central nervous 

system microvasculature. Histopathology 2 4 : 

477-480. 

895. Foote FW, Stewart FW (1946). A histologic 

classification of carcinoma of the 

breast. Surgery 19: 74-99. 

896. Ford D, Easton DF, Bishop DT, Narod 

SA, Goldgar DE (1994). Risks of cancer in 

BRCA1-mutation carriers. Breast Cancer 

Linkage Consortium. Lancet 343: 692-695. 


897. Ford D, Easton DF, Peto J (1995). 

Estimates of the gene frequency of BRCA1 

and its contribution to breast and ovarian 

cancer incidence. Am J Hum Genet 57: 

1457-1462. 

898. Ford D, Easton DF, Stratton M, Narod 

S, Goldgar D, Devilee P, Bishop DT, Weber 

B, Lenoir G, Chang-Claude J, Sobol H, 

Teare MD, Struewing J, Arason A, 

Scherneck S, Peto J, Rebbeck TR, Tonin P, 

Neuhausen S, Barkardottir R, Eyfjord J, 

Lynch H, Ponder BA, Gayther SA, Zelada- 

Hedman M, Birch JM, Lindblom A, Stoppa- 

Lyonnet D, Bignon Y, Borg A, Hamann U, 

Haites N, Scott RJ, Maugard CM, Vasen H 

(1998). Genetic heterogeneity and penetrance 

analysis of the BRCA1 and BRCA2 

genes in breast cancer families. The 

Breast Cancer Linkage Consortium. Am J 

Hum Genet 62: 676-689. 

899. Ford D, Easton DF, Stratton M, Narod 

S, Goldgar D, Devilee P, Bishop DT, Weber 

B, Lenoir G, Chang-Claude J, Sobol H, 

Teare MD, Struewing J, Arason A, 

Scherneck S, Peto J, Rebbeck TR, Tonin P, 

Neuhausen S, Barkardottir R, Eyfjord J, 

Lynch H, Ponder BA, Gayther SA, Zelada- 

Hedman M (1998). Genetic heterogeneity 

and penetrance analysis of the BRCA1 and 

BRCA2 genes in breast cancer families. 

The Breast Cancer Linkage Consortium. 

Am J Hum Genet 62: 676-689. 

900. Foschini MP, Eusebi V (1998). 

Carcinomas of the breast showing myoep - 

ithelial cell differentiation. A review of the 

literature. Virchows Arch 432: 303-310. 

901. Foschini MP, Eusebi V, Tison V (1989). 

Alveolar soft part sarcoma of the cervix 

uteri. A case report. Pathol Res Pract 184: 

354-358. 

902. Foschini MP, Marucci G, Eusebi V 

(2002). Low-grade mucoepidermoid carcinoma 

of salivary glands: characteristic 

immunohistochemical profile and evidence 

of striated duct differentiation. 


903. Foschini MP, Pizzicannella G, Peterse 

JL, Eusebi V (1995). Adenomyoepithelioma 

of the breast associated with low-grade 

adenosquamous and sarcomatoid carcinomas. 


904. Foulkes WD, Wong N, Brunet JS, 

Narod SA (1998). BRCA mutations and sur - 

vival in breast cancer. J Clin Oncol 16: 

3206-3208. 

905. Fox H, Agrawal K, Langley FA (1972). 

The Brenner tumour of the ovary. A clinicopathological 

study of 54 cases. J Obstet 


906. Fox H, Agrawal K, Langley FA (1975). A 

clinicopathologic study of 92 cases of 

granulosa cell tumor of the ovary with special 

reference to the factors influencing 

prognosis. Cancer 35: 231-241. 

907. Fox H, Laurini RN (1988). Intraplacental 

choriocarcinoma: a report of two cases. J 

Clin Pathol 41: 1085-1088. 

908. Fox H, Sen DK (1967). A Krukenberg 

tumour of the uterine cervix. J Obstet 


909. Fox H, Wells M, Harris M, McWilliam 

LJ, Anderson GS (1988). Enteric tumours of 

the lower female genital tract: a report of 

three cases. Histopathology 12: 167-176. 

910. Frable WJ, Kay S (1968). Carcinoma of 

the breast. Histologic and clinical features 

of apocrine tumors. Cancer 21: 756-763. 

911. Fracchia AA, Robinson D, Legaspi A, 

Greenall MJ, Kinne DW, Groshen S (1985). 

Survival in bilateral breast cancer. Cancer 

55: 1414-1421. 

912. Fraga M, Prieto O, Garcia-Caballero T, 

Beiras A, Forteza J (1994). Myxoid 

leiomyosarcoma of the uterine cervix. 


913. Franceschi S, Dal Maso L, Arniani S, 

Crosignani P, Vercelli M, Simonato L, 

Falcini F, Zanetti R, Barchielli A, Serraino 

D, Rezza G (1998). Risk of cancer other than 

Kaposi's sarcoma and non-Hodgkin's lymphoma 

in persons with AIDS in Italy. 

Cancer and AIDS Registry Linkage Study. 

Br J Cancer 78: 966-970. 

9 1 4 . Franquemont DW, Frierson HF Jr., 

Mills SE (1991). An immunohistochemical 

study of normal endometrial stroma and 

endometrial stromal neoplasms. Evidence 

for smooth muscle differentiation. Am J 


915. Fraser JL, Raza S, Chorny K, Connolly 

JL, Schnitt SJ (1998). Columnar alteration 

with prominent apical snouts and secretions: 

a spectrum of changes frequently 

present in breast biopsies performed for 

microcalcifications. Am J Surg Pathol 22: 

1521-1527. 

916. Frei KA, Kinkel K (2001). Staging 

endometrial cancer: role of magnetic resonance 

imaging. J Magn Reson Imaging 13: 

850-855. 

917. Friedman HD, Mazur MT (1991). 

Primary ovarian leiomyosarcoma. An 

immunohistochemical and ultrastructural 

study. Arch Pathol Lab Med 115: 941-945. 

918. Friedman LS, Gayther SA, Kurosaki T, 

Gordon D, Noble B, Casey G, Ponder BA, 

Anton-Culver H (1997). Mutation analysis 

of BRCA1 and BRCA2 in a male breast cancer 

population. Am J Hum Genet 60: 313- 

319. 

919. Friedrich EG Jr., Wilkinson EJ, Fu YS 

(1980). Carcinoma in situ of the vulva: a 

continuing challenge. Am J Obstet 

Gynecol 136: 830-843. 

920. Frisch M, Biggar RJ, Goedert JJ 

(2000). Human papillomavirus-associated 

cancers in patients with human immunodeficiency 

virus infection and acquired 

immunodeficiency syndrome. J Natl 

Cancer Inst 92: 1500-1510. 

921. Fritz A, Percy C, Jack A, 

Shanmugaratnam K, Sobin LH, Parkin DM, 

Whelan S (2000). International Classification 

of Diseases for Oncology (ICD-O). 3rd 

ed. World Health Organization: Geneva. 

922. Frixen UH, Behrens J, Sachs M, Eberle 

G, Voss B, Warda A, Lochner D, Birchmeier 

W (1991). E-cadherin-mediated cell-cell 

adhesion prevents invasiveness of human 

carcinoma cells. J Cell Biol 113: 173-185. 

923. Fujii H, Matsumoto T, Yoshida M, 

Furugen Y, Takagaki T, Iwabuchi K, Nakata 

Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, 

Hirose S, Shirai T (2002). Genetics of synchronous 

uterine and ovarian endometrioid 

carcinoma: combined analyses of loss 

of heterozygosity, PTEN mutation, and 

microsatellite instability. Hum Pathol 33: 

421-428. 

924. Fujii H, Szumel R, Marsh C, Zhou W, 

Gabrielson E (1996). Genetic progression, 

histological grade, and allelic loss in ductal 

carcinoma in situ of the breast.Cancer Res 

56: 5260-5265. 

925. Fujii H, Yoshida M, Gong ZX, 

Matsumoto T, Hamano Y, Fukunaga M, 

Hruban RH, Gabrielson E, Shirai T (2000). 

Frequent genetic heterogeneity in the 

clonal evolution of gynecological carcinosarcoma 

and its influence on phenotypic 

diversity. Cancer Res 60: 114-120. 

926. Fujita M, Enomoto T, Wada H, Inoue 

M, Okudaira Y, Shroyer KR (1996). 

Application of clonal analysis. Differential 

diagnosis for synchronous primary ovarian 

and endometrial cancers and metastatic 

cancer. Am J Clin Pathol 105: 350-359. 

927. Fujiwaki R, Yoshida M, Iida K, Ohnishi 

Y, Ryuko K, Miyazaki K (1998). Epithelioid 


Acta Obstet Gynecol Scand 77: 246-248. 

928. Fukunaga M (2001). Pseudoangiomatous 

hyperplasia of mammary stroma: a 

case of pure type after removal of fibroadenoma. 

APMIS 109: 113-116. 

929. Fukunaga M, Ishihara A, Ushigome S 

(1998). Extrauterine low-grade endometrial 

stromal sarcoma: report of three cases. 

Pathol Int 48: 297-302. 

930. Fukunaga M, Miyazawa Y, Ushigome S 

(1997). Endometrial low-grade stromal sarcoma 

with ovarian sex cord-like differentiation: 

report of two cases with an immunohistochemical 

and flow cytometric study. 

Pathol Int 47: 412-415. 

931. Fukunaga M, Nomura K, Endo Y, 

Ushigome S, Aizawa S (1996). Carcino-sarcoma 

of the uterus with extensive neuroectodermal 

differentiation. 


932. Fukunaga M, Nomura K, Ishikawa E, 

Ushigome S (1997). Ovarian atypical 

endometriosis: its close association with 

malignant epithelial tumours. H i s t o - 

pathology 30: 249-255. 

933. Fukunaga M, Ushigome S (1993). 

Malignant trophoblastic tumors: immunohistochemical 

and flow cytometric comparison 

of choriocarcinoma and placental 

site trophoblastic tumors. Hum Pathol 24: 

1098-1106. 

934. Fukunaga M, Ushigome S (1997). 

Myofibroblastoma of the breast with 

diverse differentiations. Arch Pathol Lab 

Med 121: 599-603. 

935. Fukunaga M, Ushigome S, Fukunaga 

M, Sugishita M (1993). Application of flow 

cytometry in diagnosis of hydatidiform 

moles. Mod Pathol 6: 353-359. 

936. Fukushima M, Twiggs LB, Okagaki T 

(1986). Mixed intestinal adenocarcinomaargentaffin 

carcinoma of the vagina. 


937. Fulop V, Mok SC, Genest DR, Gati I, 

Doszpod J, Berkowitz RS (1998). p53, p21, 

Rb and mdm2 oncoproteins. Expression in 

normal placenta, partial and complete 

mole, and choriocarcinoma. J Reprod 

Med 43: 119-127. 

9 3 8 . Fulop V, Mok SC, Genest DR, Szigetvari 

I, Cseh I, Berkowitz RS (1998). c-myc, cerbB-2, 

c-fms and bcl-2 oncoproteins. 

Expression in normal placenta, partial and 

complete mole, and choriocarcinoma. J 

Reprod Med 43: 101-110. 

939. Funk KC, Heiken JP (1989). Papillary 

cystadenoma of the broad ligament in a 

patient with von Hippel-Lindau disease. 


940. Furuya M, Shimizu M, Nishihara H, Ito 

T, Sakuragi N, Ishikura H, Yoshiki T (2001). 

Clear cell variant of malignant melanoma 

of the uterine cervix: a case report and 

review of the literature. Gynecol Oncol 80: 

409-412. 

941. Gabbay-Moore M, Ovadia Y, Neri A 

(1982). Accessory ovaries with bilateral 

dermoid cysts. Eur J Obstet Gynecol 

Reprod Biol 14: 171-173. 

942. Gaber LW, Redline RW, Mostoufi- 

Zadeh M, Driscoll SG (1986). Invasive partial 

mole. Am J Clin Pathol 85: 722-724.

943. Gad A, Azzopardi JG (1975). Lobular 

carcinoma of the breast: a special variant 

of mucin-secreting carcinoma. J Clin 

Pathol 28: 711-716. 

944. Gad S, Caux-Moncoutier V, Pages- 

Berhouet S, Gauthier-Villars M, Coupier I, 

Pujol P, Frenay M, Gilbert B, Maugard C, 

Bignon YJ, Chevrier A, Rossi A, Fricker JP, 

Nguyen TD, Demange L, Aurias A, 

Bensimon A, Stoppa-Lyonnet D (2002). 

Significant contribution of large BRCA1 

gene rearrangements in 120 French breast 

and ovarian cancer families. Oncogene 21: 

6841-6847. 

945. Gadaleanu V, Craciun C (1987). 

Malignant oncocytoma of the breast. 

Zentralbl Allg Pathol 133: 279-283. 

946. Gadducci A, Ferdeghini M, Prontera C, 

Moretti L, Mariani G, Bianchi R, Fioretti P 

(1992). The concomitant determination of 

different tumor markers in patients with 

epithelial ovarian cancer and benign ovarian 

masses: relevance for differential diagnosis. 


947. Gadducci A, Landoni F, Sartori E, Zola 

P, Maggino T, Lissoni A, Bazzurini L, Arisio 

R, Romagnolo C, Cristofani R (1996). 

Uterine leiomyosarcoma: analysis of treatment 

failures and survival. Gynecol Oncol 

62: 25-32. 

948. Gaertner EM, Farley JH, Taylor RR, 

Silver SA (1999). Collision of uterine rhabdoid 

tumor and endometrioid adenocarcinoma: 

a case report and review of the literature. 


949. Gaffey MJ, Mills SE, Boyd JC (1994). 

Aggressive papillary tumor of middle 

ear/temporal bone and adnexal papillary 

cystadenoma. Manifestations of von 

Hippel-Lindau disease. Am J Surg Pathol 

18: 1254-1260. 

950. Gaffey MJ, Mills SE, Frierson HF Jr., 

Zarbo RJ, Boyd JC, Simpson JF, Weiss LM 

(1995). Medullary carcinoma of the breast: 

interobserver variability in histopathologic 

diagnosis. Mod Pathol 8: 31-38. 

951. Gagnon Y, Tetu B (1989). Ovarian 

metastases of breast carcinoma. A clinicopathologic 

study of 59 cases. Cancer 64: 

892-898. 

952. Gal R, Dekel A, Ben David M, Goldman 

JA, Kessler E (1988). Granular cell 

myoblastoma of the cervix. Case report. Br 


953. Galant C, Mazy S, Berliere M, Mazy G, 

Wallon J, Marbaix E (1997). Two schwannomas 

presenting as lumps in the same 

breast. Diagn Cytopathol 16: 281-284. 

954. Galea MH, Blamey RW, Elston CE, Ellis 

IO (1992). The Nottingham Prognostic 

Index in primary breast cancer. Breast 


955. Gamallo C, Palacios J, Moreno G, 

Calvo dM, Suarez A, Armas A (1999). betacatenin 

expression pattern in stage I and II 

ovarian carcinomas : relationship with 

beta-catenin gene mutations, clinicopathological 

features, and clinical outcome. 

Am J Pathol 155: 527-536. 

956. Gamallo C, Palacios J, Suarez A, 

Pizarro A, Navarro P, Quintanilla M, Cano A 

(1993). Correlation of E-cadherin expression 

with differentiation grade and histological 

type in breast carcinoma. Am J 

Pathol 142: 987-993. 

957. Garber JE, Goldstein AM, Kantor AF, 

Dreyfus MG, Fraumeni JF Jr., Li FP (1991). 

Follow-up study of twenty-four families 

with Li-Fraumeni syndrome. Cancer Res 

51: 6094-6097. 

958. Garcia-Higuera I, Taniguchi T, 

Ganesan S, Meyn MS, Timmers C, Hejna J, 

Grompe M, D'Andrea AD (2001). 

Interaction of the Fanconi anemia proteins 

and BRCA1 in a common pathway. Mol 

Cell 7: 249-262. 

959. Garcia A, Bussaglia E, Machin P, 

Matias-Guiu X, Prat J (2000). Loss of heterozygosity 

on chromosome 17q in epithelial 

ovarian tumors: association with carcinomas 

with serous differentiation. Int J 


960. Garcia R, Troyas RG, Bercero EA 

(1995). Mullerian adenosarcoma of the 

cervix: differential diagnosis, histogenesis 

and review of the literature. Pathol Int 45: 

890-894. 

961. Gardella C, Chumas JC, Pearl ML 

(1996). Ovarian lipoma of teratomatous ori - 

gin. Obstet Gynecol 87: 874-875. 

962. Gardner GH, Greene RR, Peckham BM 

(1948). Normal and cystic structures of the 

broad ligament. Am J Obstet Gynecol 55: 

917-939. 

963. Garg PP, Kerlikowske K, Subak L, 

Grady D (1998). Hormone replacement 

therapy and the risk of epithelial ovarian 

carcinoma: a meta-analysis. O b s t e t 

Gynecol 92: 472-479. 

964. Garrett AP, Lee KR, Colitti CR, Muto 

MG, Berkowitz RS, Mok SC (2001). k-ras 

mutation may be an early event in mucinous 

ovarian tumorigenesis. Int J Gynecol 

Pathol 20: 244-251. 

965. Garrett AP, Ng SW, Muto MG, Welch 

WR, Bell DA, Berkowitz RS, Mok SC (2000). 

ras gene activation and infrequent mutation 

in papillary serous carcinoma of the 

peritoneum. Gynecol Oncol 77: 105-111. 

966. Garzetti GG, Ciavattini A, Goteri G, 

Stramazzoti D, Fabris G, Mannello B, 

Romanini C (1996). Proliferating cell 

nuclear antigen (PCNA) immunoreactivity 

in stage I endometrial cancer: A new prognostic 

factor. Int J Gynecol Cancer 6: 186- 

192. 

967. Garzetti GG, Ciavattini A, Goteri G, 

Menzo S, de Nictolis M, Clementi M, 

Brugia M, Romanini C (1994). Vaginal 

micropapillary lesions are not related to 

human papillomavirus infection: in situ 

hybridization and polymerase chain reaction 

detection techniques. Gynecol Obstet 

Invest 38: 134-139. 

968. Gatalica Z, Norris BA, Kovatich AJ 

(2000). Immunohistochemical localization 

of prostate-specific antigen in ductal 

epithelium of male breast. Potential diagnostic 

pitfall in patients with gynecomastia. 

Appl Immunohistochem Molecul 

Morphol 8: 158-161. 

969. Gatchell FG, Dockerty MB, Clagett OT 

(1958). Intracystic carcinoma of the breast. 

Surg Gynecol Obstet 106: 347. 

970. Gatta G, Lasota MB, Verdecchia A 

(1998). Survival of European women with 

gynaecological tumours, during the period 

1978-1989. Eur J Cancer 34: 2218-2225. 

971. Gatti RA, Tward A, Concannon P 

(1999). Cancer risk in ATM heterozygotes: 

a model of phenotypic and mechanistic differences 

between missense and truncating 

mutations. Mol Genet Metab 68: 419- 

423. 

972. Gayther SA, Mangion J, Russell P, 

Seal S, Barfoot R, Ponder BA, Stratton MR, 

Easton D (1997). Variation of risks of breast 

and ovarian cancer associated with different 

germline mutations of the BRCA2 gene. 

Nat Genet 15: 103-105. 

973. Gayther SA, Russell P, Harrington P, 

Antoniou AC, Easton DF, Ponder BA (1999). 

The contribution of germline BRCA1 and 

BRCA2 mutations to familial ovarian cancer: 

no evidence for other ovarian cancersusceptibility 

genes. Am J Hum Genet 65: 

1021-1029. 

974. Gayther SA, Warren W, Mazoyer S, 

Russell PA, Harrington PA, Chiano M, Seal 

S, Hamoudi R, van Rensburg EJ, Dunning 

AM, Love R, Evans G, Easton D, Clayton D, 

Stratton MR, Ponder BAJ (1995). Germline 

mutations of the BRCA1 gene in breast and 

ovarian cancer families provide evidence 

for a genotype-phenotype correlation. Nat 

Genet 11: 428-433. 

975. Gehrig PA, Groben PA, Fowler WC Jr., 

Walton LA, Van Le L (2001). Noninvasive 

papillary serous carcinoma of the 

endometrium. Obstet Gynecol 97: 153-157. 

976. Geisler S, Lonning PE, Aas T, Johnsen 

H, Fluge O, Haugen DF, Lillehaug JR, 

Akslen LA, Borresen-Dale AL (2001). 

Influence of TP53 gene alterations and cerbB-2 

expression on the response to 

treatment with doxorubicin in locally 

advanced breast cancer. Cancer Res 61: 

2505-2512. 

977. Genest DR (2001). Partial hydatidiform 

mole: clinicopathological features, differential 

diagnosis, ploidy and molecular 

studies, and gold standards for diagnosis. 


978. Genest DR, Laborde O, Berkowitz RS, 

Goldstein DP, Bernstein MR, Lage J (1991). 

A clinicopathologic study of 153 cases of 

complete hydatidiform mole (1980-1990): 

histologic grade lacks prognostic significance. 


979. Geng L, Connolly DC, Isacson C, Ronnett 

BM, Cho KR (1999). Atypical immature metaplasia 

(AIM) of the cervix: is it related to 

high-grade squamous intraepithelial lesion 

(HSIL)? Hum Pathol 30: 345-351. 

980. Gentile G, Formelli G, Pelusi G, 

Flamigni C (1997). Is vestibular micropapillomatosis 

associated with human papillomavirus 

infection? Eur J Gynaecol Oncol 

18: 523-525. 

981. Geoffroy-Perez B, Janin N, Ossian K, 

Lauge A, Croquette MF, Griscelli C, Debre 

M, Bressac-de-Paillerets B, Aurias A, 

Stoppa-Lyonnet D, Andrieu N (2001). 

Cancer risk in heterozygotes for ataxiatelangiectasia. 

Int J Cancer 93: 288-293. 

982. Georgiannos SN, Chin Aleong J, 

Goode AW, Sheaff M (2001). Secondary 

Neoplasms of the Breast: A survey of the 

20th Century. Cancer 92: 2259-2266. 

983. Geraads A, Tary P, Cloup N (1991). 

[Demons-Meigs syndrome caused by 

ovarian goiter]. Rev Pneumol Clin 47: 194- 

196. 

984. Gerald WL, Miller HK, Battifora H, 

Miettinen M, Silva EG, Rosai J (1991). Intraabdominal 

desmoplastic small round-cell 

tumor. Report of 19 cases of a distinctive 

type of high-grade polyphenotypic malignancy 

affecting young individuals. Am J 


985. Gernow A, Ahrentsen OD (1989). 

Adenoid cystic carcinoma of the 

endometrium. Histopathology 15: 197-198. 

986. Gersell DJ, Fulling KH (1989). Localized 

neurofibromatosis of the female genitourinary 

tract. Am J Surg Pathol 13: 873-878. 

987. Gersell DJ, Katzenstein AL (1981). 

Spindle cell carcinoma of the breast. A 

clinocopathologic and ultrastructural 

study. Hum Pathol 12: 550-561. 

988. Gersell DJ, King TC (1988). Papillary 

cystadenoma of the mesosalpinx in von 

Hippel-Lindau disease. Am J Surg Pathol 

12: 145-149. 

989. Gershenson DM, del Junco G, Silva 

EG, Copeland LJ, Wharton JT, Rutledge FN 

(1986). Immature teratoma of the ovary. 


990. Ghadially FN (1985). D i a g n o s t i c 

Electron Microscopy of Tumors. Butterworth 

& Company: London. 

991. Ghazali S (1973). Embryonic rhabdomyosarcoma 

of the urogenital tract. Br 

J Surg 60: 124-128. 

992. Giannacopoulos K, Giannacopoulou C, 

Matalliotakis I, Neonaki M, Papanicolaou 

N, Koumantakis E (1998). Pseudo-Meigs' 

syndrome caused by paraovarian fibroma. 

Eur J Gynaecol Oncol 19: 389-390. 

993. Giannotti FO, Miiji LN, Vainchenker M, 

Gordan AN (2001). Breast cancer with 

choriocarcinomatous and neuroendocrine 

features. Sao Paulo Med J 119: 154-155. 

994. Giardini R, Piccolo C, Rilke F (1992). 

Primary non-Hodgkin's lymphomas of the 

female breast. Cancer 69: 725-735. 

995. Gibbons D, Leitch M, Coscia J, 

Lindberg G, Molberg K, Ashfaq R, 

Saboorian MH (2000). Fine Needle 

Aspiration Cytology and Histologic 

Findings of Granular Cell Tumor of the 

Breast: Review of 19 Cases with 

Clinical/Radiologic Correlation. Breast J 6: 

27-30. 

996. Gil-Moreno A, Garcia-Jimenez A, 

Gonzalez-Bosquet J, Esteller M, Castellvi- 

Vives J, Martinez Palones JM, Xercavins J 

(1997). Merkel cell carcinoma of the vulva. 


997. Gilbey S, Moore DH, Look KY, Sutton 

GP (1997). Vulvar keratoacanthoma. Obstet 

Gynecol 89: 848-850. 

998. Gilchrist KW, Gould VE, Hirschl S, 

Imbriglia JE, Patchefsky AS, Penner DW, 

Pickren J, Schwartz IS, Wheeler JE, 

Barnes JM, Mansour EG (1982). 

Interobserver variation in the identification 

of breast carcinoma in intramammary lymphatics. 

Hum Pathol 13: 170-172. 

999. Gilchrist KW, Gray R, Fowble B, 

Tormey DC, Taylor SG (1993). Tumor necrosis 

is a prognostic predictor for early 

recurrence and death in lymph node-positive 

breast cancer: a 10-year follow-up 

study of 728 Eastern Cooperative Oncology 

Group patients. J Clin Oncol 11: 1929-1935. 

1000. Gilks CB, Alkushi A, Yue JJ, Lanvin D, 

Ehlen TG, Miller DM (2003). Advancedstage 

serous borderline tumors of the 

ovary: a clinicopathological study of 49 


1001. Gilks CB, Bell DA, Scully RE (1990). 

Serous psammocarcinoma of the ovary 

and peritoneum. Int J Gynecol Pathol 9: 

110-121. 

1002. Gilks CB, Clement PB, Hart WR, 

Young RH (2000). Uterine adenomyomas 

excluding atypical polypoid adenomyomas 

and adenomyomas of endocervical type: a 

clinicopathologic study of 30 cases of an 

underemphasized lesion that may cause 

diagnostic problems with brief consideration 

of adenomyomas of other female genital 

tract sites. Int J Gynecol Pathol 19: 195- 

205. 

1003. Gilks CB, Clement PB, Wood WS 

(1989). Trichoblastic fibroma. A clinicopathologic 

study of three cases. Am J 

Dermatopathol 11: 397-402. 


1004. Gilks CB, Young RH, Aguirre P, 

DeLellis RA, Scully RE (1989). Adenoma 

malignum (minimal deviation adenocarcinoma) 

of the uterine cervix. A clinicopathological 

and immunohistochemical 


717-729. 

1005. Gilks CB, Young RH, Clement PB, Hart 

WR, Scully RE (1996). Adenomyomas of the 

uterine cervix of of endocervical type: a 

report of ten cases of a benign cervical 

tumor that may be confused with adenoma 

malignum. Mod Pathol 9: 220-224. 

1006. Gilks CB, Young RH, Gersell DJ, 

Clement PB (1997). Large cell neuroendocrine 

carcinoma of the uterine cervix: a 

clinicopathologic study of 12 cases. Am J 


1007. Gillett CE, Lee AH, Millis RR, Barnes 

DM (1998). Cyclin D1 and associated proteins 

in mammary ductal carcinoma in situ 

and atypical ductal hyperplasia. J Pathol 

184: 396-400. 

1008. Gimm O, Attie-Bitach T, Lees JA, 

Vekemans M, Eng C (2000). Expression of 

the PTEN tumour suppressor protein during 

human development. Hum Mol Genet 9: 

1633-1639. 

1009. Ginolhac SM, Gad S, Corbex M, 

Bressac-de-Paillerets B, Chompret A, 

Bignon YJ, Peyrat JP, Fournier J, Lasset C, 

Giraud S, Muller D, Fricker JP, Hardouin A, 

Berthet P, Maugard C, Nogues C, Lidereau 

R, Longy M, Olschwang S, Toulas C, 

Guimbaud R, Yannoukakos D, Szabo C, 

Durocher F, Moisan AM, Simard J, 

Mazoyer S, Lynch HT, Goldgar D, Stoppa- 

Lyonnet D, Lenoir GM, Sinilnikova OM 

(2003). BRCA1 wild-type allele modifies risk 

of ovarian cancer in carriers of BRCA1 

germ-line mutations. Cancer Epidemiol 

Biomarkers Prev 12: 90-95. 

1010. Giri DD, Dundas SA, Nottingham JF, 

Underwood JC (1989). Oestrogen receptors 

in benign epithelial lesions and 

intraduct carcinomas of the breast: an 

immunohistological study. Histopathology 

15: 575-584. 

1011. Giroud F, Haroske G, Reith A, Bocking 

A (1998). 1997 ESACP consensus report on 

diagnostic DNA image cytometry. Part II: 

Specific recommendations for quality 

assurance. European Society for 

Analytical Cellular Pathology. Anal Cell 

Pathol 17: 201-208. 

1012. Gisser SD (1986). Obstructing fallopian 

tube papilloma. Int J Gynecol Pathol 5: 

179-182. 

1013. Gissmann L, deVilliers EM, zur 

Hausen H (1982). Analysis of human genital 

warts (condylomata acuminata) and other 

genital tumors for human papillomavirus 

type 6 DNA. Int J Cancer 29: 143-146. 

1014. Gissmann L, Wolnik L, Ikenberg H, 

Koldovsky U, Schnurch HG, zur Hausen H 

(1983). Human papillomavirus types 6 and 

11 DNA sequences in genital and laryngeal 

papillomas and in some cervical cancers. 

Proc Natl Acad Sci USA 80: 560-563. 

1015. Glaser SL, Ambinder RF, DiGiuseppe 

JA, Horn-Ross PL, Hsu JL (1998). Absence 

of Epstein-Barr virus EBER-1 transcripts in 

an epidemiologically diverse group of 

breast cancers. Int J Cancer 75: 555-558. 

1016. Glaubitz LC, Bowen JH, Cox EB, 

McCarty KS Jr. (1984). Elastosis in human 

breast cancer. Correlation with sex steroid 

receptors and comparison with clinical 

outcome. Arch Pathol Lab Med 108: 27-30. 


1017. Gleeson NC, Ruffolo EH, Hoffman MS, 

Cavanagh D (1994). Basal cell carcinoma 

of the vulva with groin node metastasis. 


1 0 1 8 . Gloor E, Dialdas J, Hurlimann J, 

Ribolzi J, Barrelet L (1983). Placental site 

trophoblastic tumor (trophoblastic pseudotumor) 

of the uterus with metastases and 

fatal outcome. Clinical and autopsy observations 

of a case. Am J Surg Pathol 7: 483- 

486. 

1019. Gloor E, Hurlimann J (1981). 

Trophoblastic pseudotumor of the uterus: 

clinicopathologic report with immunohistochemical 

and ultrastructural studies. Am 


1020. Glorieux I, Chabbert V, Rubie H, 

Baunin C, Gaspard MH, Guitard J, Duga I, 

Suc A, Puget C, Robert A (1998). 

[Autoimmune hemolytic anemia associated 

with a mature ovarian teratoma]. Arch 

Pediatr 5: 41-44. 

1021. Glusac EJ, Hendrickson MS, Smoller 

BR (1994). Apocrine cystadenoma of the 

vulva. J Am Acad Dermatol 31: 498-499. 

1022. Gobbi H, Simpson JF, Borowsky A, 

Jensen RA, Page DL (1999). Metaplastic 

breast tumors with a dominant fibromatosis-like 

phenotype have a high risk of local 

recurrence. Cancer 85: 2170-2182. 

1023. Gocht A, Bosmuller HC, Bassler R, 

Tavassoli FA, Moinfar F, Katenkamp D, 

Schirrmacher K, Luders P, Saeger W 

(1999). Breast tumors with myofibroblastic 

differentiation: clinico-pathological observations 

in myofibroblastoma and myofibrosarcoma. 

Pathol Res Pract 195: 1-10. 

1 0 2 4 . Goff BA, Mandel L, Muntz HG, 

Melancon CH (2000). Ovarian carcinoma 

diagnosis. Cancer 89: 2068-2075. 

1 0 2 5 . Goffin J, Chappuis PO, Wong N, 

Foulkes WD (2001). Re: Magnetic resonance 

imaging and mammography in 

women with a hereditary risk of breast 

cancer. J Natl Cancer Inst 93: 1754-1755. 

1 0 2 6 . Golbang P, Khan A, Scurry J, 

MacIsaac I, Planner R (1997). Cervical sarcoma 

botryoides and ovarian Sertoli- 

Leydig cell tumor. Gynecol Oncol 67: 102- 

106. 

1 0 2 7 . Goldblum J, Hart WR (1995). 

Localized and diffuse mesotheliomas of 

the genital tract and peritoneum in women. 

A clinicopathologic study of nineteen true 

mesothelial neoplasms, other than adenomatoid 

tumors, multicystic mesotheliomas, 

and localized fibrous tumors. Am J Surg 

Pathol 19: 1124-1137. 

1 0 2 8 . Goldblum JR, Hart WR (1998). 

Perianal Paget's disease: a histologic and 

immunohistochemical study of 11 cases 

with and without associated rectal adeno - 

carcinoma. Am J Surg Pathol 22: 170-179. 

1 0 2 9 . Goldgar DE, Easton DF, Cannon- 

Albright LA, Skolnick MH (1994). 

Systematic population-based assessment 

of cancer risk in first-degree relatives of 

cancer probands. J Natl Cancer Inst 86: 

1600-1608. 

1030. Goldhirsch A, Glick JH, Gelber RD, 

Coates AS, Senn HJ (2001). Meeting highlights: 

International Consensus Panel on 

the Treatment of Primary Breast Cancer. 

Seventh International Conference on 

Adjuvant Therapy of Primary Breast 

Cancer. J Clin Oncol 19: 3817-3827. 

1031. Goldhirsch A, Glick JH, Gelber RD, 

Senn HJ (1998). Meeting highlights: 

International consensus panel on the 

treatment of primary breast cancer. J Natl 

Cancer Inst 90: 1601-1608. 

1032. Goldstein NS, Ahmad E, Hussain M, 

Hankin RC, Perez-Reyes N (1998). 

Endocervical glandular atypia: does a pre - 

neoplastic lesion of adenocarcinoma in 

situ exist? Am J Clin Pathol 110: 200-209. 

1033. Goldstein NS, Bassi D, Watts JC, 

Layfield LJ, Yaziji H, Gown AM (2001). Ecadherin 

reactivity of 95 noninvasive ductal 

and lobular lesions of the breast. 

Implications for the interpretation of problematic 

lesions. Am J Clin Pathol 115: 534- 

542. 

1034. Goldstein NS, O'Malley BA (1997). 

Cancerization of small ectatic ducts of the 

breast by ductal carcinoma in situ cells 

with apocrine snouts: a lesion associated 

with tubular carcinoma. Am J Clin Pathol 

107: 561-566. 

1035. Gollamudi SV, Gelman RS, Peiro G, 

Schneider LJ, Schnitt SJ, Recht A, Silver 

BJ, Harris JR, Connolly JL (1997). Breastconserving 

therapy for stage I-II synchronous 

bilateral breast carcinoma. Cancer 

79: 1362-1369. 

1036. Gollard R, Kosty M, Bordin G, Wax A, 

Lacey C (1995). Two unusual presentations 

of mullerian adenosarcoma: case reports, 

literature review, and treatment considerations. 


1037. Gong G, Devries S, Chew KL, Cha I, 

Ljung BM, Waldman FM (2001). Genetic 

changes in paired atypical and usual ductal 

hyperplasia of the breast by comparative 

genomic hybridization. Clin Cancer 

Res 7: 2410-2414. 

1038. Gonzalez-Crussi F, Crawford SE, Sun 

CC (1990). Intraabdominal desmoplastic 

small-cell tumors with divergent differentiation. 

Observations on three cases of 

childhood. Am J Surg Pathol 14: 633-642. 

1039. Gonzalez-Moreno S, Yan H, Alcorn 

KW, Sugarbaker PH (2002). Malignant 

transformation of "benign" cystic mesothelioma 

of the peritoneum. J Surg Oncol 79: 

243-251. 

1040. Goodman ZD, Taxy JB (1981). 

Fibroadenomas of the breast with prominent 

smooth muscle. Am J Surg Pathol 5: 

99-101. 

1041. Gordon AN, Montag TW (1990). 

Sarcoma botryoides of the cervix: excision 

followed by adjuvant chemotherapy for 

preservation of reproductive function. 


1042. Gorlin RJ (1987). Nevoid basal-cell 

carcinoma syndrome. Medicine (Baltimore) 

66: 98-113. 

1043. Gorski GK, McMorrow LE, Blumstein 

L, Faasse D, Donaldson MH (1992). Trisomy 

14 in two cases of granulosa cell tumor of 

the ovary. Cancer Genet Cytogenet 60: 202- 

205. 

1044. Gotlieb WH, Friedman E, Bar-Sade 

RB, Kruglikova A, Hirsh-Yechezkel G, 

Modan B, Inbar M, Davidson B, Kopolovic 

J, Novikov I, Ben Baruch G (1998). Rates of 

Jewish ancestral mutations in BRCA1 and 

BRCA2 in borderline ovarian tumors. J 


1045. Gotoh T, Kikuchi Y, Takano M, Kita T, 

Ogata S, Aida S (2001). Epithelioid 



1046. Gottlieb C, Raju U, Greenwald KA 

(1990). Myoepithelial cells in the differential 

diagnosis of complex benign and 

malignant breast lesions: an immunohisto - 

chemical study. Mod Pathol 3: 135-140. 

1047. Gould S (1967). Neurilemmoma within 

the broad ligament. A case report. J S C 

Med Assoc 63: 6-8. 

1048. Govender NS, Goldstein DP (1977). 

Metastatic tubal mole and coexisting 

intrauterine pregnancy. Obstet Gynecol 49: 

67-69. 

1049. Govoni E, Pileri S, Bazzocchi F, Severi 

B, Martinelli G (1981). Postmastectomy 

angiosarcoma: ultrastructural study of a 

case. Tumori 67: 79-86. 

1051. Goyert G, Budev H, Wright C, Jones 

A, Deppe G (1987). Vaginal mullerian stromal 

sarcoma. A case report. J Reprod 

Med 32: 129-130. 

1052. Gradishar WJ (1996). Inflammatory 

breast cancer: the evolution of multimodality 

treatment strategies. Semin Surg Oncol 

12: 352-363. 

1053. Graham MD, Yelland A, Peacock J, 

Beck N, Ford H, Gazet JC (1993). Bilateral 

carcinoma of the breast. Eur J Surg Oncol 

19: 259-264. 

1054. Granter SR, Nucci MR, Fletcher CD 

(1997). Aggressive angiomyxoma: reappraisal 

of its relationship to angiomyofibroblastoma 

in a series of 16 cases. 


1055. Gras E, Catasus L, Arguelles R, 

Moreno-Bueno G, Palacios J, Gamallo C, 

Matias-Guiu X, Prat J (2001). Microsatellite 

instability, MLH-1 promoter hypermethylation, 

and frameshift mutations at coding 

mononucleotide repeat microsatellites in 

ovarian tumors. Cancer 92: 2829-2836. 

1056. Gray GF Jr., Glick AD, Kurtin PJ, 

Jones HW III (1986). Alveolar soft part sarcoma 

of the uterus. Hum Pathol 17: 297- 

300. 

1057. Grayson W, Cooper K (2002). A reappraisal 

of "Basaloid Carcinoma" of the 

cervix, and the differential diagnosis of 

basaloid cervical neoplasms. Adv Anat 

Pathol 9: 290-300. 

1058. Grayson W, Fourie J, Tiltman AJ 

(1998). Xanthomatous leiomyosarcoma of 

the uterine cervix. Int J Gynecol Pathol 17: 

89-90. 

1059. Grayson W, Taylor LF, Cooper K 

(1999). Adenoid cystic and adenoid basal 

carcinoma of the uterine cervix: comparative 

morphologic, mucin, and immunohistochemical 

profile of two rare neoplasms of 

putative 'reserve cell' origin. Am J Surg 

Pathol 23: 448-458. 

1060. Grayson W, Taylor LF, Cooper K 

(2001). Carcinosarcoma of the uterine 

cervix: a report of eight cases with 

immunohistochemical analysis and evaluation 

of human papillomavirus status. Am 


1061. Green DM (1990). Mucoid carcinoma 

of the breast with choriocarcinoma in its 

metastases. Histopathology 16: 504-506. 

1062. Green I, McCormick B, Cranor M, 

Rosen PP (1997). A comparative study of 

pure tubular and tubulolobular carcinoma 

of the breast. Am J Surg Pathol 21: 653-657. 

1063. Green JA, Kirwan JM, Tierney JF, 

Symonds P, Fresco L, Collingwood M, 

Williams CJ (2001). Survival and recurrence 

after concomitant chemotherapy 

and radiotherapy for cancer of the uterine 

cervix: a systematic review and metaanalysis. 

Lancet 358: 781-786. 

1064. Green LK, Kott ML (1989). 

Histopathologic findings in ectopic tubal 

pregnancy. Int J Gynecol Pathol 8: 255-262. 

1065. Greene JB, McCue SA (1978). 

Chorioadenoma destruens. Ann N Y Acad 

Sci 80: 143. 

1066. Greenlee RT, Hill-Harmon MB, 

Murray T, Thun M (2001). Cancer statistics, 

2001. CA Cancer J Clin 51: 15-36.

1067. Grimes MM (1992). Cystosarcoma 

phyllodes of the breast: histologic features, 

flow cytometric analysis, and clinical 

correlations. Mod Pathol 5: 232-239. 

1068. Grody WW, Nieberg RK, Bhuta S 

(1985). Ependymoma-like tumor of the 

mesovarium. Arch Pathol Lab Med 109: 

291-293. 

1069. Gronroos M, Meurman L, Kahra K 

(1983). Proliferating glia and other heterotopic 

tissues in the uterus: fetal homografts? 


1070. Gross GE, Barrasso R (1997). Human 

Pamilloma Virus Infection - A Clinical 

Atlas. Berlin. 

1071. Gruber SB, Thompson WD (1996). A 

population-based study of endometrial 

cancer and familial risk in younger women. 

Cancer and Steroid Hormone Study Group. 

Cancer Epidemiol Biomarkers Prev 5: 411- 

417. 

1072. Gruvberger S, Ringner M, Chen Y, 

Panavally S, Saal LH, Borg A, Ferno M, 

Peterson C, Meltzer PS (2001). Estrogen 

receptor status in breast cancer is associated 

with remarkably distinct gene expression 

patterns. Cancer Res 61: 5979-5984. 

1073. Gudmundsson J, Barkardottir RB, 

Eiriksdottir G, Baldursson T, Arason A, 

Egilsson V, Ingvarsson S (1995). Loss of 

heterozygosity at chromosome 11 in breast 

cancer: association of prognostic factors 

with genetic alterations. Br J Cancer 72: 

696-701. 

1074. Guerin M, Gabillot M, Mathieu MC, 

Travagli JP, Spielmann M, Andrieu N, Riou 

G (1989). Structure and expression of cerbB-2 

and EGF receptor genes in inflammatory 

and non-inflammatory breast cancer: 

prognostic significance. Int J Cancer 

43: 201-208. 

1075. Guerrieri C, Franlund B, Boeryd B 

(1995). Expression of cytokeratin 7 in simultaneous 

mucinous tumors of the ovary and 

appendix. Mod Pathol 8: 573-576. 

1076. Guerrieri C, Hogberg T, Wingren S, 

Fristedt S, Simonsen E, Boeryd B (1994). 

Mucinous borderline and malignant 

tumors of the ovary. A clinicopathologic 

and DNA ploidy study of 92 cases. Cancer 

74: 2329-2340. 

1077. Guerrieri C, Jarlsfelt I (1993). 

Ependymoma of the ovary. A case report 

with immunohistochemical, ultrastructural, 

and DNA cytometric findings, as well as 

histogenetic considerations. Am J Surg 

Pathol 17: 623-632. 

1078. Guillou L, Wadden C, Coindre JM, 

Krausz T, Fletcher CD (1997). "Proximaltype" 

epithelioid sarcoma, a distinctive 

aggressive neoplasm showing rhabdoid 

features. Clinicopathologic, immunohistochemical, 

and ultrastructural study of a 

series. Am J Surg Pathol 21: 130-146. 

1079. Guinee VF, Olsson H, Moller T, Hess 

KR, Taylor SH, Fahey T, Gladikov JV, van 

den Blink JW, Bonichon F, Dische S, Yates 

JW, Cleaton FJ (1994). Effect of pregnancy 

on prognosis for young women with breast 

cancer. Lancet 343: 1587-1589. 

1080. Guinet C, Ghossain MA, Buy JN, 

Malbec L, Hugol D, Truc JB, Vadrot D 

(1995). Mature cystic teratomas of the 

ovary: CT and MR findings. Eur J Radiol 20: 

137-143. 

1081. Gultekin SH, Cody HS III, Hoda SA 

(1996). Schwannoma of the breast. South 

Med J 89: 238-239. 

1082. Gump FE (1990). Lobular carcinoma in 

situ. Pathology and treatment. Surg Clin 

North Am 70: 873-883. 

1083. Gump FE, Sternschein MJ, Wolff M 

(1981). Fibromatosis of the breast. Surg 


1084. Gunn RA, Gallager HS (1980). Vulvar 

Paget's disease: a topographic study. 

Cancer 46: 590-594. 

1085. Gunther K, Merkelbach-Bruse S, 

Amo-Takyi BK, Handt S, Schroder W, 

Tietze L (2001). Differences in genetic 

alterations between primary lobular and 

ductal breast cancers detected by comparative 

genomic hybridization. J Pathol 

193: 40-47. 

1 0 8 6 . Guo Z, Thunberg U, Sallstrom J, 

Wilander E, Ponten J (1998). Clonality 

analysis of cervical cancer on microdissected 

archival materials by PCR-based Xchromosome 

inactivation approach. Int J 

Oncol 12: 1327-1332. 

1087. Gupta D, Balsara G (1999). 

Extrauterine malignancies. Role of Pap 

smears in diagnosis and management. 

Acta Cytol 43: 806-813. 

1088. Gupta JW, Saito K, Saito A, Fu YS, 

Shah KV (1989). Human papillomaviruses 

and the pathogenesis of cervical neoplasia. 

A study by in situ hybridization. Cancer 

64: 2104-2110. 

1089. Gupta RK (1996). Aspiration cytodiagnosis 

of a rare carcinoma of breast with 

bizarre malignant giant cells. D i a g n 

Cytopathol 15: 66-69. 

1090. Gupta SK, Douglas-Jones AG, Jasani 

B, Morgan JM, Pignatelli M, Mansel RE 

(1997). E-cadherin (E-cad) expression in 

duct carcinoma in situ (DCIS) of the breast. 


1091. Gustafson ML, Lee MM, Scully RE, 

Moncure AC, Hirakawa T, Goodman A, 

Muntz HG, Donahoe PK, MacLaughlin DT, 

Fuller AF Jr. (1992). Mullerian inhibiting 

substance as a marker for ovarian sexcord 

tumor. N Engl J Med 326: 466-471. 

1092. Gustafsson A, Tartter PI, Brower ST, 

Lesnick G (1994). Prognosis of patients 

with bilateral carcinoma of the breast. J 

Am Coll Surg 178: 111-116. 

1093. Gwavava NJ, Traub AI (1980). A 

neurilemmoma of the cervix. Br J Obstet 

Gynaecol 87: 444-446. 

1094. Ha HK, Baek SY, Kim SH, Kim HH, 

Chung EC, Yeon KM (1995). Krukenberg's 

tumor of the ovary: MR imaging features. 


1095. Haagensen CD (1971). Inflammatory 

Carcinoma. In: Diseases of the Breast. CD 

Haagensen (Ed.) 2nd ed. WB Sauders: 

Philadelphia, pp. 576-584. 

1096. Haagensen CD (1986). Diseases of 

the Breast. 3rd ed. WB Saunders: 

Philadelphia. 

1097. Haagensen CD (1986). Multiple intraductal 

papilloma. In: Diseases of the 

Breast. 3rd ed. WB Saunders: 


1098. Haagensen CD (1986). Solitary intraductal 

papilloma. In: Diseases of the 

B r e a s t . 3rd ed. WB Saunders: 


1099. Haagensen CD, Lane N, Lattes R 

(1972). Neoplastic proliferation of the 

epithelium of the mammary lobules: 

adenosis, lobular neoplasia, and small cell 

carcinoma. Surg Clin North Am 52: 497-524. 

1100. Haagensen CD, Lane N, Lattes R, 

Bodian C (1978). Lobular neoplasia (socalled 

lobular carcinoma in situ) of the 


1101. Haberal A, Turgut F, Ozbey B, 

Kucukali T, Sapmaz M (1995). Granular cell 

myoblastoma of the cervix in a 14 year old 

girl. Cent Afr J Med 41: 298-300. 

1102. Hachi H, Othmany A, Douayri A, 

Bouchikhi C, Tijami F, Laalou L, Chami M, 

Boughtab A, Jalil A, Benjelloun S, Ahyoud 

F, Kettani F, Souadka A (2002). [Association 

of ovarian juvenile granulosa cell tumor 

with Maffucci's syndrome]. G y n e c o l 

Obstet Fertil 30: 692-695. 

1103. Hachisuga T, Sugimori H, Kaku T, 

Matsukuma K, Tsukamoto N, Nakano H 

(1990). Glassy cell carcinoma of the 

endometrium. Gynecol Oncol 36: 134-138. 

1104. Hacker NF (2000). Uterine cancer. In: 

Practical Gynecologic Oncology. 3rd ed. 

Lippincott, William & Wilkins: Philadelphia, 

pp. 407-455. 

1105. Hacker NF, Berek JS, Lagasse LD, 

Nieberg RK, Leuchter RS (1984). 

Individualization of treatment for stage I 

squamous cell vulvar carcinoma. Obstet 

Gynecol 63: 155-162. 

1106. Haefner HK, Tate JE, McLachlin CM, 

Crum CP (1995). Vulvar intraepithelial neoplasia: 

age, morphological phenotype, 

papillomavirus DNA, and coexisting invasive 

carcinoma. Hum Pathol 26: 147-154. 

1107. Hainaut P, Hollstein M (2000). p53 and 

human cancer: the first ten thousand 

mutations. Adv Cancer Res 77: 81-137. 

1108. Hakem R, de la Pompa JL, Elia A, 

Potter J, Mak TW (1997). Partial rescue of 

Brca1 (5-6) early embryonic lethality by p53 

or p21 null mutation. Nat Genet 16: 298-302. 

1109. Hall JM, Lee MK, Newman B, 

Morrow JE, Anderson LA, Huey B, King MC 

(1990). Linkage of early-onset familial 

breast cancer to chromosome 17q21. 

Science 250: 1684-1689. 

1110. Hallgrimsson J, Scully RE (1972). 

Borderline and malignant Brenner tumours 

of the ovary. A report of 15 cases. Acta 

Pathol Microbiol Scand [A] 233: 56-66. 

1111. Hamby LS, McGrath PC, Cibull ML, 

Schwartz RW (1991). Gastric carcinoma 

metastatic to the breast. J Surg Oncol 48: 

117-121. 

1112. Hameed K, Burslem MR (1970). A 

melanotic ovarian neoplasm resembling 

the "retinal anlage" tumor. Cancer 25: 564- 

567. 

1113. Hamele-Bena D, Cranor ML, Sciotto 

C, Erlandson R, Rosen PP (1996). 

Uncommon presentation of mammary 

myofibroblastoma. Mod Pathol 9: 786-790. 

1114. Hamilton S, Aaltonen L (2000). WHO 

Classification of Tumours. Pathology and 

Genetics of Tumours of the Digestive 

System. IARC Press: Lyon. 

1115. Hamilton SR, Liu B, Parsons RE, 

Papadopoulos N, Jen J, Powell SM, Krush 

AJ, Berk T, Cohen Z, Tetu B, Burger PC, 

Wood PA, Taqi F, Booker SV, Petersen GM, 

Offerhaus GJA, Tersmette AC, Giardiello 

FM, Volgelstein B, Kinzler KW. (1995). The 

molecular basis of Turcot's syndrome. N 

Engl J Med 332: 839-847. 

1116. Hamm B, Kubik-Huch RA, Fleige B 

(1999). MR imaging and CT of the female 

pelvis: radiologic-pathologic correlation. 

Eur Radiol 9: 3-15. 

1117. Hampl M, Hampl JA, Reiss G, 

Schackert G, Saeger HD, Schackert HK 

(1999). Loss of heterozygosity accumulation 

in primary breast carcinomas and 

additionally in corresponding distant 

metastases is associated with poor outcome. 

Clin Cancer Res 5: 1417-1425. 

1118. Hampton GM, Mannermaa A, 

Winquist R, Alavaikko M, Blanco G, 

Taskinen PJ, Kiviniemi H, Newsham I, 

Cavenee WK, Evans GA (1994). Loss of heterozygosity 

in sporadic human breast carcinoma: 

a common region between 11q22 

and 11q23.3. Cancer Res 54: 4586-4589. 

1119. Hampton GM, Penny LA, Baergen 

RN, Larson A, Brewer C, Liao S, Busby- 

Earle RM, Williams AW, Steel CM, Bird CC, 

Stanbridge EJ, Evans GA. (1994). Loss of 

heterozygosity in cervical carcinoma: subchromosomal 

localization of a putative 

tumor-suppressor gene to chromosome 

11q22-q24. Proc Natl Acad Sci USA 91: 

6953-6957. 

1120. Hampton HL, Huffman HT, Meeks GR 

(1992). Extraovarian Brenner tumor. Obstet 

Gynecol 79: 844-846. 

1121. Han HJ, Maruyama M, Baba S, Park 

JG, Nakamura Y (1995). Genomic structure 

of human mismatch repair gene, hMLH1, 

and its mutation analysis in patients with 

hereditary non-polyposis colorectal cancer 

(HNPCC). Hum Mol Genet 4: 237-242. 

1122. Han HS, Park IA, Kim SH, Lee HP 

(1998). The clear cell variant of epithelioid 

intravenous leiomyomatosis of the uterus: 

report of a case. Pathol Int 48: 892-896. 

1123. Hancock BW, Welch EM, Gillespie 

AM, Newlands ES (2000). A retrospective 

comparison of current and proposed staging 

and scoring systems for persistent gestational 

trophoblastic disease. Int J 

Gynecol Cancer 10: 318-322. 

1124. Hanjani P, Petersen RO, Bonnell SA 

(1980). Malignant mixed Mullerian tumor of 

the fallopian tube. Report of a case and 

review of literature. Gynecol Oncol 9: 381- 

393. 

1125. Hankins GR, De Souza AT, Bentley 

RC, Patel MR, Marks JR, Iglehart JD, Jirtle 

RL (1996). M6P/IGF2 receptor: a candidate 

breast tumor suppressor gene. Oncogene 

12: 2003-2009. 

1126. Hankinson SE, Hunter DJ, Colditz GA, 

Willett WC, Stampfer MJ, Rosner B, 

Hennekens CH, Speizer FE (1993). Tubal ligation, 

hysterectomy, and risk of ovarian 

cancer. A prospective study. JAMA 270: 

2813-2818. 

1127. Hankinson SE, Willett WC, Colditz GA, 

Hunter DJ, Michaud DS, Deroo B, Rosner 

B, Speizer FE, Pollak M (1998). Circulating 

concentrations of insulin-like growth factor-I 

and risk of breast cancer. Lancet 351: 

1393-1396. 

1128. Hankinson SE, Willett WC, Manson 

JE, Colditz GA, Hunter DJ, Spiegelman D, 

Barbieri RL, Speizer FE (1998). Plasma sex 

steroid hormone levels and risk of breast 

cancer in postmenopausal women. J Natl 

Cancer Inst 90: 1292-1299. 

1129. Hanna NN, O'Donnell K, Wolfe GR 

(1996). Alveolar soft part sarcoma metastatic 

to the breast. J Surg Oncol 61: 159-162. 

1130. Hanna W, Kahn HJ (1985). 

Ultrastructural and immunohistochemical 

characteristics of mucoepidermoid carcinoma 

of the breast. Hum Pathol 16: 941- 

946. 

1131. Hanselaar A, van Loosbroek M, 

Schuurbiers O, Helmerhorst T, Bulten J, 

Bernhelm J (1997). Clear cell adenocarcinoma 

of the vagina and cervix. An update 

of the central Netherlands registry showing 

twin age incidence peaks. Cancer 79: 

2229-2236. 


1132. Hanselaar AG, Boss EA, Massuger 

LF, Bernheim JL (1999). Cytologic examination 

to detect clear cell adenocarcinoma of 

the vagina or cervix. Gynecol Oncol 75: 

338-344. 

1133. Hanssen AM, Fryns JP (1995). 

Cowden syndrome. J Med Genet 32: 117- 

119. 

1134. Harada Y, Katagiri T, Ito I, Akiyama F, 

Sakamoto G, Kasumi F, Nakamura Y, Emi M 

(1994). Genetic studies of 457 breast cancers. 

Clinicopathologic parameters compared 

with genetic alterations. Cancer 74: 

2281-2286. 

1135. Hardesty LA, Sumkin JH, Hakim C, 

Johns C, Nath M (2001). The ability of helical 

CT to preoperatively stage endometrial 

carcinoma. Am J Roentgenol 176: 603-606. 

1136. Hardesty LA, Sumkin JH, Nath ME, 

Edwards RP, Price FV, Chang TS, Johns 

CM, Kelley JL (2000). Use of preoperative 

MR imaging in the management of 

endometrial carcinoma: cost analysis. 

Radiology 215: 45-49. 

1137. Hardisson D, Simon RS, Burgos E 

(2001). Primary osteosarcoma of the uterine 

corpus: report of a case with immunohistochemical 



1138. Harkin DP, Bean JM, Miklos D, Song 

YH, Truong VB, Englert C, Christians FC, 

Ellisen LW, Maheswaran S, Oliner JD, 

Haber DA (1999). Induction of GADD45 and 

JNK/SAPK-dependent apoptosis following 

inducible expression of BRCA1. Cell 97: 

575-586. 

1139. Harlow BL, Weiss NS, Lofton S (1986). 

The epidemiology of sarcomas of the 

uterus. J Natl Cancer Inst 76: 399-402. 

1140. Harnden P, Kennedy W, Andrew AC, 

Southgate J (1999). Immunophenotype of 

transitional metaplasia of the uterine 

cervix. Int J Gynecol Pathol 18: 125-129. 

1141. Haroske G, Giroud F, Reith A, Bocking 

A (1998). 1997 ESACP consensus report on 

diagnostic DNA image cytometry. Part I: 

basic considerations and recommendations 

for preparation, measurement and 

interpretation. European Society for 

Analytical Cellular Pathology. Anal Cell 

Pathol 17: 189-200. 

1142. Harris M, Howell A, Chrissohou M, 

Swindell RI, Hudson M, Sellwood RA 

(1984). A comparison of the metastatic pattern 

of infiltrating lobular carcinoma and 

infiltrating duct carcinoma of the breast. 

Br J Cancer 50: 23-30. 

1143. Harris M, Wells S, Vasudev KS (1978). 

Primary signet ring cell carcinoma of the 


1144. Harris NL, Jaffe ES, Diebold J, 

Flandrin G, Muller-Hermelink HK, Vardiman 

J, Lister TA, Bloomfield CD (2000). The 

World Health Organization classification of 

hematological malignancies report of the 

Clinical Advisory Committee Meeting, 

Airlie House, Virginia, November 1997. 

Mod Pathol 13: 193-207. 

1145. Harris NL, Scully RE (1984). Malignant 

lymphoma and granulocytic sarcoma of 

the uterus and vagina. A clinicopathologic 

analysis of 27 cases. Cancer 53: 2530-2545. 

1146. Harrison M, Magee HM, O'Loughlin 

J, Gorey TF, Dervan PA (1995). 

Chromosome 1 aneusomy, identified by 

interphase cytogenetics, in mammograph - 

ically detected ductal carcinoma in situ of 

the breast. J Pathol 175: 303-309. 

1147. Hart WR (1977). Ovarian epithelial 

tumors of borderline malignancy (carcinomas 

of low malignant potential). H u m 

Pathol 8: 541-549. 


1148. Hart WR, Billman JK Jr. (1978). A 

reassessment of uterine neoplasms originally 

diagnosed as leiomyosarcomas. 

Cancer 41: 1902-1910. 

1149. Hart WR, Craig JR (1978). 

Rhabdomyosarcomas of the uterus. Am J 

Clin Pathol 70: 217-223. 

1150. Hart WR, Norris HJ (1973). Borderline 

and malignant mucinous tumors of the 

ovary. Histologic criteria and clinical 

behavior. Cancer 31: 1031-1045. 

1151. Hartge P, Struewing JP, Wacholder 

S, Brody LC, Tucker MA (1999). The prevalence 

of common BRCA1 and BRCA2 mutations 

among Ashkenazi Jews. Am J Hum 

Genet 64: 963-970. 

1152. Hartveit E (1990). Attenuated cells in 

breast stroma: the missing lymphatic system 

of the breast. Histopathology 16: 533- 

543. 

1153. Hasebe T, Mukai K, Tsuda H, Ochiai A 

(2000). New prognostic histological parameter 

of invasive ductal carcinoma of the 

breast: clinicopathological significance of 

fibrotic focus. Pathol Int 50: 263-272. 

1154. Hashiguchi J, Ito M, Kishikawa M, 

Sekine I, Kase Y (1994). Intravascular 

leiomyomatosis with uterine lipoleiomyoma. 


1155. Haskel S, Chen SS, Spiegel G (1989). 

Vaginal endometrioid adenocarcinoma 

arising in vaginal endometriosis: a case 

report and literature review. G y n e c o l 

Oncol 34: 232-236. 

1156. Hastrup N, Sehested M (1985). Highgrade 

mucoepidermoid carcinoma of the 


1157. Haswani P, Arseneau J, Ferenczy A 

(1998). Primary signet cell carcinoma of the 

uterine cervix: a clinicopathologic study of 

two cases with review of the literature. Int 

J Gynecol Cancer 8: 374-379. 

1 1 5 8 . Hata JI, Ueyama Y, Tamaoki N, 

Akatsuka A, Yoshimura S, Shimuzu K, 

Morikawa Y, Furukawa T (1980). Human 

yolk sac tumor serially transplanted in 

nude mice: its morphologic and functional 

properties. Cancer 46: 2446-2455. 

1159. Hauptmann S, Dietel M (2001). 

Serous tumors of low malignant potential 

of the ovary-molecular pathology: part 2. 


1160. Hausen H. (2000). Papillomaviruses 

causing cancer: evasion from host-cell 

control in early events in carcinogenesis. 


1161. Hawkins RE, Schofield JB, Fisher C, 

Wiltshaw E, McKinna JA (1992). The clinical 

and histologic criteria that predict 

metastases from cystosarcoma phyllodes. 

Cancer 69: 141-147. 

1162. Hayashi K, Bracken MB, Freeman DH 

Jr., Hellenbrand K (1982). Hydatidiform 

mole in the United States (1970-1977): a 

statistical and theoretical analysis. Am J 


1163. Hayes MC, Scully RE (1987). Ovarian 

steroid cell tumors (not otherwise specified). 

A clinicopathological analysis of 63 


1164. Hayes MC, Scully RE (1987). Stromal 

luteoma of the ovary: a clinicopathological 

analysis of 25 cases. Int J Gynecol Pathol 

6: 313-321. 

1165. Hayes MM, Seidman JD, Ashton MA 

(1995). Glycogen-rich clear cell carcinoma 

of the breast. A clinicopathologic study of 


1166. Hays DM, Donaldson SS, Shimada H, 

Crist WM, Newton WA Jr., Andrassy RJ, 

Wiener E, Green J, Triche T, Maurer HM 

(1997). Primary and metastatic rhabdomyosarcoma 

in the breast: neoplasms of 

adolescent females, a report from the 

Intergroup Rhabdomyosarcoma Study. 

Med Pediatr Oncol 29: 181-189. 

1167. Healey CS, Dunning AM, Teare MD, 

Chase D, Parker L, Burn J, Chang-Claude 

J, Mannermaa A, Kataja V, Huntsman DG, 

Pharoah PD, Luben RN, Easton DF, Ponder 

BA (2000). A common variant in BRCA2 is 

associated with both breast cancer risk 

and prenatal viability. Nat Genet 26: 362- 

364. 

1168. Healey EA, Cook EF, Orav EJ, Schnitt 

SJ, Connolly JL, Harris JR (1993). 

Contralateral breast cancer: clinical characteristics 

and impact on prognosis. J Clin 

Oncol 11: 1545-1552. 

1169. Heatley MK (2000). Adenomatous 

hyperplasia of the rete ovarii. 


1170. Heatley MK (2001). Polyp of the fallopian 

tube. Pathology 33: 538-539. 

1171. Hedenfalk I, Duggan D, Chen Y, 

Radmacher M, Bittner M, Simon R, Meltzer 

P, Gusterson B, Esteller M, Kallioniemi OP, 

Wilfond B, Borg A, Trent J (2001). Geneexpression 

profiles in hereditary breast 

cancer. N Engl J Med 344: 539-548. 

1172. Heffelfinger SC, Yassin R, Miller MA, 

Lower EE (2000). Cyclin D1, retinoblastoma, 

p53, and Her2/neu protein expression in 

preinvasive breast pathologies: correlation 

with vascularity. Pathobiology 68: 129-136. 

1173. Hefler LA, Rosen AC, Graf AH, 

Lahousen M, Klein M, Leodolter S, 

Reinthaller A, Kainz C, Tempfer CB (2000). 

The clinical value of serum concentrations 

of cancer antigen 125 in patients with primary 

fallopian tube carcinoma: a multicenter 

study. Cancer 89: 1555-1560. 

1 1 7 4 . Heifetz SA, Cushing B, Giller R, 

Shuster JJ, Stolar CJ, Vinocur CD, 

Hawkins EP (1998). Immature teratomas in 

children: pathologic considerations: a 

report from the combined Pediatric 

Oncology Group/Children's Cancer Group. 


1175. Heim S, Teixeira MR, Dietrich CU, 

Pandis N (1997). Cytogenetic polyclonality 

in tumors of the breast. Cancer Genet 

Cytogenet 95: 16-19. 

1176. Heimann R, Lan F, McBride R, 

Hellman S (2000). Separating favorable 

from unfavorable prognostic markers in 

breast cancer: the role of E-cadherin. 

Cancer Res 60: 298-304. 

1177. Heintz AP, Schaberg A, Engelsman E, 

van Hall EV (1985). Placental-site trophoblastic 

tumor: diagnosis, treatment, 

and biological behavior. Int J Gynecol 

Pathol 4: 75-82. 

1178. Helland A, Karlsen F, Due EU, Holm R, 

Kristensen G, Borresen-Dale A (1998). 

Mutations in the TP53 gene and protein 

expression of p53, MDM 2 and p21/WAF-1 

in primary cervical carcinomas with no or 

low human papillomavirus load. Br J 

Cancer 78: 69-72. 

1179. Heller DS, Keohane M, Bessim S, 

Jagirdar J, Deligdisch L (1989). Pituitarycontaining 

benign cystic teratoma arising 

from the uterosacral ligament. Arch Pathol 

Lab Med 113: 802-804. 

1180. Heller DS, Rubinstein N, Dikman S, 

Deligdisch L, Moss R (1991). Adenomatous 

polyp of the fallopian tube. A case report. 

J Reprod Med 36: 82-84. 

1181. Hellman S, Harris JR (1987). The 

appropriate breast cancer paradigm. 

Cancer Res 47: 339-342. 

1181 a. Hellstrom AC, Hue J, Silfversward 

C, Auer G (1994). DNA-ploidy and mutant 

p53 overexpression in primary fallopian 

tube cancer. Int J Gynecol Cancer 4: 408- 

413. 

1182. Hellstrom AC, Tegerstedt G, 

Silfversward C, Pettersson F (1999). 

Malignant mixed mullerian tumors of the 

ovary: histopathologic and clinical review 

of 36 cases. Int J Gynecol Cancer 9: 312- 

316. 

1183. Helzlsouer KJ, Alberg AJ, Bush TL, 

Longcope C, Gordon GB, Comstock GW 

(1994). A prospective study of endogenous 

hormones and breast cancer. C a n c e r 

Detect Prev 18: 79-85. 

1184. Hemminki K, Dong C, Vaittinen P 

(1999). Familial risks in cervical cancer: is 

there a hereditary component? Int J 

Cancer 82: 775-781. 

1185. Hemminki K, Vaittinen P (1999). Male 

breast cancer: risk to daughters. Lancet 

353: 1186-1187. 

1186. Hendrickson M, Ross J, Eifel P, 

Martinez A, Kempson R (1982). Uterine 

papillary serous carcinoma: a highly malignant 

form of endometrial adenocarcinoma. 


1187. Hendrickson MR, Kempson RL (1983). 

Ciliated carcinoma--a variant of endometrial 

adenocarcinoma: a report of 10 cases. 


1188. Hendrickson MR, Scheithauer BW 

(1986). Primitive neuroectodermal tumor of 

the endometrium: report of two cases, one 

with electron microscopic observations. 


1189. Hennig Y, Caselitz J, Bartnitzke S, 

Bullerdiek J (1997). A third case of a lowgrade 

endometrial stromal sarcoma with a 

t(7;17)(p14 approximately 21;q11.2 approxi - 

mately 21). Cancer Genet Cytogenet 98: 84- 

86. 

1190. Henson DE, Ries L, Freedman LS, 

Carriaga M (1991). Relationship among 

outcome, stage of disease, and histologic 

grade for 22,616 cases of breast cancer. 

The basis for a prognostic index. Cancer 

68: 2142-2149. 

1191. Herbold DR, Axelrod JH, Bobowski 

SJ, Freel JH (1988). Glassy cell carcinoma 

of the fallopian tube. A case report. Int J 


1192. Herbold DR, Fu YS, Silbert SW (1983). 

Leiomyosarcoma of the broad ligament. A 

case report and literature review with follow-up. 


1193. Herbst AL, Green TH Jr., Ulfelder H 

(1970). Primary carcinoma of the vagina. 

An analysis of 68 cases. Am J Obstet 

Gynecol 106: 210-218. 

1194. Herbst AL, Ulfelder H, Poskanzer DC 

(1971). Adenocarcinoma of the vagina. 

Association of maternal stilbestrol therapy 

with tumor appearance in young women. 

N Engl J Med 284: 878-881. 

1195. Hermanek P, Hutter RV, Sobin LH, 

Wittekind C (1999). International Union 

Against Cancer. Classification of isolated 

tumor cells and micrometastasis. Cancer 

86: 2668-2673. 

1 1 9 6 . Hernandez-Boussard TR-TPMRHP 

(2001). IARC p53 mutation database: a relational 

database to compile and analyze p53 

mutations in human tumors and cell lines (R5 

version). WHO/IARC http://www.iarc.fr/P53.

1197. Herod JJ, Shafi MI, Rollason TP, 

Jordan JA, Luesley DM (1996). Vulvar 

intraepithelial neoplasia with superficially 

invasive carcinoma of the vulva. Br J 


1198. Herrera LJ, Lugo-Vicente H (1998). 

Primary embryonal rhabdomyosarcoma of 

the breast in an adolescent female: a case 

report. J Pediatr Surg 33: 1582-1584. 

1199. Herrero R, Munoz N (1999). Human 

papillomavirus and cancer. Cancer surv 

33: 75-98. 

1200. Herrington CS, Tarin D, Buley I, 

Athanasou N (1994). Osteosarcomatous 

differentiation in carcinoma of the breast: 

a case of 'metaplastic' carcinoma with 

osteoclasts and osteoclast-like giant cells. 


1201. Herrington CS, Wells M (2002). 

Premalignant and malignant squamous 

lesions of the cervix. In: Haines and Taylor 

Obstetrical and Gynaecological Pathology. 

H Fox, M Wells (Eds.) Fifth ed. Churchill 

Livingstone: Edinburgh, pp. 297-338. 

1202. Hertel BF, Zaloudek C, Kempson RL 

(1976). Breast adenomas. Cancer 37: 2891- 

2905. 

1203. Hertig AT, Mansell H (1956). Tumours 

of the female sex organs. Part I 

Hydatidiform mole and choriocarcinoma. 

In: Atlas of Tumour Pathology, AFIP (Ed.) 

AFIP: Washington,DC. 

1204. Hessler C, Schnyder P, Ozzello L 

(1978). Hamartoma of the breast: diagnostic 

observation of 16 cases. Radiology 126: 

95-98. 

1205. Hetzel DJ, Wilson TO, Keeney GL, 

Roche PC, Cha SS, Podratz KC (1992). HER- 

2/neu expression: a major prognostic factor 

in endometrial cancer. Gynecol Oncol 

47: 179-185. 

1206. Heywang-Kobrunner SH, Dershaw 

DD, Schreer I (2000). Diagnostic Breast 

Imaging. 2nd ed. Thieme: New York. 

1207. Hibberd AD, Horwood LJ, Wells JE 

(1983). Long term prognosis of women with 

breast cancer in New Zealand: study of 

survival to 30 years. Br Med J (Clin Res Ed) 

286: 1777-1779. 

1208. Hidalgo A, Schewe C, Petersen S, 

Salcedo M, Gariglio P, Schluns K, Dietel M, 

Petersen I (2000). Human papilloma virus 

status and chromosomal imbalances in 

primary cervical carcinomas and tumour 

cell lines. Eur J Cancer 36: 542-548. 

1209. Hierro I, Blanes A, Matilla A, Munoz 

S, Vicioso L, Nogales FF (2000). Merkel cell 

(neuroendocrine) carcinoma of the vulva. 

A case report with immunohistochemical 

and ultrastructural findings and review of 

the literature. Pathol Res Pract 196: 503- 

509. 

1210. Hill A, Yagmur Y, Tran KN, Bolton JS, 

Robson M, Borgen PI (1999). Localized 

male breast carcinoma and family history. 

An analysis of 142 patients. Cancer 86: 

821-825. 

1211. Hill RP, Miller FN (1954). With case 

report of carcinomatous transformation in 

an adenoma. Cancer 7: 318-324. 

1212. Hinkula M, Pukkala E, Kyyronen P, 

Kauppila A (2002). Grand multiparity and 

incidence of endometrial cancer: a population-based 

study in Finland. Int J Cancer 

98: 912-915. 

1213. Hiort O, Naber SP, Lehners A, 

Muletta-Feurer S, Sinnecker GH, Zollner A, 

Komminoth P (1996). The role of androgen 

receptor gene mutations in male breast 

carcinoma. J Clin Endocrinol Metab 81: 

3404-3407. 

1214. Hirakawa T, Tsuneyoshi M, Enjoji M 

(1989). Squamous cell carcinoma arising in 

mature cystic teratoma of the ovary. 

Clinicopathologic and topographic analysis. 


1215. Hirakawa T, Tsuneyoshi M, Enjoji M, 

Shigyo R (1988). Ovarian sarcoma with histologic 

features of telangiectatic osteosarcoma 

of the bone. Am J Surg Pathol 12: 

567-572. 

1216. Hirano A, Emi M, Tsuneizumi M, 

Utada Y, Yoshimoto M, Kasumi F, Akiyama 

F, Sakamoto G, Haga S, Kajiwara T, 

Nakamura Y (2001). Allelic losses of loci at 

3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate 

with postoperative recurrence in 

breast cancer. Clin Cancer Res 7: 876-882. 

1217. Hirohashi S (1998). Inactivation of the 

E-cadherin-mediated cell adhesion system 

in human cancers. Am J Pathol 153: 333- 

339. 

1218. Hiroi H, Yasugi T, Matsumoto K, Fujii 

T, Watanabe T, Yoshikawa H, Taketani Y 

(2001). Mucinous adenocarcinoma arising 

in a neovagina using the sigmoid colon 

thirty years after operation: a case report. 

J Surg Oncol 77: 61-64. 

1219. Hislop TG, Elwood JM, Coldman AJ, 

Spinelli JJ, Worth AJ, Ellison LG (1984). 

Second primary cancers of the breast: 

incidence and risk factors. Br J Cancer 49: 

79-85. 

1220. Hitchcock CL, Norris HJ (1992). Flow 

cytometric analysis of endometrial stromal 

sarcoma. Am J Clin Pathol 97: 267-271. 

1221. Hittmair AP, Lininger RA, Tavassoli 

FA (1998). Ductal carcinoma in situ (DCIS) 

in the male breast: a morphologic study of 

84 cases of pure DCIS and 30 cases of 

DCIS associated with invasive carcinoma- 

-a preliminary report. Cancer 83: 2139- 

2149. 

1222. Ho YB, Robertson DI, Clement PB, 

Mincey EK (1982). Sclerosing stromal 

tumor of the ovary. Obstet Gynecol 60: 252- 

256. 

1223. Hock YL, Mohamid W (1995). Myxoid 

neurofibroma of the male breast: fine needle 

aspiration cytodiagnosis. C y t o p a t h o l o g y 

6: 44-47. 

1224. Hocking GR, Hayman JA, Östör AG 

(1996). Adenocarcinoma in situ of the uterine 

cervix progressing to invasive adenocarcinoma. 

Aust N Z J Obstet Gynaecol 36: 

218-220. 

1225. Hoda SA, Cranor ML, Rosen PP 

(1992). Hemangiomas of the breast with 

atypical histological features. Further 

analysis of histological subtypes confirming 

their benign character. Am J Surg 

Pathol 16: 553-560. 

1226. Hoda SA, Prasad ML, Moore A, Hoda 

RS, Giri D (1999). Microinvasive carcinoma 

of the breast: can it be diagnosed reliably 

and is it clinically significant? H i s t o - 

pathology 35: 468-470. 

1227. Hodak E, Jones RE, Ackerman AB 

(1993). Solitary keratoacanthoma is a 

squamous-cell carcinoma: three examples 

with metastases. Am J Dermatopathol 15: 

332-342. 

1228. Hoerl HD, Hart WR (1998). Primary 

ovarian mucinous cystadenocarcinomas: 

a clinicopathologic study of 49 cases with 

long-term follow-up. Am J Surg Pathol 22: 

1449-1462. 

1229. Hogervorst FB, Nederlof PM, Gille JJ, 

McElgunn CJ, Grippeling M, Pruntel R, 

Regnerus R, van Welsem T, van 

Spaendonk R, Menko FH, Kluijt I, 

Dommering C, Verhoef S, Schouten JP, 

van't Veer LJ, Pals G (2003). Large genomic 

deletions and duplications in the BRCA1 

gene identified by a novel quantitative 

method. Cancer Res 63: 1449-1453. 

1230. Holland R, Faverly D (1997). Whole 

organ studies. In: Ductal Carcinoma in Situ 

of the Breast. MJ Silverstein (Ed.) Williams 

& Wilkins: Baltimore. pp. 233-240. 

1230a. Holland R, Faverly D (1997). The 

local distribution of ductal carcinoma in 

situ of the breast. In: Ductal Carcinoma in 

Situ of the Breast. MJ Silverstein (Ed.) 

Williams & Wilkins: Baltimore. pp. 233-240. 

1231. Holland R, Hendriks JH (1994). 

Microcalcifications associated with ductal 

carcinoma in situ: mammographic-pathologic 

correlation. Semin Diagn Pathol 11: 

181-192. 

1232. Hollingsworth HC, Steinberg SM, 

Silverberg SG, Merino MJ (1996). 

Advanced stage transitional cell carcinoma 

of the ovary. Hum Pathol 27: 1267-1272. 

1233. Holmberg L, Adami HO, Ekbom A, 

Bergstrom R, Sandstrom A, Lindgren A 

(1988). Prognosis in bilateral breast cancer. 

Effects of time interval between first 

and second primary tumours. Br J Cancer 

58: 191-194. 

1234. Holway AH, Rieger-Christ KM, Miner 

WR, Cain JW, Dugan JM, Pezza JA, 

Silverman ML, Shapter A, McLellan R, 

Summerhayes IC (2000). Somatic mutation 

of PTEN in vulvar cancer. Clin Cancer Res 

6: 3228-3235. 

1235. Homesley HD, Bundy BN, Sedlis A, 

Yordan E, Berek JS, Jahshan A, Mortel R 

(1993). Prognostic factors for groin node 

metastasis in squamous cell carcinoma of 

the vulva (a Gynecologic Oncology Group 

study). Gynecol Oncol 49: 279-283. 

1236. Honore LH, Nickerson KG (1976). 

Papillary serous cystadenoma arising in a 

paramesonephric cyst of the parovarium. 

Am J Obstet Gynecol 125: 870-871. 

1237. Hopkins M, Nunez C, Murphy JR, 

Wentz WB (1985). Malignant placental site 

trophoblastic tumor. Obstet Gynecol 66: 

95S-100S. 

1238. Hopper JL, Carlin JB (1992). Familial 

aggregation of a disease consequent upon 

correlation between relatives in a risk factor 

measured on a continuous scale. Am J 

Epidemiol 136: 1138-1147. 

1239. Horie Y, Ikawa S, Kadowaki K, 

Minagawa Y, Kigawa J, Terakawa N 

(1995). Lipoadenofibroma of the uterine 

corpus. Report of a new variant of adenofibroma 

(benign mullerian mixed tumor). 


1240. Horn LC, Einenkel J, Baier D (2000). 

Endometrial metastasis from breast cancer 

in a patient receiving tamoxifen therapy. 

Gynecol Obstet Invest 50: 136-138. 

1241. Horn PL, Thompson WD (1988). Risk 

of contralateral breast cancer. A s s ociations 

with histologic, clinical, and therapeutic 

factors. Cancer 62: 412-424. 

1242. Horn T, Jao W, Keh PC (1983). Benign 

cystic teratoma of the fallopian tube. Arch 

Pathol Lab Med 107: 48. 

1243. Horne CH, Reid IN, Milne GD (1976). 

Prognostic significance of inappropriate 

production of pregnancy proteins by 

breast cancers. Lancet 2: 279-282. 

1244. Horsfall DJ, Tilley WD, Orell SR, 

Marshall VR, Cant EL (1986). Relationship 

between ploidy and steroid hormone 

receptors in primary invasive breast cancer. 

Br J Cancer 53: 23-28. 

1245. Houghton CR, Iversen T (1982). 

Squamous cell carcinoma of the vagina: a 

clinical study of the location of the tumor. 


1246. Houlston RS, McCarter E, Parbhoo S, 

Scurr JH, Slack J (1992). Family history and 

risk of breast cancer. J Med Genet 29: 154- 

157. 

1247. Houvras Y, Benezra M, Zhang H, 

Manfredi JJ, Weber BL, Licht JD (2000). 

BRCA1 physically and functionally interacts 

with ATF1. J Biol Chem 275: 36230- 

36237. 

1248. Howarth CB, Caces JN, Pratt CB 

(1980). Breast metastases in children with 

rhabdomyosarcoma. Cancer 46: 2520-2524. 

1249. Howat AJ, Armour A, Ellis IO (2000). 

Microinvasive lobular carcinoma of the 


1250. Howe JR, Bair JL, Sayed MG, 

Anderson ME, Mitros FA, Petersen GM, 

Velculescu VE, Traverso G, Vogelstein B 

(2001). Germline mutations of the gene 

encoding bone morphogenetic protein 

receptor 1A in juvenile polyposis. N a t 

Genet 28: 184-187. 

1251. Howlett NG, Taniguchi T, Olson S, 

Cox B, Waisfisz Q, Die-Smulders C, Persky 

N, Grompe M, Joenje H, Pals G, Ikeda H, 

Fox EA, D'Andrea AD (2002). Biallelic inactivation 

of BRCA2 in Fanconi anemia. 

Science 297: 606-609. 

1252. Hrynchak M, Horsman D, Salski C, 

Berean K, Benedet JL (1994). Complex 

karyotypic alterations in an endometrial 

stromal sarcoma. Cancer Genet Cytogenet 

77: 45-49. 

1253. Hsing AW, McLaughlin JK, Cocco P, 

Co Chien HT, Fraumeni JFJr. (1998). Risk 

factors for male breast cancer (United 

States). Cancer Causes Control 9: 269-275. 

1254. Hsu SM, Raine L, Nayak RN (1981). 

Medullary carcinoma of breast: an 

immunohistochemical study of its lymphoid 

stroma. Cancer 48: 1368-1376. 

1255. Hsueh S, Chang TC (1996). Malignant 

rhabdoid tumor of the uterine corpus. 


1256. Hu CY, Taymor ML, Hertig AT (1950). 

Primary carcinoma of the fallopian tube. 


1257. Huang E, Cheng SH, Dressman H, 

Pittman J, Tsou MH, Horng CF, Bild A, 

Iversen ES, Liao M, Chen CM, West M, 

Nevins JR, Huang AT (2003). Gene expression 

predictors of breast cancer outcomes. 

Lancet 361: 1590-1596. 

1258. Huang KT, Chen CA, Cheng WF, Wu 

CC, Jou HJ, Hsieh CY, Lin GJ, Hsieh FJ 

(1996). Sonographic characteristics of 

adenofibroma of the endometrium following 

tamoxifen therapy for breast cancer: 

two case reports. Ultrasound Obstet 

Gynecol 7: 363-366. 

1259. Huang LW, Garrett AP, Schorge JO, 

Muto MG, Bell DA, Welch WR, Berkowitz 

RS, Mok SC (2000). Distinct allelic loss patterns 

in papillary serous carcinoma of the 

peritoneum. Am J Clin Pathol 114: 93-99. 

1260. Huettner PC, Gersell DJ (1994). 

Placental site nodule: a clinicopathologic 

study of 38 cases. Int J Gynecol Pathol 1 3: 

191-198. 

1261. Hugh JC, Jackson FI, Hanson J, 

Poppema S (1990). Primary breast lymphoma. 

An immunohistologic study of 20 

new cases. Cancer 66: 2602-2611. 


1262. Hughesdon PE (1982). Ovarian 

tumours of Wolffian or allied nature: their 

place in ovarian oncology. J Clin Pathol 35: 

526-535. 

1263. Hugues FC, Gourlot C, Le Jeunne C 

(2000). [Drug-induced gynecomastia]. Ann 

Med Interne (Paris) 151: 10-17. 

1264. Hull MT, Warfel KA (1986). Glycogenrich 

clear cell carcinomas of the breast. A 

clinicopathologic and ultrastructural 

study. Am J Surg Pathol 10: 553-559. 

1265. Hull MT, Warfel KA (1987). Mucinous 

breast carcinomas with abundant intracytoplasmic 

mucin and neuroendocrine features: 

light microscopic, immunohistochemical, 



1266. Humeniuk V, Forrest AP, Hawkins RA, 

Prescott R (1983). Elastosis and primary 


1267. Hunt CR, Hale RJ, Armstrong C, 

Rajkumar T, Gullick WJ, Buckley CH (1995). 

c-erbB-3 proto-oncogene expression in 

uterine cervical carcinoma. Int J Gynecol 

Cancer 5: 282-285. 

1268. Hunt SJ, Santa Cruz DJ, Barr RJ 

(1990). Cellular angiolipoma. Am J Surg 

Pathol 14: 75-81. 

1269. Hunter CE Jr., Sawyers JL (1980). 

Intracystic papillary carcinoma of the 

breast. South Med J 73: 1484-1486. 

1270. Huntington RW Jr., Bullock WK 

(1970). Yolk sac tumors of extragonadal origin. 

Cancer 25: 1368-1376. 

1271. Huntsman DG, Clement PB, Gilks CB, 

Scully RE (1994). Small-cell carcinoma of 

the endometrium. A clinicopathological 

study of sixteen cases. Am J Surg Pathol 

18: 364-375. 

1272. Husseinzadeh N, Recinto C (1999). 

Frequency of invasive cancer in surgically 

excised vulvar lesions with intraepithelial 

neoplasia (VIN 3). Gynecol Oncol 73: 119- 

120. 

1273. Huvos AG, Lucas JC Jr., Foote FW Jr. 

(1973). Metaplastic breast carcinoma. Rare 

form of mammary cancer. N Y State J Med 

73: 1078-1082. 

1274. Iacocca MV, Maia DM (2001). 

Bilateral infiltrating lobular carcinoma of 

the breast with osteoclast-like giant cells. 

Breast J 7: 60-65. 

1275. Ibrahim RE, Sciotto CG, Weidner N 

(1989). Pseudoangiomatous hyperplasia of 

mammary stroma. Some observations 

regarding its clinicopathologic spectrum. 

Cancer 63: 1154-1160. 

1275a. Ichihara S, Aoyama H (1994). 

Intraductal carcinoma of the breast arising in 

sclerosing adenosis. Pathol Int 44: 722-726. 

1276. Ichikawa Y, Lemon SJ, Wang S, 

Franklin B, Watson P, Knezetic JA, Bewtra 

C, Lynch HT (1999). Microsatellite instability 

and expression of MLH1 and MSH2 in 

normal and malignant endometrial and 

ovarian epithelium in hereditary nonpolyposis 

colorectal cancer family members. 


1277. Ichikawa Y, Tsunoda H, Takano K, Oki 

A, Yoshikawa H (2002). Microsatellite 

instability and immunohistochemical 

analysis of MLH1 and MSH2 in normal 

endometrium, endometrial hyperplasia and 

endometrial cancer from a hereditary nonpolyposis 

colorectal cancer patient. Jpn J 

Clin Oncol 32: 110-112. 


1278. Ichinohasama R, Teshima S, Kishi K, 

Mukai K, Tsunematsu R, Ishii-Ohba H, 

Shimosato Y (1989). Leydig cell tumor of the 

ovary associated with endometrial carcinoma 

and containing 17 beta-hydroxysteroid 

dehydrogenase. Int J Gynecol 

Pathol 8: 64-71. 

1279. Iczkowski KA, Han AC, Edelson MI, 

Rosenblum NG (2000). Primary, localized 

vulvar B-cell lymphoma expressing CD44 

variant 6 but not cadherins. A case report. 

J Reprod Med 45: 853-856. 

1280. Idvall I, Andersson C, Fallenius G, 

Ingvar C, Ringberg A, Strand C, Akerman 

M, Ferno M (2001). Histopathological and 

cell biological factors of ductal carcinoma 

in situ before and after the introduction of 

mammographic screening. Acta Oncol 40: 

653-659. 

1280a. Ihara N, Togashi K, Todo G, Nakai A, 

Kojima N, Ishigaki T, Suginami N, Kinoshita 

M, Shintaku M (1999). Sclerosing stromal 

tumor of the ovary: MRI. J Comput Assist 

Tomogr 23: 555-557. 

1281. Ihekwaba FN (1994). Breast cancer in 

men in black Africa: a report of 73 cases. J 

R Coll Surg Edinb 39: 344-347. 

1282. Imachi M, Tsukamoto N, Amagase H, 

Shigematsu T, Amada S, Nakano H (1993). 

Metastatic adenocarcinoma to the uterine 

cervix from gastric cancer. A clinicopathologic 

analysis of 16 cases. Cancer 71: 3472- 

3477. 

1283. Imachi M, Tsukamoto N, Shigematsu 

T, Nakano H (1992). Cytologic diagnosis of 

primary adenocarcinoma of Bartholin's 

gland. A case report. Acta Cytol 36: 167- 

170. 

1284. Imachi M, Tsukamoto N, Shigematsu 

T, Watanabe T, Uehira K, Amada S, Umezu 

T, Nakano H (1992). Malignant mixed 

Mullerian tumor of the fallopian tube: 

report of two cases and review of literature. 


1285. Imachi M, Tsukamoto N, Shimamoto 

T, Hirakawa T, Uehira K, Nakano H (1991). 

Clear cell carcinoma of the ovary: a clinicopathological 

analysis of 34 cases. Int J 


1286. Imai H, Kitamura H, Nananura T, 

Watanabe M, Koyama T, Kitamura H 

(1999). Mullerian carcinofibroma of the 

uterus. A case report. Acta Cytol 43: 667- 

674. 

1287. Inaji H, Koyama H (1991). [Tumor 

markers. Personal experience--screening 

of breast cancer by determining CEA in 

nipple discharge]. Gan To Kagaku Ryoho 

18: 313-317. 

1288. Innes KE, Byers TE (1999). 

Preeclampsia and breast cancer risk. 

Epidemiology 10: 722-732. 

1289. Inoue H, Kikuchi Y, Hori T, Nabuchi K, 

Kobayashi M, Nagata I (1995). An ovarian 

tumor of probable Wolffian origin with hormonal 

function. Gynecol Oncol 59: 304-308. 

1290. Inoue T, Nabeshima K, Shimao Y, 

Akiyama Y, Ohtsuka T, Koono M (2001). 

Tubal ectopic pregnancy associated with 

an adenomatoid tumor. Pathol Int 51: 211- 

214. 

1291. Inskip HM, Kinlen LJ, Taylor AM, 

Woods CG, Arlett CF (1999). Risk of breast 

cancer and other cancers in heterozygotes 

for ataxia-telangiectasia. Br J 

Cancer 79: 1304-1307. 

1292. International Agency for Research 

on Cancer (2002). IARC Handbooks of 

Cancer Prevention Vol. 6: Weight Control 

and Physical Activity. IARC Press: Lyon. 


on Cancer (1995). IARC Monographs on the 

Evaluation of the Carcinogenic Risks to 

Humans. Volume 64: Human papillomaviruses. 

IARC Press: Lyon. 


on Cancer (1999). Hormonal contraceptives, 

progestogens only. In: IARC 

Monographs on the Evaluation of 

Carcinogenic Risks to Humans Vol. 72 

Hormonal Contraception and Post- 

Menopausal Hormonal Therapy. I A R C 

Press: Lyon , pp. 339-397. 


on Cancer (1999). IARC Monograph on the 

Evaluation of Carcinogenic Risk to 

Humans. Volume 72: Hormonal contraception 

and post menopausal Hormonal 

Therapy. IARC Press: Lyon. 


on Cancer (1999). Oral contraceptives, 

combined. In: IARC Monographs on the 

Evaluation of Carcinogenic Risks to 

Humans Vol. 72 Hormonal Contraception 

and Post-Menopausal Hormonal Therapy. 

IARC Press: Lyon, pp. 49-338. 


on Cancer (1999). Post-menopausal 

oestrogen-progestogen therapy. In: IARC 

Monographs on the Evaluation of 

Carcinogenic Risks to Humans Vol. 72 

Hormonal Contraception and Post- 

Menopausal Hormonal Therapy. I A R C 

Press: Lyon, pp. 531-628. 


on Cancer (1999). Post-menopausal 

oestrogen therapy. In: IARC Monographs 

on the Evaluation of Carcinogenic Risks to 

Humans Vol. 72 Hormonal Contraception 

and Post-Menopausal Hormonal Therapy. 

IARC Press: Lyon, pp. 399-530. 

1299. International Cowden's Syndrome 

Consortium, Operational Criteria for the 

Diagnosis of CS, Daly M (1999). NCCN 

practice guidelines: Genetics/familial highrisk 

cancer screening. Oncology 13: 161- 

186. 

1 3 0 0 . International Federation of 

Gynecology and Obstretrics (1995). 

Modifications in the Staging for Stage I 

Vulvar and Stage I Cervical Cancer. 

Reports of the FIGO Committee on 

Gynaecologic Oncology. Int J Gynaecol 

Obstet 50: 215-216. 

1301. Iqbal M, Davies MP, Shoker BS, 

Jarvis C, Sibson DR, Sloane JP (2001). 

Subgroups of non-atypical hyperplasia of 

breast defined by proliferation of oestrogen 

receptor-positive cells. J Pathol 193: 

333-338. 

1302. Iraniha S, Shen V, Kruppe CN, 

Downey EC (1999). Uterine cervical 

extrarenal Wilms tumor managed without 

hysterectomy. J Pediatr Hematol Oncol 21: 

548-550. 

1303. Isaac MA, Vijayalakshmi S, Madhu 

CS, Bosincu L, Nogales FF (2000). Pure cystic 

nephroblastoma of the ovary with a 

review of extrarenal Wilms' tumors. Hum 

Pathol 31: 761-764. 

1304. Isaacs C, Stearns V, Hayes DF (2001). 

New prognostic factors for breast cancer 

recurrence. Semin Oncol 28: 53-67. 

1305. Isaacson PG, Spencer J (1987). 

Malignant lymphoma of mucosa-associated 

lymphoid tissue. Histopathology 11: 445- 

462. 

1 3 0 6 . Ishikura H, Kojo T, Ichimura H, 

Yoshiki T (1998). Desmoplastic malignant 

melanoma of the uterine cervix: a rare primary 

malignancy in the uterus mimicking a 

sarcoma. Histopathology 33: 93-94. 

1307. Ishikura H, Scully RE (1987). Hepatoid 

carcinoma of the ovary. A newly described 

tumor. Cancer 60: 2775-2784. 

1 3 0 8 . Ismail SM, Walker SM (1990). 

Bilateral virilizing sclerosing stromal 

tumours of the ovary in a pregnant woman 

with Gorlin's syndrome: implications for 

pathogenesis of ovarian stromal neoplasms. 


1309. Ito K, Watanabe K, Nasim S, Sasano 

H, Sato S, Yajima A, Silverberg SG, Garrett 

CT (1994). Prognostic significance of p53 

overexpression in endometrial cancer. 

Cancer Res 54: 4667-4670. 

1310. Ito T, Saga S, Nagayoshi S, Imai M, 

Aoyama A, Yokoi T, Hoshino M (1986). 

Class distribution of immunoglobulin-containing 

plasma cells in the stroma of 

medullary carcinoma of breast. B r e a s t 


1311. Itoh T, Mochizuki M, Kumazaki S, 

Ishihara T, Fukayama M (1997). Cystic pulmonary 

metastases of endometrial stromal 

sarcoma of the uterus, mimicking lymphangiomyomatosis: 

a case report with 

immunohistochemistry of HMB45. Pathol 

Int 47: 725-729. 

1312. Iversen T, Tretli S (1998). Intraepithelial 

and invasive squamous cell neoplasia 

of the vulva: trends in incidence, recurrence, 

and survival rate in Norway. Obstet 

Gynecol 91: 969-972. 

1313. Iversen UM (1996). Two cases of 

benign vaginal rhabdomyoma. Case 

reports. APMIS 104: 575-578. 

1314. Iwasaka T, Yokoyama M, Ohuchida 

M, Matsuo N, Hara K, Fukuyama K, 

Hachisuga T, Fukuda K, Sugimori H (1992). 

Detection of human papillomavirus 

genome and analysis of expression of cmyc 

and Ha-ras oncogenes in invasive 

cervical carcinomas. Gynecol Oncol 46: 

298-303. 

1315. Jack MT, Woo RA, Hirao A, Cheung 

A, Mak TW, Lee PW (2002). Chk2 is dispensable 

for p53-mediated G1 arrest but is 

required for a latent p53-mediated apoptotic 

response. Proc Natl Acad Sci USA . 

99:9825-9829. 

1316. Jackson-York GL, Ramzy I (1992). 

Synchronous papillary mucinous adenocarcinoma 

of the endocervix and fallopian 

tubes. Int J Gynecol Pathol 11: 63-67. 

1317. Jacobs AJ, Newland JR, Green RK 

(1982). Pure choriocarcinoma of the ovary. 

Obstet Gynecol Surv 37: 603-609. 

1318. Jacobs DM, Sandles LG, Leboit PE 

(1986). Sebaceous carcinoma arising from 

Bowen's disease of the vulva. A r c h 

Dermatol 122: 1191-1193. 

1319. Jacobs PA, Szulman AE, Funkhouser 

J, Matsuura JS, Wilson CC (1982). Human 

triploidy: relationship between parental 

origin of the additional haploid complement 

and development of partial hydatidiform 

mole. Ann Hum Genet 46: 223-231. 

1320. Jacobs TW, Byrne C, Colditz G, 

Connolly JL, Schnitt SJ (1999). Radial scars 

in benign breast-biopsy specimens and the 

risk of breast cancer. N Engl J Med 340: 

430-436. 

1321. Jacobsen GK, Braendstrup O, 

Talerman A (1991). Bilateral mixed germ 

cell sex-cord stroma tumour in a young 

adult woman. Case report. APMIS Suppl 

23: 132-137. 

1321a. Jacobsen O (1946). Heredity and 

Breast Cancer. London. 

1322. Jacoby AF, Fuller AF Jr., Thor AD, 

Muntz HG (1993). Primary leiomyosarcoma 

of the fallopian tube. Gynecol Oncol 51: 

404-407.

1323. Jacques SM, Qureshi F, Ramirez NC, 

Malviya VK, Lawrence WD (1997). Tumors 

of the uterine isthmus: clinicopathologic 

features and immunohistochemical characterization 

of p53 expression and hormone 

receptors. Int J Gynecol Pathol 16: 

38-44. 

1324. Jaffe R, Altaras M, Bernheim J, Ben 

Aderet N (1985). Endocervical stromal sar - 

coma--a case report. Gynecol Oncol 22: 

105-108. 

1325. Jafri NH, Niemann TH, Nicklin JL, 

Copeland LJ (1998). A carcinoid tumor of 

the broad ligament. Obstet Gynecol 92: 708. 

1326. Jain AN, Chin K, Borresen-Dale AL, 

Erikstein BK, Eynstein LP, Kaaresen R, 

Gray JW (2001). Quantitative analysis of 

chromosomal CGH in human breast tumors 

associates copy number abnormalities 

with p53 status and patient survival. Proc 

Natl Acad Sci USA 98: 7952-7957. 

1327. Jain S, Fisher C, Smith P, Millis RR, 

Rubens RD (1993). Patterns of metastatic 

breast cancer in relation to histological 

type. Eur J Cancer 29A: 2155-2157. 

1328. Jakubowska A, Narod SA, Goldgar 

DE, Mierzejewski M, Masojc B, Nej K, 

Huzarska J, Byrski T, Gorski B, Lubinski J 

(2003). Breast Cancer Risk Reduction 

Associated with the RAD51 Polymorphism 

among Carriers of the BRCA1 5382insC 

Mutation in Poland. Cancer Epidemiol 


1329. Jamal AA (2001). Pattern of breast 

diseases in a teaching hospital in Jeddah, 

Saudi Arabia. Saudi Med J 22: 110-113. 

1330. Jamal S, Mushtaq S, Malik IA, Khan 

AH, Mamoon N (1994). Malignant tumours 

of the male breast - a review of 50 cases. J 

Pak Med Assoc 44: 275-277. 

1331. James BA, Cranor MI, Rosen PP 

(1993). Carcinoma of the breast arising in 

microglandular adenosis. Am J Clin Pathol 

100: 507-513. 

1332. James K, Bridger J, Anthony PP 

(1988). Breast tumour of pregnancy ('lactating' 

adenoma). J Pathol 156: 37-44. 

1333. James LA, Mitchell EL, Menasce L, 

Varley JM (1997). Comparative genomic 

hybridisation of ductal carcinoma in situ of 

the breast: identification of regions of DNA 

amplification and deletion in common with 

invasive breast carcinoma. Oncogene 14: 

1059-1065. 

1334. Janin N, Andrieu N, Ossian K, Lauge 

A, Croquette MF, Griscelli C, Debre M, 

Bressac-de-Paillerets B, Aurias A, Stoppa- 

Lyonnet D (1999). Breast cancer risk in 

ataxia telangiectasia (AT) heterozygotes: 

haplotype study in French AT families. Br J 

Cancer 80: 1042-1045. 

1335. Janvoski NA, Paramanandhan TL 

(1973). Ovarian Tumors. Tumors and tumorlike 

conditions of the ovaries, fallopian 

tubes and ligaments of the uterus. Major 

problems in obstetrics and gynecology. 

WB Sauders: Philadelphia. 

1336. Japaze H, Van Dinh T, Woodruff JD 

(1982). Verrucous carcinoma of the vulva: 

study of 24 cases. Obstet Gynecol 60: 462- 

466. 

1337. Jauniaux E, Nicolaides KH, Hustin J 

(1997). Perinatal features associated with 

placental mesenchymal dysplasia. 

Placenta 18: 701-706. 

1338. Jee KJ, Kim YT, Kim KR, Kim HS, Yan 

A, Knuutila S (2001). Loss in 3p and 4p and 

gain of 3q are concomitant aberrations in 

squamous cell carcinoma of the vulva. 

Mod Pathol 14: 377-381. 

1339. Jensen ML, Kiaer H, Andersen J, 

Jensen V, Melsen F (1997). Prognostic 

comparison of three classifications for 

medullary carcinomas of the breast. 


1340. Jensen ML, Kiaer H, Melsen F (1996). 

Medullary breast carcinoma vs. poorly dif - 

ferentiated ductal carcinoma: an immunohistochemical 

study with keratin 19 and 

oestrogen receptor staining. 


1341. Jensen ML, Nielsen MN (1989). 

Broad ligament mucinous and serous cystadenomas 

of borderline malignancy. Acta 

Obstet Gynecol Scand 68: 663-667. 

1342. Jensen ML, Nielsen MN (1990). 

Broad ligament mucinous cystadenoma of 

borderline malignancy. Histopathology 16: 

89-91. 

1343. Jensen PA, Dockerty MB, Symmonds 

RE, Wilson RB (1966). Endometrioid sarcoma 

("stromal endometriosis"). Report of 15 

cases including 5 with metastases. Am J 


1344. Jensen RD, Norris HJ, Fraumeni JF 

Jr. (1974). Familial arrhenoblastoma and 

thyroid adenoma. Cancer 33: 218-223. 

1345. Jensen V, Jensen ML, Kiaer H, 

Andersen J, Melsen F (1997). MIB-1 

expression in breast carcinomas with 

medullary features. An immunohistological 

study including correlations with p53 and 

bcl-2. Virchows Arch 431: 125-130. 

1346. Jeon HJ, Akagi T, Hoshida Y, Hayashi 

K, Yoshino T, Tanaka T, Ito J, Kamei T, 

Kawabata K (1992). Primary non-Hodgkin 

malignant lymphoma of the breast. An 

immunohistochemical study of seven 

patients and literature review of 152 

patients with breast lymphoma in Japan. 

Cancer 70: 2451-2459. 

1347. Jernstrom H (2001). Breast-feeding 

and the Risk of Breast Cancer in BRCA1 

and BRCA2 Carriers. Am J Hum Genet 69: 

9. 

1348. Jernstrom H, Lerman C, Ghadirian P, 

Lynch HT, Weber B, Garber J, Daly M, 

Olopade OI, Foulkes WD, Warner E, Brunet 

JS, Narod SA (1999). Pregnancy and risk of 

early breast cancer in carriers of BRCA1 

and BRCA2. Lancet 354: 1846-1850. 

1349. Jhala DN, Atkinson BF, Balsara GR, 

Hernandez E, Jhala NC (2001). Role of DNA 

ploidy analysis in endometrial adenocarci - 

noma. Ann Diagn Pathol 5: 267-273. 

1350. Jiao YF, Nakamura S, Oikawa T, 

Sugai T, Uesugi N (2001). Sebaceous gland 

metaplasia in intraductal papilloma of the 

breast. Virchows Arch 438: 505-508. 

1351. Johannsson O, Loman N, Borg A, 

Olsson H (1998). Pregnancy-associated 

breast cancer in BRCA1 and BRCA2 

germline mutation carriers. Lancet 3 5 2 : 

1359-1360. 

1352. Johannsson OT, Idvall I, Anderson C, 

Borg A, Barkardottir RB, Egilsson V, Olsson 

H (1997). Tumour biological features of 

BRCA1-induced breast and ovarian cancer. 

Eur J Cancer 33: 362-371. 

1353. Johannsson OT, Ranstam J, Borg A, 

Olsson H (1998). Survival of BRCA1 breast 

and ovarian cancer patients: a populationbased 

study from southern Sweden. J Clin 

Oncol 16: 397-404. 

1 3 5 4 . Johnson AD, Hebert AA, Esterly NB 

(1986). Nevoid basal cell carcinoma syndrome: 

bilateral ovarian fibromas in a 3 1/2year-old 

girl. J Am Acad Dermatol 14: 371-374. 

1355. Johnson TL, Kumar NB, White CD, 

Morley GW (1986). Prognostic features of 

vulvar melanoma: a clinicopathologic 

analysis. Int J Gynecol Pathol 5: 110-118. 

1356. Jones D.B. (1955). Florid papillomatosis 

of the nipple ducts. Cancer 8: 315-319. 

1357. Jones C, Damiani S, Wells D, 

Chaggar R, Lakhani SR, Eusebi V (2001). 

Molecular cytogenetic comparison of 

apocrine hyperplasia and apocrine carcinoma 

of the breast. Am J Pathol 158: 207- 

214. 

1358. Jones C, Merrett S, Thomas VA, 

Barker TH, Lakhani SR (2003). Comparative 

genomic hybridization analysis of bilateral 

hyperplasia of usual type of the breast. J 

Pathol 199: 152-156. 

1359. Jones HW, III (1999). The importance 

of grading in endometrial cancer. Gynecol 

Oncol 74: 1-2. 

1360. Jones HW, III, Droegemueller W, 

Makowski EL (1971). A primary melanocarcinoma 

of the cervix. Am J Obstet Gynecol 

111: 959-963. 

1361. Jones MA, Mann EW, Caldwell CL, 

Tarraza HM, Dickersin GR, Young RH 

(1990). Small cell neuroendocrine carcino - 

ma of Bartholin's gland. Am J Clin Pathol 

94: 439-442. 

1362. Jones MA, Young RH, Scully RE 

(1991). Diffuse laminar endocervical glandular 

hyperplasia. A benign lesion often 

confused with adenoma malignum (minimal 

deviation adenocarcinoma). Am J 

Surg Pathol 15: 1123-1129. 

1363. Jones MW, Kounelis S, Papadaki H, 

Bakker A, Swalsky PA, Woods J, 

Finkelstein SD (2000). Well-differentiated 

villoglandular adenocarcinoma of the uterine 

cervix: oncogene/tumor suppressor 

gene alterations and human papillomavirus 

genotyping. Int J Gynecol Pathol 

19: 110-117. 

1 3 6 4 . Jones MW, Norris HJ (1995). 

Clinicopathologic study of 28 uterine 

leiomyosarcomas with metastasis. Int J 


1365. Jones MW, Norris HJ, Snyder RC 

(1989). Infiltrating syringomatous adenoma 

of the nipple. A clinical and pathological 

study of 11 cases. Am J Surg Pathol 13: 

197-201. 

1366. Jones MW, Silverberg SG, Kurman 

RJ (1993). Well-differentiated villoglandular 

adenocarcinoma of the uterine cervix: a 

clinicopathological study of 24 cases. Int J 


1367. Jones MW, Tavassoli FA (1995). 

Coexistence of nipple duct adenoma and 

breast carcinoma: a clinicopathologic 

study of five cases and review of the literature. 

Mod Pathol 8: 633-636. 

1368. Jones PA, Laird PW (1999). Cancer 

epigenetics comes of age. Nat Genet 21: 

163-167. 

1369. Jones RW, Rowan DM (1994). Vulvar 

intraepithelial neoplasia III: a clinical study 

of the outcome in 113 cases with relation 

to the later development of invasive vulvar 

carcinoma. Obstet Gynecol 84: 741-745. 

1 3 7 0 . Jordan LB, Abdul-Kader M, al 

Nafussi A (2001). Uterine serous papillary 

carcinoma: histopathologic changes within 

the female genital tract. Int J Gynecol 

Cancer 11: 283-289. 

1371. Joseph RE, Enghardt MH, Doering 

DL, Brown BF, Shaffer DW, Raval HB 

(1992). Small cell neuroendocrine carcino - 

ma of the vagina. Cancer 70: 784-789. 

1372. Joshi MG, Lee AK, Pedersen CA, 

Schnitt S, Camus MG, Hughes KS (1996). 

The role of immunocytochemical markers 

in the differential diagnosis of proliferative 

and neoplastic lesions of the breast. Mod 

Pathol 9: 57-62. 

1373. Jozefczyk MA, Rosen PP (1985). 

Vascular tumors of the breast. II. 

Perilobular hemangiomas and hemangiomas. 


1374. Julien M, Trojani M, Coindre JM 

(1994). [Myofibroblastoma of the breast. 

Report of 8 cases]. Ann Pathol 14: 143-147. 

1375. Junge J, Horn T, Bock J (1989). 

Primary malignant Schwannoma of the 

uterine cervix. Case report. Br J Obstet 

Gynaecol 96: 111-116. 

1376. Kaaks R (1996). Nutrition, hormones, 

and breast cancer: is insulin the missing 

link? Cancer Causes Control 7: 605-625. 

1377. Kaaks R, Lundin E, Manjer J, Rinaldi 

S, Biessy C, Soderberg S, Lenner P, Janzon 

L, Riboli E, Berglund G, Hallmans G (2002). 

Prospective study of IGF-I, IGF-binding 

proteins and breast cancer risk, in northern 

and southern Sweden. Cancer Causes 

Control 13: 307-316. 

1378. Kachel G, Bornkamm GW, Hermanek 

P, Kaduk B, Schricker KT (1980). [Burkitt 

lymphoma of African type in Europe 

(author's transl)]. Dtsch Med Wochenschr 

105: 413-417. 

1 3 7 9 . Kader HA, Jackson J, Mates D, 

Andersen S, Hayes M, Olivotto IA (2001). 

Tubular carcinoma of the breast: a population-based 

study of nodal metastases at 

presentation and of patterns of relapse. 

Breast J 7: 8-13. 

1380. Kaern J, Trope CG, Kristensen GB, 

Abeler VM, Pettersen EO (1993). DNA 

ploidy; the most important prognostic factor 

in patients with borderline tumors of the 

ovary. Int J Gynecol Cancer 3: 349-358. 

1381. Kahanpaa KV, Wahlstrom T, Grohn P, 

Heinonen E, Nieminen U, Widholm O 

(1986). Sarcomas of the uterus: a clinicopathologic 

study of 119 patients. Obstet 

Gynecol 67: 417-424. 

1382. Kahner S, Ferenczy A, Richart RM 

(1975). Homologous mixed Mullerian 

tumors (carcinosarcomal) confined to 

endometrial polyps. Am J Obstet Gynecol 

121: 278-279. 

1383. Kainu T, Juo SH, Desper R, Schaffer 

AA, Gillanders E, Rozenblum E, Freas-Lutz 

D, Weaver D, Stephan D, Bailey-Wilson J, 

Kallioniemi OP, Tirkkonen M, Syrjakoski K, 

Kuukasjarvi T, Koivisto P, Karhu R, Holli K, 

Arason A, Johannesdottir G, Bergthorsson 

JT, Johannsdottir H, Egilsson V, 

Barkardottir RB, Johannsson O, 

Haraldsson K, Sandberg T, Holmberg E, 

Gronberg H, Olsson H, Borg A, Vehmanen 

P, Eerola H, Heikkila P, Pyrhonen S, 

Nevanlinna H (2000). Somatic deletions in 

hereditary breast cancers implicate 13q21 

as a putative novel breast cancer susceptibility 

locus. Proc Natl Acad Sci USA 97: 

9603-9608. 

1384. Kairouz R, Clarke RA, Marr PJ, 

Watters D, Lavin MF, Kearsley JH, Lee CS 

(1999). ATM protein synthesis patterns in 

sporadic breast cancer. Mol Pathol 52: 

252-256. 

1385. Kajii T, Ohama K (1977). Androgenetic 

origin of hydatidiform mole. Nature 268: 

633-634. 

1386. Kajiwara M, Toyoshima S, Yao T, 

Tanaka M, Tsuneyoshi M (1999). Apoptosis 

and cell proliferation in medullary carcinoma 

of the breast: a comparative study 

between medullary and non-medullary 

carcinoma using the TUNEL method and 

immunohistochemistry. J Surg Oncol 70: 

209-216. 


1387. Kaku T, Kamura T, Shigematsu T, 

Sakai K, Nakanami N, Uehira K, Amada S, 

Kobayashi H, Saito T, Nakano H (1997). 

Adenocarcinoma of the uterine cervix with 

predominantly villogladular papillary 

growth pattern. Gynecol Oncol 64: 147-152. 

1388. Kaku T, Silverberg SG, Major FJ, 

Miller A, Fetter B, Brady MF (1992). 

Adenosarcoma of the uterus: a 

Gynecologic Oncology Group clinicopathologic 

study of 31 cases.Int J Gynecol 

Pathol 11: 75-88. 

1389. Kallenberg GA, Pesce CM, Norman 

B, Ratner RE, Silvergerg SG (1990). Ectopic 

hyperprolactinemia resulting from an ovarian 

teratoma. JAMA 263: 2472-2474. 

1390. Kalstone CE, Jaffe RB, Abell MR 

(1969). Massive edema of the ovary simulating 

fibroma. Obstet Gynecol 34: 564-571. 

1391. Kaminski PF, Norris HJ (1983). 

Minimal deviation carcinoma (adenoma 

malignum) of the cervix. Int J Gynecol 

Pathol 2: 141-152. 

1392. Kaminski PF, Norris HJ (1984). 

Coexistence of ovarian neoplasms and 

endocervical adenocarcinoma. O b s t e t 

Gynecol 64: 553-556. 

1393. Kamoi S, Iskander M, Akin MR, 

Silverberg SG (1998). Immunohistochemical 

distinction between endometrial and 

endocervical adenocarcinomas: Site of 

origin versus pathway of differentiation. 

Mod Pathol 11: 106 A. 

1394. Kanai Y, Oda T, Tsuda H, Ochiai A, 

Hirohashi S (1994). Point mutation of the Ecadherin 

gene in invasive lobular carcinoma 

of the breast. Jpn J Cancer Res 85: 

1035-1039. 

1395. Kang Y, Siegel PM, Shu W, Drobnjak 

M, Kakonen SM, Cordon-Cardo C, Guise 

TA, Massague J (2003). A multigenic program 

mediating breast cancer metastasis 

to bone. Cancer Cell 3: 537-549. 

1396. Kao GF, Norris HJ (1978). Benign and 

low grade variants of mixed mesodermal 

tumor (adenosarcoma) of the ovary and 

adnexal region. Cancer 42: 1314-1324. 

1397. Kapadia SB, Norris HJ (1993). 

Rhabdomyoma of the vagina. Mod Pathol 

6: 75A. 

1398. Kaplan EJ, Caputo TA, Shen PU, 

Sassoon RI, Soslow RA (1998). Familial 

papillary serous carcinoma of the cervix, 

peritoneum, and ovary: a report of the first 

case. Gynecol Oncol 70: 289-294. 

1399. Karayiannakis AJ, Bastounis EA, 

Chatzigianni EB, Makri GG, Alexiou D, 

Karamanakos P (1996). Immunohistochemical 

detection of oestrogen receptors 

in ductal carcinoma in situ of the breast. 

Eur J Surg Oncol 22: 578-582. 

1400. Kariminejad MH, Scully RE (1973). 

Female adnexal tumor of probable 

Wolffian origin. A distinctive pathologic 

entity. Cancer 31: 671-677. 

1401. Karl SR, Ballentine TVN, Hershey RZ 

(1985). Juvenile secretory carcinoma of 

the breast. J Ped Surg 20: 368-371. 

1402. Karlan BY, Baldwin RL, Lopez- 

Luevanos E, Raffel LJ, Barbuto D, Narod S, 

Platt LD (1999). Peritoneal serous papillary 

carcinoma, a phenotypic variant of familial 

ovarian cancer: implications for ovarian 

cancer screening. Am J Obstet Gynecol 

180: 917-928. 

1403. Karseladze AI (2001). On the site of 

origin of epithelial tumors of the ovary. Eur 

J Gynaecol Oncol 22: 110-115. 

1404. Karseladze AI, Zakharova TI, Navarro 

S, Llombart-Bosch A (2000). Malignant 

fibrous histiocytoma of the uterus. Eur J 



1405. Kasamatsu T, Shiromizu K, Takahashi 

M, Kikuchi A, Uehara T (1998). Leiomyosarcoma 

of the uterine cervix. Gynecol 

Oncol 69: 169-171. 

1406. Kasami M, Olson SJ, Simpson JF, 

Page DL (1998). Maintenance of polarity 

and a dual cell population in adenoid cystic 

carcinoma of the breast: an immunohistochemical 

study. Histopathology 32: 232- 

238. 

1 4 0 7 . Kaspersen P, Buhl L, Moller BR 

(1988). Fallopian tube papilloma in a patient 

with primary sterility. Acta Obstet Gynecol 

Scand 67: 93-94. 

1408. Katabuchi H, Tashiro H, Cho KR, 

Kurman RJ, Hedrick EL (1998). 

Micropapillary serous carcinoma of the 

ovary: an immunohistochemical and mutational 

analysis of p53. Int J Gynecol Pathol 

17: 54-60. 

1409. Katsube Y, Berg JW, Silverberg SG 

(1982). Epidemiologic pathology of ovarian 

tumors: a histopathologic review of primary 

ovarian neoplasms diagnosed in the 

Denver Standard Metropolitan Statistical 

Area, 1 July-31 December 1969 and 1 July- 

31 December 1979. Int J Gynecol Pathol 1: 

3-16. 

1409 a. Katsube Y, Iwaoki Y, Silverberg SG, 

Fujiwara A (1988). Sclerosing stromal 

tumor of the ovary associated with 

endometrial adenocarcinoma: a case 

report. Gynecol Oncol 29: 392-398. 

1410. Katsube Y, Mukai K, Silverberg SG 

(1982). Cystic mesothelioma of the peritoneum: 

a report of five cases and review 

of the literature. Cancer 50: 1615-1622. 

1411. Katz L, Merino MJ, Sakamoto H, 

Schwartz PE (1987). Endometrial stromal 

sarcoma: a clinicopathologic study of 11 

cases with determination of estrogen and 

progestin receptor levels in three tumors. 


1412. Katzenstein AL, Mazur MT, Morgan 

TE, Kao MS (1978). Proliferative serous 

tumors of the ovary. Histologic features 

and prognosis. Am J Surg Pathol 2: 339- 

355. 

1413. Kauff ND, Satagopan JM, Robson 

ME, Scheuer L, Hensley M, Hudis CA, Ellis 

NA, Boyd J, Borgen PI, Barakat RR, Norton 

L, Castiel M, Nafa K, Offit K (2002). Riskreducing 

salpingo-oophorectomy in 

women with a BRCA1 or BRCA2 mutation. 

N Engl J Med 346: 1609-1615. 

1414. Kaufman MW, Marti JR, Gallager HS, 

Hoehn JL (1984). Carcinoma of the breast 

with pseudosarcomatous metaplasia. 

Cancer 53: 1908-1917. 

1415. Kaufman SL, Stout AP (1960). 

Hemangiopericytoma in children. Cancer 

13: 695-710. 

1416. Kawai K, Horiguchi H, Sekido N, 

Akaza H, Koiso K (1996). Leiomyosarcoma 

of the ovarian vein: an unusual cause of 

severe abdominal and flank pain.Int J Urol 

3: 234-236. 

1417. Kawamoto S, Urban BA, Fishman EK 

(1999). CT of epithelial ovarian tumors. 

Radiographics 19 Spec No: S85-102. 

1418. Kawauchi S, Fukuda T, Miyamoto S, 

Yoshioka J, Shirahama S, Saito T, 

Tsukamoto N (1998). Peripheral primitive 

neuroectodermal tumor of the ovary confirmed 

by CD99 immunostaining, karyotypic 

analysis, and RT-PCR for EWS/FLI-1 

chimeric mRNA. Am J Surg Pathol 2 2 : 

1417-1422. 

1419. Kawauchi S, Tsuji T, Kaku T, Kamura 

T, Nakano H, Tsuneyoshi M (1998). 

Sclerosing stromal tumor of the ovary: a 

clinicopathologic, immunohistochemical, 

ultrastructural, and cytogenetic analysis 

with special reference to its vasculature. 


1420. Kay S, Schneider V (1985). Reactive 

spindle cell nodule of the endocervix simulating 

uterine sarcoma. Int J Gynecol 

Pathol 4: 255-257. 

1421. Kayaalp E, Heller DS, Majmudar B 

(2000). Serous tumor of low malignant 

potential of the fallopian tube. Int J 


1422. Keating JT, Cviko A, Riethdorf S, 

Riethdorf L, Quade BJ, Sun D, Duensing S, 

Sheets EE, Munger K, Crum CP (2001). Ki- 

67, cyclin E, and p16INK4 are complimentary 

surrogate biomarkers for human papilloma 

virus-related cervical neoplasia. Am J 


1423. Keatings L, Sinclair J, Wright C, 

Corbett IP, Watchorn C, Hennessy C, 

Angus B, Lennard T, Horne CH (1990). cerbB-2 

oncoprotein expression in mammary 

and extramammary Paget's disease. 


1424. Keel SB, Clement PB, Prat J, Young 

RH (1998). Malignant schwannoma of the 

uterine cervix: a study of three cases.Int J 


1424a. Keelan PA, Myers JL, Wold LE, 

Katzmann JA, Gibney DJ (1992). Phyllodes 

tumor: clinicopathologic review of 60 

patients and flow cytometric analysis in 30 

patients. Hum Pathol 23: 1048-1054. 

1425. Keeney GL, Thrasher TV (1988). 

Metaplastic papillary tumor of the fallopian 

tube: a case report with ultrastructure. Int 


1426. Keep D, Zaragoza MV, Hassold T, 

Redline RW (1996). Very early complete 

hydatidiform mole. Hum Pathol 27: 708-713. 

1427. Keitoku M, Konishi I, Nanbu K, 

Yamamoto S, Mandai M, Kataoka N, Oishi 

T, Mori T (1997). Extraovarian sex cordstromal 

tumor: case report and review of 

the literature. Int J Gynecol Pathol 16: 180- 

185. 

1428. Kelley JL, III, Burke TW, Tornos C, 

Morris M, Gershenson DM, Silva EG, 

Wharton JT (1992). Minimally invasive vulvar 

carcinoma: an indication for conservative 

surgical therapy. Gynecol Oncol 44: 

240-244. 

1429. Kelly RR, Scully RE (1961). Cancer 

developing in dermoid cysts of the ovary. A 

report of 8 cases, including a carcinoid and 

a leiomyosarcoma. Cancer 14: 989-1000. 

1430. Kelsey JL, Gammon MD, John EM 

(1993). Reproductive factors and breast 

cancer. Epidemiol Rev 15: 36-47. 

1431. Kempson RL, Fletcher CDM, Evans 

HL, Hendrikson MR, Sibley RK (2001). 

Tumours of the Soft Tissues. AFIP: 

Washington, DC. 

1432. Kempson RL, Hendrickson MR (2000). 

Smooth muscle, endometrial stromal, and 

mixed Mullerian tumors of the uterus. Mod 

Pathol 13: 328-342. 

1433. Kendall BS, Ronnett BM, Isacson C, 

Cho KR, Hedrick L, Diener-West M, 

Kurman RJ (1998). Reproducibility of the 

diagnosis of endometrial hyperplasia, 

atypical hyperplasia, and well-differentiated 

carcinoma. Am J Surg Pathol 22: 1012- 

1019. 

1434. Kennebeck CH, Alagoz T (1998). 

Signet ring breast carcinoma metastases 

limited to the endometrium and cervix. 


1435. Kennedy AW, Biscotti CV, Hart WR, 

Webster KD (1989). Ovarian clear cell adenocarcinoma. 


1436. Kennedy AW, Markman M, Webster 

KD, Kulp B, Peterson G, Rybicki LA, 

Belinson JL (1998). Experience with platinum-paclitaxel 

chemotherapy in the initial 

management of papillary serous carcinoma 

of the peritoneum. Gynecol Oncol 71: 

288-290. 

1437. Kennedy MM, Baigrie CF, Manek S 

(1999). Tamoxifen and the endometrium: 

review of 102 cases and comparison with 

HRT-related and non-HRT-related 

endometrial pathology. Int J Gynecol 

Pathol 18: 130-137. 

1438. Kenny-Moynihan MB, Hagen J, 

Richman B, McIntosh DG, Bridge JA 

(1996). Loss of an X chromosome in 

aggressive angiomyxoma of female soft 

parts: a case report. Cancer Genet 


1439. Kerangueven F, Eisinger F, Noguchi 

T, Allione F, Wargniez V, Eng C, Padberg G, 

Theillet C, Jacquemier J, Longy M, Sobol 

H, Birnbaum D (1997). Loss of heterozygosity 

in human breast carcinomas in the ataxia 

telangiectasia, Cowden disease and 

BRCA1 gene regions. Oncogene 14: 339- 

347. 

1439a. Kerlikowske K, Barclay J, Grady D, 

Sickles EA, Ernster V (1997). Comparison of 

risk factors for ductal carcinoma in situ 

and invasive breast cancer. J Natl Cancer 

Inst 89: 76-82. 

1440. Kermarec J, Plouvier S, Duplay H, 

Daniel R (1973). [Myoepithelial cell breast 

tumor. Ultrastructural study]. Arch Anat 

Pathol (Paris) 21: 225-231. 

1441. Kerner H, Sabo E, Friedman M, Beck 

D, Samare O, Lichtig C (1995). An immunohistochemical 

study of estrogen and prog - 

esterone receptors in adenocarcinoma of 

the endometrium and in the adjacent 

mucosa. Int J Gynecol Cancer 5: 275-281. 

1442. Kerr P, Ashworth A (2001). New complexities 

for BRCA1 and BRCA2. Curr Biol 

11: R668-R676. 

1443. Kerrigan SA, Turnnir RT, Clement PB, 

Young RH, Churg A (2002). Diffuse malignant 

epithelial mesotheliomas of the peritoneum 

in women: a clinicopathologic 

study of 25 patients. Cancer 94: 378-385. 

1 4 4 4 . Kersemaekers AM, Hermans J, 

Fleuren GJ, Van de Vijver MJ (1998). Loss 

of heterozygosity for defined regions on 

chromosomes 3, 11 and 17 in carcinomas 

of the uterine cervix. Br J Cancer 77: 192- 

200. 

1445. Kersemaekers AM, Van de Vijver MJ, 

Kenter GG, Fleuren GJ (1999). Genetic 

alterations during the progression of squamous 

cell carcinomas of the uterine cervix. 

Genes Chromosomes Cancer 26: 346-354. 

1446. Key TJ (1999). Serum oestradiol and 

breast cancer risk. Endocr Relat Cancer 6: 

175-180. 

1447. Key TJ, Pike MC (1988). The role of 

oestrogens and progestagens in the epidemiology 

and prevention of breast cancer. 

Eur J Cancer Clin Oncol 24: 29-43. 

1448. Khalifa MA, Hansen CH, Moore JL 

Jr., Rusnock EJ, Lage JM (1996). 

Endometrial stromal sarcoma with focal 

smooth muscle differentiation: recurrence 

after 17 years: a follow-up report with discussion 

of the nomenclature. Int J 

Gynecol Pathol 15: 171-176.

1449. Khalifa MA, Mannel RS, Haraway SD, 

Walker J, Min KW (1994). Expression of 

EGFR, HER-2/neu, P53, and PCNA in 

endometrioid, serous papillary, and clear 

cell endometrial adenocarcinomas. 


1450. Khan MS, Dodson AR, Heatley MK 

(1999). Ki-67, oestrogen receptor, and 

progesterone receptor proteins in the 

human rete ovarii and in endometriosis. J 


1451. Khoor A, Fleming MV, Purcell CA, 

Seidman JD, Ashton AH, Weaver DL (1995). 

Mature teratoma of the uterine cervix with 

pulmonary differentiation. Arch Pathol Lab 

Med 119: 848-850. 

1452. Khoury S, Odeh M, Ophir E, Cohen H, 

Oettinger M (1997). Uterine metastasis 

from gastric cancer. Acta Obstet Gynecol 

Scand 76: 803. 

1453. Khunamornpong S, Russell P, 

Dalrymple JC (1999). Proliferating (LMP) 

mucinous tumours of the ovaries with 

microinvasion: morphological assessment 


246. 

1454. Kiaer H, Nielsen B, Paulsen S, 

Sorensen IM, Dyreborg U, Blichert-Toft M 

(1984). Adenomyoepithelial adenosis and 

low-grade malignant adenomyoepithelioma 

of the breast. Virchows Arch A 

Pathol Anat Histopathol 405: 55-67. 

1455. Kiaer W, Holm-Jensen S (1972). 

Metastases to the uterus. Five cases diagnosed 

on the basis of curettings. Acta 

Pathol Microbiol Scand [A] 80: 835-840. 

1456. Kido A, Togashi K, Konishi I, Kataoka 

ML, Koyama T, Ueda H, Fujii S, Konishi J 

(1999). Dermoid cysts of the ovary with 

malignant transformation: MR appearance. 


1457. Kiechle-Schwarz M, Kommoss F, 

Schmidt J, Lukovic L, Walz L, Bauknecht T, 

Pfleiderer A (1992). Cytogenetic analysis of 

an adenoid cystic carcinoma of the 

Bartholin's gland. A rare, semimalignant 

tumor of the female genitourinary tract. 


1458. Kikkawa F, Kawai M, Tamakoshi K, 

Suganuma N, Nakashima N, Furuhashi Y, 

Kuzuya K, Hattori S, Arii Y, Tomoda Y 

(1996). Mucinous carcinoma of the ovary. 

Clinicopathologic analysis. Oncology 5 3 : 

303-307. 

1459. Kim KR, Scully RE (1990). Peritoneal 

keratin granulomas with carcinomas of 

endometrium and ovary and atypical polypoid 

adenomyoma of endometrium. A clinicopathological 

analysis of 22 cases. Am J 


1460. Kim SH, Kim WH, Park KJ, Lee JK, 

Kim JS (1996). CT and MR findings of 

Krukenberg tumors: comparison with primary 

ovarian tumors. J Comput Assist 

Tomogr 20: 393-398. 

1461. Kim YT, Thomas NF, Kessis TD, 

Wilkinson EJ, Hedrick L, Cho KR (1996). p53 

mutations and clonality in vulvar carcinomas 

and squamous hyperplasias: evidence 

suggesting that squamous hyperplasias do 

not serve as direct precursors of human 

papillomavirus-negative vulvar carcinomas. 

Hum Pathol 27: 389-395. 

1462. Kindblom LG, Stenman G, Angervall L 

(1991). Morphological and cytogenetic 

studies of angiosarcoma in Stewart- 

Treves syndrome. Virchows Arch A Pathol 

Anat Histopathol 419: 439-445. 

1463. King BF, Enders AC (1993). T h e 

Human Yolk Sac and Yolk Sac Tumours. 

Springer: Berlin. 

1464. King MC, Wieand S, Hale K, Lee M, 

Walsh T, Owens K, Tait J, Ford L, Dunn BK, 

Costantino J, Wickerham L, Wolmark N, 

Fisher B (2001). Tamoxifen and breast cancer 

incidence among women with inherited 

mutations in BRCA1 and BRCA2: 


Bowel Project (NSABP-P1) Breast Cancer 

Prevention Trial. JAMA 286: 2251-2256. 

1465. King ME, Dickersin GR, Scully RE 

(1982). Myxoid leiomyosarcoma of the 

uterus. A report of six cases. Am J Surg 

Pathol 6: 589-598. 

1466. King ME, Micha JP, Allen SL, 

Mouradian JA, Chaganti RS (1985). 

Immature teratoma of the ovary with predominant 

malignant retinal anlage compo - 

nent. A parthenogenically derived tumor. 


1467. Kinne DW, Petrek JA, Osborne MP, 

Fracchia AA, DePalo AA, Rosen PP (1989). 

Breast carcinoma in situ. Arch Surg 124: 

33-36. 

1468. Kinzler K, Vogelstein B (1998). The 

Genetic Basis of Human Cancer. McGraw 

Hill: Toronto. 

1469. Kirchhoff M, Rose H, Petersen BL, 

Maahr J, Gerdes T, Lundsteen C, Bryndorf 

T, Kryger-Baggesen N, Christensen L, 

Engelholm SA, Philip J (1999). Comparative 

genomic hybridization reveals a recurrent 

pattern of chromosomal aberrations in 

severe dysplasia/carcinoma in situ of the 

cervix and in advanced-stage cervical carcinoma. 

Genes Chromosomes Cancer 24: 

144-150. 

1470. Kister SJ, Sommers SC, Haagensen 

CD, Cooley E (1966). Reevaluation of blood 

vessel invasion and lymphocytic infiltrates 

ni breast carcinoma. Cancer 19: 1213-1216. 

1471. Kitchen PR, Smith TH, Henderson 

MA, Goldhirsch A, Castiglione-Gertsch M, 

Coates AS, Gusterson B, Brown RW, 

Gelber RD, Collins JP (2001). Tubular carcinoma 

of the breast: prognosis and 

response to adjuvant systemic therapy. 

Aust N Z J Surg 71: 27-31. 

1472. Klauber-DeMore N, Tan LK, Liberman 

L, Kaptain S, Fey J, Borgen P, Heerdt A, 

Montgomery L, Paglia M, Petrek JA, Cody 

HS, Van Zee KJ (2000). Sentinel lymph 

node biopsy: is it indicated in patients with 

high-risk ductal carcinoma-in-situ and 

ductal carcinoma-in-situ with microinvasion? 

Ann Surg Oncol 7: 636-642. 

1473. Kleer CG, Giordano TJ, Braun T, 

Oberman HA (2001). Pathologic, immunohistochemical, 

and molecular features of 

benign and malignant phyllodes tumors of 

the breast. Mod Pathol 14: 185-190. 

1474. Kleihues P, Cavenee WK (2000). 

WHO Classification of Tumours. Pathology 

and Genetics of Tumours of the Nervous 

System. IARC Press: Lyon, France. 

1475. Kleihues P, Schauble B, zur Hausen 

A, Esteve J, Ohgaki H (1997). Tumors associated 

with p53 germline mutations: a synopsis 

of 91 families. Am J Pathol 150: 1-13. 

1476. Kleinman GM, Young RH, Scully RE 

(1993). Primary neuroectodermal tumors of 

the ovary. A report of 25 cases. Am J Surg 

Pathol 17: 764-778. 

1 4 7 7 . Klemi PJ, Gronroos M (1979). 

Endometrioid carcinoma of the ovary. A 

clinicopathologic, histochemical, and 

electron microscopic study. O b s t e t 

Gynecol 53: 572-579. 

1478. Kliewer EV, Smith KR (1995). Breast 

cancer mortality among immigrants in 

Australia and Canada. J Natl Cancer Inst 

87: 1154-1161. 

1479. Kline RC, Wharton JT, Atkinson EN, 

Burke TW, Gershenson DM, Edwards CL 

(1990). Endometrioid carcinoma of the 

ovary: retrospective review of 145 cases. 


1480. Ko SF, Wan YL, Ng SH, Lee TY, Lin 

JW, Chen WJ, Kung FT, Tsai CC (1999). 

Adult ovarian granulosa cell tumors: spectrum 

of sonographic and CT findings with 

pathologic correlation. AJR Am J 

Roentgenol 172: 1227-1233. 

1481. Kobayashi K, Sagae S, Kudo R, Saito 

H, Koi S, Nakamura Y (1995). Microsatellite 

instability in endometrial carcinomas: frequent 

replication errors in tumors of early 

onset and/or of poorly differentiated type. 


1481a. Kobayashi Y, Yamazaki K, Shinohara 

M, Iwahashi K, Suzuki A, Fujii T, Sasaki H, 

Shiraishi S (1996). Undifferentiated carcinoma 

of the broad ligament in a 28-yearold 

woman--a case report and results of 

immunohistochemical and electron-microscopic 

studies. Gynecol Oncol 63: 382-387. 

1482. Kocova L, Skalova A, Fakan F, 

Rousarova M (1998). Phyllodes tumour of 

the breast: immunohistochemical study of 

37 tumours using MIB1 antibody. Pathol 

Res Pract 194: 97-104. 

1483. Koenig C, Dadmanesh F, Bratthauer 

GL, Tavassoli FA (2000). Carcinoma arising 

in microglandular adenosis: an immunohistochemical 

analysis of 20 intraepithelial 

and invasive neoplasms. Int J Surg Pathol 

8: 303-315. 

1485. Koenig C, Demopoulos RI, Vamvakas 

EC, Mittal KR, Feiner HD, Espiritu EC (1993). 

Flow cytometric DNA ploidy and quantitative 

histopathology in partial moles. Int J 


1486. Koenig C, Tavassoli FA (1998). 

Mucinous cystadenocarcinoma of the 


1487. Koenig C, Tavassoli FA (1998). 

Nodular hyperplasia, adenoma, and adenomyoma 

of Bartholin's gland. Int J 


1488. Koenig C, Turnicky RP, Kankam CF, 

Tavassoli FA (1997). Papillary squamotran - 

sitional cell carcinoma of the cervix: a 

report of 32 cases. Am J Surg Pathol 21: 

915-921. 

1489. Kofinas AD, Suarez J, Calame RJ, 

Chipeco Z (1984). Chondrosarcoma of the 

uterus. Gynecol Oncol 19: 231-237. 

1490. Kokal WA, Hill LR, Porudominsky D, 

Beatty JD, Kemeny MM, Riihimaki DU, Terz 

JJ (1985). Inflammatory breast carcinoma: 

a distinct entity? J Surg Oncol 30: 152-155. 

1491. Kollias J, Ellis IO, Elston CW, Blamey 

RW (1999). Clinical and histological predictors 

of contralateral breast cancer. Eur J 

Surg Oncol 25: 584-589. 

1492. Kollias J, Ellis IO, Elston CW, Blamey 

RW (2001). Prognostic significance of synchronous 

and metachronous bilateral 

breast cancer. World J Surg 25: 1117-1124. 

1 4 9 3 . Kollias J, Elston CW, Ellis IO, 

Robertson JF, Blamey RW (1997). Earlyonset 

breast cancer--histopathological 

and prognostic considerations. Br J 

Cancer 75: 1318-1323. 

1494. Kolodner RD, Hall NR, Lipford J, Kane 

MF, Morrison PT, Finan PJ, Burn J, 

Chapman P, Earabino C, Merchant E, 

Bishop DT. (1995). Structure of the human 

MLH1 locus and analysis of a large hereditary 

nonpolyposis colorectal carcinoma 

kindred for mlh1 mutations. Cancer Res 55: 

242-248. 

1495. Kolodner RD, Hall NR, Lipford J, Kane 

MF, Rao MR, Morrison P, Wirth L, Finan PJ, 

Burn J, Chapman P (1994). Structure of the 

human MSH2 locus and analysis of two 

Muir-Torre kindreds for msh2 mutations. 

Genomics 24: 516-526. 

1496. Kolodner RD, Marsischky GT (1999). 

Eukaryotic DNA mismatch repair. C u r r 

Opin Genet Dev 9: 89-96. 

1497. Kolodner RD, Tytell JD, Schmeits JL, 

Kane MF, Gupta RD, Weger J, Wahlberg S, 

Fox EA, Peel D, Ziogas A, Garber JE, 

Syngal S, Anton-Culver H, Li FP (1999). 

Germ-line msh6 mutations in colorectal 

cancer families. Cancer Res 59: 5068-5074. 

1498. Komaki K, Sakamoto G, Sugano H, 

Morimoto T, Monden Y (1988). Mucinous 

carcinoma of the breast in Japan. A prognostic 

analysis based on morphologic fea - 

tures. Cancer 61: 989-996. 

1499. Kommoss F, Oliva E, Bhan AK, Young 

RH, Scully RE (1998). Inhibin expression in 

ovarian tumors and tumor-like lesions: an 

immunohistochemical study. Mod Pathol 

11: 656-664. 

1500. Kommoss F, Schmidt M, Merz E, 

Knapstein PG, Young RH, Scully RE (1999). 

Ovarian endometrioid-like yolk sac tumor 

treated by surgery alone, with recurrence 

at 12 years. Gynecol Oncol 72: 421-424. 

1501. Kondi-Paphitis A, Deligeorgi-Politi H, 

Liapis A, Plemenou-Frangou M (1998). 

Human papilloma virus in verrucus carcinoma 

of the vulva: an immunopathological 

study of three cases. Eur J Gynaecol 

Oncol 19: 319-320. 

1502. Koonings PP, Campbell K, Mishell DR 

Jr., Grimes DA (1989). Relative frequency 

of primary ovarian neoplasms: a 10-year 

review. Obstet Gynecol 74: 921-926. 

1503. Koontz JI, Soreng AL, Nucci M, Kuo 

FC, Pauwels P, Van den Berghe H, Cin PD, 

Fletcher JA, Sklar J (2001). Frequent fusion 

of the JAZF1 and JJAZ1 genes in endome - 

trial stromal tumors. Proc Natl Acad Sci 

USA 98: 6348-6353. 

1504. Kopolovic J, Weiss DB, Dolberg L, 

Brezinsky A, Ne'eman Z, Anteby SO (1987). 

Alveolar soft-part sarcoma of the female 

genital tract. Case report with ultrastructural 

findings. Arch Gynecol 240: 125-129. 

1505. Korn WT, Schatzki SC, DiSciullo AJ, 

Scully RE (1990). Papillary cystadenoma of 

the broad ligament in von Hippel-Lindau 

disease. Am J Obstet Gynecol 163: 596-598. 

1506. Kosary CL (1994). FIGO stage, histology, 

histologic grade, age and race as 

prognostic factors in determining survival 

for cancers of the female gynecological 

system: an analysis of 1973-87 SEER cases 

of cancers of the endometrium, cervix, 

ovary, vulva, and vagina. Semin Surg 

Oncol 10: 31-46. 

1507. Koss LG, Brannan CD, Ashikari R 

(1970). Histologic and ultrastructural features 

of adenoid cystic carcinoma of the 


1508. Koss LG, Durfee GR (1956). Unusual 

patterns of squamous epithelium of the 

uterine cervix and pathological study of 

kaoilocytotic atypia. Ann N Y Acad Sci 63: 

1245-1261. 

1509. Koss LG, ShapiroR.H., Brunschwig A 

(1965). Endometrial stromal sarcoma. Surg 


1510. Kotlan B, Gruel N, Zafrani B, Furedi G, 

Foldi J, Petranyi G, Fridman W, Teillaud J 

(1999). Immunoglobulin variable regions 

usage by B-lymphocytes infiltrating a 

human breast medullary carcinoma. 

Immunology Letters 65: 143-151. 


1511. Kotylo PK, Michael H, Davis TE, 

Sutton GP, Mark PR, Roth LM (1992). Flow 

cytometric DNA analysis of placental-site 

trophoblastic tumors. Int J Gynecol Pathol 

11: 245-252. 

1512. Kounelis S, Kapranos N, Kouri E, 

Coppola D, Papadaki H, Jones MW (2000). 

Immunohistochemical profile of endometrial 

adenocarcinoma: a study of 61 cases 

and review of the literature. Mod Pathol 13: 

379-388. 

1513. Koutsky LA, Holmes KK, Critchlow 

CW, Stevens CE, Paavonen J, Beckmann 

AM, DeRouen TA, Galloway DA, Vernon D, 

Kiviat NB (1992). A cohort study of the risk 

of cervical intraepithelial neoplasia grade 

2 or 3 in relation to papillomavirus infection. 

N Engl J Med 327: 1272-1278. 

1514. Kouvidou C, Karayianni M, Liapi- 

Avgeri G, Toufexi H, Karaiossifidi H (2000). 

Old ectopic pregnancy remnants with morphological 

features of placental site nodule 

occurring in fallopian tube and broad 

ligament. Pathol Res Pract 196: 329-332. 

1515. Kovi J, Duong HD, Leffall LS Jr. 

(1981). High-grade mucoepidermoid carcinoma 

of the breast. Arch Pathol Lab Med 

105: 612-614. 

1516. Koyama M, Kurotaki H, Yagihashi N, 

Aizawa S, Sugai M, Kamata Y, Oyama T, 

Yagihashi S (1997). Immunohistochemical 

assessment of proliferative activity in 

mammary adenomyoepithelioma. Histopathology 

31: 134-139. 

1517. Kraemer BB, Silva EG, Sneige N 

(1984). Fibrosarcoma of ovary. A new component 

in the nevoid basal-cell carcinoma 

syndrome. Am J Surg Pathol 8: 231-236. 

1518. Kraggerud SM, Szymanska J, Abeler 

VM, Kaern J, Eknaes M, Heim S, Teixeira 

MR, Trope CG, Peltomaki P, Lothe RA 

(2000). DNA copy number changes in 

malignant ovarian germ cell tumors. 

Cancer Res 60: 3025-3030. 

1 5 1 9 . Krausz T, Jenkins D, Grontoft O, 

Pollock DJ, Azzopardi JG (1989). Secretory 

carcinoma of the breast in adults: emphasis 

on late recurrence and metastasis. 


1520. Krieger N, Hiatt RA (1992). Risk of 

breast cancer after benign breast diseases. 

Variation by histologic type, degree 

of atypia, age at biopsy, and length of follow-up. 

Am J Epidemiol 135: 619-631. 

1521. Krishnamurthy S, Jungbluth AA, 

Busam KJ, Rosai J (1998). Uterine tumors 

resembling ovarian sex-cord tumors have 

an immunophenotype consistent with true 

sex-cord differentiation. Am J Surg Pathol 

22: 1078-1082. 

1521 a. Krivak TC, McBroom JW, Sundborg 

MJ, Crothers B, Parker MF (2001). Large 

cell neuroendocrine cervical carcinoma: a 

report of two cases and review of the literature. 


1522. Kubik-Huch RA, Dorffler W, von 

Schulthess GK, Marincek B, Kochli OR, 

Seifert B, Haller U, Steinert HC (2000). 

Value of (18F)-FDG positron emission 

tomography, computed tomography, and 

magnetic resonance imaging in diagnosing 

primary and recurrent ovarian carcinoma. 

Eur Radiol 10: 761-767. 


1523. Kucera E, Speiser P, Gnant M, Szabo 

L, Samonigg H, Hausmaninger H, Mittlbock 

M, Fridrik M, Seifert M, Kubista E, Reiner A, 

Zeillinger R, Jakesz R (1999). Prognostic 

significance of mutations in the p53 gene, 

particularly in the zinc-binding domains, in 

lymph node- and steroid receptor positive 

breast cancer patients. Austrian Breast 

Cancer Study Group. Eur J Cancer 35: 398- 

405. 

1524. Kucera H, Langer M, Smekal G, 

Weghaupt K (1985). Radiotherapy of primary 

carcinoma of the vagina: management 

and results of different therapy 

schemes. Gynecol Oncol 21: 87-93. 

1525. Kuijper A, Mommers EC, van der Wall 

E, van Diest PJ (2001). Histopathology of 

fibroadenoma of the breast. Am J Clin 

Pathol 115: 736-742. 

1526. Kuiper GG, Enmark E, Pelto-Huikko 

M, Nilsson S, Gustafsson JA (1996). 

Cloning of a novel receptor expressed in 

rat prostate and ovary. Proc Natl Acad Sci 

USA 93: 5925-5930. 

1527. Kuismanen SA, Moisio AL, Schweizer 

P, Truninger K, Salovaara R, Arola J, 

Butzow R, Jiricny J, Nystrom-Lahti M, 

Peltomaki P (2002). Endometrial and colorectal 

tumors from patients with hereditary 

nonpolyposis colon cancer display different 

patterns of microsatellite instability. 

Am J Pathol 160: 1953-1958. 

1528. Kulski JK, Demeter T, Rakoczy P, 

Sterrett GF, Pixley EC (1989). Human papillomavirus 

coinfections of the vulva and 

uterine cervix. J Med Virol 27: 244-251. 

1529. Kumar A, Schneider V (1983). 

Metastases to the uterus from extrapelvic 

primary tumors. Int J Gynecol Pathol 2: 

134-140. 

1530. Kumar L, Pokharel YH, Dawar R, 

Thulkar S (1999). Cervical cancer metasta - 

tic to the breast: a case report and review 

of the literature. Clin Oncol (R Coll Radiol ) 

11: 414-416. 

1531. Kumar NB, Hart WR (1982). 

Metastases to the uterine corpus from 

extragenital cancers. A clinicopathologic 


1532. Kupets R, Covens A (2001). Is the 

International Federation of Gynecology 

and Obstetrics staging system for cervical 

carcinoma able to predict survival in 

patients with cervical carcinoma?: an 

assessment of clinimetric properties. 

Cancer 92: 796-804. 

1533. Kupryjanczyk J, Kujawa M (1992). 

Signet-ring cells in squamous cell carcinoma 

of the cervix and in non-neoplastic 

ectocervical epithelium. Int J Gynecol 

Cancer 2: 152-156. 

1534. Kurian K, al Nafussi A (1999). Relation 

of cervical glandular intraepithelial neoplasia 

to microinvasive and invasive adenocarcinoma 

of the uterine cervix: a study 

of 121 cases. J Clin Pathol 52: 112-117. 

1535. Kurman RJ, Kaminski PF, Norris HJ 

(1985). The behavior of endometrial hyperplasia. 

A long-term study of "untreated" 

hyperplasia in 170 patients. Cancer 56: 403- 

412. 

1536. Kurman RJ, Norris HJ (1976). 

Embryonal carcinoma of the ovary: a clinicopathologic 

entity distinct from endodermal 

sinus tumor resembling embryonal 

carcinoma of the adult testis. Cancer 38: 

2420-2433. 


Endodermal sinus tumor of the ovary: a 

clinical and pathologic analysis of 71 

cases. Cancer 38: 2404-2419. 


Mesenchymal tumors of the uterus. VI. 

Epithelioid smooth muscle tumors including 

leiomyoblastoma and clear-cell leiomyoma: 

a clinical and pathologic analysis of 

26 cases. Cancer 37: 1853-1865. 

1539. Kurman RJ, Norris HJ, Wilkinson E 

(1992). Tumours of the cervix, vagina, and 

vulva. In: Atlas of Tumour Pathology, AFIP, 

ed., AFIP: Washington,DC . 

1540. Kurman RJ, Scully RE, Norris HJ 

(1976). Trophoblastic pseudotumor of the 

uterus: an exaggerated form of "syncytial 

endometritis" simulating a malignant 

tumor. Cancer 38: 1214-1226. 

1541. Kurman RJ, Toki T, Schiffman MH 

(1993). Basaloid and warty carcinomas of 

the vulva. Distinctive types of squamous 

cell carcinoma frequently associated with 

human papillomaviruses. Am J Surg 

Pathol 17: 133-145. 

1542. Kurman RJ, Trimble CL (1993). The 

behavior of serous tumors of low malignant 

potential: are they ever malignant? Int 


1543. Kurman RJ, Young RH, Norris HJ, 

Main CS, Lawrence WD, Scully RE (1984). 

Immunocytochemical localization of placental 

lactogen and chorionic 

gonadotropin in the normal placenta and 

trophoblastic tumors, with emphasis on 

intermediate trophoblast and the placental 

site trophoblastic tumor. Int J Gynecol 

Pathol 3: 101-121. 1544. Kuroda N, Hirano K, 

Inui Y, Yamasaki Y, Toi M, Nakayama H, 

Hiroi M, Enzan H (2001). Compound 

melanocytic nevus arising in a mature cystic 

teratoma of the ovary. Pathol Int 51: 902- 

904. 

1545. Kurose K, Hoshaw-Woodard S, 

Adeyinka A, Lemeshow S, Watson PH, Eng 

C (2001). Genetic model of multi-step 

breast carcinogenesis involving the 

epithelium and stroma: clues to tumourmicroenvironment 

interactions. Hum Mol 

Genet 10: 1907-1913. 

1546. Kurosumi M, Ishida T, Kurebayashi J, 

Kawai T, Joshita T, Honjo T, Izuo M (1988). 

Lipid-secreting mammary carcinoma: a 

light and electon microscopic investigation. 

J Clin Electron Microscopy 21: 147- 

156. 

1547. Kushner BH, LaQuaglia MP, Wollner 

N, Meyers PA, Lindsley KL, Ghavimi F, 

Merchant TE, Boulad F, Cheung NK, 

Bonilla MA, Crouch G, Kelleher JF Jr., 

Steinherz PG, Gerald WL (1996). 

Desmoplastic small round-cell tumor: prolonged 

progression-free survival with 

aggressive multimodality therapy. J Clin 

Oncol 14: 1526-1531. 

1548. Kuukasjarvi T, Tanner M, Pennanen 

S, Karhu R, Kallioniemi OP, Isola J (1997). 

Genetic changes in intraductal breast cancer 

detected by comparative genomic 

hybridization. Am J Pathol 150: 1465-1471. 

1549. Kuwabara H, Uda H (1997). Clear cell 

mammary malignant myoepithelioma with 

abundant glycogens. J Clin Pathol 50: 700- 

702. 

1550. Kwiatkowska E, Teresiak M, 

Lamperska KM, Karczewska A, 

Breborowicz D, Stawicka M, Godlewski D, 

Krzyzosiak WJ, Mackiewicz A (2001). 

BRCA2 germline mutations in male breast 

cancer patients in the Polish population. 

Hum Mutat 17: 73. 

1551. La Vecchia C, Levi F, Lucchini F 

(1992). Descriptive epidemiology of male 

breast cancer in Europe. Int J Cancer 51: 

62-66. 

1551 a. La Vecchia C, Parazzini F, 

Franceschi S, Decarli A (1985). Risk factors 

for benign breast disease and their relation 

with breast cancer risk. Pooled information 

from epidemiologic studies. Tumori 71: 

167-178. 

1552. Laake K, Launonen V, Niederacher D, 

Gudlaugsdottir S, Seitz S, Rio P, 

Champeme MH, Bieche I, Birnbaum D, 

White G, Sztan M, Sever N, Plummer S, 

Osorio A, Broeks A, Huusko P, Spurr N, 

Borg A, Cleton-Jansen AM, van't Veer L, 

Benitez J, Casey G, Peterlin B, Olah E, 

Varley J, Bignon YJ, Scherneck S, 

Sigurdardottir V, Lidereau R, Eyfjord J, 

Beckmann MW, Winqvist R, Skovlund E, 

Borresen-Dale AL. (1999). Loss of heterozygosity 

at 11q23.1 and survival in 

breast cancer: results of a large European 

study. Breast Cancer Somatic Genetics 

Consortium. Genes Chromosomes Cancer 

25: 212-221. 

1553. Laake K, Odegard A, Andersen TI, 

Bukholm IK, Karesen R, Nesland JM, 

Ottestad L, Shiloh Y, Borresen-Dale AL 

(1997). Loss of heterozygosity at 11q23.1 in 

breast carcinomas: indication for involvement 

of a gene distal and close to ATM. 


1554. Labonte S, Tetu B, Boucher D, Larue 

H (2001). Transitional cell carcinoma of the 

endometrium associated with a benign 

ovarian Brenner tumor: a case report. Hum 

Pathol 32: 230-232. 

1555. Lack EE, Goldstein DP (1984). Primary 

ovarian tumours in childhood and adolescence. 

Current Probl Obstet Gynecol 7: 9- 

36. 

1556. Lacson AG, Gillis DA, Shawwa A 

(1988). Malignant mixed germ-cell-sex 

cord-stromal tumors of the ovary associated 

with isosexual precocious puberty. 

Cancer 61: 2122-2133. 

1557. Lage JM (1991). Placentomegaly with 

massive hydrops of placental stem villi, 

diploid DNA content, and fetal omphaloceles: 

possible association with Beckwith- 

Wiedemann syndrome. Hum Pathol 2 2 : 

591-597. 

1558. Lage JM, Berkowitz RS, Rice LW, 

Goldstein DP, Bernstein MR, Weinberg DS 

(1991). Flow cytometric analysis of DNA 

content in partial hydatidiform moles with 

persistent gestational trophoblastic tumor. 


1559. Lage JM, Driscoll SG, Yavner DL, 

Olivier AP, Mark SD, Weinberg DS (1988). 

Hydatidiform moles. Application of flow 

cytometry in diagnosis. Am J Clin Pathol 

89: 596-600. 

1560. Lage JM, Mark SD, Roberts DJ, 

Goldstein DP, Bernstein MR, Berkowitz RS 

(1992). A flow cytometric study of 137 fresh 

hydropic placentas: correlation between 

types of hydatidiform moles and nuclear 

DNA ploidy. Obstet Gynecol 79: 403-410. 

1561. Lage JM, Popek EJ (1993). The role of 

DNA flow cytometry in evaluation of partial 

and complete hydatidiform moles and 

hydropic abortions. Semin Diagn Pathol 10: 

267-274. 

1562. Lage JM, Roberts DJ (1993). 

Choriocarcinoma in a term placenta: 

pathologic diagnosis of tumor in an asymptomatic 

patient with metastatic disease. 


1563. Lage JM, Weinberg DS, Yavner DL, 

Bieber FR (1989). The biology of tetraploid 

hydatidiform moles: histopathology, cytogenetics, 

and flow cytometry. Hum Pathol 

20: 419-425.

1564. Lagios MD (1977). Multicentricity of 

breast carcinoma demonstrated by routine 

correlated serial subgross and radiographic 

examination. Cancer 40: 1726-1734. 

1565. Lagios MD, Margolin FR, Westdahl 

PR, Rose MR (1989). Mammographically 

detected duct carcinoma in situ. 

Frequency of local recurrence following 

tylectomy and prognostic effect of nuclear 

grade on local recurrence. Cancer 63: 618- 

624. 

1566. Lagios MD, Rose MR, Margolin FR 

(1980). Tubular carcinoma of the breast: 

association with multicentricity, bilaterality, 

and family history of mammary carcinoma. 


1567. Lakhani SR (1999). The transition from 

hyperplasia to invasive carcinoma of the 

breast. J Pathol 187: 272-278. 

1568. Lakhani SR, Chaggar R, Davies S, 

Jones C, Collins N, Odel C, Stratton MR, 

O'Hare MJ (1999). Genetic alterations in 

'normal' luminal and myoepithelial cells of 

the breast. J Pathol 189: 496-503. 

1569. Lakhani SR, Collins N, Sloane JP, 

Stratton MR (1995). Loss of heterozygosity 

in lobular carcinoma in situ of the breast. 

Jounal of Clinical Pathology:Molecular 

Pathology 48: M74-M78. 

1570. Lakhani SR, Collins N, Stratton MR, 

Sloane JP (1995). Atypical ductal hyperplasia 

of the breast: clonal proliferation with 

loss of heterozygosity on chromosomes 

16q and 17p. J Clin Pathol 48: 611-615. 

1571. Lakhani SR, Gusterson BA, 

Jacquemier J, Sloane JP, Anderson TJ, 

Van de Vijver MJ, Venter D, Freeman A, 

Antoniou A, McGuffog L, Smyth E, Steel 

CM, Haites N, Scott RJ, Goldgar D, 

Neuhausen S, Daly PA, Ormiston W, 

McManus R, Scherneck S, Ponder BA, 

Futreal PA, Peto J, Stoppa-Lyonnet D, 

Bignon YJ, Stratton MR (2000). The pathology 

of familial breast cancer: histological 

features of cancers in families not attributable 

to mutations in BRCA1 or BRCA2. Clin 

Cancer Res 6: 782-789. 

1572. Lakhani SR, Jacquemier J, Sloane 

JP, Gusterson BA, Anderson TJ, Van de 

Vijver MJ, Farid LM, Venter D, Antoniou A, 

Storfer-Isser A, Smyth E, Steel CM, Haites 

N, Scott RJ, Goldgar D, Neuhausen S, Daly 

PA, Ormiston W, McManus R, Scherneck 

S, Ponder BA, Ford D, Peto J, Stoppa- 

Lyonnet D, Bignon YJ, Struewing JP, Spurr 

NK, Bishop DT, Klijn JGM, Devilee P, 

Cornelisse CJ, Lasset C, Lenoir G, 

Barkardottir RB, Egilsson V, Hamann U, 

Chang-claude J, Sobol H, Weber B, 

Stratton MR, Easton DF. (1998). 

Multifactorial analysis of differences 

between sporadic breast cancers and 

cancers involving BRCA1 and BRCA2 

mutations. J Natl Cancer Inst 90: 1138- 

1145. 

1573. Lakhani SR, O'Hare MJ, Monaghan 

P, Winehouse J, Gazet JC, Sloane JP 

(1995). Malignant myoepithelioma (myoep - 

ithelial carcinoma) of the breast: a detailed 

cytokeratin study. J Clin Pathol 48: 164-167. 

1574. Lakhani SR, Van de Vijver MJ, 

Jacquemier J, Anderson TJ, Osin PP, 

McGuffog L, Easton DF (2002). The pathology 

of familial breast cancer: predictive 

value of immunohistochemical markers 

estrogen receptor, progesterone receptor, 

HER-2, and p53 in patients with mutations 

in BRCA1 and BRCA2. J Clin Oncol 20: 

2310-2318. 

1575. Lam RM, Geittmann P (1988). 

Sclerosing stromal tumor of the ovary. A 

light, electron microscopic and enzyme 

histochemical study. Int J Gynecol Pathol 

7: 280-290. 

1576. Lambot MA, Eddafali B, Simon P, Fayt 

I, Noel JC (2001). Metastasis from apocrine 

carcinoma of the breast to an endometrial 

polyp. Virchows Arch 438: 517-518. 

1577. Lammie GA, Millis RR (1989). Ductal 

adenoma of the breast--a review of fifteen 

cases. Hum Pathol 20: 903-908. 

1578. Lamovec J, Bracko M (1991). 

Metastatic pattern of infiltrating lobular 

carcinoma of the breast: an autopsy study. 


1579. Lamovec J, Bracko M (1994). 

Secretory carcinoma of the breast: light 

microscopical, immunohistochemical and 

flow cytometric study. Mod Pathol 7: 475- 

479. 

1580. Lamovec J, Jancar J (1987). Primary 

malignant lymphoma of the breast. 

Lymphoma of the mucosa-associated lym - 

phoid tissue. Cancer 60: 3033-3041. 

1581. Lamovec J, Us-Krasovec M, Zidar A, 

Kljun A (1989). Adenoid cystic carcinoma 

of the breast: a histologic, cytologic, and 

immunohistochemical study. Semin Diagn 

Pathol 6: 153-164. 

1582. Lane TF, Deng C, Elson A, Lyu MS, 

Kozak CA, Leder P (1995). Expression of 

Brca1 is associated with terminal differentiation 

of ectodermally and mesodermally 

derived tissues in mice. Genes Dev 9: 2712- 

2722. 

1583. Laricchia R, Wierdis T, Loiudice L, 

Trisolini A, Riezzo A (1977). [Vulvar neoplasms 

(myeloblastoma) as the first manifestation 

of acute myeloblastic leukemia]. 

Minerva Ginecol 29: 957-961. 

1584. Larson AA, Liao SY, Stanbridge EJ, 

Cavenee WK, Hampton GM (1997). Genetic 

alterations accumulate during cervical 

tumorigenesis and indicate a common origin 

for multifocal lesions. Cancer Res 57: 

4171-4176. 

1585. Larson B, Silfversward C, Nilsson B, 

Pettersson F (1990). Prognostic factors in 

uterine leiomyosarcoma. A clinical and 

histopathological study of 143 cases. The 

Radiumhemmet series 1936-1981. A c t a 

Oncol 29: 185-191. 1586. Larson PS, de las 

MA, Cupples LA, Huang K, Rosenberg CL 

(1998). Genetically abnormal clones in histologically 

normal breast tissue. Am J 

Pathol 152: 1591-1598. 

1587. Lash RH, Hart WR (1987). Intestinal 

adenocarcinomas metastatic to the 

ovaries. A clinicopathologic evaluation of 


1588. Lathrop JC (1967). Malignant pelvic 

lymphomas. Obstet Gynecol 30: 137-145. 

1589. Lathrop JC, Lauchlan S, Nayak R, 

Ambler M (1988). Clinical characteristics of 

placental site trophoblastic tumor (PSTT). 


1590. Lauchlan SC (1981). Tubal (serous) 

carcinoma of the endometrium. A r c h 


1591. Laufer MR, Heerema AE, Parsons KE, 

Barbieri RL (1998). Endosalpingiosis: clinical 

presentation and follow-up. Gynecol 

Obstet Invest 46: 195-198. 

1592. Lauria R, Perrone F, Carlomagno C, 

De Laurentiis M, Morabito A, Gallo C, 

Varriale E, Pettinato G, Panico L, Petrella 

G, Bianco AR, Deplacido S. (1995). The 

prognostic value of lymphatic and blood 

vessel invasion in operable breast cancer. 

Cancer 76: 1772-1778. 

1593. Lawler SD, Fisher RA, Dent J (1991). A 

prospective genetic study of complete and 

partial hydatidiform moles. Am J Obstet 

Gynecol 164: 1270-1277. 

1594. Lax SF, Kendall B, Tashiro H, Slebos 

RJ, Hedrick L (2000). The frequency of p53, 

K-ras mutations, and microsatellite instability 

differs in uterine endometrioid and 

serous carcinoma: evidence of distinct 

molecular genetic pathways. Cancer 88: 

814-824. 

1595. Lax SF, Pizer ES, Ronnett BM, 

Kurman RJ (1998). Clear cell carcinoma of 

the endometrium is characterized by a distinctive 

profile of p53, Ki-67, estrogen, and 

progesterone receptor expression. H u m 

Pathol 29: 551-558. 

1596. Layfield LJ, Hart J, Neuwirth H, 

Bohman R, Trumbull WE, Giuliano AE 

(1989). Relation between DNA ploidy and 

the clinical behavior of phyllodes tumors. 

Cancer 64: 1486-1489. 

1597. Lazure T, Alsamad IA, Meuric S, 

Orbach D, Fabre M (2001). [Primary uterine 

and vulvar Ewing's sarcoma/peripheral 

neuroectodermal tumors in children: two 

unusual locations]. Ann Pathol 21: 263-266. 

1598. Le Bouedec G, de Latour M, Levrel O, 

Dauplat J (1997). [Krukenberg tumors of 

breast origin. 10 cases]. Presse Med 26: 

454-457. 

1599. Le Gal M, Ollivier L, Asselain B, 

Meunier M, Laurent M, Vielh P, 

Neuenschwander S (1992). Mammographic 

features of 455 invasive lobular 

carcinomas. Radiology 185: 705-708. 

1600. Le Gal Y (1961). Adenoma of the 

Breast. Am Surg 27: 14-22. 

1601. Le Doussal V, Tubiana-Hulin M, 

Friedman S, Hacene K, Spyratos F, Brunet 

M (1989). Prognostic value of histologic 

grade nuclear components of Scarff- 

Bloom-Richardson (SBR). An improved 

score modification based on a multivariate 

analysis of 1262 invasive ductal breast carcinomas. 

Cancer 64: 1914-1921. 

1602. Leach FS, Polyak K, Burrell M, 

Johnson KA, Hill D, Dunlop MG, Wyllie AH, 

Peltomaki P, de la CA, Hamilton SR, Kinzler 

KW, Vogelstein B (1996). Expression of the 

human mismatch repair gene hMSH2 in 

normal and neoplastic tissues. Cancer Res 

56: 235-240. 

1603. Leake J, Woolas RP, Daniel J, Oram 

DH, Brown CL (1994). Immunocytochemical 

and serological expression of CA 125: a 

clinicopathological study of 40 malignant 

ovarian epithelial tumours. Histopathology 

24: 57-64. 

1604. Leal C, Costa I, Fonseca D, Lopes P, 

Bento MJ, Lopes C (1998). Intracystic 

(encysted) papillary carcinoma of the 

breast: a clinical, pathological, and 

immunohistochemical study. Hum Pathol 

29: 1097-1104. 

1605. Leal C, Henrique R, Monteiro P, Lopes 

C, Bento MJ, De Sousa CP, Lopes P, Olson 

S, Silva MD, Page DL (2001). Apocrine ductal 

carcinoma in situ of the breast: histologic 

classification and expression of biologic 

markers. Hum Pathol 32: 487-493. 

1606. Lee A.K.C., Loda M, Mackarem G, 

Bosari S., DeLellis R.A., Heatley G.J., 

Hughes K. (1997). Lymph node negative 

invasive breast carcinoma 1 centimeter or 

less in size: clinicopathological features 

and outcome. Cancer 79: 761-771. 

1607. Lee BJ, Tannenbaum E (1924). 

Inflammatory carcinoma of the breast: a 

report of twenty-eight cases from the 

breast clinic of the Memorial Hospital. 

Surg Gynecol Obstet 39: 580-595. 

1608. Lee JF, Yang YC, Lee YN, Wang KL, 

Lin YN (1991). Leiomyosarcoma of the 

broad ligament--report of two cases. 

Zhonghua Yi Xue Za Zhi (Taipei) 48: 59-65. 

1609. Lee JS, Collins KM, Brown AL, Lee 

CH, Chung JH (2000). hCds1-mediated 

phosphorylation of BRCA1 regulates the 

DNA damage response. Nature 404: 201- 

204. 

1610. Lee JY, Dong SM, Kim HS, Kim SY, Na 

EY, Shin MS, Lee SH, Park WS, Kim KM, 

Lee YS, Jang JJ, Yoo NJ (1998). A distinct 

region of chromosome 19p13.3 associated 

with the sporadic form of adenoma 

malignum of the uterine cervix.Cancer Res 

58: 1140-1143. 

1611. Lee KR, Flynn CE (2000). Early invasive 

adenocarcinoma of the cervix. 

Cancer 89: 1048-1055. 

1612. Lee KR, Minter LJ, Crum CP (1997). 

Koilocytotic atypia in Papanicolaou 

smears. Reproducibility and biopsy correlations. 

Cancer 81: 10-15. 

1613. Lee KR, Scully RE (2000). Mucinous 

tumors of the ovary: a clinicopathologic 

study of 196 borderline tumors (of intestinal 

type) and carcinomas, including an evaluation 

of 11 cases with 'pseudomyxoma 

peritonei'. Am J Surg Pathol 24: 1447-1464. 

1614. Lee KR, Young RH (2003). The distinction 

between primary and metastatic mucinous 

carcinomas of the ovary: gross and 

histologic findings in 50 cases. Am J Surg 

Pathol 27: 281-292. 

1615. Lee WL, Wang PH (2001). Torsion of 

benign serous cystadenoma of the fallopian 

tube: a challenge in differential diagnosis 

of abdominal pain in women during 

their childbearing years--a case report. 

Kaohsiung J Med Sci 17: 270-273. 

1616. Lee YS (1995). p53 expression in ges - 

tational trophoblastic disease. Int J 


1617. Leeper K, Garcia R, Swisher E, Goff B, 

Greer B, Paley P (2002). Pathologic findings 

in prophylactic oophorectomy specimens 

in high-risk women. Gynecol Oncol 87: 52- 

56. 

1618. Lefkowitz M, Lefkowitz W, Wargotz 

ES (1994). Intraductal (intracystic) papillary 

carcinoma of the breast and its variants: a 

clinicopathological study of 77 cases. Hum 

Pathol 25: 802-809. 

1619. Lehman MB, Hart WR (2001). Simple 

and complex hyperplastic papillary proliferations 

of the endometrium: a clinicopathologic 

study of nine cases of apparently 

localized papillary lesions with 

fibrovascular stromal cores and epithelial 

metaplasia. Am J Surg Pathol 25: 1347- 

1354. 

1620. Leiberman J, Chaim W, Cohen A, 

Czernobilsky B (1975). Primary carcinoma 

of stomach with uterine metastasis. Br J 


1621. Leibowitch M, Neill S, Pelisse M, 

Moyal-Baracco M (1990). The epithelial 

changes associated with squamous cell 

carcinoma of the vulva: a review of the 

clinical, histological and viral findings in 78 

women. Br J Obstet Gynaecol 97: 1135- 

1139. 

1622. Leibsohn S, d'Ablaing G, Mishell DR 

Jr., Schlaerth JB (1990). Leiomyosarcoma 

in a series of hysterectomies performed for 

presumed uterine leiomyomas. Am J 


1623. Leitner SP, Swern AS, Weinberger D, 

Duncan LJ, Hutter RV (1995). Predictors of 

recurrence for patients with small (one 

centimeter or less) localized breast cancer 

(T1a,b N0 M0). Cancer 76: 2266-2274. 


1624. Lele SB, Piver MS, Barlow JJ, 

Tsukada Y (1978). Squamous cell carcinoma 

arising in ovarian endometriosis. 


1625. Lemoine NR, Hall PA (1986). Epithelial 

tumors metastatic to the uterine cervix. A 

study of 33 cases and review of the literature. 

Cancer 57: 2002-2005. 

1626. Lenehan PM, Meffe F, Lickrish GM 

(1986). Vaginal intraepithelial neoplasia: 

biologic aspects and management. Obstet 

Gynecol 68: 333-337. 

1627. Lenfant-Pejovic MH, Mlika-Cabanne 

N, Bouchardy C, Auquier A (1990). Risk factors 

for male breast cancer: a Franco- 

Swiss case-control study. Int J Cancer 45: 

661-665. 

1628. Leoncini L (1980). [Brenner tumor of 

the broad ligament]. Arch De Vecchi Anat 

Patol 64: 97-102. 

1629. Leong AS, Williams JA (1985). 

Mucoepidermoid carcinoma of the breast: 

high grade variant. Pathology 17: 516-521. 

1630. Leppien G (1987). Non-uterine gynecological 

sarcomas. Arch Gynecol Obstet 

241: 25-32. 

1631. Lerner LB, Andrews SJ, Gonzalez JL, 

Heaney JA, Currie JL (1999). Vulvar metastases 

secondary to transitional cell carcinoma 

of the bladder. A case report. J 

Reprod Med 44: 729-732. 

1632. Lesser ML, Rosen PP, Kinne DW 

(1982). Multicentricity and bilaterality in 

invasive breast carcinoma. Surgery 91: 

234-240. 

1633. Lesueur GC, Brown RW, Bhathal PS 

(1983). Incidence of perilobular hemangioma 

in the female breast. Arch Pathol 

Lab Med 107: 308-310. 

1634. Leuchter RS, Hacker NF, Voet RL, 

Berek JS, Townsend DE, Lagasse LD 

(1982). Primary carcinoma of the Bartholin 

gland: a report of 14 cases and review of 

the literature. Obstet Gynecol 60: 361-368. 

1635. Leung WY, Schwartz PE, Ng HT, 

Yang-Feng TL (1990). Trisomy 12 in benign 

fibroma and granulosa cell tumor of the 

ovary. Gynecol Oncol 38: 28-31. 

1636. Levi F, La Vecchia C, Gulie C, Negri E 

(1993). Dietary factors and breast cancer 

risk in Vaud, Switzerland. Nutr Cancer 19: 

327-335. 

1637. Levi F, Lucchini F, Negri E, Boyle P, La 

Vecchia C (1999). Cancer mortality in 

Europe, 1990-1994, and an overview of 

trends from 1955 to 1994. Eur J Cancer 35: 

1477-1516. 

1638. Levi F, Lucchini F, Negri E, Franceschi 

S, La Vecchia C (2000). Cervical cancer 

mortality in young women in Europe: patterns 

and trends. Eur J Cancer 36: 2266- 

2271. 

1639. Levi F, Pasche C, Lucchini F, La 

Vecchia C (2001). Dietary intake of selected 

micronutrients and breast-cancer risk. 

Int J Cancer 91: 260-263. 

1640. Levi F, Randimbison L, Te VC, La 

Vecchia C (1994). Incidence of breast can - 

cer in women with fibroadenoma. Int J 

Cancer 57: 681-683. 

1641. Levine PH, Steinhorn SC, Ries LG, 

Aron JL (1985). Inflammatory breast cancer: 

the experience of the surveillance, 

epidemiology, and end results (SEER) program. 


1642. Levine RL, Cargile CB, Blazes MS, 

van Rees B, Kurman RJ, Ellenson LH (1998). 

PTEN mutations and microsatellite instability 

in complex atypical hyperplasia, a 

precursor lesion to uterine endometrioid 

carcinoma. Cancer Res 58: 3254-3258. 


1643. Levrero M, De Laurenzi V, Costanzo 

A, Gong J, Wang JY, Melino G (2000). The 

p53/p63/p73 family of transcription factors: 

overlapping and distinct functions. J Cell 

Sci 113: 1661-1670. 

1644. Levy-Lahad E, Lahad A, Eisenberg S, 

Dagan E, Paperna T, Kasinetz L, Catane R, 

Kaufman B, Beller U, Renbaum P, 

Gershoni-Baruch R (2001). A single 

nucleotide polymorphism in the RAD51 

gene modifies cancer risk in BRCA2 but 

not BRCA1 carriers. Proc Natl Acad Sci 

USA 98: 3232-3236. 

1645. Lew WY (1993). Spindle cell lipoma of 

the breast: a case report and literature 

review. Diagn Cytopathol 9: 434-437. 

1646. Lewis TL (1971). Colloid (mucus 

secreting) carcinoma of the cervix. J 

Obstet Gynaecol Br Commonw 78: 1128- 

1132. 

1647. Li CI, Anderson BO, Porter P, Holt SK, 

Daling JR, Moe RE (2000). Changing incidence 

rate of invasive lobular breast carcinoma 

among older women. Cancer 8 8 : 

2561-2569. 

1648. Li CI, Weiss NS, Stanford JL, Daling 

JR (2000). Hormone replacement therapy 

in relation to risk of lobular and ductal 

breast carcinoma in middle-aged women. 

Cancer 88: 2570-2577. 

1649. Li DM, Sun H (1997). TEP1, encoded 

by a candidate tumor suppressor locus, is 

a novel protein tyrosine phosphatase regulated 

by transforming growth factor beta. 

Cancer Res 57: 2124-2129. 

1650. Li FP, Fraumeni JF Jr., Mulvihill JJ, 

Blattner WA, Dreyfus MG, Tucker MA, 

Miller RW (1988). A cancer family syndrome 

in twenty-four kindreds. Cancer Res 

48: 5358-5362. 

1651. Li J, Yen C, Liaw D, Podsypanina K, 

Bose S, Wang SI, Puc J, Miliaresis C, 

Rodgers L, McCombie R, Bigner SH, 

Giovanella BC, Ittmann M, Tycko B, 

Hibshoosh H, Wigler MH, Parsons R (1997). 

PTEN, a putative protein tyrosine phosphatase 

gene mutated in human brain, 

breast, and prostate cancer. Science 275: 

1943-1947. 

1652. Li S, Zimmerman RL, LiVolsi VA (1999). 

Mixed malignant germ cell tumor of the fallopian 

tube. Int J Gynecol Pathol 18: 183- 

185. 

1653. Liang SB, Sonobe H, Taguchi T, 

Takeuchi T, Furihata M, Yuri K, Ohtsuki Y 

(2001). Tetrasomy 12 in ovarian tumors of 

thecoma-fibroma group: A fluorescence in 

situ hybridization analysis using paraffin 

sections. Pathol Int 51: 37-42. 

1654. Liaw D, Marsh DJ, Li J, Dahia PL, 

Wang SI, Zheng Z, Bose S, Call KM, Tsou 

HC, Peacocke M, Eng C, Parsons R (1997). 

Germline mutations of the PTEN gene in 

Cowden disease, an inherited breast and 

thyroid cancer syndrome. Nat Genet 16: 

64-67. 

1655. Liberman L (2000). Pathologic analysis 

of sentinel lymph nodes in breast carcinoma. 

Cancer 88: 971-977. 

1656. Liberman L, Dershaw DD, Kaufman 

RJ, Rosen PP (1992). Angiosarcoma of the 

breast. Radiology 183: 649-654. 

1657. Liberman L, Giess CS, Dershaw DD, 

Louie DC, Deutch BM (1994). Non-Hodgkin 

lymphoma of the breast: imaging characteristics 

and correlation with histopathologic 

findings. Radiology 192: 157-160. 

1658. Lichtenstein P, Holm NV, Verkasalo 

PK, Iliadou A, Kaprio J, Koskenvuo M, 

Pukkala E, Skytthe A, Hemminki K (2000). 

Environmental and heritable factors in the 

causation of cancer--analyses of cohorts 

of twins from Sweden, Denmark, and 

Finland. N Engl J Med 343: 78-85. 

1659. Lie AK, Skarsvag S, Skomedal H, 

Haugen OA, Holm R (1999). Expression of 

p53, MDM2, and p21 proteins in high-grade 

cervical intraepithelial neoplasia and rela - 

tionship to human papillomavirus infection. 


1660. Lifschitz-Mercer B, Walt H, Kushnir I, 

Jacob N, Diener PA, Moll R, Czernobilsky B 

(1995). Differentiation potential of ovarian 

dysgerminoma: an immunohistochemical 

study of 15 cases. Hum Pathol 26: 62-66. 

1661. Lillemoe TJ, Perrone T, Norris HJ, 

Dehner LP (1991). Myogenous phenotype 

of epithelial-like areas in endometrial stromal 

sarcomas. Arch Pathol Lab Med 115: 

215-219. 

1662. Lim CL, Walker MJ, Mehta RR, Das 

Gupta TK (1986). Estrogen and antiestrogen 

binding sites in desmoid tumors. Eur J 

Cancer Clin Oncol 22: 583-587. 

1663. Lin MC, Mutter GL, Trivijisilp P, 

Boynton KA, Sun D, Crum CP (1998). 

Patterns of allelic loss (LOH) in vulvar 

squamous carcinomas and adjacent noninvasive 

epithelia. Am J Pathol 152: 1313- 

1318. 

1664. Lin WM, Forgacs E, Warshal DP, Yeh 

IT, Martin JS, Ashfaq R, Muller CY (1998). 

Loss of heterozygosity and mutational 

analysis of the PTEN/MMAC1 gene in syn - 

chronous endometrial and ovarian carcinomas. 


1665. Lin Y, Govindan R, Hess JL (1997). 

Malignant hematopoietic breast tumors. 


1666. Lindblom A, Tannergard P, Werelius 

B, Nordenskjold M (1993). Genetic mapping 

of a second locus predisposing to 

hereditary non-polyposis colon cancer. 

Nat Genet 5: 279-282. 

1667. Linder D, Power J (1970). Further evi - 

dence for post-meiotic origin of teratomas 

in the human female. Ann Hum Genet 34: 

21-30. 

1668. Linell F, Ljungberg O, Andersson I 

(1980). Breast carcinoma. Aspects of early 

stages, progression and related problems. 

Acta Pathol Microbiol Scand Suppl 1-233. 

1669. Lininger RA, Ashfaq R, Albores- 

Saavedra J, Tavassoli FA (1997). 

Transitional cell carcinoma of the 

endometrium and endometrial carcinoma 

with transitional cell differentiation. 

Cancer 79: 1933-1943. 

1670. Lininger RA, Fujii H, Man YG, 

Gabrielson E, Tavassoli FA (1998). 

Comparison of loss heterozygosity in primary 

and recurrent ductal carcinoma in 

situ of the breast. Mod Pathol 11: 1151- 

1159. 

1671. Lininger RA, Park WS, Man YG, Pham 

T, MacGrogan G, Zhuang Z, Tavassoli FA 

(1998). LOH at 16p13 is a novel chromosomal 

alteration detected in benign and 

malignant microdissected papillary neoplasms 

of the breast. Hum Pathol 29: 1113- 

1118. 

1672. Lininger RA, Wistuba I, Gazdar A, 

Koenig C, Tavassoli FA, Albores-Saavedra 

J (1998). Human papillomavirus type 16 is 

detected in transitional cell carcinomas 

and squamotransitional cell carcinomas of 

the cervix and endometrium. Cancer 83: 

521-527. 

1673. Lininger RA, Zhuang Z, Man Y, Park 

WS, Emmert-Buck M, Tavassoli FA (1999). 

Loss of heterozygosity is detected at chromosomes 

1p35-36 (NB), 3p25 (VHL), 16p13 

(TSC2/PKD1), and 17p13 (TP53) in microdissected 

apocrine carcinomas of the breast. 

Mod Pathol 12: 1083-1089. 

1674. Lipkin SM, Wang V, Jacoby R, 

Banerjee-Basu S, Baxevanis AD, Lynch 

HT, Elliott RM, Collins FS (2000). MLH3: a 

DNA mismatch repair gene associated 

with mammalian microsatellite instability. 

Nat Genet 24: 27-35. 

1675. Lipper S, Wilson C, Copeland KC 

(1981). Pseudogynecomastia due to neurofibromatosis: 

a light microscopic and 

ultrastructural study. Hum Pathol 12: 755- 

759. 

1676. Lipworth L, Hsieh CC, Wide L, Ekbom 

A, Yu SZ, Yu GP, Xu B, Hellerstein S, 

Carlstrom K, Trichopoulos D, Adami HO 

(1999). Maternal pregnancy hormone levels 

in an area with a high incidence 

(Boston, USA) and in an area with a low 

incidence (Shanghai, China) of breast cancer. 

Br J Cancer 79: 7-12. 

1677. Lissoni A, Cormio G, Perego P, 

Gabriele A, Cantu MG, Bratina G (1997). 

Conservative management of endometrial 

stromal sarcoma en young women. Int J 


1678. Little MP, Boice JDJ (1999). 

Comparison of breast cancer incidence in 

the Massachusetts tuberculosis fluoroscopy 

cohort and in the Japanese atomic 

bomb survivors. Radiat Res 151: 218-224. 

1679. Liu B, Nicolaides NC, Markowitz S, 

Willson JK, Parsons RE, Jen J, 

Papadopolous N, Peltomaki P, de la 

Chapelle A, Hamilton SR, Kinzler KW, 

Vogelstein B (1995). Mismatch repair gene 

defects in sporadic colorectal cancers 

with microsatellite instability. Nat Genet 9: 

48-55. 

1680. Liu B, Parsons RE, Hamilton SR, 

Petersen GM, Lynch HT, Watson P, 

Markowitz S, Willson JK, Green J, de la 

Chapelle A, Kinzler KW, Vogelstein B 

(1994). hMSH2 mutations in hereditary 

nonpolyposis colorectal cancer kindreds. 

Cancer Res 54: 4590-4594. 

1681. Liu FS, Kohler MF, Marks JR, Bast RC 

Jr., Boyd J, Berchuck A (1994). Mutation 

and overexpression of the p53 tumor suppressor 

gene frequently occurs in uterine 

and ovarian sarcomas. Obstet Gynecol 83: 

118-124. 

1682. Liu MM (1988). Fibromyoma of the 

vagina. Eur J Obstet Gynecol Reprod Biol 

29: 321-328. 

1683. Liu WM, Chen CJ, Kan YY, Chao KC, 

Yuan CC, Ng HT (1989). Simultaneous 

endometrioid carcinoma of the uterine 

corpus and ovary. Zhonghua Yi Xue Za Zhi 

(Taipei) 44: 38-44. 

1684. LiVolsi VA, Kelsey JL, Fischer DB, 

Holford TR, Mostow ED, Goldenberg IS 

(1982). Effect of age at first childbirth on 

risk of developing specific histologic subtype 

of breast cancer. Cancer 49: 1937- 

1940. 

1685. Lloreta J, Prat J (1992). Endometrial 

stromal nodule with smooth and skeletal 

muscle components simulating stromal 

sarcoma. Int J Gynecol Pathol 11: 293-298. 

1686. Lobaccaro JM, Lumbroso S, Belon C, 

Galtier-Dereure F, Bringer J, Lesimple T, 

Namer M, Cutuli BF, Pujol H, Sultan C 

(1993). Androgen receptor gene mutation 

in male breast cancer. Hum Mol Genet 2: 

1799-1802.

1687. Loman N, Johannsson O, 

Kristoffersson U, Olsson H, Borg A (2001). 

Family history of breast and ovarian cancers 

and BRCA1 and BRCA2 mutations in a 

population-based series of early-onset 


1223. 

1688. London SJ, Connolly JL, Schnitt SJ, 

Colditz GA (1992). A prospective study of 

benign breast disease and the risk of 

breast cancer. JAMA 267: 941-944. 

1689. Longacre TA, Chung MH, Jensen DN, 

Hendrickson MR (1995). Proposed criteria 

for the diagnosis of well-differentiated 

endometrial carcinoma. A diagnostic test 

for myoinvasion. Am J Surg Pathol 19: 371- 

406. 

1690. Longacre TA, Chung MH, Rouse RV, 

Hendrickson MR (1996). Atypical polypoid 

adenomyofibromas (atypical polypoid adenomyomas) 

of the uterus. A clinicopathologic 

study of 55 cases. Am J Surg Pathol 

20: 1-20. 

1691. Longnecker MP (1994). Alcoholic 

beverage consumption in relation to risk of 

breast cancer: meta-analysis and review. 

Cancer Causes Control 5: 73-82. 

1692. Longway SR, Lind HM, Haghighi P 

(1986). Extraskeletal Ewing's sarcoma arising 

in the broad ligament. Arch Pathol Lab 

Med 110: 1058-1061. 

1693. Longy M, Lacombe D (1996). Cowden 

disease. Report of a family and review. 

Ann Genet 39: 35-42. 

1694. Look KY, Roth LM, Sutton GP (1993). 

Vulvar melanoma reconsidered. Cancer 72: 

143-146. 

1695. Loose JH, Patchefsky AS, Hollander 

IJ, Lavin LS, Cooper HS, Katz SM (1992). 

Adenomyoepithelioma of the breast. A 

spectrum of biologic behavior. Am J Surg 

Pathol 16: 868-876. 

1 6 9 5 a . Lopes JM, Seruca R, Hall AP, 

Branco P, Castedo SM (1990). Cytogenetic 

study of a sclerosing stromal tumor of the 

ovary. Cancer Genet Cytogenet 49: 103- 

106. 

1696. Lopez-Rios F, Miguel PS, Bellas C, 

Ballestin C, Hernandez L (2000). 

Lymphoepithelioma-like carcinoma of the 

uterine cervix: a case report studied by in 

situ hybridization and polymerase chain 

reaction for Epstein-Barr virus. A r c h 


1697. Lorenz G (1978). [Adenomatoid tumor 

of the ovary and vagina (author's transl)]. 

Zentralbl Gynakol 100: 1412-1416. 

1698. Lorigan PC, Grierson AJ, Goepel JR, 

Coleman RE, Goyns MH (1996). Gestational 

choriocarcinoma of the ovary diagnosed 

by analysis of tumour DNA. Cancer Lett 

104: 27-30. 

1699. Lorincz AT, Reid R, Jenson AB, 

Greenberg MD, Lancaster W, Kurman RJ 

(1992). Human papillomavirus infection of 

the cervix: relative risk associations of 15 

common anogenital types. Obstet Gynecol 

79: 328-337. 

1700. Losi L., Lorenzini R., Eusebi V, 

Bussolati G (1995). Apocrine differentiation 

in invasive carcinoma of the breast. Appl 

Immunohistochem 3: 91-98. 

1701. Lotocki RJ, Krepart GV, Paraskevas 

M, Vadas G, Heywood M, Fung FK (1992). 

Glassy cell carcinoma of the cervix: a 

bimodal treatment strategy. G y n e c o l 

Oncol 44: 254-259. 

1702. Loverro G, Cormio G, Renzulli G, 

Lepera A, Ricco R, Selvaggi L (1997). 

Serous papillary cystadenoma of borderline 

malignancy of the broad ligament. Eur 

J Obstet Gynecol Reprod Biol 74: 211-213. 

1703. Loy TS, Calaluce RD, Keeney GL 

(1996). Cytokeratin immunostaining in differentiating 

primary ovarian carcinoma 

from metastatic colonic adenocarcinoma. 

Mod Pathol 9: 1040-1044. 

1704. Lu KH, Cramer DW, Muto MG, Li EY, 

Niloff J, Mok SC (1999). A populationbased 

study of BRCA1 and BRCA2 mutations 

in Jewish women with epithelial 

ovarian cancer. Obstet Gynecol 93: 34-37. 

1705. Lu SL, Kawabata M, Imamura T, 

Akiyama Y, Nomizu T, Miyazono K, Yuasa Y 

(1998). HNPCC associated with germline 

mutation in the TGF-beta type II receptor 

gene. Nat Genet 19: 17-18. 

1706. Lu X, Nikaido T, Toki T, Zhai YL, Kita 

N, Konishi I, Fujii S (2000). Loss of heterozygosity 

among tumor suppressor 

genes in invasive and in situ carcinoma of 

the uterine cervix. Int J Gynecol Cancer 10: 

452-458. 

1707. Lu YJ, Osin P, Lakhani SR, Di Palma S, 

Gusterson BA, Shipley JM (1998). 

Comparative genomic hybridization analysis 

of lobular carcinoma in situ and atypical 

lobular hyperplasia and potential roles 

for gains and losses of genetic material in 

breast neoplasia. Cancer Res 58: 4721- 

4727. 

1708. Lucas FV, Perez-Mesa C (1978). 

Inflammatory carcinoma of the breast. 

Cancer 41: 1595-1605. 

1709. Luchtrath H, Moll R (1989). 

Mucoepidermoid mammary carcinoma. 

Immunohistochemical and biochemical 

analyses of intermediate filaments. 

Virchows Arch A Pathol Anat Histopathol 

416: 105-113. 

1710. Ludwig T, Chapman DL, Papaioannou 

VE, Efstratiadis A (1997). Targeted mutations 

of breast cancer susceptibility gene 

homologs in mice: lethal phenotypes of 

Brca1, Brca2, Brca1/Brca2, Brca1/p53, and 

Brca2/p53 nullizygous embryos. G e n e s 

Dev 11: 1226-1241. 

1711. Luevano-Flores E, Sotelo J, Tena- 

Suck M (1985). Glial polyp (glioma) of the 

uterine cervix, report of a case with 

demonstration of glial fibrillary acidic protein. 


1712. Luft F, Gebert J, Schneider A, 

Melsheimer P, von Knebel DM (1999). 

Frequent allelic imbalance of tumor suppressor 

gene loci in cervical dysplasia. Int 


1713. Lui M, Dahlstrom JE, Bell S, James 

DT (2001). Apocrine adenoma of the breast: 

diagnosis on large core needle biopsy. 

Pathology 33: 149-152. 

1714. Lukas C, Bartkova J, Latella L, Falck 

J, Mailand N, Schroeder T, Sehested M, 

Lukas J, Bartek J (2001). DNA damageactivated 

kinase Chk2 is independent of 

proliferation or differentiation yet correlates 

with tissue biology. Cancer Res 61: 

4990-4993. 

1715. Luna-More S, Gonzalez B, Acedo C, 

Rodrigo I, Luna C (1994). Invasive 

micropapillary carcinoma of the breast. A 

new special type of invasive mammary 

carcinoma. Pathol Res Pract 190: 668-674. 

1716. Lund B, Thomsen HK, Olsen J (1991). 

Reproducibility of histopathological evaluation 

in epithelial ovarian carcinoma. 

Clinical implications. APMIS 99: 353-358. 

1717. Lurain JR, Brewer JI, Torok EE, 

Halpern B (1982). Gestational trophoblastic 

disease: treatment results at the Brewer 

Trophoblastic Disease Center. O b s t e t 

Gynecol 60: 354-360. 

1718. Luton JP, Clerc J, Paoli V, Bonnin A, 

Dumez Y, Vacher-Lavenu MC (1991). 

[Bilateral Leydig cell tumor of the ovary in 

a woman with congenital adrenal hyperplasia. 

The first reported case]. Presse 

Med 20: 109-112. 

1 7 1 9 . Luttges JE, Lubke M (1994). 

Recurrent benign Mullerian papilloma of 

the vagina. Immunohistological findings 

and histogenesis. Arch Gynecol Obstet 

255: 157-160. 

1720. Luxman D, Jossiphov J, Cohen JR, 

Wolf Y, David MP (1997). Uterine metastasis 

from vulvar malignant melanoma. A 

case report. J Reprod Med 42: 244-246. 

1721. Luzzi V, Holtschlag V, Watson MA 

(2001). Expression profiling of ductal carcinoma 

in situ by laser capture microdissection 

and high-density oligonucleotide 

arrays. Am J Pathol 158: 2005-2010. 

1722. Lyday RO (1952). Fibroma of the ovary 

with abdominal implants. Am J Surg 84: 

737-738. 

1723. Lynch ED, Ostermeyer EA, Lee MK, 

Arena JF, Ji H, Dann J, Swisshelm K, 

Suchard D, MacLeod PM, Kvinnsland S, 

Gjertsen BT, Heimdal K, Lubs H, Moller P, 

King MC (1997). Inherited mutations in 

PTEN that are associated with breast can - 

cer, cowden disease, and juvenile polyposis. 

Am J Hum Genet 61: 1254-1260. 

1724. Lynch HT, Albano WA, Heieck JJ, 

Mulcahy GM, Lynch JF, Layton MA, Danes 

BS (1984). Genetics, biomarkers, and control 

of breast cancer: a review. Cancer 

Genet Cytogenet 13: 43-92. 

1725. Lynch HT, de la Chapelle A (1999). 

Genetic susceptibility to non-polyposis 

colorectal cancer. J Med Genet 36: 801- 

818. 

1726. Mabuchi K, Bross DS, Kessler II 

(1985). Risk factors for male breast cancer. 


1727. MacLachlan TK, Somasundaram K, 

Sgagias M, Shifman Y, Muschel RJ, Cowan 

KH, El Deiry WS (2000). BRCA1 effects on 

the cell cycle and the DNA damage 

response are linked to altered gene 

expression. J Biol Chem 275: 2777-2785. 

1728. MacSweeney JE, King DM (1994). 

Computed tomography, diagnosis, staging 

and follow-up of pure granulosa cell 

tumour of the ovary. Clin Radiol 49: 241-245. 

1729. Madison T, Schottenfeld D, Baker V 

(1998). Cancer of the corpus uteri in white 

and black women in Michigan, 1985-1994: 

an analysis of trends in incidence and mortality 

and their relation to histologic subtype 

and stage. Cancer 83: 1546-1554. 

1730. Maehama T, Dixon JE (1998). The 

tumor suppressor, PTEN/MMAC1, dephosphorylates 

the lipid second messenger, 

phosphatidylinositol 3,4,5-trisphosphate. J 

Biol Chem 273: 13375-13378. 

1731. Magi-Galluzi C, O'Connor JT, Neffen 

F, Sun D, Quade BJ, Crum CP, Nucci MR 

(2001). Are mucinous cystadenomas of the 

ovary derived from germ cells ? M o d 

Pathol 14: 140 A. 

1732. Magrina JF, Gonzalez-Bosquet J, 

Weaver AL, Gaffey TA, Leslie KO, Webb 

MJ, Podratz KC (2000). Squamous cell car - 

cinoma of the vulva stage IA: long-term 

results. Gynecol Oncol 76: 24-27. 

1733. Magro G, Bisceglia M, Michal M 

(2000). Expression of steroid hormone 

receptors, their regulated proteins, and 

bcl-2 protein in myofibroblastoma of the 


1734. Magro G, Fraggetta F, Torrisi A, 

Emmanuele C, Lanzafame S (1999). 

Myofibroblastoma of the breast with 

hemangiopericytoma-like pattern and 

pleomorphic lipoma-like areas. Report of a 

case with diagnostic and histogenetic 

considerations. Pathol Res Pract 195: 257- 

262. 

1735. Magro G, Michal M, Bisceglia M 

(2001). Benign spindle cell tumors of the 

mammary stroma: diagnostic criteria, classification, 

and histogenesis. Pathol Res 

Pract 197: 453-466. 

1736. Magro G, Michal M, Vasquez E, 

Bisceglia M (2000). Lipomatous myofibroblastoma: 

a potential diagnostic pitfall in the 

spectrum of the spindle cell lesions of the 


1737. Mahmoud-Ahmed AS, Suh JH, 

Barnett GH, Webster KD, Kennedy AW 

(2001). Tumor distribution and survival in 

six patients with brain metastases from 

cervical carcinoma. Gynecol Oncol 8 1 : 

196-200. 

1738. Mai KT, Yazdi HM, Bertrand MA, 

LeSaux N, Cathcart LL (1996). Bilateral primary 

ovarian squamous cell carcinoma 

associated with human papilloma virus 

infection and vulvar and cervical intraepithelial 

neoplasia. A case report with 

review of the literature. Am J Surg Pathol 

20: 767-772. 

1739. Maier RC, Norris HJ (1980). 

Coexistence of cervical intraepithelial neoplasia 

with primary adenocarcinoma of the 

endocervix. Obstet Gynecol 56: 361-364. 

1740. Maier WP, Rosemond GP, Goldman 

LI, Kaplan GF, Tyson RR (1977). A ten year 

study of medullary carcinoma of the 

breast. Surg Gynecol Obstet 144: 695-698. 

1741. Maiorano E, Ricco R, Virgintino D, et 

al. (1994). Infiltrating myoepithelioma of the 

breast. Appl Immunohistochem 2: 130-136. 

1742. Maitra A, Wistuba II, Gibbons D, 

Gazdar AF, Albores-Saavedra J (1999). 

Allelic losses at chromosome 3p are seen 

in human papilloma virus 16 associated 

transitional cell carcinoma of the cervix. 


1743. Maitra A, Wistuba II, Washington C, 

Virmani AK, Ashfaq R, Milchgrub S, Gazdar 

AF, Minna JD (2001). High-resolution chromosome 

3p allelotyping of breast carcinomas 

and precursor lesions demonstrates 

frequent loss of heterozygosity and a discontinuous 

pattern of allele loss. Am J 

Pathol 159: 119-130. 

1744. Majmudar B, Ross RJ, Gorelkin L 

(1979). Benign blue nevus of the uterine 

cervix. Am J Obstet Gynecol 134: 600-601. 

1745. Major FJ, Blessing JA, Silverberg SG, 

Morrow CP, Creasman WT, Currie JL, 

Yordan E, Brady MF (1993). Prognostic factors 

in early-stage uterine sarcoma. A 

Gynecologic Oncology Group study. 

Cancer 71: 1702-1709. 

1746. Malik SN, Wilkinson EJ (1999). 

Pseudo-Paget's disease of the vulva: a 

case report. J Lower Genital Tract Disease 

3: 201-203. 

1747. Malinak LR, Miller GV, Armstrong JT 


of the Fallopian tube. Am J Obstet Gynecol 

95: 1167-1168. 

1748. Mallory SB (1995). Cowden syndrome 

(multiple hamartoma syndrome). Dermatol 

Clin 13: 27-31. 

1749. Malmstrom H, Janson H, Simonsen E, 

Stenson S, Stendahl U (1990). Prognostic 

factors in invasive squamous cell carcinoma 

of the vulva treated with surgery and 

irradiation. Acta Oncol 29: 915-919. 


1750. Maluf FC, Sabbatini P, Schwartz L, 

Xia J, Aghajanian C (2001). Endometrial 

stromal sarcoma: objective response to 

letrozole. Gynecol Oncol 82: 384-388. 

1751. Maluf HM, Koerner FC (1994). 

Carcinomas of the breast with endocrine 

differentiation: a review. Virchows Arch 

425: 449-457. 

1752. Maluf HM, Koerner FC (1995). Solid 

papillary carcinoma of the breast. A form 

of intraductal carcinoma with endocrine 

differentiation frequently associated with 

mucinous carcinoma. Am J Surg Pathol 19: 

1237-1244. 

1753. Mambo NC, Burke JS, Butler JJ 

(1977). Primary malignant lymphomas of 

the breast. Cancer 39: 2033-2040. 

1754. Man S, Ellis IO, Sibbering M, Blamey 

RW, Brook JD (1996). High levels of allele 

loss at the FHIT and ATM genes in noncomedo 

ductal carcinoma in situ and 

grade I tubular invasive breast cancers. 

Cancer Res 56: 5484-5489. 

1755. Mandai M, Konishi I, Kuroda H, 

Komatsu T, Yamamoto S, Nanbu K, 

Matsushita K, Fukumoto M, Yamabe H, 

Mori T (1998). Heterogeneous distribution 

of K-ras-mutated epithelia in mucinous 

ovarian tumors with special reference to 

histopathology. Hum Pathol 29: 34-40. 

1756. Manegold E, Tietze L, Gunther K, 

Fleischer A, Amo-Takyi BK, Schroder W, 

Handt S (2001). Trisomy 8 as sole karyotypic 

aberration in an ovarian metastasizing 

Sertoli-Leydig cell tumor. Hum Pathol 32: 

559-562. 

1757. Manhoff DT, Schiffman R, Haupt HM 

(1995). Adenoid cystic carcinoma of the 

uterine cervix with malignant stroma. An 

unusual variant of carcinosarcoma? Am J 


1758. Manini C, Pietribiasi F, Sapino A, 

Donadio S (1998). [Serous cystadenocarcinoma 

of the ovary with simultaneous 

breast metastases. Description of a case]. 


1759. Manivel JC, Niehans G, Wick MR, 

Dehner LP (1987). Intermediate trophoblast 

in germ cell neoplasms. Am J Surg Pathol 

11: 693-701. 

1760. Manjer J, Malina J, Berglund G, 

Bondeson L, Garne JP, Janzon L (2001). 

Increased incidence of small and well-differentiated 

breast tumours in postmenopausal 

women following hormonereplacement 

therapy. Int J Cancer 9 2 : 

919-922. 

1761. Mannion C, Park WS, Man YG, 

Zhuang Z, Albores-Saavedra J, Tavassoli 

FA (1998). Endocrine tumors of the cervix: 

morphologic assessment, expression of 

human papillomavirus, and evaluation for 

loss of heterozygosity on 1p, 3p, 11q, and 

17p. Cancer 83: 1391-1400. 

1762. Manson CM, Hirsch PJ, Coyne JD 

(1995). Post-operative spindle cell nodule 

of the vulva. Histopathology 26: 571-574. 

1763. Mansour EG, Ravdin PM, Dressler L 

(1994). Prognostic factors in early breast 


1764. Marchal C, Weber B, de Lafontan B, 

Resbeut M, Mignotte H, du Chatelard PP, 

Cutuli B, Reme-Saumon M, Broussier- 

Leroux A, Chaplain G, Lesaunier F, 

Dilhuydy JM, Lagrange JL (1999). Nine 

breast angiosarcomas after conservative 

treatment for breast carcinoma: a survey 

from French comprehensive Cancer 

Centers. Int J Radiat Oncol Biol Phys 44: 

113-119. 


1765. Marchese MJ, Liskow AS, Crum CP, 

McCaffrey RM, Frick HC (1984). Uterine 

sarcomas: a clinicopathologic study, 1965- 

1981. Gynecol Oncol 18: 299-312. 

1766. Marchetti A, Buttitta F, Pellegrini S, 

Campani D, Diella F, Cecchetti D, Callahan 

R, Bistocchi M (1993). p53 mutations and 

histological type of invasive breast carcinoma. 

Cancer Res 53: 4665-4669. 

1767. Marcus JN, Watson P, Page DL, 

Narod SA, Lenoir GM, Tonin P, Linder- 

Stephenson L, Salerno G, Conway TA, 

Lynch HT (1996). Hereditary breast cancer: 

pathobiology, prognosis, and BRCA1 and 

BRCA2 gene linkage. Cancer 77: 697-709. 

1768. Marcus VA, Madlensky L, Gryfe R, 

Kim H, So K, Millar A, Temple LK, Hsieh E, 

Hiruki T, Narod S, Bapat BV, Gallinger S, 

Redston M (1999). Immunohistochemistry 

for hMLH1 and hMSH2: a practical test for 

DNA mismatch repair-deficient tumors. 


1769. Marquis ST, Rajan JV, Wynshaw- 

Boris A, Xu J, Yin GY, Abel KJ, Weber BL, 

Chodosh LA (1995). The developmental 

pattern of Brca1 expression implies a role 

in differentiation of the breast and other 

tissues. Nat Genet 11: 17-26. 

1770. Marsden DE, Friedlander M, Hacker 

NF (2000). Current management of epithelial 

ovarian carcinoma: a review. Semin 

Surg Oncol 19: 11-19. 

1771. Marsh DJ, Coulon V, Lunetta KL, 

Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, 

Caron S, Duboue B, Lin AY, Richardson AL, 

Bonnetblanc JM, Bressieux JM, Cabarrot- 

Moreau A, Chompret A, Demange L, Eeles 

RA, Yahanda AM, Fearon ER, Fricker JP, 

Gorlin RJ, Hodgson SV, Huson S, Lacombe 

D, Leprat F, Odent S, Toulouse C, Olopade 

OI, Sobol H, Tishler S, Woods CG, Robinson 

BG, Weber HC, Parsons R, Peacocke M, 

Longy M, Eng C. (1998). Mutation spectrum 

and genotype-phenotype analyses in 

Cowden disease and Bannayan-Zonana 

syndrome, two hamartoma syndromes 

with germline PTEN mutation. Hum Mol 

Genet 7: 507-515. 

1772. Marsh DJ, Dahia PL, Caron S, Kum 

JB, Frayling IM, Tomlinson IP, Hughes KS, 

Eeles RA, Hodgson SV, Murday VA, 

Houlston R, Eng C (1998). Germline PTEN 

mutations in Cowden syndrome-like families. 

J Med Genet 35: 881-885. 

1773. Marsh DJ, Dahia PL, Zheng Z, Liaw D, 

Parsons R, Gorlin RJ, Eng C (1997). 

Germline mutations in PTEN are present in 

Bannayan-Zonana syndrome. Nat Genet 

16: 333-334. 

1774. Marsh DJ, Kum JB, Lunetta KL, 

Bennett MJ, Gorlin RJ, Ahmed SF, 

Bodurtha J, Crowe C, Curtis MA, Dasouki 

M, Dunn T, Feit H, Geraghty MT, Graham 

JM Jr., Hodgson SV, Hunter A, Korf BR, 

Manchester D, Miesfeldt S, Murday VA, 

Nathanson KL, Parisi M, Pober B, Romano 

C, Tolmie JL, Trembath R, Winter RM, 

Zackai EH, Zori RT, Weng LP, Dahia PLM, 

Eng C (1999). PTEN mutation spectrum and 

genotype-phenotype correlations in 

Bannayan-Riley-Ruvalcaba syndrome suggest 

a single entity with Cowden syndrome. 

Hum Mol Genet 8: 1461-1472. 

1774a. Marsh WL, Jr., Lucas JG, Olsen J 

(1989). Chondrolipoma of the breast. Arch 

Pathol Lab Med 113: 369-371 

1775. Marshall LM, Hunter DJ, Connolly JL, 

Schnitt SJ, Byrne C, London SJ, Colditz GA 

(1997). Risk of breast cancer associated 

with atypical hyperplasia of lobular and 

ductal types. Cancer Epidemiol 


1776. Marshall RJ, Braye SG, Jones DB 

(1986). Leiomyosarcoma of the uterus with 

giant cells resembling osteoclasts. Int J 


1777. Martin-Hirsch PL, Paraskevaidis E, 

Kitchener H (2001). Surgery for cervical 

intraepithelial neoplasia ( C o c h r a n e 

Review). The Cochrane Library. 

1778. Martinelli G, Govoni E, Pileri S, 

Grigioni FW, Doglioni C, Pelusi G (1983). 

Sclerosing stromal tumor of the ovary. A 

hormonal, histochemical and ultrastructural 

study. Virchows Arch A Pathol Anat 

Histopathol 402: 155-161. 

1779. Martinez A, Walker RA, Shaw JA, 

Dearing SJ, Maher ER, Latif F (2001). 

Chromosome 3p allele loss in early invasive 

breast cancer: detailed mapping and 

association with clinicopathological features. 

Mol Pathol 54: 300-306. 

1780. Martinez V, Azzopardi JG (1979). 

Invasive lobular carcinoma of the breast: 

incidence and variants. Histopathology 3: 

467-488. 

1781. Martino A, Zamparelli M, Santinelli A, 

Cobellis G, Rossi L, Amici G (2001). Unusual 

clinical presentation of a rare case of phyllodes 

tumor of the breast in an adolescent 

girl. J Pediatr Surg 36: 941-943. 

1782. Mascarello JT, Cajulis TR, Billman 

GF, Spruce WE (1993). Ovarian germ cell 

tumor evolving to myelodysplasia. Genes 


1783. Massarelli G, Bosincu L, Costanzi G, 

Onida GA (1999). Uterine Wilms' tumor. Int 


1784. Matanoski GM, Breysse PN, Elliott 

EA (1991). Electromagnetic field exposure 

and male breast cancer. Lancet 337: 737. 

1785. Mathoulin-Portier MP, Penault- 

Llorca F, Labit-Bouvier C, Charafe E, Martin 

F, Hassoun J, Jacquemier J (1998). 

Malignant mullerian mixed tumor of the 

uterine cervix with adenoid cystic component. 


1786. Matias-Guiu X, Bussaglia E, Catasus 

L, Lagarda H, Gras E, Machin P, Prat J 

(2000). Correspondence re: W.M. Lin et al., 

loss of heterozygosity and mutational 

analysis of the PTEN/MMAC1 gene in syn - 

chronous endometrial and ovarian carcinomas. 

Clin. Cancer Res., 4: 2577-2583, 

1998. Clin Cancer Res 6: 1598-1600. 

1787. Matias-Guiu X, Catasus L, Bussaglia 

E, Lagarda H, Garcia A, Pons C, Munoz J, 

Arguelles R, Machin P, Prat J (2001). 

Molecular pathology of endometrial hyperplasia 

and carcinoma. Hum Pathol 32: 569- 

577. 

1788. Matias-Guiu X, Lagarda H, Catasus 

LI, Bussaglia E, Gallardo A, Gras E, Prat J 

(2002). Clonality analysis in synchronous or 

metachronous tumors of the female genital 

tract. Int J Gynecol Pathol 21: 205-211. 

1789. Matias-Guiu X, Pons C, Prat J (1998). 

Mullerian inhibiting substance, alphainhibin, 

and CD99 expression in sex cordstromal 

tumors and endometrioid ovarian 

carcinomas resembling sex cord-stromal 

tumors. Hum Pathol 29: 840-845. 

1790. Matias-Guiu X, Prat J (1990). Ovarian 

tumors with functioning stroma. An 

immunohistochemical study of 100 cases 

with human chorionic gonadotropin monoclonal 

and polyclonal antibodies. Cancer 

65: 2001-2005. 

1791. Matsuoka S, Huang M, Elledge SJ 

(1998). Linkage of ATM to cell cycle regulation 

by the Chk2 protein kinase. Science 

282: 1893-1897. 

1792. Mattia AR, Ferry JA, Harris NL (1993). 

Breast lymphoma. A B-cell spectrum 

including the low grade B-cell lymphoma 

of mucosa associated lymphoid tissue. Am 


1793. Mauillon JL, Michel P, Limacher JM, 

Latouche JB, Dechelotte P, Charbonnier F, 

Martin C, Moreau V, Metayer J, Paillot B, 

Frebourg T (1996). Identification of novel 

germline hMLH1 mutations including a 22 

kb Alu-mediated deletion in patients with 

familial colorectal cancer. Cancer Res 56: 

5728-5733. 

1794. Mauz-Korholz C, Harms D, Calaminus 

G, Gobel U (2000). Primary chemotherapy 

and conservative surgery for vaginal yolksac 

tumour. Maligne Keimzelltumoren 

Study Group. Lancet 355: 625. 

1795. Mawhinney RR, Powell MC, 

Worthington BS, Symonds EM (1988). 

Magnetic resonance imaging of benign 

ovarian masses. Br J Radiol 61: 179-186. 

1796. Mayall F, Rutty K, Campbell F, 

Goddard H (1994). p53 immunostaining 

suggests that uterine carcinosarcomas 

are monoclonal. Histopathology 24: 211- 

214. 

1797. Mayerhofer K, Obermair A, 

Windbichler G, Petru E, Kaider A, Hefler L, 

Czerwenka K, Leodolter S, Kainz C (1999). 

Leiomyosarcoma of the uterus: a clinicopathologic 

multicenter study of 71 cases. 


1798. Maymon E, Piura B, Mazor M, Bashiri 

A, Silberstein T, Yanai-Inbar I (1998). 

Primary hepatoid carcinoma of ovary in 

pregnancy. Am J Obstet Gynecol 179: 820- 

822. 

1799. Mayorga M, Garcia-Valtuille A, 

Fernandez I, et al. (1997). Adenocarcinoma 

of the uterine cervix with massive signetring 

cell differentiation. Int J Surg Pathol 5: 

95-100. 

1800. Mazoujian G, Pinkus GS, Davis S, 

Haagensen DE Jr. (1983). Immunohistochemistry 

of a gross cystic disease 

fluid protein (GCDFP-15) of the breast. A 

marker of apocrine epithelium and breast 

carcinomas with apocrine features. Am J 

Pathol 110: 105-112. 

1801. Mazur MT (1981). Atypical polypoid 

adenomyomas of the endometrium. Am J 


1801a. Mazur MT (1989). Metastatic gestational 

choriocarcinoma. Unusual pathologic 

variant following therapy. Cancer 63: 

1370-1377. 

1802. Mazur MT, Hsueh S, Gersell DJ 

(1984). Metastases to the female genital 

tract. Analysis of 325 cases. Cancer 53: 

1978-1984. 

1802a. Mazur MT, Lurain JR, Brewer JI 

(1982). Fatal gestational choriocarcinoma. 

Clinicopathologic study of patients treated 

at a trophoblastic disease center. Cancer 

50: 1833-1846. 

1803. Mazzella FM, Sieber SC, Braza F 

(1995). Ductal carcinoma of male breast 

with prominent lipid-rich component. 

Pathology 27: 280-283. 

1804. McAdam JA, Stewart F, Reid R (1998). 

Vaginal epithelioid angiosarcoma. J Clin 

Pathol 51: 928-930. 

1805. McBride CM, Hortobagyi GN (1985). 

Primary inflammatory carcinoma of the 

female breast: staging and treatment possibilities. 

Surgery 98: 792-798. 

1806. McCarthy JH, Aga R (1988). A fallopian 

tube lesion of borderline malignancy 

associated with pseudo-myxoma peritonei. 

Histopathology 13: 223-225.

1807. McCluggage G, McBride H, Maxwell 

P, Bharucha H (1997). Immunohistochemical 

detection of p53 and bcl-2 proteins in 

neoplastic and non-neoplastic endocervical 

glandular lesions. Int J Gynecol Pathol 

16: 22-27. 

1808. McCluggage WG (1999). Uterine 

tumours resembling ovarian sex cord 

tumours: immunohistochemical evidence 

for true sex cord differentiation. 


1809. McCluggage WG (2002). Malignant 

biphasic uterine tumours: carcinosarcomas 

or metaplastic carcinomas (Review 

article). J Clin Pathol 55: 321-325. 

1810. McCluggage WG (2002). Uterine car - 

cinosarcomas (malignant mixed Mullerian 

tumors) are metaplastic carcinomas. Int J 


1811. McCluggage WG, Abdulkader M, 

Price JH, Kelehan P, Hamilton S, Beattie J, 

al Nafussi A (2000). Uterine carcinosarcomas 

in patients receiving tamoxifen. A 

report of 19 cases. Int J Gynecol Cancer 

10: 280-284. 

1812. McCluggage WG, Cromie AJ, Bryson 

C, Traub AI (2001). Uterine endometrial 

stromal sarcoma with smooth muscle and 

glandular differentiation. J Clin Pathol 54: 

481-483. 

1813. McCluggage WG, Date A, Bharucha 

H, Toner PG (1996). Endometrial stromal 

sarcoma with sex cord-like areas and 

focal rhabdoid differentiation. H i s t o p a - 

thology 29: 369-374. 

1814. McCluggage WG, Lioe TF, 

McClelland HR, Lamki H (2002). 

Rhabdomyosarcoma of the uterus: report 

of two cases including one of the spindle 

cell variant. Int J Gynecol Cancer 12: 128- 

132. 

1815. McCluggage WG, Maxwell P (2001). 

Immunohistochemical staining for calretinin 

is useful in the diagnosis of ovarian 

sex cord-stromal tumours. Histopathology 

38: 403-408. 

1816. McCluggage WG, Maxwell P, Sloan 

JM (1997). Immunohistochemical staining 

of ovarian granulosa cell tumors with monoclonal 

antibody against inhibin. H u m 

Pathol 28: 1034-1038. 

1817. McCluggage WG, Nirmala V, 

Radhakumari K (1999). Intramural mullerian 

papilloma of the vagina. Int J Gynecol 

Pathol 18: 94-95. 

1818. McCluggage WG, Perenyei M, Irwin 

ST (2002). Recurrent cellular angiofibroma 

of the vulva. J Clin Pathol 55: 477-479. 

1819. McCluggage WG, Sloan JM, Boyle 

DD, Toner PG (1998). Malignant fibrothecomatous 

tumour of the ovary: diagnostic 

value of anti-inhibin immunostaining. J Clin 

Pathol 51: 868-871. 

1820. McCluggage WG, Sloan JM, 

Murnaghan M, White R (1996). 

Gynandroblastoma of ovary with juvenile 

granulosa cell component and heterologous 

intestinal type glands. Histopathology 

29: 253-257. 

1821. McCluggage WG, Sumathi VP, 

Maxwell P (2001). CD10 is a sensitive and 

diagnostically useful immunohistochemical 

marker of normal endometrial stroma 

and of endometrial stromal neoplasms. 


1822. McCluggage WG, Sumathi VP, 

McBride HA, Patterson A (2002). A panel of 

immunohistochemical stains, including 

carcinoembryonic antigen, vimentin, and 

estrogen receptor, aids in the distinction 

between primary endometrial and endocervical 

adenocarcinomas. Int J Gynecol 

Pathol 21: 11-15. 

1823. McCluskey LL, Dubeau L (1997). 

Biology of ovarian cancer. Curr Opin Oncol 

9: 465-470. 

1824. McConnell DT, Miller ID, Parkin DE, 

Murray GI (1997). p53 protein expression in 

a population-based series of primary vulval 

squamous cell carcinoma and immediate 

adjacent field change. Gynecol Oncol 

67: 248-254. 

1825. McConville CM, Stankovic T, Byrd 

PJ, McGuire GM, Yao QY, Lennox GG, 

Taylor MR (1996). Mutations associated 

with variant phenotypes in ataxia-telangiectasia. 

Am J Hum Genet 59: 320-330. 

1826. McCready DR, Hortobagyi GN, Kau 

SW, Smith TL, Buzdar AU, Balch CM (1989). 

The prognostic significance of lymph node 

metastases after preoperative chemotherapy 

for locally advanced breast cancer. 

Arch Surg 124: 21-25. 

1827. McCulloch GL, Evans AJ, Yeoman L, 

Wilson AR, Pinder SE, Ellis IO, Elston CW 

(1997). Radiological features of papillary 

carcinoma of the breast. Clin Radiol 52: 

865-868. 

1828. McCullough K, Froats ER, Falk HC 

(1946). Epidermoid carcinoma arising in an 

endometrial cyst of the ovary. Arch Pathol 

Lab Med 41: 335-337. 

1829. McDivitt RW, Boyce W, Gersell D 


Clinical and pathological observations 

concerning 135 cases. Am J Surg Pathol 6: 

401-411. 

1830. McDivitt RW, Stevens JA, Lee NC, 

Wingo PA, Rubin GL, Gersell D (1992). 

Histologic types of benign breast disease 

and the risk for breast cancer. The Cancer 

and Steroid Hormone Study Group. Cancer 

69: 1408-1414. 

1831. McDivitt RW, Stewart FW (1966). 

Breast carcinoma in children. JAMA 195: 

388-390. 

1832. McDivitt RW, Stewart FW, Berg JW 

(1968). Atlas of Tumour Pathology. 2 n d 

series ed. Washington. 

1833. McGuire WL, Clark GM (1992). 

Prognostic factors and treatment decisions 

in axillary node-negative breast cancer. 

N Engl J Med 326: 1756-1761. 

1834. McKittrick JE, Doane WA, Failing RM 

(1969). Intracystic papillary carcinoma of 

the breast. Am Surg 35: 195-202. 

1835. McKusick VA (1998). M e n d e l i a n 

Inheritance in Man. Catalogs of Human 

Genes and Genetic Disorders. 12th ed. 

John Hopkins University Press: Baltimore. 

1836. McLachlan SA, Erlichman C, Liu FF, 

Miller N, Pintilie M (1996). Male breast 

cancer: an 11 year review of 66 patients. 


1837. McLachlin CM, Kozakewich H, 

Craighill M, O'Connell B, Crum CP (1994). 

Histologic correlates of vulvar human 

papillomavirus infection in children and 

young adults. Am J Surg Pathol 18: 728-735. 

1838. Meier-Ruge W (1992). Epidemiology 

of congenital innervation defects of the 

distal colon. Virchows Arch A Pathol Anat 


1839. Meigs JV (1954). Fibroma of the ovary 

with ascites and hydrothorax. Meigs' syndrome. 


1840. Meijers-Heijboer H, van den 

Ouweland A, Klijn J, Wasielewski M, de 

Snoo A, Oldenburg R, Hollestelle A, 

Houben M, Crepin E, Veghel-Plandsoen M, 

Elstrodt F, van Duijn C, Bartels C, Meijers C, 

Schutte M, McGuffog L, Thompson D, 

Easton D, Sodha N, Seal S, Barfoot R, 

Mangion J, Chang-Claude J, Eccles D, 

Eeles R, Evans DG, Houlston R, Murday V, 

Narod S, Peretz T, Peto J, Phelan C, Zhang 

HX, Szabo C, Devilee P, Goldgar D, Futreal 

PA, Nathanson KL, Weber B, Rahman N, 

Stratton MR (2002). Low-penetrance susceptibility 

to breast cancer due to 

CHEK2(*)1100delC in noncarriers of BRCA1 

or BRCA2 mutations. Nat Genet 31: 55-59. 

1841. Meisels A, Fortin R (1976). 

Condylomatous lesions of the cervix and 

vagina. I. Cytologic patterns. Acta Cytol 20: 

505-509. 

1842. Melhem MF, Tobon H (1987). 

Mucinous adenocarcinoma of the 

endometrium: a clinico-pathological 

review of 18 cases. Int J Gynecol Pathol 6: 

347-355. 

1843. Melnick S, Cole P, Anderson D, 

Herbst A (1987). Rates and risks of diethylstilbestrol-related 

clear-cell adenocarcinoma 

of the vagina and cervix. An update. 

N Engl J Med 316: 514-516. 

1844. Mendez LE, Joy S, Angioli R, Estape 

R, Penalver M (1999). Primary uterine 

angiosarcoma. Gynecol Oncol 75: 272-276. 

1845. Mentzel T (2001). Myofibroblastic 

sarcomas: a brief review of sarcomas 

showing a myofibroblastic line of differentiation 

and discussion of the differential 

diagnosis. Current Diagn Pathol 7: 17-24. 

1846. Merajver SD, Pham TM, Caduff RF, 

Chen M, Poy EL, Cooney KA, Weber BL, 

Collins FS, Johnston C, Frank TS (1995). 

Somatic mutations in the BRCA1 gene in 

sporadic ovarian tumours. Nat Genet 9: 

439-443. 

1846 a. Merina MJ, Llombart-Bosch A, 

Menteagudo C (1990). Malignant changes 

associated with sclerosing adenosis: a 

morphologic and immunohistocheical 

analysis of seven cases. Mod Pathol 3. 

1847. Merino MJ, Carter D, Berman M 

(1983). Angiosarcoma of the breast. Am J 


1848. Merino MJ, Edmonds P, LiVolsi V 

(1985). Appendiceal carcinoma metastatic 

to the ovaries and mimicking primary ovarian 

tumors. Int J Gynecol Pathol 4: 110-120. 

1849. Merino MJ, LiVolsi VA (1981). Signet 

ring carcinoma of the female breast: a clinicopathologic 

analysis of 24 cases. Cancer 

48: 1830-1837. 

1850. Merino MJ, LiVolsi VA, Schwartz PE, 

Rudnicki J (1982). Adenoid basal cell carcinoma 

of the vulva. Int J Gynecol Pathol 1: 

299-306. 

1850 a. Merrill JA (1959). Carcinoma of the 

broad ligament. Obstet Gynecol 13: 472- 

476. 

1851. Meyer AC, Dokerty MB, Harrington 

SW (1948). Inflammatory carcinoma of the 

breast. A correlation of clinical radiologic 

and pathological findings. Surg Gynecol 

Obstet 87: 417-424. 

1852. Meyer JE, Lester SC, DiPrio PJ, 

Ferraro FA, Frenna TH, Denison CM (1995). 

Occult calcified fibroadenomas. B r e a s t 

disease 8: 29-38. 

1853. Meyer JS (1986). Cell kinetics of histologic 

variants of in situ breast carcinoma. 


1854. Michael H, Ulbright TM, Brodhecker 

CA (1989). The pluripotential nature of the 

mesenchyme-like component of yolk sac 

tumor. Arch Pathol Lab Med 113: 1115- 

1119. 

1855. Michaels BM, Nunn CR, Roses DF 

(1994). Lobular carcinoma of the male 

breast. Surgery 115: 402-405. 

1856. Micheletti L, Preti M, Bogliatto F, 

Chieppa P (2000). [Vestibular papillomatosis]. 

Minerva Ginecol 52: 87-91. 

1857. Michels KB, Trichopoulos D, Robins 

JM, Rosner BA, Manson JE, Hunter DJ, 

Colditz GA, Hankinson SE, Speizer FE, 

Willett WC (1996). Birthweight as a risk 

factor for breast cancer. Lancet 348: 1542- 

1546. 

1858. Middleton LP, Palacios DM, Bryant 

BR, Krebs P, Otis CN, Merino MJ (2000). 

Pleomorphic lobular carcinoma: morphology, 

immunohistochemistry, and molecular 

analysis. Am J Surg Pathol 24: 1650-1656. 

1859. Middleton LP, Palacios DM, Bryant 

BR, Krebs P, Otis CN, Merino MJ (2000). 

Pleomorphic lobular carcinoma: morphology, 

immunohistochemistry, and molecular 

analysis. Am J Surg Pathol 24: 1650-1656. 

1860. Mies C (1993). Recurrent secretory 

carcinoma in residual mammary tissue 

after mastectomy. Am J Surg Pathol 17: 

715-721. 

1861. Mies C, Rosen PP (1987). Juvenile 

fibroadenoma with atypical epithelial 

hyperplasia. Am J Surg Pathol 11: 184-190. 

1862. Miettinen M, Lehto VP, Virtanen I 

(1983). Postmastectomy angiosarcoma 

(Stewart-Treves syndrome). Light-microscopic, 

immunohistological, and ultrastructural 

characteristics of two cases. 


1863. Mikami M, Ezawa S, Sakaiya N, 

Komuro Y, Tei C, Fukuchi T, Mukai M 

(2000). Response of glassy-cell carcinoma 

of the cervix to cisplatin, epirubicin, and 

mitomycin C. Lancet 355: 1159-1160. 

1864. Miki Y, Swensen J, Shattuck-Eidens 

D, Futreal PA, Harshman K, Tavtigian S, Liu 

Q, Cochran C, Bennett LM, Ding W, Bell R, 

Rosenthal J, Hussey C, Tran T, McClure M, 

Frye C, Hattier T, Phelps R, Haugenstrano 

A, Katcher H, Dayananth P, Ward J, Tonin 

P, Narod S, Bristow PK, Norris FH, 

Helvering L, Morrison P, Rostek P, Lai M, 

Barrett JC, Lewis C, Neuhasen S, 

Cannonalbright L, Goldgar D, Wiseman R, 

Kamb A, Skolnick MH. (1994). A strong 

candidate for the breast and ovarian cancer 

susceptibility gene BRCA1. Science 

266: 66-71. 

1865. Milanezi MF, Saggioro FP, Zanati SG, 

Bazan R, Schmitt FC (1998). 

Pseudoangiomatous hyperplasia of mammary 

stroma associated with gynaecomastia. 


1866. Milde-Langosch K, Albrecht K, Joram 

S, Schlechte H, Giessing M, Loning T 

(1995). Presence and persistence of HPV 

infection and p53 mutation in cancer of the 

cervix uteri and the vulva. Int J Cancer 63: 

639-645. 

1867. Miles PA, Kiley KC, Mena H (1985). 

Giant fibrosarcoma of the ovary. Int J 


1868. Miles PA, Norris HJ (1972). 

Proliferative and malignant Brenner 

tumors of the ovary. Cancer 30: 174-186. 

1 8 6 9 . Miliauskas JR, Leong AS (1992). 

Small cell (neuroendocrine) carcinoma of 

the vagina. Histopathology 21: 371-374. 


1870. Miller B, Flax S, Dockter M, 

Photopulos G (1994). Nucleolar organizer 

regions in adenocarcinoma of the uterine 

cervix. Cancer 74: 3142-3145. 

1871. Miller BE, Barron BA, Dockter ME, 

Delmore JE, Silva EG, Gershenson DM 

(2001). Parameters of differentiation and 

proliferation in adult granulosa cell tumors 

of the ovary. Cancer Detect Prev 25: 48-54. 

1872. Miller ES, Fairley JA, Neuburg M 

(1997). Vulvar basal cell carcinoma. 

Dermatol Surg 23: 207-209. 

1873. Miller KN, McClure SP (1992). 

Papillary adenofibroma of the uterus. 

Report of a case involved by adenocarcinoma 

and review of the literature. Am J 


1874. Miller WR, Telford J, Dixon JM, 

Shivas AA (1985). Androgen metabolism 

and apocrine differentiation in human 

breast cancer. Breast Cancer Res Treat 5: 

67-73. 

1875. Minato H, Shimizu M, Hirokawa M, 

Fujiwara K, Kohno I, Manabe T (1998). 

Adenocarcinoma in situ of the fallopian 

tube. A case report. Acta Cytol 42: 1455- 

1457. 

1876. Miremadi A, Pinder SE, Lee A, Bell 

JA, Paish EC, Wencyk P, Elston CW, 

Nicholson RI, Blamey RW, Robertson JF, 

Ellis IO (2002). Neuroendocrine differentiation 

and prognosis in breast adenocarcinoma. 


1877. Mirhashemi R, Kratz A, Weir MM, 

Molpus KL, Goodman AK (1998). Vaginal 

small cell carcinoma mimicking a 

Bartholin's gland abscess: a case report. 


1878. Mitao M, Nagai N, Levine RU, 

Silverstein SJ, Crum CP (1986). Human 

papillomavirus type 16 infection: a morphological 

spectrum with evidence for late 

gene expression. Int J Gynecol Pathol 5: 

287-296. 

1879. Mitelman F, Johansson B, Mertens F 

(2001). Mitelman Database of Chromosome 

Aberrations in Cancer. on-line 

h t t p : / / c g a p . n c i . n i h . g o v / C h r o m o s o m e s / M i t e 

lman. 

1880. Mitnick JS, Vazquez MF, Harris MN, 

Schechter S, Roses DF (1990). Invasive 

papillary carcinoma of the breast: mammographic 

appearance. Radiology 177: 803- 

806. 

1881. Mittal K, Mesia A, Demopoulos RI 

(1999). MIB-1 expression is useful in distinguishing 

dysplasia from atrophy in elderly 

women. Int J Gynecol Pathol 18: 122-124. 

1882. Mittal KR, Peng XC, Wallach RC, 

Demopoulos RI (1995). Coexistent atypical 

polypoid adenomyoma and endometrial 

adenocarcinoma. Hum Pathol 26: 574-576. 

1883. Mittendorf R (1995). Teratogen 

update: carcinogenesis and teratogenesis 

associated with exposure to diethylstilbestrol 

(DES) in utero. Teratology 51: 435-445. 

1884. Miyaki M, Konishi M, Tanaka K, 

Kikuchi-Yanoshita R, Muraoka M, Yasuno 

M, Igari T, Koike M, Chiba M, Mori T (1997). 

Germline mutation of MSH6 as the cause 

of hereditary nonpolyposis colorectal cancer. 

Nat Genet 17: 271-272. 

1885. Miyoshi Y, Iwao K, Egawa C, Noguchi 

S (2001). Association of centrosomal 

kinase STK15/BTAK mRNA expression 

with chromosomal instability in human 

breast cancers. Int J Cancer 92: 370-373. 


1886. Modan B, Hartge P, Hirsh-Yechezkel 

G, Chetrit A, Lubin F, Beller U, Ben Baruch 

G, Fishman A, Menczer J, Ebbers SM, 

Tucker MA, Wacholder S, Struewing JP, 

Friedman E, Piura B (2001). Parity, oral contraceptives, 

and the risk of ovarian cancer 

among carriers and noncarriers of a 

BRCA1 or BRCA2 mutation. N Engl J Med 

345: 235-240. 

1 8 8 7 . Moffat CJ, Pinder SE, Dixon AR, 

Elston CW, Blamey RW, Ellis IO (1995). 

Phyllodes tumours of the breast: a clinicopathological 

review of thirty-two cases. 


1888. Moffatt EJ, Kerns BJ, Madden JM, 

Layfield LJ (1997). Prognostic factors for 

fibromatoses: a correlation of proliferation 

index, estrogen receptor, p53, retinoblastoma, 

and src gene products and clinical 

features with outcome. J Surg Oncol 65: 

117-122. 

1889. Moinfar F, Man YG, Arnould L, 

Bratthauer GL, Ratschek M, Tavassoli FA 

(2000). Concurrent and independent genetic 

alterations in the stromal and epithelial 

cells of mammary carcinoma: implications 

for tumorigenesis. Cancer Res 60: 2562- 

2566. 

1890. Moinfar F, Man YG, Lininger RA, 

Bodian C, Tavassoli FA (1999). Use of keratin 

35betaE12 as an adjunct in the diagnosis 

of mammary intraepithelial neoplasiaductal 

type--benign and malignant 

intraductal proliferations. Am J Surg 

Pathol 23: 1048-1058. 

1891. Mok SC, Bell DA, Knapp RC, 

Fishbaugh PM, Welch WR, Muto MG, 

Berkowitz RS, Tsao SW (1993). Mutation of 

K-ras protooncogene in human ovarian 

epithelial tumors of borderline malignancy. 

Cancer Res 53: 1489-1492. 

1892. Moll R, Mitze M, Frixen UH, 

Birchmeier W (1993). Differential loss of Ecadherin 

expression in infiltrating ductal 

and lobular breast carcinomas. Am J 

Pathol 143: 1731-1742. 

1893. Moll UM, Chumas JC, Mann WJ, 

Patsner B (1990). Primary signet ring cell 

carcinoma of the uterine cervix. N Y State 

J Med 90: 559-560. 

1894. Molyneux AJ, Deen S, Sundaresan V 

(1992). Primitive neuroectodermal tumour 

of the uterus. Histopathology 21: 584-585. 

1895. Monk BJ, Nieberg R, Berek JS (1993). 

Primary leiomyosarcoma of the ovary in a 

perimenarchal female. Gynecol Oncol 48: 

389-393. 

1896. Monni O, Barlund M, Mousses S, 

Kononen J, Sauter G, Heiskanen M, 

Paavola P, Avela K, Chen Y, Bittner ML, 

Kallioniemi A (2001). Comprehensive copy 

number and gene expression profiling of 

the 17q23 amplicon in human breast cancer. 


1897. Montag AG, Jenison EL, Griffiths CT, 

Welch WR, Lavin PT, Knapp RC (1989). 

Ovarian clear cell carcinoma. A clinicopathologic 

analysis of 44 cases. Int J 


1898. Montag TW, d'Ablaing G, Schlaerth 

JB, Gaddis O Jr., Morrow CP (1986). 

Embryonal rhabdomyosarcoma of the uterine 

corpus and cervix. Gynecol Oncol 25: 

171-194. 

1899. Monteiro AN (2000). BRCA1: exploring 

the links to transcription. T r e n d s 

Biochem Sci 25: 469-474. 

1900. Monterroso V, Jaffe ES, Merino MJ, 

Medeiros LJ (1993). Malignant lymphomas 

involving the ovary. A clinicopathologic 


154-170. 

1901. Montes M, Roberts D, Berkowitz RS, 

Genest DR (1996). Prevalence and significance 

of implantation site trophoblastic 

atypia in hydatidiform moles and spontaneous 

abortions. Am J Clin Pathol 105: 

411-416. 

1902. Mooney EE, Man YG, Bratthauer GL, 

Tavassoli FA (1999). Evidence that Leydig 

cells in Sertoli-Leydig cell tumors have a 

reactive rather than a neoplastic profile. 

Cancer 86: 2312-2319. 

1903. Mooney EE, Nogales FF, Bergeron C, 

Tavassoli FA (2002). Retiform Sertoli- 

Leydig cell Tumours: Clinical, 

Morphological, and Immunohistochemical 

Findings. Histopathology 41: 110-117. 

1904. Mooney EE, Nogales FF, Tavassoli FA 

(1999). Hepatocytic differentiation in retiform 

Sertoli-Leydig cell tumors: distinguishing 

a heterologous element from 

Leydig cells. Hum Pathol 30: 611-617. 

1905. Mooney EE, Tavassoli FA (1999). 

Papillary transitional cell carcinoma of the 

breast: a report of five cases with distinction 

from eccrine acrospiroma. M o d 

Pathol 12: 287-294. 

1906. Moore DH, Michael H, Furlin JJ, Von 

Stein A (1998). Adenoid basal carcinoma of 

the vagina. Int J Gynecol Cancer 8: 261- 

263. 

1907. Moore MP, Ihde JK, Crowe JP Jr., 

Hakes TP, Kinne DW (1991). Inflammatory 

breast cancer. Arch Surg 126: 304-306. 

1908. Moore OS, Foote FW (1949). The relatively 

favorable prognosis of medullary 

carcinoma of the breast. Cancer 2: 635-642. 

1909. Moreno-Bueno G, Gamallo C, Perez- 

Gallego L, de Mora JC, Suarez A, Palacios 

J (2001). beta-Catenin expression pattern, 

beta-catenin gene mutations, and 

microsatellite instability in endometrioid 

ovarian carcinomas and synchronous 

endometrial carcinomas. Diagn Mol 

Pathol 10: 116-122. 

1910. Moreno-Rodriguez M, Perez-Sicilia 

M, Delinois R (1999). Lipoma of the endocervix. 


1911. Moreno V, Bosch FX, Munoz N, 

Meijer CJ, Shah KV, Walboomers JM, 

Herrero R, Franceschi S, International 

Agency for Research on Cancer. 

Multicentric Cervical Cancer Study Group 

(2002). Effect of oral contraceptives on risk 

of cervical cancer in women with papillomavirus 

infection: the IARC multicentric 

case-control study. Lancet 30: 1085-1092. 

1912. Morgan LS, Joslyn P, Chafe W, 

Ferguson K (1988). A report on 18 cases of 

primary malignant melanoma of the vulva. 

Colposcopy and Gynecologic Laser 

Surgery 4 (3) and Laser Surg 4: 161-170. 

1913. Morgan MB, Pitha JV (1998). 

Myofibroblastoma of the breast revisited: 

an etiologic association with androgens? 

Hum Pathol 29: 347-351. 

1914. Morice P, Haie-Meder C, Pautier P, 

Lhomme C, Castaigne D (2001). Ovarian 

metastasis on transposed ovary in patients 

treated for squamous cell carcinoma of the 

uterine cervix: report of two cases and surgical 

implications. Gynecol Oncol 83: 605- 

607. 

1915. Morikawa K, Hatabu H, Togashi K, 

Kataoka ML, Mori T, Konishi J (1997). 

Granulosa cell tumor of the ovary: MR findings. 

J Comput Assist Tomogr 21: 1001- 

1004. 

1916. Morimitsu Y, Tanaka H, Iwanaga S, 

Kojiro M (1993). Alveolar soft part sarcoma 

of the uterine cervix. Acta Pathol Jpn 43: 

204-208. 

1917. Morimoto T, Komaki K, Yamakawa T, 

Tanaka T, Oomine Y, Konishi Y, Mori T, 

Monden Y (1990). Cancer of the male 

breast. J Surg Oncol 44: 180-184. 

1918. Morimura Y, Honda T, Hoshi K, 

Yamada J, Nemoto K, Sato A (1995). A case 

of uterine cervical adenoid cystic carcinoma: 

immunohistochemical study for basement 

membrane material. Obstet Gynecol 

85: 903-905. 

1 9 1 9 . Moross T, Lang AP, Mahoney L 

(1983). Tubular adenoma of breast. Arch 


1920. Morrison JG, Gray GF Jr., Dao AH, 

Adkins RB Jr. (1987). Granular cell tumors. 

Am Surg 53: 156-160. 

1921. Morrow M, Berger D, Thelmo W 

(1988). Diffuse cystic angiomatosis of the 


1922. Moscovic EA, Azar HA (1967). 

Multiple granular cell tumors ("myoblastomas"). 

Case report with electron microscopic 

observations and review of the literature. 

Cancer 20: 2032-2047. 

1923. Mosher R, Genest DR (1997). Primary 

intraplacental chorioacarcinoma: clinical 

and pathological features of seven case 

(1967-1996) and discussion of the differential 

diagnosis. J Surg Pathol 2: 83-97. 

1924. Mosher R, Goldstein DP, Berkowitz R, 

Bernstein M, Genest DR (1998). Complete 

hydatidiform mole. Comparison of clinicopathologic 

features, current and past. J 

Reprod Med 43: 21-27. 

1925. Mosselman S, Polman J, Dijkema R 

(1996). ER beta: identification and characterization 

of a novel human estrogen 

receptor. FEBS Lett 392: 49-53. 

1926. Mossler JA, Barton TK, Brinkhous 

AD, McCarty KS, Moylan JA, McCarty KS 

Jr. (1980). Apocrine differentiation in 

human mammary carcinoma. Cancer 46: 

2463-2471. 

1927. Mostoufizadeh M, Scully RE (1980). 

Malignant tumors arising in endometriosis. 

Clin Obstet Gynecol 23: 951-963. 

1928. Motoyama T, Watanabe H (1996). 

Extremely well differentiated squamous 

cell carcinoma of the breast. Report of a 

case with a comparative study of an epidermal 

cyst. Acta Cytol 40: 729-733. 

1929. Mount PM, Norris HJ (1982). Overial 

Tumouren. Springer: Berlin. 

1930. Moyal-Barracco M, Leibowitch M, 

Orth G (1990). Vestibular papillae of the 

vulva. Lack of evidence for human papillomavirus 

etiology. Arch Dermatol 126: 1594- 

1598. 

1931. Moynahan ME, Chiu JW, Koller BH, 

Jasin M (1999). Brca1 controls homologydirected 

DNA repair. Mol Cell 4: 511-518. 

1932. Mrad K, Driss M, Maalej M, 

Romdhane KB (2000). Bilateral cystosarcoma 

phyllodes of the breast: a case report 

of malignant form with contralateral 

benign form. Ann Diagn Pathol 4: 370-372. 

1933. Mrad K, Morice P, Fabre A, Pautier P, 

Lhomme C, Duvillard P, Sabourin JC (2000). 

Krukenberg tumor: a clinico-pathological 

study of 15 cases. Ann Pathol 20: 202-206. 

1934. Muc RS, Grayson W, Grobbelaar JJ 

(2001). Adult extrarenal Wilms tumor 

occurring in the uterus. Arch Pathol Lab 

Med 125: 1081-1083. 

1935. Mudhar HS, Smith JH, Tidy J (2001). 

Primary vaginal adenocarcinoma of intestinal 

type arising from an adenoma: case 

report and review of the literature. Int J 


1936. Mueller CB, Ames F (1978). Bilateral 

carcinoma of the breast: frequency and 

mortality. Can J Surg 21: 459-465.

1937. Mukai M, Torikata C, Iri H (1990). 

Alveolar soft part sarcoma: an electron 

microscopic study especially of uncrystal - 

lized granules using a tannic acid-containing 

fixative. Ultrastruct Pathol 14: 41-50. 

1938. Muller CY, O'Boyle JD, Fong KM, 

Wistuba II, Biesterveld E, Ahmadian M, 

Miller DS, Gazdar AF, Minna JD (1998). 

Abnormalities of fragile histidine triad 

genomic and complementary DNAs in cervical 

cancer: association with human 

papillomavirus type. J Natl Cancer Inst 90: 

433-439. 

1939. Mulvany NJ, Nirenberg A, Östör AG 

(1996). Non-primary cervical adenocarcinomas. 

Pathology 28: 293-297. 

1940. Mulvany NJ, Slavin JL, Östör AG, 

Fortune DW (1994). Intravenous leiomyomatosis 

of the uterus: a clinicopathologic 

study of 22 cases. Int J Gynecol Pathol 13: 

1-9. 

1941. Munkarah A, Malone JM Jr., Budev 

HD, Evans TN (1994). Mucinous adenocarcinoma 

arising in a neovagina. Gynecol 

Oncol 52: 272-275. 

1942. Munn KE, Walker RA, Varley JM 

(1995). Frequent alterations of chromosome 

1 in ductal carcinoma in situ of the 

breast. Oncogene 10: 1653-1657. 

1943. Munoz N, Franceschi S, Bosetti C, 

Moreno V, Herrero R, Shah KV, Smith J, 

Meijer CJ, for the IARC Multi-centre 

Cervical Cancer Study Group (2001). The 

role of parity and HPV in cervical cancer: 

The IARC multi-centric cas-control study. 

Lancet . 

1944. Munoz N, Franceschi S, Bosetti C, 

Moreno V, Herrero R, Smith JS, Shah KV, 

Meijer CJ, Bosch FX (2002). Role of parity 

and human papillomavirus in cervical cancer: 

the IARC multicentric case-control 

study. Lancet 359: 1093-1101. 

1945. Murad TM, Contesso G, Mouriesse H 

(1981). Papillary tumors of large lactiferous 

ducts. Cancer 48: 122-133. 

1946. Murao T, Nakai M, Hamada E (1986). 

[Intravascular papillary endothelial hyperplasia 

of the breast--report of a case with 

scanning electron microscopic observations]. 

Gan No Rinsho 32: 1471-1474. 

1947. Murase E, Siegelman ES, Outwater 

EK, Perez-Jaffe LA, Tureck RW (1999). 

Uterine leiomyomas: histopathologic features, 

MR imaging findings, differential 

diagnosis, and treatment. Radiographics 

19: 1179-1197. 

1948. Murayama Y, Yamamoto Y, 

Shimojima N, Takahara T, Kikuchi K, Iida S, 

Kondo Y (1999). T1 Breast Cancer 

Associated with Von Recklinghausen's 

Neurofibromatosis. Breast Cancer 6: 227- 

230. 

1949. Murphy DS, Hoare SF, Going JJ, 

Mallon EE, George WD, Kaye SB, Brown R, 

Black DM, Keith WN (1995). 

Characterization of extensive genetic 

alterations in ductal carcinoma in situ by 

fluorescence in situ hybridization and 

molecular analysis. J Natl Cancer Inst 87: 

1694-1704. 

1950. Murphy GF, Elder DE (1991). Nonmelanocytic 

Tumors of the Skin. Atlas of 

Tumor Pathology, 3rd series, Fascicle 1 

AFIP: Washington,D.C. 

1951. Musgrave MA, Aronson KJ, Narod S, 

Hanna W, Miller AB, McCready DR (1998). 

Breast cancer and organochlorines: a 

marker for susceptibility? Surg Oncol 7: 1- 

4. 

1952. Mussurakis S, Carleton PJ, Turnbull 

LW (1997). MR imaging of primary non- 

Hodgkin's breast lymphoma. A case report. 

Acta Radiol 38: 104-107. 

1953. Muto MG, Lage JM, Berkowitz RS, 

Goldstein DP, Bernstein MR (1991). 

Gestational trophoblastic disease of the 

fallopian tube. J Reprod Med 36: 57-60. 

1954. Muto MG, Welch WR, Mok SC, 

Bandera CA, Fishbaugh PM, Tsao SW, Lau 

CC, Goodman HM, Knapp RC, Berkowitz RS 

(1995). Evidence for a multifocal origin of 

papillary serous carcinoma of the peritoneum. 

Cancer Res 55: 490-492. 

1955. Mutter GL (2000). Endometrial 

intraepithelial neoplasia (EIN): will it bring 

order to chaos? The Endometrial 

Collaborative Group. Gynecol Oncol 7 6 : 

287-290. 

1956. Mutter GL (2000). Histopathology of 

genetically defined endometrial precancers. 


1957. Mutter GL (2001). Pten, a protean 

tumor suppressor. Am J Pathol 158: 1895- 

1898. 

1958. Mutter GL, Baak JP, Crum CP, Richart 

RM, Ferenczy A, Faquin WC (2000). 

Endometrial precancer diagnosis by 

histopathology, clonal analysis, and computerized 

morphometry. J Pathol 190: 462- 

469. 

1959. Mutter GL, Ince TA, Baak JP, Kust 

GA, Zhou XP, Eng C (2001). Molecular identification 

of latent precancers in histologically 

normal endometrium. Cancer Res 61: 

4311-4314. 

1960. Myles JL, Hart WR (1985). Apoplectic 

leiomyomas of the uterus. A clinicopathologic 

study of five distinctive hemorrhagic 

leiomyomas associated with oral contraceptive 

usage. Am J Surg Pathol 9: 798- 

805. 

1961. Naganawa S, Endo T, Aoyama H, 

Ichihara S (1996). MR lmaging of the 

Primary Breast Lymphoma: A Case Report. 

Breast Cancer 3: 209-213. 

1962. Nagasaki K, Maass N, Manabe T, 

Hanzawa H, Tsukada T, Kikuchi K, 

Yamaguchi K (1999). Identification of a 

novel gene, DAM1, amplified at chromosome 

1p13.3-21 region in human breast 

cancer cell lines. Cancer Lett 140: 219-226. 

1963. Nagle RB, Bocker W, Davis JR, Heid 

HW, Kaufmann M, Lucas DO, Jarasch ED 

(1986). Characterization of breast carcinomas 

by two monoclonal antibodies distinguishing 

myoepithelial from luminal epithelial 

cells. J Histochem Cytochem 3 4 : 

869-881. 

1964. Nakagawa S, Yoshikawa H, Kimura 

M, Kawana K, Matsumoto K, Onda T, Kino 

N, Yamada M, Yasugi T, Taketani Y (1999). 

A possible involvement of aberrant expression 

of the FHIT gene in the carcinogenesis 

of squamous cell carcinoma of the uterine 

cervix. Br J Cancer 79: 589-594. 

1965. Nakamura Y, Nakashima T, 

Nakashima H, Hashimoto T (1981). Bilateral 

cystic nephroblastomas and botryoid sarcoma 

involving vagina and urinary bladder 

in a child with microcephaly, arhinencephaly, 

and bilateral cataracts. Cancer 

48: 1012-1015. 

1966. Nakanishi T, Wakai K, Ishikawa H, 

Nawa A, Suzuki Y, Nakamura S, Kuzuya K 

(2001). A comparison of ovarian metastasis 

between squamous cell carcinoma and 

adenocarcinoma of the uterine cervix. 


1967. Nakano T, Oka K, Ishikawa A, Morita 

S (1997). Correlation of cervical carcinoma 

c-erb B-2 oncogene with cell proliferation 

parameters in patients treated with radiation 

therapy for cervical carcinoma. 

Cancer 79: 513-520. 

1968. Nakashima N, Fukatsu T, Nagasaka 

T, Sobue M, Takeuchi J (1987). The frequency 

and histology of hepatic tissue in 

germ cell tumors. Am J Surg Pathol 11: 

682-692. 

1969. Nakashima N, Murakami S, Fukatsu 

T, Nagasaka T, Fukata S, Ohiwa N, Nara Y, 

Sobue M, Takeuchi J (1988). 

Characteristics of "embryoid body" in 

human gonadal germ cell tumors. Hum 

Pathol 19: 1144-1154. 

1970. Nakashima N, Nagasaka T, Fukata S, 

Oiwa N, Nara Y, Fukatsu T, Takeuchi J 

(1990). Study of ovarian tumors treated at 

Nagoya University Hospital, 1965-1988. 


1971. Nakashima N, Young RH, Scully RE 

(1984). Androgenic granulosa cell tumors 

of the ovary. A clinicopathologic analysis 

of 17 cases and review of the literature. 


1972. Nanbu K, Konishi I, Yamamoto S, 

Koshiyama M, Mandai M, Komatsu T, Li W, 

Tokushige M, Higuchi K, Mori T (1995). 

Minimal deviation adenocarcinoma of 

endometrioid type may arise in the isthmus: 

clinicopathological and immunohistochemical 

study of two cases. G y n e c o l 

Oncol 58: 136-141. 

1973. Naresh KN, Ahuja VK, Rao CR, 

Mukherjee G, Bhargava MK (1991). 

Squamous cell carcinoma arising in 

endometriosis of the ovary. J Clin Pathol 

44: 958-959. 

1974. Narod S, Tonin P, Lynch H, Watson P, 

Feunteun J, Lenoir G (1994). Histology of 

BRCA1-associated ovarian tumours. 

Lancet 343: 236. 

1975. Narod SA (2002). Modifiers of risk of 

hereditary breast and ovarian cancer. Nat 

Rev Cancer 2: 113-123. 

1976. Narod SA, Brunet JS, Ghadirian P, 

Robson M, Heimdal K, Neuhausen SL, 

Stoppa-Lyonnet D, Lerman C, Pasini B, de 

los Rios P, Weber B, Lynch H (2000). 

Tamoxifen and risk of contralateral breast 

cancer in BRCA1 and BRCA2 mutation carriers: 

a case-control study. Hereditary 

Breast Cancer Clinical Study Group. 

Lancet 356: 1876-1881. 

1977. Narod SA, Dube MP, Klijn J, Lubinski 

J, Lynch HT, Ghadirian P, Provencher D, 

Heimdal K, Moller P, Robson M, Offit K, 

Isaacs C, Weber B, Friedman E, Gershoni- 

Baruch R, Rennert G, Pasini B, Wagner T, 

Daly M, Garber JE, Neuhausen SL, 

Ainsworth P, Olsson H, Evans G, Osborne 

M, Couch F, Foulkes WD, Warner E, Kim- 

Sing C, Olopade O, Tung N, Saal HM, 

Weitzel J, Merajver S, Gauthier-Villars M, 

Jernstrom H, Sun P, Brunet JS (2002). Oral 

contraceptives and the risk of breast cancer 

in BRCA1 and BRCA2 mutations carriers. 


1978. Narod SA, Goldgar D, Cannon- 

Albright L, Weber B, Moslehi R, Ives E, 

Lenoir G, Lynch H (1995). Risk modifiers in 

carriers of BRCA1 mutations. Int J Cancer 

64: 394-398. 

1979. Narod SA, Risch H, Moslehi R, Dorum 

A, Neuhausen S, Olsson H, Provencher D, 

Radice P, Evans G, Bishop S, Brunet JS, 

Ponder BA (1998). Oral contraceptives and 

the risk of hereditary ovarian cancer. 

Hereditary Ovarian Cancer Clinical Study 

Group. N Engl J Med 339: 424-428. 

1980. Narod SA, Sun P, Ghadirian P, Lynch 

H, Isaacs C, Garber J, Weber B, Karlan B, 

Fishman D, Rosen B, Tung N, Neuhausen 

SL (2001). Tubal ligation and risk of ovarian 

cancer in carriers of BRCA1 or BRCA2 

mutations: a case-control study. Lancet 

357: 1467-1470. 

1981. Nascimento AG, Karas M, Rosen PP, 

Caron AG (1979). Leiomyoma of the nipple. 


1982. Nassar H, Wallis T, Andea A, Dey J, 

Adsay V, Visscher D (2001). 

Clinicopathologic analysis of invasive 

micropapillary differentiation in breast carcinoma. 

Mod Pathol 14: 836-841. 

1983. Nasu M, Inoue J, Matsui M, Minoura 

S, Matsubara O (2000). Ovarian 

leiomyosarcoma: an autopsy case report. 

Pathol Int 50: 162-165. 

1984. National Co-ordinating Group for 

Breast Screening Pathology (1995). 

Pathology Reporting. In: Breast Screening 

Pathology, Breast Screening Pathology, 

2nd ed. ed. NHSBSP Publications. 

1 9 8 5 . Navani SS, Alvarado-Cabrero I, 

Young RH, Scully RE (1996). Endometrioid 

carcinoma of the fallopian tube: a clinicopathologic 

analysis of 26 cases. Gynecol 

Oncol 63: 371-378. 

1986. Naves AE, Monti JA, Chichoni E 

(1980). Basal cell-like carcinoma in the 

upper third of the vagina. Am J Obstet 

Gynecol 137: 136-137. 

1987. Nayar R, Siriaunkgul S, Robbins KM, 

McGowan L, Ginzan S, Silverberg SG 

(1996). Microinvasion in low malignant 

potential tumors of the ovary. Hum Pathol 

27: 521-527. 

1988. Nayar R, Zhuang Z, Merino MJ, 

Silverberg SG (1997). Loss of heterozygosity 

on chromosome 11q13 in lobular lesions 

of the breast using tissue microdissection 

and polymerase chain reaction. H u m 

Pathol 28: 277-282. 

1989. Nelen MR, Kremer H, Konings IB, 

Schoute F, van Essen AJ, Koch R, Woods 

CG, Fryns JP, Hamel B, Hoefsloot LH, 

Peeters EA, Padberg GW (1999). Novel 

PTEN mutations in patients with Cowden 

disease: absence of clear genotype-phenotype 

correlations. Eur J Hum Genet 7: 

267-273. 

1990. Nelen MR, Padberg GW, Peeters EA, 

Lin AY, van den Helm B, Frants RR, Coulon 

V, Goldstein AM, van Reen MM, Easton DF, 

Eeles RA, Hodgsen S, Mulvihill JJ, Murday 

VA, Tucker MA, Mariman EC, Starink TM, 

Ponder BA, Ropers HH, Kremer H, Longy 

M, Eng C (1996). Localization of the gene 

for Cowden disease to chromosome 

10q22-23. Nat Genet 13: 114-116. 

1991. Nelen MR, van Staveren WC, Peeters 

EA, Hassel MB, Gorlin RJ, Hamm H, 

Lindboe CF, Fryns JP, Sijmons RH, Woods 

DG, Mariman EC, Padberg GW, Kremer H 

(1997). Germline mutations in the 

PTEN/MMAC1 gene in patients with 

Cowden disease. Hum Mol Genet 6: 1383- 

1387. 

1992. Nelson CL, Sellers TA, Rich SS, Potter 

JD, McGovern PG, Kushi LH (1993). Familial 

clustering of colon, breast, uterine, and 

ovarian cancers as assessed by family history. 

Genet Epidemiol 10: 235-244. 

1993. Nemoto T, Castillo N, Tsukada Y, Koul 

A, Eckhert KH Jr., Bauer RL (1998). Lobular 

carcinoma in situ with microinvasion. J 

Surg Oncol 67: 41-46. 

1994. Nesland JM, Holm R, Johannessen 

JV (1985). Ultrastructural and immunohistochemical 

features of lobular carcinoma 

of the breast. J Pathol 145: 39-52. 


1995. Nesland JM, Lunde S, Holm R, 

Johannessen JV (1987). Electron 

microscopy and immunostaining of the 

normal breast and its benign lesions. A 

search for neuroendocrine cells. H i s t o l 


1 9 9 6 . Neubecker RD, Breen JL (1962). 

Gynandroblastoma. A report of five cases 

with a discussion of the histogenesis ans 

classification of ovarian tumours. Am J 


1997. Neuhausen SL, Godwin AK, 

Gershoni-Baruch R, Schubert E, Garber J, 

Stoppa-Lyonnet D, Olah E, Csokay B, 

Serova O, Lalloo F, Osorio A, Stratton M, 

Offit K, Boyd J, Caligo MA, Scott RJ, 

Schofield A, Teugels E, Schwab M, 

Cannon-Albright L, Bishop T, Easton D, 

Benitez J, King MC, Ponder BAJ, Weber B, 

Devilee P, Borg A, Narod SA, Goldgar D. 

(1998). Haplotype and phenotype analysis 

of nine recurrent BRCA2 mutations in 111 

families: results of an international study. 

Am J Hum Genet 62: 1381-1388. 

1998. Nevin J, Laing D, Kaye P, McCulloch 

T, Barnard R, Silcocks P, Blackett T, 

Paterson M, Sharp F, Cruse P (1999). The 

significance of Erb-b2 immunostaining in 

cervical cancer. Gynecol Oncol 73: 354- 

358. 

1999. Newcomer JR (1998). Ampullary 

tubal hydatidiform mole treated with linear 

salpingotomy. A case report. J Reprod 

Med 43: 913-915. 

2000. Newman PL, Fletcher CD (1991). 

Smooth muscle tumours of the external 

genitalia: clinicopathological analysis of a 

series. Histopathology 18: 523-529. 

2001. Newman W (1966). Lobular carcinoma 

of the female breast. Report of 73 

cases. Ann Surg 164: 305-314. 

2002. Newton WA Jr., Gehan EA, Webber 

BL, Marsden HB, van Unnik AJ, Hamoudi 

AB, Tsokos MG, Shimada H, Harms D, 

Schmidt D, Ninfo V, Cavazzana AO, 

Gonzalezcrussi F, Parham DM, Reiman 

HM, Asmar L, Beltangady MS, Sachs NE, 

Triche TJ, Maurer HM. (1995). 

Classification of rhabdomyosarcomas and 

related sarcomas. Pathologic aspects and 

proposal for a new classification--an 

Intergroup Rhabdomyosarcoma Study. 

Cancer 76: 1073-1085. 

2003. Ng WK (2001). Fine needle aspiration 

cytology of invasive cribriform carcinoma 

of the breast with osteoclastlike giant 

cells: a case report. Acta Cytol 45: 593-598. 

2004. Ngan HY, Liu SS, Yu H, Liu KL, Cheung 

AN (1999). Proto-oncogenes and p53 protein 

expression in normal cervical stratified 

squamous epithelium and cervical 

intra-epithelial neoplasia. Eur J Cancer 35: 

1546-1550. 

2005. Nguyen NP, Sallah S, Karlsson U, Vos 

P, Ludin A, Semer D, Tait D, Salehpour M, 

Jendrasiak G, Robiou C (2001). Prognosis 

for papillary serous carcinoma of the 

endometrium after surgical staging. Int J 


2006. Ngwalle KE, Hirakawa T, Tsuneyoshi 

M, Enjoji M (1990). Osteosarcoma arising in 

a benign dermoid cyst of the ovary. 


2007. Nichols GE, Mills SE, Ulbright TM, 

Czernobilsky B, Roth LM (1991). Spindle 

cell mural nodules in cystic ovarian mucinous 

tumors. A clinicopathologic and 

immunohistochemical study of five cases. 



2008. Nicolaides NC, Carter KC, Shell BK, 

Papadopoulos N, Vogelstein B, Kinzler KW 

(1995). Genomic organization of the human 

PMS2 gene family. Genomics 30: 195-206. 

2009. Nicolaides NC, Palombo F, Kinzler 

KW, Vogelstein B, Jiricny J (1996). 

Molecular cloning of the N-terminus of 

GTBP. Genomics 31: 395-397. 

2010. Nicolaides NC, Papadopoulos N, Liu 

B, Wei YF, Carter KC, Ruben SM, Rosen CA, 

Haseltine WA, Fleischmann RD, Fraser 

CM, Adams MD, Venter JC, Dunlop MG, 

Hamilton SR, Petersen GM, de la Chapelle 

A, Vogelstein B, Kinzler KW. (1994). 

Mutations of two PMS homologues in 

hereditary nonpolyposis colon cancer. 

Nature 371: 75-80. 

2011. Niehans GA, Manivel JC, Copland GT, 

Scheithauer BW, Wick MR (1988). 

Immunohistochemistry of germ cell and 

trophoblastic neoplasms. Cancer 62: 1113- 

1123. 

2012. Nielsen AL, Nyholm HC, Engel P 

(1994). Expression of MIB-1 (paraffin ki-67) 

and AgNOR morphology in endometrial 

adenocarcinomas of endometrioid type. 


2013. Nielsen BB (1981). Oncocytic breast 

papilloma. Virchows Arch A Pathol Anat 

393: 345-351. 

2014. Nielsen BB (1984). Leiomyosarcoma 

of the breast with late dissemination. 


403: 241-245. 

2015. Nielsen BB (1987). Adenosis tumour 

of the breast--a clinicopathological investigation 

of 27 cases. Histopathology 11: 

1259-1275. 

2016. Nielsen BB, Holm-Nielsen P, Kiaer 

HR (1993). Microglandular adenosis of the 

breast concomitant with secretory carcinoma. 

Pathol Res Pract 189: 769. 

2017. Nielsen GP, Oliva E, Young RH, 

Rosenberg AE, Dickersin GR, Scully RE 

(1995). Alveolar soft-part sarcoma of the 

female genital tract: a report of nine cases 

and review of the literature. Int J Gynecol 

Pathol 14: 283-292. 

2018. Nielsen GP, Oliva E, Young RH, 

Rosenberg AE, Prat J, Scully RE (1998). 

Primary ovarian rhabdomyosarcoma: a 

report of 13 cases. Int J Gynecol Pathol 17: 

113-119. 

2019. Nielsen GP, Rosenberg AE, Young 

RH, Dickersin GR, Clement PB, Scully RE 

(1996). Angiomyofibroblastoma of the vulva 

and vagina. Mod Pathol 9: 284-291. 

2020. Nielsen GP, Young RH (2001). 

Mesenchymal tumors and tumor-like 

lesions of the female genital tract: a selective 

review with emphasis on recently 

described entities. Int J Gynecol Pathol 20: 

105-127. 

2021. Nielsen GP, Young RH, Prat J, Scully 

RE (1997). Primary angiosarcoma of the 

ovary: a report of seven cases and review 

of the literature. Int J Gynecol Pathol 16: 

378-382. 

2022. Nielsen M, Andersen JA, Henriksen 

FW, Kristensen PB, Lorentzen M, Ravn V, 

Schiodt T, Thorborg JV, Ornvold K (1981). 

Metastases to the breast from extramammary 

carcinomas. Acta Pathol Microbiol 

Scand [A] 89: 251-256. 

2023. Nielsen VT, Andreasen C (1987). 

Phyllodes tumour of the male breast. 


2024. Nirmul D, Pegoraro RJ, Jialal I, 

Naidoo C, Joubert SM (1983). The sex hormone 

profile of male patients with breast 

cancer. Br J Cancer 48: 423-427. 

2024 a. Nishikawa Y, Kaseki S, Tomoda Y, 

Ishizuka T, Asai Y, Suzuki T, Ushijima H 

(1985). Histopathologic classification of 

uterine choriocarcinoma. Cancer 55: 1044- 

1051. 

2 0 2 5 . Nishimori H, Sasaki M, Hirata K, 

Zembutsu H, Yasoshima T, Fukui R, 

Kobayashi K (2000). Tubular adenoma of 

the breast in a 73-year-old woman. Breast 

Cancer 7: 169-172. 

2026. Nishioka T, West CM, Gupta N, Wilks 

DP, Hendry JH, Davidson SE, Hunter RD 

(1999). Prognostic significance of c-erbB-2 

protein expression in carcinoma of the 

cervix treated with radiotherapy. J Cancer 

Res Clin Oncol 125: 96-100. 

2027. Nishizaki T, Chew K, Chu L, Isola J, 

Kallioniemi A, Weidner N, Waldman FM 

(1997). Genetic alterations in lobular breast 

cancer by comparative genomic hybridization. 

Int J Cancer 74: 513-517. 

2028. Nishizaki T, Devries S, Chew K, 

Goodson WH, III, Ljung BM, Thor A, 

Waldman FM (1997). Genetic alterations in 

primary breast cancers and their metastases: 

direct comparison using modified 

comparative genomic hybridization. Genes 


2029. Nixon AJ, Neuberg D, Hayes DF, 

Gelman R, Connolly JL, Schnitt S, Abner A, 

Recht A, Vicini F, Harris JR (1994). 

Relationship of patient age to pathologic 

features of the tumor and prognosis for 

patients with stage I or II breast cancer. J 

Clin Oncol 12: 888-894. 

2 0 3 0 . Nixon AJ, Schnitt SJ, Gelman R, 

Gage I, Bornstein B, Hetelekidis S, Recht A, 

Silver B, Harris JR, Connolly JL (1996). 

Relationship of tumor grade to other pathologic 

features and to treatment outcome of 

patients with early stage breast carcinoma 

treated with breast-conserving therapy. 

Cancer 78: 1426-1431. 

2031. Nobukawa B, Fujii H, Hirai S, 

Kumasaka T, Shimizu H, Matsumoto T, 

Suda K, Futagawa S (1999). Breast carcinoma 

diverging to aberrant melanocytic 

differentiation: a case report with 

histopathologic and loss of heterozygosity 

analyses. Am J Surg Pathol 23: 1280-1287. 

2032. Nogales-Fernandez F, Silverberg SG, 

Bloustein PA, Martinez-Hernandez A, 

Pierce GB (1977). Yolk sac carcinoma 

(endodermal sinus tumor): ultrastructure 

and histogenesis of gonadal and extragonadal 

tumors in comparison with normal 

human yolk sac. Cancer 39: 1462-1474. 

2033. Nogales-Ortiz F, Puerta J, Nogales FF 

Jr. (1978). The normal menstrual cycle. 

Chronology and mechanism of endometrial 

desquamation. Obstet Gynecol 51: 259-264. 

2 0 3 4 . Nogales FF, Isaac MA (2002). 

Functioning uterine sex cord tumour. 


2035. Nogales FF (1993). Embryologic clues 

to human yolk sac tumors: a review. Int J 


2036. Nogales FF (1995). Mesonephric 

(Wolffian) Tumours of the Female Genital 

Tract : is Mesonephric Histogenesis a 

Mirage and a Trap ? Current Diagn Pathol 

2: 94-100. 

2037. Nogales FF, Ayala A, Ruiz-Avila I, 

Sirvent JJ (1991). Myxoid leiomyosarcoma 

of the ovary: analysis of three cases. Hum 

Pathol 22: 1268-1273. 

2038. Nogales FF, Beltran E, Pavcovich M 

(1993). Pathology of ovarian yolk sac 

tumours. In: The Human Yolk Sac and Yolk 

Sac Tumours, FF Nogales (ed.), Springer- 

Verlag: Berlin , pp. 228-244. 

2039. Nogales FF, Bergeron C, Carvia RE, 

Alvaro T, Fulwood HR (1996). Ovarian 

endometrioid tumors with yolk sac tumor 

component, an unusual form of ovarian 

neoplasm. Analysis of six cases. Am J 

Surg Pathol 20: 1056-1066. 

2040. Nogales FF, Carvia RE, Donne C, 

Campello TR, Vidal M, Martin A (1997). 

Adenomas of the rete ovarii. Hum Pathol 

28: 1428-1433. 

2041. Nogales FF, Isaac MA, Hardisson D, 

Bosincu L, Palacios J, Ordi J, Mendoza E, 

Manzarbeitia F, Olivera H, O'Valle F, 

Krasevic M, Marquez M (2002). 

Adenomatoid tumors of the uterus: an 

analysis of 60 cases. Int J Gynecol Pathol 

21: 34-40. 

2042. Nogales FF, Ruiz A, I, Concha A, del 

Moral E (1993). Immature endodermal teratoma 

of the ovary: embryologic correlations 

and immunohistochemistry. H u m 

Pathol 24: 364-370. 

2043. Nogales FF Jr., Matilla A, Nogales 

Ortiz F, Galera-Davidson H (1978). Yolk sac 

tumors with pure and mixed polyvesicular 

vitelline patterns. Hum Pathol 9: 553-566. 

2044. Nogueira M, Andre S, Mendonca E 

(1998). Metaplastic carcinomas of the 

breast--fine needle aspiration (FNA) cytology 

findings. Cytopathology 9: 291-300. 

2045. Nola M, Babic D, Ilic J, Marusic M, 

Uzarevic B, Petrovecki M, Sabioncello A, 

Kovac D, Jukic S (1996). Prognostic parameters 

for survival of patients with malignant 

mesenchymal tumors of the uterus. 

Cancer 78: 2543-2550. 

2046. Noller KL (1993). Role of colposcopy 

in the examination of diethylstilbestrolexposed 

women. Obstet Gynecol Clin 

North Am 20: 165-176. 

2047. Nomura K, Aizawa S (2000). 

Noninvasive, microinvasive, and invasive 

mucinous carcinomas of the ovary: a clinicopathologic 


89: 1541-1546. 

2048. Nordal RN, Kjorstad KE, Stenwig AE, 

Trope CG (1993). Leiomyosarcoma (LMS) 

and endometrial stromal sarcoma (ESS) of 

the uterus. A survey of patients treated in 

the Norwegian Radium Hospital 1976-1985. 


2049. Nordal RR, Kristensen GB, Kaern J, 

Stenwig AE, Pettersen EO, Trope CG (1995). 

The prognostic significance of stage, 

tumor size, cellular atypia and DNA ploidy 

in uterine leiomyosarcoma. Acta Oncol 34: 

797-802. 

2050. Norris HJ, Hilliard GD, Irey NS (1988). 

Hemorrhagic cellular leiomyomas 

("apoplectic leiomyoma") of the uterus 

associated with pregnancy and oral contraceptives. 

Int J Gynecol Pathol 7: 212- 

224. 

2051. Norris HJ, Parmley T (1975). 

Mesenchymal tumors of the uterus. V. 

Intravenous leiomyomatosis. A clinical and 

pathologic study of 14 cases. Cancer 36: 

2164-2178. 

2 0 5 2 . Norris HJ, Robinowitz M (1971). 

Ovarian adenocarcinoma of mesonephric 

type. Cancer 28: 1074-1081. 

2053. Norris HJ, Taylor HB (1965). 

Prognosis of mucinous (gelatinous) carcinoma 



Mesenchymal tumors of the uterus. I. A 

clinical and pathological study of 53 

endometrial stromal tumors. Cancer 1 9 : 

755-766. 

2055. Norris HJ, Taylor HB (1966). Polyps of 

the vagina. A benign lesion resembling 

sarcoma botryoides. Cancer 19: 227-232.

2056. Norris HJ, Taylor HB (1967). Nodular 

theca-lutein hyperplasia of pregnancy (socalled 

"pregnancy luteoma"). A clinical and 

pathologic study of 15 cases. Am J Clin 

Pathol 47: 557-566. 


Relationship of histologic features to 

behavior of cystosarcoma phyllodes. 

Analysis of ninety-four cases. Cancer 20: 

2090-2099. 


Prognosis of granulosa-theca tumors of 

the ovary. Cancer 21: 255-263. 


Virilization associated with cystic granulosa 

tumors. Obstet Gynecol 34: 629-635. 

2060. Norris HJ, Zirkin HJ, Benson WL 

(1976). Immature (malignant) teratoma of 

the ovary: a clinical and pathologic study 

of 58 cases. Cancer 37: 2359-2372. 

2061. Nucci MR, Clement PB, Young RH 

(1999). Lobular endocervical glandular 

hyperplasia, not otherwise specified: a 

clinicopathologic analysis of thirteen 

cases of a distinctive pseudoneoplastic 

lesion and comparison with fourteen 

cases of adenoma malignum. Am J Surg 

Pathol 23: 886-891. 

2062. Nucci MR, Fletcher CD (1998). 

Liposarcoma (atypical lipomatous tumors) 

of the vulva: a clinicopathologic study of 

six cases. Int J Gynecol Pathol 17: 17-23. 

2063. Nucci MR, Granter SR, Fletcher CD 

(1997). Cellular angiofibroma: a benign 

neoplasm distinct from angiomyofibroblastoma 

and spindle cell lipoma. Am J Surg 

Pathol 21: 636-644. 

2064. Nucci MR, Krausz T, Lifschitz-Mercer 

B, Chan JK, Fletcher CD (1998). 

Angiosarcoma of the ovary: clinicopathologic 

and immunohistochemical analysis of 

four cases with a broad morphologic spectrum. 


2065. Nucci MR, O'Connell JT, Huettner 

PC, Cviko A, Sun D, Quade BJ (2001). h- 

Caldesmon expression effectively distinguishes 

endometrial stromal tumors from 

uterine smooth muscle tumors. Am J Surg 

Pathol 25: 455-463. 

2 0 6 6 . Nucci MR, Prasad CJ, Crum CP, 

Mutter GL (1999). Mucinous endometrial 

epithelial proliferations: a morphologic 

spectrum of changes with diverse clinical 

significance. Mod Pathol 12: 1137-1142. 

2067. Nucci MR, Young RH, Fletcher CD 

(2000). Cellular pseudosarcomatous 

fibroepithelial stromal polyps of the lower 

female genital tract: an underrecognized 

lesion often misdiagnosed as sarcoma. Am 


2068. Nuovo J, Melnikow J, Willan AR, 

Chan BK (2000). Treatment outcomes for 

squamous intraepithelial lesions. Int J 


2069. Nuovo MA, Nuovo GJ, Smith D, Lewis 

SH (1990). Benign mesenchymoma of the 

round ligament. A report of two cases with 

immunohistochemistry. Am J Clin Pathol 

93: 421-424. 

2070. Nystrom-Lahti M, Kristo P, 

Nicolaides NC, Chang SY, Aaltonen LA, 

Moisio AL, Jarvinen HJ, Mecklin JP, 

Kinzler KW, Vogelstein B, de la Chapelle A, 

Peltomaki P. (1995). Founding mutations 

and Alu-mediated recombination in hereditary 

colon cancer. Nat Med 1: 1203-1206. 

2071. O'Connell P, Pekkel V, Fuqua SA, 

Osborne CK, Clark GM, Allred DC (1998). 

Analysis of loss of heterozygosity in 399 

premalignant breast lesions at 15 genetic 

loci. J Natl Cancer Inst 90: 697-703. 

2072. O'Connor DM, Norris HJ (1994). The 

influence of grade on the outcome of stage 

I ovarian immature (malignant) teratomas 

and the reproducibility of grading. Int J 


2073. O'Connor IF, Shembekar MV, 

Shousha S (1998). Breast carcinoma developing 

in patients on hormone replacement 

therapy: a histological and immunohistological 

study. J Clin Pathol 51: 935-938. 

2074. O'Hara MF, Page DL (1985). 

Adenomas of the breast and ectopic 

breast under lactational influences. Hum 

Pathol 16: 707-712. 

2075. Obata K, Morland SJ, Watson RH, 

Hitchcock A, Chenevix-Trench G, Thomas 

EJ, Campbell IG (1998). Frequent 

PTEN/MMAC mutations in endometrioid 

but not serous or mucinous epithelial ovarian 

tumors. Cancer Res 58: 2095-2097. 

2076. Obata N, Sasaki A, Takeuchi S, 

Ishiguro Y (1987). Clinico-pathologic study 

on the early diagnosis of cervical adenocarcinoma. 

Nippon Sanka Fujinka Gakkai 

Zasshi 39: 771-776. 

2077. Obata NH, Nakashima N, Kawai M, 

Kikkawa F, Mamba S, Tomoda Y (1995). 

Gonadoblastoma with dysgerminoma in 

one ovary and gonadoblastoma with dysgerminoma 

and yolk sac tumor in the contralateral 

ovary in a girl with 46XX karyotype. 


2077a. Ober WB, Edgcomb JH, Price EB Jr. 

(1971). The pathology of choriocarcinoma. 

Ann N Y Acad Sci 172: 299-426. 

2078. Ober WB, Maier RC (1981). 

Gestational choriocarcinoma of the fallop - 

ian tube. Diagn Gynecol Obstet 3: 213-231. 

2079. Oberman HA (1965). Cystosarcoma 

phyllodes. A clinicopathological study of 

hypercellular periductal stromal neoplasms 

of breast. Cancer 18: 697-710. 

2080. Oberman HA (1980). Secretory carci - 

noma of the breast in adults. Am J Surg 

Pathol 4: 465-470. 

2081. Oberman HA, Fidler WJ Jr. (1979). 

Tubular carcinoma of the breast. Am J 


2082. Ockner DM, Sayadi H, Swanson PE, 

Ritter JH, Wick MR (1997). Genital 

angiomyofibroblastoma. Comparison with 

aggressive angiomyxoma and other myxoid 

neoplasms of skin and soft tissue. Am 


2083. Oddoux C, Struewing JP, Clayton CM, 

Neuhausen S, Brody LC, Kaback M, Haas 

B, Norton L, Borgen P, Jhanwar S, Goldgar 

D, Ostrer H, Offit K (1996). The carrier frequency 

of the BRCA2 6174delT mutation 

among Ashkenazi Jewish individuals is 

approximately 1%. Nat Genet 14: 188-190. 

2 0 8 4 . Offit K, Pierce H, Kirchhoff T, 

Kolachana P, Rapaport B, Gregersen P, 

Johnson S, Yossepowitch O, Huang H, 

Satagopan J, Robson M, Scheuer L, Nafa 

K, Ellis N (2003). Frequency of 

CHEK2*1100delC in New York breast cancer 

cases and controls. BMC Med Genet 

4: 1. 

2085. Ogawa K, Johansson SL, Cohen SM 

(1999). Immunohistochemical analysis of 

uroplakins, urothelial specific proteins, in 

ovarian Brenner tumors, normal tissues, 

and benign and neoplastic lesions of the 

female genital tract. Am J Pathol 155: 1047- 

1050. 

2086. Ohgaki H, Hernandez T, Kleihues P, 

Hainaut P (1999). p53 germline mutations 

and the molecular basis of Li-Fraumeni 

syndrome. In: Molecular Biology in Cancer 

Medicine, R Kurzrock, M Talpaz (eds.), 2nd 

ed. Martin Dunitz: London, pp. 477-492. 

2087. Ohgaki H, Vital A, Kleihues P, Hainaut 

P (2000). Familial tumour syndromes involving 

the nervous system. Li-Fraumeni syndrome 

and TP53 germline mutations. In: 

WHO Classification of Tumours. Pathology 

and Genetics of the Tumours of the 

Nervous System., P Kleihues, WK Cavenee 

(eds.), 1st ed. IARC Press: Lyon, France, 

pp. 231-234. 

2088. Ohnishi T, Watanabe S (2000). The 

use of cytokeratins 7 and 20 in the diagnosis 

of primary and secondary extramammary 

Paget's disease. Br J Dermatol 142: 

243-247. 

2 0 8 9 . Ohtake T, Abe R, Kimijima I, 

Fukushima T, Tsuchiya A, Hoshi K, Wakasa 

H (1995). Intraductal extension of primary 

invasive breast carcinoma treated by 

breast-conservative surgery. Computer 

graphic three-dimensional reconstruction 

of the mammary duct-lobular systems. 

Cancer 76: 32-45. 

2090. Ohuchi N (1999). Breast-conserving 

surgery for invasive cancer: a principle 

based on segmental anatomy. Tohoku J 

Exp Med 188: 103-118. 

2091. Ohuchi N, Abe R, Kasai M (1984). 

Possible cancerous change of intraductal 

papillomas of the breast. A 3-D reconstruction 


2 0 9 2 . Ohuchi N, Abe R, Takahashi T, 

Tezuka F (1984). Origin and extension of 

intraductal papillomas of the breast: a 

three-dimensional reconstruction study. 


2093. Ohuchi N, Furuta A, Mori S (1994). 

Management of ductal carcinoma in situ 

with nipple discharge. Intraductal spreading 

of carcinoma is an unfavorable pathologic 

factor for breast-conserving surgery. 

Cancer 74: 1294-1302. 

2 0 9 4 . Oka H, Shiozaki H, Kobayashi K, 

Inoue M, Tahara H, Kobayashi T, 

Takatsuka Y, Matsuyoshi N, Hirano S, 

Takeichi M, Mori T (1993). Expression of Ecadherin 

cell adhesion molecules in 

human breast cancer and its relationship 

to metastasis. Cancer Res 53: 1696-1701. 

2095. Okagaki T, Ishida T, Hilgers RD (1976). 

A malignant tumor of the vagina resembling 

synovial sarcoma: a light and electron 

microscopic study. Cancer 37: 2306- 

2320. 

2096. Olah KS, Dunn JA, Gee H (1992). 

Leiomyosarcomas have a poorer prognosis 

than mixed mesodermal tumours when 

adjusting for known prognostic factors: the 

result of a retrospective study of 423 cases 

of uterine sarcoma. Br J Obstet Gynaecol 

99: 590-594. 

2097. Oliva E, Clement PB, Young RH (2000). 

Endometrial stromal tumors: an update on 

a group of tumors with a protean phenotype. 

Adv Anat Pathol 7: 257-281. 

2098. Oliva E, Clement PB, Young RH, Scully 

RE (1998). Mixed endometrial stromal and 

smooth muscle tumors of the uterus: a clinicopathologic 

study of 15 cases. Am J 

Surg Pathol 22: 997-1005. 

2099. Oliva E, Ferry JA, Young RH, Prat J, 

Srigley JR, Scully RE (1997). Granulocytic 

sarcoma of the female genital tract: a clinicopathologic 

study of 11 cases. Am J 

Surg Pathol 21: 1156-1165. 

2100. Oliva E, Musulen E, Prat J, Young RH 

(1995). Transitional cell carinoma of the 

renal pelvis with symptomatic ovarian 

metastases. Int J Surg Pathol 2: 231-236. 

2101. Oliva E, Young RH, Clement PB, Bhan 

AK, Scully RE (1995). Cellular benign mesenchymal 

tumors of the uterus. A comparative 

morphologic and immunohistochemical 

analysis of 33 highly cellular 

leiomyomas and six endometrial stromal 

nodules, two frequently confused tumors. 


2102. Oliva E, Young RH, Clement PB, Scully 

RE (1999). Myxoid and fibrous endometrial 

stromal tumors of the uterus: a report of 10 


2103. Olive DL, Lurain JR, Brewer JI (1984). 

Choriocarcinoma associated with term 

gestation. Am J Obstet Gynecol 148: 711- 

716. 

2104. Olivier M, Eeles R, Hollstein M, Khan 

MA, Harris CC, Hainaut P (2002). The IARC 

TP53 database: new online mutation analysis 

and recommendations to users. Hum 

Mutat 19: 607-614. 

2104a. Olivier M, Goldgar DE, Sodha N, 

Ohgaki H, Kleihues P, Hainaut P, Eeles RA 

(2003). Li-Fraumeni and related syndromes: 

correlation between tumour type, family 

structure and TP53 genotype. Cancer Res 

(in press). 

2105. Olsen JH, Hahnemann JM, Borresen- 

Dale AL, Brondum-Nielsen K, 

Hammarstrom L, Kleinerman R, Kaariainen 

H, Lonnqvist T, Sankila R, Seersholm N, 

Tretli S, Yuen J, Boice JD Jr., Tucker M 

(2001). Cancer in patients with ataxiatelangiectasia 

and in their relatives in the 

nordic countries. J Natl Cancer Inst 93: 

121-127. 

2106. Olson SH, Mignone L, Nakraseive C, 

Caputo TA, Barakat RR, Harlap S (2001). 

Symptoms of ovarian cancer. O b s t e t 

Gynecol 98: 212-217. 

2107. Olsson H, Alm P, Aspegren K, 

Gullberg B, Jonsson PE, Ranstam J (1990). 

Increased plasma prolactin levels in a 

group of men with breast cancer--a preliminary 

study. Anticancer Res 10: 59-62. 

2108. Olszewski W, Darzynkiewicz Z, 

Rosen PP, Schwartz MK, Melamed MR 

(1981). Flow cytometry of breast carcinoma: 

I. Relation of DNA ploidy level to histology 

and estrogen receptor. Cancer 48: 

980-984. 

2109. Orbo A, Stalsberg H, Kunde D (1990). 

Topographic criteria in the diagnosis of 

tumor emboli in intramammary lymphatics. 

Cancer 66: 972-977. 

2 1 1 0 . Ordi J, Nogales FF, Palacin A, 

Marquez M, Pahisa J, Vanrell JA, Cardesa 

A (2001). Mesonephric adenocarcinoma of 

the uterine corpus: CD10 expression as 

evidence of mesonephric differentiation. 


2111. Ordi J, Schammel DP, Rasekh L, 

Tavassoli FA (1999). Sertoliform endometrioid 

carcinomas of the ovary: a clinicopathologic 

and immunohistochemical 

study of 13 cases. Mod Pathol 12: 933-940. 

2112. Ordi J, Stamatakos MD, Tavassoli FA 

(1997). Pure pleomorphic rhabdomyosarcomas 

of the uterus. Int J Gynecol Pathol 

16: 369-377. 

2113. Ordonez NG (1998). Role of immunohistochemistry 

in distinguishing epithelial 

peritoneal mesotheliomas from peritoneal 

and ovarian serous carcinomas. Am J 

Surg Pathol 22: 1203-1214. 

2114. Ordonez NG (1999). Granular cell 

tumor: a review and update. Adv Anat 

Pathol 6: 186-203. 

2115. Ordonez NG (2000). Transitional cell 

carcinomas of the ovary and bladder are 

immunophenotypically different. 



2116. Ordonez NG, Mackay B (2000). 

Brenner tumor of the ovary: a comparative 


study with transitional cell carcinoma of 

the bladder. Ultrastruct Pathol 24: 157-167. 

2117. Ordonez NG, Manning JT, Luna MA 

(1981). Mixed tumor of the vulva: a report of 

two cases probably arising in Bartholin's 

gland. Cancer 48: 181-186. 

2118. Origoni M, Rossi M, Ferrari D, Lillo F, 

Ferrari AG (1999). Human papillomavirus 

with co-existing vulvar vestibulitis syndrome 

and vestibular papillomatosis. Int J 


2119. Osborne BM, Robboy SJ (1983). 

Lymphomas or leukemia presenting as 

ovarian tumors. An analysis of 42 cases. 

Cancer 52: 1933-1943. 

2120. Osborne CK (1998). Steroid hormone 

receptors in breast cancer management. 


2121. Osin P, Crook T, Powles T, Peto J, 

Gusterson B (1998). Hormone status of insitu 

cancer in BRCA1 and BRCA2 mutation 

carriers. Lancet 351: 1487. 

2122. Osin P, Gusterson BA, Philp E, Waller 

J, Bartek J, Peto J, Crook T (1998). 

Predicted anti-oestrogen resistance in 

BRCA-associated familial breast cancers. 

Eur J Cancer 34: 1683-1686. 

2123. Otis CN (1996). Uterine adenomatoid 

tumors: immunohistochemical characteristics 

with emphasis on Ber-EP4 

immunoreactivity and distinction from adenocarcinoma. 

Int J Gynecol Pathol 15: 146- 

151. 

2124. Otis CN, Powell JL, Barbuto D, 

Carcangiu ML (1992). Intermediate filamentous 

proteins in adult granulosa cell 

tumors. An immunohistochemical study of 


2125. Ott G, Katzenberger T, Greiner A, 

Kalla J, Rosenwald A, Heinrich U, Ott MM, 

Muller-Hermelink HK (1997). The t(11;18) 

(q21;q21) chromosome translocation is a 

frequent and specific aberration in lowgrade 

but not high-grade malignant non- 

Hodgkin's lymphomas of the mucosaassociated 

lymphoid tissue (MALT)- type. 

Cancer Res 57: 3944-3948. 

2126. Otterbach F, Bankfalvi A, Bergner S, 

Decker T, Krech R, Boecker W (2000). 

Cytokeratin 5/6 immunohistochemistry 

assists the differential diagnosis of atypical 

proliferations of the breast. 


2127. Ottesen GL, Graversen HP, Blichert- 

Toft M, Christensen IJ, Andersen JA 

(2000). Carcinoma in situ of the female 

breast. 10 year follow-up results of a 

prospective nationwide study. B r e a s t 


2128. Ottesen GL, Graversen HP, Blichert- 

Toft M, Zedeler K, Andersen JA (1993). 

Lobular carcinoma in situ of the female 

breast. Short-term results of a prospective 

nationwide study. The Danish Breast 

Cancer Cooperative Group. Am J Surg 

Pathol 17: 14-21. 

2 1 2 9 . Ottman R, Pike MC, King MC, 

Casagrande JT, Henderson BE (1986). 

Familial breast cancer in a populationbased 

series. Am J Epidemiol 123: 15-21. 

2130. Ouchi T, Monteiro AN, August A, 

Aaronson SA, Hanafusa H (1998). BRCA1 

regulates p53-dependent gene expression. 


2131. Outwater EK, Marchetto B, Wagner 

BJ (2000). Virilizing tumors of the ovary: 

imaging features. Ultrasound Obstet 

Gynecol 15: 365-371. 


2132. Outwater EK, Siegelman ES, Hunt JL 

(2001). Ovarian teratomas: tumor types and 

imaging characteristics. Radiographics 21: 

475-490. 

2133. Oyama T, Kashiwabara K, Yoshimoto 

K, Arnold A, Koerner F (1998). Frequent 

overexpression of the cyclin D1 oncogene 

in invasive lobular carcinoma of the breast. 

Cancer Res 58: 2876-2880. 

2134. Ozguroglu M, Ersavasti G, Ilvan S, 

Hatemi G, Demir G, Demirelli FH (1999). 

Bilateral inflammatory breast metastases 

of epithelial ovarian cancer. Am J Clin 

Oncol 22: 408-410. 

2135. Ozguroglu M, Ozaras R, Tahan V, 

Demirkesen C, Demir G, Dogusoy G, 

Buyukunal E, Serdengecti S, Berkarda B 

(1999). Anorectal melanoma metastatic to 

the breast. J Clin Gastroenterol 29: 197-199. 

2136. Ozzello L, Gump FE (1985). The management 

of patients with carcinomas in 

fibroadenomatous tumors of the breast. 


2137. Östör AG (1993). Natural history of 

cervical intraepithelial neoplasia: a critical 

review. Int J Gynecol Pathol 12: 186-192. 

2138. Östör AG (1995). Pandora's box or 

Ariadne's thread? Definition and prognostic 

significance of microinvasion in the 

uterine cervix. Squamous lesions. Pathol 

Annu 30: 103-136. 

2139. Östör AG (2000). Early invasive adenocarcinoma 

of the uterine cervix. Int J 


2140. Östör AG, Duncan A, Quinn M, Rome 

R (2000). Adenocarcinoma in situ of the 

uterine cervix: an experience with 100 


2141. Östör AG, Fortune DW, Riley CB 

(1988). Fibroepithelial polyps with atypical 

stromal cells (pseudosarcoma botryoides) 

of vulva and vagina. A report of 13 cases. 


2142. Östör AG, Pagano R, Davoren RA, 

Fortune DW, Chanen W, Rome R (1984). 

Adenocarcinoma in situ of the cervix. Int J 


2143. Östör AG, Rome R, Quinn M (1997). 

Microinvasive adenocarcinoma of the 

cervix: a clinicopathologic study of 77 

women. Obstet Gynecol 89: 88-93. 

2144. Paavonen J (1985). Colposcopic findings 

associated with human papillomavirus 

infection of the vagina and the 

cervix. Obstet Gynecol Surv 40: 185-189. 

2145. Padberg BC, Stegner HE, von 

Sengbusch S, Arps H, Schroder S (1992). 

DNA-cytophotometry and immunocytochemistry 

in ovarian tumours of borderline 

malignancy and related peritoneal lesions. 


421: 497-503. 

2146. Padmore RF, Lara JF, Ackerman DJ, 

Gales T, Sigurdson ER, Ehya H, Cooper HS, 

Patchefsky AS (1996). Primary combined 

malignant melanoma and ductal carcinoma 

of the breast. A report of two cases. 

Cancer 78: 2515-2525. 

2147. Page DL, Anderson TJ, Sakamoto G 

(1987). Infiltrating Carcinoma:Major 

Histoligical Types. WB Saunders: London. 

2148. Page DL, Dixon JM, Anderson T, Lee 

D, Stwewart H (1993). Invasive cribriform 

carcinoma of the breast. Histopathology 7: 

525-536. 

2149. Page DL, Dupont WD (1990). 

Anatomic markers of human premalignancy 

and risk of breast cancer. Cancer 66: 

1326-1335. 

2150. Page DL, Kidd TE Jr., Dupont WD, 

Simpson JF, Rogers LW (1991). Lobular 

neoplasia of the breast: higher risk for subsequent 

invasive cancer predicted by 

more extensive disease. Hum Pathol 22: 

1232-1239. 

2151. Page DL, Salhany KE, Jensen RA, 

Dupont WD (1996). Subsequent breast carcinoma 

risk after biopsy with atypia in a 

breast papilloma. Cancer 78: 258-266. 

2152. Palacios J, Benito N, Pizarro A, 

Suarez A, Espada J, Cano A, Gamallo C 

(1995). Anomalous expression of P- 

Cadherin in breast carcinoma. Correlation 

with E-Cadherin expression and pathological 

features. Am J Pathol 146: 605-612. 

2153. Palacios J, Gamallo C (1998). 

Mutations in the beta-catenin gene 

(CTNNB1) in endometrioid ovarian carcinomas. 

Cancer Res 58: 1344-1347. 

2154. Palangie T, Mosseri V, Mihura J, 

Campana F, Beuzeboc P, Dorval T, Garcia- 

Giralt E, Jouve M, Scholl S, Asselain B, 

Pouillart P. (1994). Prognostic factors in 

inflammatory breast cancer and therapeu - 

tic implications. Eur J Cancer 30A: 921-927. 

2155. Palazzo J, Hyslop T (1998). 

Hyperplastic ductal and lobular lesions 

and carcinoma in situ of the breast: 

Reproducibility of current diagnostic crite - 

ria among community and academic based 

pathologists. Breast J 4: 230-237. 

2156. Palazzo JP, Gibas Z, Dunton CJ, 

Talerman A (1993). Cytogenetic study of 

botryoid rhabdomyosarcoma of the uterine 

cervix. Virchows Arch A Pathol Anat 


2157. Palli D, Galli M, Bianchi S, Bussolati 

G, Di Palma S, Eusebi V, Gambacorta M, 

Rosselli DT (1996). Reproducibility of histo - 

logical diagnosis of breast lesions: results 

of a panel in Italy. Eur J Cancer 32A: 603- 

607. 

2158. Palli D, Rosselli DT, Simoncini R, 

Bianchi S (1991). Benign breast disease 

and breast cancer: a case-control study in 

a cohort in Italy. Int J Cancer 47: 703-706. 

2159. Pallis L, Wilking N, Cedermark B, 

Rutqvist LE, Skoog L (1992). Receptors for 

estrogen and progesterone in breast carcinoma 

in situ. Anticancer Res 12: 2113- 

2115. 

2160. Palmer JP, Biback SM (1954). 

Primary cancer of the vagina. Am J Obstet 

Gynecol 67: 377-397. 

2161. Palmer JR, Anderson D, Helmrich SP, 

Herbst AL (2000). Risk factors for diethylstilbestrol-associated 

clear cell adenocarcinoma. 


2162. Palmer PE, Bogojavlensky S, Bhan 

AK, Scully RE (1990). Prolactinoma in wall 

of ovarian dermoid cyst with hyperprolactinemia. 


2163. Palombo F, Gallinari P, Iaccarino I, 

Lettieri T, Hughes M, D'Arrigo A, Truong O, 

Hsuan JJ, Jiricny J (1995). GTBP, a 160kilodalton 

protein essential for mismatchbinding 

activity in human cells. Science 

268: 1912-1914. 

2164. Pantoja E, Rodriguez-Ibanez I, 

Axtmayer RW, Noy MA, Pelegrina I (1975). 

Complications of dermoid tumors of the 

ovary. Obstet Gynecol 45: 89-94. 

2165. Paoletti M, Pridjian G, Okagaki T, 

Talerman A (1987). A stromal Leydig cell 

tumor of the ovary occurring in a pregnant 

15-year-old girl. Ultrastructural findings. 

Cancer 60: 2806-2810. 

2166. Papadatos G, Rangan AM, Psarianos 

T, Ung O, Taylor R, Boyages J (2001). 

Probability of axillary node involvement in 

patients with tubular carcinoma of the 

breast. Br J Surg 88: 860-864. 

2167. Papadopoulos N, Nicolaides NC, Wei 

YF, Ruben SM, Carter KC, Rosen CA, 

Haseltine WA, Fleischmann RD, Fraser 

CM, Adams MD, Venter JC, Hamilton SR, 

Petersen GM, Watson P, Lynch HT, 

Peltomaki T, Mecklin JP, de la Chapelle A, 

Kinzler KW, Vogelstein B. (1994). Mutation 

of a mutL homolog in hereditary colon cancer. 

Science 263: 1625-1629. 

2168. Papchristou DN, Kinne DW, Ashikari 

R, Fortner JG (1979). Melanoma of the nipple 

and aerola. Br J Surg (4) 66: 287-288. 

2169. Papotti M, Macri L, Bussolati G, 

Reubi JC (1989). Correlative study on 

neuro-endocrine differentiation and presence 

of somatostatin receptors in breast 

carcinomas. Int J Cancer 43: 365-369. 

2170. Paradinas FJ, Browne P, Fisher RA, 

Foskett M, Bagshawe KD, Newlands E 

(1996). A clinical, histopathological and 

flow cytometric study of 149 complete 

moles, 146 partial moles and 107 non-molar 

hydropic abortions. Histopathology 28: 101- 

110. 

2171. Paraskevas M, Scully RE (1989). Hilus 

cell tumor of the ovary. A clinicopathological 

analysis of 12 Reinke crystal-positive 

and nine crystal-negative cases. Int J 


2172. Parazzini F, Franceschi S, La Vecchia 

C, Fasoli M (1991). The epidemiology of 

ovarian cancer. Gynecol Oncol 43: 9-23. 

2173. Parazzini F, La Vecchia C, Moroni S, 

Chatenoud L, Ricci E (1994). Family history 

and the risk of endometrial cancer. Int J 

Cancer 59: 460-462. 

2174. Parc YR, Halling KC, Burgart LJ, 

McDonnell SK, Schaid DJ, Thibodeau SN, 

Halling AC (2000). Microsatellite instability 

and hMLH1/hMSH2 expression in young 

endometrial carcinoma patients: associations 

with family history and histopathology. 

Int J Cancer 86: 60-66. 

2175. Parham DM, Hagen N, Brown RA 

(1992). Simplified method of grading primary 

carcinomas of the breast. J Clin 

Pathol 45: 517-520. 

2176. Park CC, Mitsumori M, Nixon A, 

Recht A, Connolly J, Gelman R, Silver B, 

Hetelekidis S, Abner A, Harris JR, Schnitt 

SJ (2000). Outcome at 8 years after breastconserving 

surgery and radiation therapy 

for invasive breast cancer: influence of 

margin status and systemic therapy on 

local recurrence. J Clin Oncol 18: 1668- 

1675. 

2177. Park J, Sun D, Genest DR, Trivijitsilp 

P, Suh I, Crum CP (1998). Coexistence of 

low and high grade squamous intraepithelial 

lesions of the cervix: morphologic progression 

or multiple papillomaviruses? 


2178. Park JG, Park YJ, Wijnen JT, Vasen 

HF (1999). Gene-environment interaction in 

hereditary nonpolyposis colorectal cancer 

with implications for diagnosis and genetic 

testing. Int J Cancer 82: 516-519. 

2179. Park JJ, Genest DR, Sun D, Crum CP 

(1999). Atypical immature metaplastic-like 

proliferations of the cervix: diagnostic 

reproducibility and viral (HPV) correlates. 

Hum Pathol 30: 1161-1165.

2180. Park JS, Jones RW, McLean MR, 

Currie JL, Woodruff JD, Shah KV, Kurman 

RJ (1991). Possible etiologic heterogeneity 

of vulvar intraepithelial neoplasia. A correlation 

of pathologic characteristics with 

human papillomavirus detection by in situ 

hybridization and polymerase chain reaction. 

Cancer 67: 1599-1607. 

2181. Park SH, Kim I (1994). Histogenetic 

consideration of ovarian sex cord-stromal 

tumors analyzed by expression pattern of 

cytokeratins, vimentin, and laminin. 

Correlation studies with human gonads. 


2182. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn 

SH, Noh DY, Choe KJ, Strickland PT, 

Hirvonen A, Kang D (2000). Alcohol consumption, 

glutathione S-transferase M1 

and T1 genetic polymorphisms and breast 

cancer risk. Pharmacogenetics 10: 301- 

309. 

2183. Park SY, Kim HS, Hong EK, Kim WH 

(2002). Expression of cytokeratins 7 and 20 

in primary carcinomas of the stomach and 

colorectum and their value in the differential 

diagnosis of metastatic carcinomas to 

the ovary. Hum Pathol 33: 1078-1085. 

2184. Park TW, Richart RM, Sun XW, 

Wright TC Jr. (1996). Association between 

human papillomavirus type and clonal status 

of cervical squamous intraepithelial 

lesions. J Natl Cancer Inst 88: 355-358. 

2 1 8 5 . Parkash V, Carcangiu ML (1995). 

Transformation of ovarian dysgerminoma 

to yolk sac tumor: evidence for a histogenetic 

continuum. Mod Pathol 8: 881-887. 

2186. Parker RG, Grimm P, Enstrom JE 

(1989). Contralateral breast cancers following 

treatment for initial breast cancers 

in women. Am J Clin Oncol 12: 213-216. 

2187. Parker WH, Fu YS, Berek JS (1994). 

Uterine sarcoma in patients operated on 

for presumed leiomyoma and rapidly growing 

leiomyoma. Obstet Gynecol 83: 414-418. 

2188. Parkin DM, Bray F, Ferlay J, Pisani P 

(2001). Estimating the world cancer burden: 

Globocan 2000. Int J Cancer 94: 153- 

156. 

2189. Parkin DM, Whelan SL, Ferlay J, 

Raymond L, Young J (1997). C a n c e r 

Incidence in Five Continents, Vol. VII (IARC 

Scientific Publication N°143). International 

Agency for Research on Cancer: 

Lyon, France. 

2190. Parl FF, Richardson LD (1983). The 

histologic and biologic spectrum of tubular 


694-698. 

2191. Patchefsky AS, Frauenhoffer CM, 

Krall RA, Cooper HS (1979). Low-grade 

mucoepidermoid carcinoma of the breast. 


2192. Patchefsky AS, Shaber GS, Schwartz 

GF, Feig SA, Nerlinger RE (1977). The 

pathology of breast cancer detected by 

mass population screening. Cancer 4 0 : 

1659-1670. 

2193. Patel KJ, Yu VP, Lee H, Corcoran A, 

Thistlethwaite FC, Evans MJ, Colledge WH, 

Friedman LS, Ponder BA, Venkitaraman AR 

(1998). Involvement of Brca2 in DNA repair. 

Mol Cell 1: 347-357. 

2194. Paterakos M, Watkin WG, Edgerton 

SM, Moore DH, Thor AD (1999). Invasive 

micropapillary carcinoma of the breast: a 

prognostic study. Hum Pathol 30: 1459- 

1463. 

2195. Patey DH, Scarff RW (1928). The position 

of histology in the prognosis of carcinoma 

of the breast. Lancet 1: 801-804. 

2196. Patsner B (2001). Primary endodermal 

sinus tumor of the endometrium presenting 

as "recurrent" endometrial adenocarcinoma. 


2197. Pattillo RA, Sasaki S, Katayama KP, 

Roesler M, Mattingly RF (1981). Genesis of 

46,XY hydatidiform mole. Am J Obstet 

Gynecol 141: 104-105. 

2198. Paull TT, Cortez D, Bowers B, Elledge 

SJ, Gellert M (2001). From the Cover: Direct 

DNA binding by Brca1. Proc Natl Acad Sci 

USA 98: 6086-6091. 

2199. Paulus DD (1990). Lymphoma of the 

breast. Radiol Clin North Am 28: 833-840. 

2200. Pautier P, Genestie C, Rey A, Morice 

P, Roche B, Lhomme C, Haie-Meder C, 

Duvillard P (2000). Analysis of clinicopathologic 

prognostic factors for 157 uterine 

sarcomas and evaluation of a grading 

score validated for soft tissue sarcoma. 

Cancer 88: 1425-1431. 

2201. Pedersen L, Holck S, Schiodt T, 

Zedeler K, Mouridsen HT (1994). Medullary 

carcinoma of the breast, prognostic importance 

of characteristic histopathological 

features evaluated in a multivariate Cox 

analysis. Eur J Cancer 30A: 1792-1797. 

2202. Pedersen L, Larsen JK, Christensen 

IJ, Lykkesfeldt A, Holck S, Schiodt T (1994). 

DNA ploidy and S-phase fraction in 

medullary carcinoma of the breast--a flow 

cytometric analysis using archival material. 


2203. Pedersen L, Zedeler K, Holck S, 

Schiodt T, Mouridsen HT (1991). Medullary 

carcinoma of the breast, proposal for a 

new simplified histopathological definition. 

Based on prognostic observations and 

observations on inter- and intraobserver 

variability of 11 histopathological characteristics 

in 131 breast carcinomas with 

medullary features. Br J Cancer 63: 591- 

595. 

2204. Pedersen L, Zedeler K, Holck S, 

Schiodt T, Mouridsen HT (1995). Medullary 

carcinoma of the breast. Prevalence and 

prognostic importance of classical risk 

factors in breast cancer. Eur J Cancer 31A: 

2289-2295. 

2204a. Pedeutour F, Ligon AH, Morton CC 

(1999). [Genetics of uterine leiomyomata]. 

Bull Cancer 86: 920-928. 

2205. Peiro G, Bornstein BA, Connolly JL, 

Gelman R, Hetelekidis S, Nixon AJ, Recht 

A, Silver B, Harris JR, Schnitt SJ (2000). 

The influence of infiltrating lobular carcinoma 

on the outcome of patients treated 

with breast-conserving surgery and radia - 

tion therapy. Breast Cancer Res Treat 59: 

49-54. 

2206. Peiro G, Diebold J, Lohse P, 

Ruebsamen H, Lohse P, Baretton GB, Lohrs 

U (2002). Microsatellite instability, loss of 

heterozygosity, and loss of hMLH1 and 

hMSH2 protein expression in endometrial 

carcinoma. Hum Pathol 33: 347-354. 

2207. Pejovic T, Burki N, Odunsi K, Fiedler 

P, Achong N, Schwartz PE, Ward DC 

(1999). Well-differentiated mucinous carcinoma 

of the ovary and a coexisting 

Brenner tumor both exhibit amplification of 

12q14-21 by comparative genomic 

hybridization. Gynecol Oncol 74: 134-137. 

2208. Pejovic T, Heim S, Alm P, Iosif S, 

Himmelmann A, Skjaerris J, Mitelman F 

(1993). Isochromosome 1q as the sole karyotypic 

abnormality in a Sertoli cell tumor of 

the ovary. Cancer Genet Cytogenet 65: 79- 

80. 

2209. Pejovic T, Heim S, Mandahl N, 

Elmfors B, Floderus UM, Furgyik S, Helm G, 

Willen H, Mitelman F (1990). Trisomy 12 is a 

consistent chromosomal aberration in 

benign ovarian tumors. G e n e s 


2210. Pekin T, Eren F, Pekin O (2000). 

Leiomyosarcoma of the broad ligament: 

case report and literature review. Eur J 


2211. Pelkey TJ, Frierson HF Jr., Mills SE, 

Stoler MH (1998). The diagnostic utility of 

inhibin staining in ovarian neoplasms. Int J 


2212. Pelosi G, Martignoni G, Bonetti F 

(1991). Intraductal carcinoma of mammarytype 

apocrine epithelium arising within a 

papillary hydradenoma of the vulva. Report 

of a case and review of the literature. 


2213. Peltomaki P, Aaltonen LA, Sistonen P, 

Pylkkanen L, Mecklin JP, Jarvinen H, 

Green JS, Jass JR, Weber JL, Leach FS, 

Petersen GM, Hamilton SR, de la Chapelle 

A, Vogelstein B. (1993). Genetic mapping of 

a locus predisposing to human colorectal 

cancer. Science 260: 810-812. 

2214. Peltomaki P, Vasen HF (1997). 

Mutations predisposing to hereditary nonpolyposis 

colorectal cancer: database and 

results of a collaborative study. The 

International Collaborative Group on 

Hereditary Nonpolyposis Colorectal 

Cancer. Gastroenterology 113: 1146-1158. 

2214a. Penrose LS, Mackenzie JH, Karn 

MN (1948). A genetical study of human 

mammary cancer. Ann Euegenics 14: 234- 

266. 

2215. Pensler JM, Silverman BL, Sanghavi 

J, Goolsby C, Speck G, Brizio-Molteni L, 

Molteni A (2000). Estrogen and progesterone 

receptors in gynecomastia. Plast 

Reconstr Surg 106: 1011-1013. 

2216. Pereira H, Pinder SE, Sibbering DM, 

Galea MH, Elston CW, Blamey RW, 

Robertson JF, Ellis IO (1995). Pathological 

prognostic factors in breast cancer. IV: 

Should you be a typer or a grader? A com - 

parative study of two histological prognostic 

features in operable breast carcinoma. 


2217. Perez CA, Arneson AN, Dehner LP, 

Galakatos A (1974). Radiation therapy in 

carcinoma of the vagina. Obstet Gynecol 

44: 862-872. 

2218. Perou CM, Sorlie T, Eisen MB, van de 

Rijn M, Jeffrey SS, Rees CA, Pollack JR, 

Ross DT, Johnsen H, Akslen LA, Fluge O, 

Pergamenschikov A, Williams C, Zhu SX, 

Lonning PE, Borresen-Dale AL, Brown PO, 

Botstein D (2000). Molecular portraits of 

human breast tumours. Nature 406: 747- 

752. 

2219. Perrin L, Ward B (1995). Small cell 

carcinoma of the cervix. Int J Gynecol 

Cancer 5: 200-203. 

2 2 2 0 . Persaud V, Anderson MF (1977). 

Endometrial stromal sarcoma of the broad 

ligament arising in an area of endometriosis 

in a paramesonephric cyst. Case 

report. Br J Obstet Gynaecol 84: 149-152. 

2221. Persons DL, Hartmann LC, Herath JF, 

Keeney GL, Jenkins RB (1994). 

Fluorescence in situ hybridization analysis 

of trisomy 12 in ovarian tumors. Am J Clin 

Pathol 102: 775-779. 

2222. Perzin KH, Lattes R (1972). Papillary 

adenoma of the nipple (florid papillomatosis, 

adenoma, adenomatosis). A clinicopathologic 

study. Cancer 29: 996-1009. 

2223. Peters GN, Wolff M (1983). Adenoid 

cystic carcinoma of the breast. Report of 

11 new cases: review of the literature and 

discussion of biological behavior. Cancer 

52: 680-686. 

2224. Peters GN, Wolff M, Haagensen CD 


Clinical pathologic correlations based on 

100 cases. Ann Surg 193: 138-149. 

2225. Peters WA, III, Andersen WA, 

Hopkins MP, Kumar NB, Morley GW (1988). 

Prognostic features of carcinoma of the 

fallopian tube. Obstet Gynecol 71: 757-762. 

2226. Peters WA, III, Kumar NB, Andersen 

WA, Morley GW (1985). Primary sarcoma 

of the adult vagina: a clinicopathologic 

study. Obstet Gynecol 65: 699-704. 

2227. Peters WA, III, Kumar NB, Morley 

GW (1985). Carcinoma of the vagina. 

Factors influencing treatment outcome. 

Cancer 55: 892-897. 

2228. Peters WM, Wells M, Bryce FC 

(1984). Mullerian clear cell carcinofibroma 

of the uterine corpus. Histopathology 8: 

1069-1078. 

2229. Peterse JL (1993). Breast carcinoma 

with an unexpected inside out growth pattern, 

rotation of polarisation associated 

with angioinvasion. Pathol Res Pract 189: 

780. 

2230. Peto J, Collins N, Barfoot R, Seal S, 

Warren W, Rahman N, Easton DF, Evans C, 

Deacon J, Stratton MR (1999). Prevalence 

of BRCA1 and BRCA2 gene mutations in 

patients with early-onset breast cancer. J 


2231. Petridou E, Giokas G, Kuper H, Mucci 

LA, Trichopoulos D (2000). Endocrine correlates 

of male breast cancer risk: a casecontrol 

study in Athens, Greece. Br J 

Cancer 83: 1234-1237. 

2232. Petru E, Pickel H, Heydarfadai M, 

Lahousen M, Haas J, Schaider H, 

Tamussino K (1992). Nongenital cancers 

metastatic to the ovary. Gynecol Oncol 44: 

83-86. 

2233. Petterson F (1991). Annual Report of 

the Treatment in Gynecological Cancer. 


and Obstetrics: Stockholm. 

2234. Pettinato G, Insabato L, De Chiara A, 

Manco A, Petrella G (1989). High-grade 

mucoepidermoid carcinoma of the breast. 

Fine needle aspiration cytology and clinicopathologic 

study of a case. Acta Cytol 

33: 195-200. 

2235. Pettinato G, Manivel JC, Insabato L, 

De Chiara A, Petrella G (1988). Plasma cell 

granuloma (inflammatory pseudotumor) of 

the breast. Am J Clin Pathol 90: 627-632. 

2236. Pharoah PD, Antoniou A, Bobrow M, 

Zimmern RL, Easton DF, Ponder BA (2002). 

Polygenic susceptibility to breast cancer 

and implications for prevention. Nat Genet 

31: 33-36. 

2237. Pharoah PD, Day NE, Caldas C (1999). 

Somatic mutations in the p53 gene and 

prognosis in breast cancer: a meta-analysis. 

Br J Cancer 80: 1968-1973. 

2238. Pharoah PD, Day NE, Duffy S, Easton 

DF, Ponder BA (1997). Family history and 

the risk of breast cancer: a systematic 

review and meta-analysis. Int J Cancer 71: 

800-809. 

2239. Pharoah PD, Easton DF, Stockton DL, 

Gayther S, Ponder BA (1999). Survival in 

familial, BRCA1-associated, and BRCA2associated 

epithelial ovarian cancer. 

United Kingdom Coordinating Committee 

for Cancer Research (UKCCCR) Familial 

Ovarian Cancer Study Group. Cancer Res 

59: 868-871. 


2240. Phelan CM, Rebbeck TR, Weber BL, 

Devilee P, Ruttledge MH, Lynch HT, Lenoir 

GM, Stratton MR, Easton DF, Ponder BA, 

Cannon-Albright L, Larsson C, Goldgar DE, 

Narod SA (1996). Ovarian cancer risk in 

BRCA1 carriers is modified by the HRAS1 

variable number of tandem repeat (VNTR) 

locus. Nat Genet 12: 309-311. 

2241. Phillipson J, Ostrzega N (1994). Fine 

needle aspiration of invasive cribriform 

carcinoma with benign osteoclast-like 

giant cells of histiocytic origin. A case 

report. Acta Cytol 38: 479-482. 

2242. Piana S, Nogales FF, Corrado S, 

Cardinale L, Gusolfino D, Rivasi F (1999). 

Pregnancy luteoma with granulosa cell 

proliferation: an unusual hyperplastic 

lesion arising in pregnancy and mimicking 

an ovarian neoplasia. Pathol Res Pract 195: 

859-863. 

2243. Picciocchi A, Masetti R, Terribile D, 

Ausili-Cefaro G, Antinori A, Marra A, 

Magistrelli P (1994). Inflammatory breast 

carcinoma: contribution of surgery as part 

of a combined modality approach. Breast 

disease 7: 143-149. 

2244. Pickel H, Reich O, Tamussino K 

(1998). Bilateral atypical hyperplasia of the 

fallopian tube associated with tamoxifen: a 

report of two cases. Int J Gynecol Pathol 

17: 284-285. 

2245. Pickel H, Thalhammer M (1971). 

[Chondrosarcoma of the Fallopian tube]. 

Geburtshilfe Frauenheilkd 31: 1243-1248. 

2246. Piek JM, van Diest PJ, Zweemer RP, 

Jansen JW, Poort-Keesom RJ, Menko FH, 

Gille JJ, Jongsma AP, Pals G, Kenemans P, 

Verheijen RH (2001). Dysplastic changes in 

prophylactically removed Fallopian tubes 

of women predisposed to developing ovarian 

cancer. J Pathol 195: 451-456. 

2247. Piek JM, van Diest PJ, Zweemer RP, 

Kenemans P, Verheijen RH (2001). Tubal 

ligation and risk of ovarian cancer. Lancet 

358: 844. 

2248. Pierce GB (1974). Neoplasms, differentiations 

and mutations. Am J Pathol 77: 

103-118. 

2 2 4 9 . Pietruszka M, Barnes L (1978). 

Cystosarcoma phyllodes: a clinicopathologic 

analysis of 42 cases. Cancer 41: 1974- 

1983. 

2 2 5 0 . Pike AM, Oberman HA (1985). 

Juvenile (cellular) adenofibromas. A clinicopathologic 

study. Am J Surg Pathol 9: 

730-736. 

2251. Pillai MR, Jayaprakash PG, Nair MK 

(1999). bcl-2 immunoreactivity but not p53 

accumulation associated with tumour 

response to radiotherapy in cervical carcinoma. 

J Cancer Res Clin Oncol 125: 55-60. 

2252. Pina L, Apesteguia L, Cojo R, Cojo F, 

Arias-Camison I, Rezola R, De Miguel C 

(1997). Myofibroblastoma of male breast: 

report of three cases and review of the literature. 

Eur Radiol 7: 931-934. 

2253. Pinder SE, Ellis IO, Galea M, O'Rouke 

S, Blamey RW, Elston CW (1994). 

Pathological prognostic factors in breast 

cancer. III. Vascular invasion: relationship 

with recurrence and survival in a large 

study with long-term follow-up. 


2254. Pinder SE, Murray S, Ellis IO, Trihia H, 

Elston CW, Gelber RD, Goldhirsch A, 

Lindtner J, Cortes-Funes H, Simoncini E, 

Byrne MJ, Golouh R, Rudenstam CM, 

Castiglione-Gertsch M, Gusterson BA 

(1998). The importance of the histologic 

grade of invasive breast carcinoma and 

response to chemotherapy. Cancer 8 3 : 

1529-1539. 


2255. Pins MR, Young RH, Daly WJ, Scully 

RE (1996). Primary squamous cell carcinoma 

of the ovary. Report of 37 cases. Am J 


2256. Pinto AP, Lin MC, Sheets EE, Muto 

MG, Sun D, Crum CP (2000). Allelic imbalance 

in lichen sclerosus, hyperplasia, and 

intraepithelial neoplasia of the vulva. 


2257. Pippard EC, Hall AJ, Barker DJ, 

Bridges BA (1988). Cancer in homozygotes 

and heterozygotes of ataxia-telangiectasia 

and xeroderma pigmentosum in Britain. 

Cancer Res 48: 2929-2932. 

2258. Pitman MB, Young RH, Clement PB, 

Dickersin GR, Scully RE (1994). 

Endometrioid carcinoma of the ovary and 

endometrium, oxyphilic cell type: a report 

of nine cases. Int J Gynecol Pathol 13: 290- 

301. 

2259. Pitts WC, Rojas VA, Gaffey MJ, Rouse 

RV, Esteban J, Frierson HF, Kempson RL, 

Weiss LM (1991). Carcinomas with metaplasia 

and sarcomas of the breast. Am J 


2260. Piura B, Rabinovich A, Dgani R (1999). 

Basal cell carcinoma of the vulva. J Surg 

Oncol 70: 172-176. 

2261. Piura B, Rabinovich A, Dgani R (1999). 

Malignant melanoma of the vulva: report of 

six cases and review of the literature. Eur 


2262. Piver MS, Jishi MF, Tsukada Y, Nava 

G (1993). Primary peritoneal carcinoma 

after prophylactic oophorectomy in 

women with a family history of ovarian 

cancer. A report of the Gilda Radner 

Familial Ovarian Cancer Registry. Cancer 

71: 2751-2755. 

2263. Piver MS, Rutledge FN, Copeland L, 

Webster K, Blumenson L, Suh O (1984). 

Uterine endolymphatic stromal myosis: a 

collaborative study. Obstet Gynecol 6 4 : 

173-178. 

2264. Planck M, Rambech E, Moslein G, 

Muller W, Olsson H, Nilbert M (2002). High 

frequency of microsatellite instability and 

loss of mismatch-repair protein expression 

in patients with double primary tumors of 

the endometrium and colorectum. Cancer 

94: 2502-2510. 

2265. Plentl AA, Frideman EA (1971). 

Lymphatic System of the Female Genitali - 

The Morphological Basis of Oncologic 

Diagnosis and Therapy. WB Saunders: 

Philadelphia. 

2266. Plouffe L Jr., Tulandi T, Rosenberg A, 

Ferenczy A (1984). Non-Hodgkin's lymphoma 

in Bartholin's gland: case report 

and review of literature. Am J Obstet 

Gynecol 148: 608-609. 

2 2 6 7 . Pluquet O, Hainaut P (2001). 

Genotoxic and non-genotoxic pathways of 

p53 induction. Cancer Lett 174: 1-15. 

2268. Podsypanina K, Ellenson LH, Nemes 

A, Gu J, Tamura M, Yamada KM, Cordon- 

Cardo C, Catoretti G, Fisher PE, Parsons R 

(1999). Mutation of Pten/Mmac1 in mice 

causes neoplasia in multiple organ systems. 

Proc Natl Acad Sci USA 96: 1563- 

1568. 

2269. Poen JC, Tran L, Juillard G, Selch MT, 

Giuliano A, Silverstein M, Fingerhut A, 

Lewinsky B, Parker RG (1992). 

Conservation therapy for invasive lobular 

carcinoma of the breast. Cancer 69: 2789- 

2795. 

2270. Polger MR, Denison CM, Lester S, 

Meyer JE (1996). Pseudoangiomatous stromal 

hyperplasia: mammographic and 

sonographic appearances. AJR Am J 

Roentgenol 166: 349-352. 

2271. Polk P, Parker KM, Biggs PJ (1996). 

Soft tissue oncocytoma. Hum Pathol 27: 

206-208. 

2272. Ponsky JL, Gliga L, Reynolds S (1984). 

Medullary carcinoma of the breast: an 

association with negative hormonal receptors. 


2273. Pope TL Jr., Fechner RE, Wilhelm MC, 

Wanebo HJ, de Paredes ES (1988). Lobular 

carcinoma in situ of the breast: mammographic 

features. Radiology 168: 63-66. 

2274. Porter PL, Garcia R, Moe R, Corwin 

DJ, Gown AM (1991). C-erbB-2 oncogene 

protein in in situ and invasive lobular 

breast neoplasia. Cancer 68: 331-334. 

2275. Pothuri B, Leitao M, Barakat R, 

Akram M, Bogomolny F, Olvera N, Lin O, 

Soslow R, Robson ME, Offit K, Boyd J 

(2001). Genetic analysis of ovarian carcinoma 

histogenesis. Gynecol Oncol 80: 277. 

2276. Potischman N, Hoover RN, Brinton 

LA, Siiteri P, Dorgan JF, Swanson CA, 

Berman ML, Mortel R, Twiggs LB, Barrett 

RJ, Wilbanks GD, Persky V, Lurain JR 

(1996). Case-control study of endogenous 

steroid hormones and endometrial cancer. 


2277. Potkul RK, Lancaster WD, Kurman 

RJ, Lewandowski G, Weck PK, Delgado G 

(1990). Vulvar condylomas and squamous 

vestibular micropapilloma. Differences in 

appearance and response to treatment. J 

Reprod Med 35: 1019-1022. 

2278. Powell CM, Cranor ML, Rosen PP 

(1994). Multinucleated stromal giant cells 

in mammary fibroepithelial neoplasms. A 

study of 11 patients. Arch Pathol Lab Med 

118: 912-916. 

2279. Powell CM, Cranor ML, Rosen PP 

(1995). Pseudoangiomatous stromal hyperplasia 

(PASH). A mammary stromal tumor 

with myofibroblastic differentiation. Am J 


2280. Powers CN, Stastny JF, Frable WJ 

(1996). Adenoid basal carcinoma of the 

cervix: a potential pitfall in cervicovaginal 

cytology. Diagn Cytopathol 14: 172-177. 

2281. Prasad CJ, Ray JA, Kessler S (1992). 

Primary small cell carcinoma of the vagina 

arising in a background of atypical adenosis. 

Cancer 70: 2484-2487. 

2282. Prasad ML, Osborne MP, Giri DD, 

Hoda SA (2000). Microinvasive carcinoma 

(T1mic) of the breast: clinicopathologic 

profile of 21 cases. Am J Surg Pathol 24: 

422-428. 

2283. Prat J (2002). Clonality analysis in 

synchronous tumors of the female genital 

tract. Hum Pathol 33: 383-385. 

2 2 8 4 . Prat J, Bhan AK, Dickersin GR, 

Robboy SJ, Scully RE (1982). Hepatoid yolk 

sac tumor of the ovary (endodermal sinus 

tumor with hepatoid differentiation): a light 

microscopic, ultrastructural and immunohistochemical 

study of seven cases. 

Cancer 50: 2355-2368. 

2285. Prat J, de Nictolis M (2002). Serous 

borderline tumors of the ovary: a long-term 

follow-up study of 137 cases, including 18 

with a micropapillary pattern and 20 with 

microinvasion. Am J Surg Pathol 26: 1111- 

1128. 

2286. Prat J, Matias-Guiu X, Barreto J 

(1991). Simultaneous carcinoma involving 

the endometrium and the ovary. A clinicopathologic, 

immunohistochemical, and 

DNA flow cytometric study of 18 cases. 

Cancer 68: 2455-2459. 

2 2 8 7 . Prat J, Matias-Guiu X, Scully RE 

(1989). Hepatic yolc sac differentiation in 

an ovarian polyembryoma. S u r g i c a l 


2287a. Prat J, Rodriguez IM, Ota S, Matias- 

Guiu X (2003). Endometrioid, clear cell, and 

mixed carcinomas of the ovary with and 

without endometriosis: a comparative clinicopathological 

and molecular analysis of 

113 cases. Mod Pathol 207A. 

2288. Prat J, Scully RE (1979). Sarcomas in 

ovarian mucinous tumors: a report of two 

cases. Cancer 44: 1327-1331. 

2289. Prat J, Scully RE (1981). Cellular fibromas 

and fibrosarcomas of the ovary: a 

comparative clinicopathologic analysis of 

seventeen cases. Cancer 47: 2663-2670. 

2290. Prat J, Young RH, Scully RE (1982). 

Ovarian mucinous tumors with foci of 

anaplastic carcinoma. Cancer 50: 300-304. 

2291. Prat J, Young RH, Scully RE (1982). 

Ovarian Sertoli-Leydig cell tumors with 

heterologous elements. II. Cartilage and 

skeletal muscle: a clinicopathologic analysis 

of twelve cases. Cancer 50: 2465-2475. 

2292. Prayson RA, Goldblum JR, Hart WR 

(1997). Epithelioid smooth-muscle tumors 

of the uterus: a clinicopathologic study of 

18 patients. Am J Surg Pathol 21: 383-391. 

2293. Prayson RA, Hart WR (1992). 

Mitotically active leiomyomas of the 

uterus. Am J Clin Pathol 97: 14-20. 

2294. Prayson RA, Hart WR, Petras RE 

(1994). Pseudomyxoma peritonei. A clinicopathologic 

study of 19 cases with emphasis 

on site of origin and nature of associated 

ovarian tumors. Am J Surg Pathol 18: 

591-603. 

2295. Prayson RA, Stoler MH, Hart WR 

(1995). Vulvar vestibulitis. A histopatholog - 

ic study of 36 cases, including human 

papillomavirus in situ hybridization analysis. 


2296. Prechtel D, Werenskiold AK, Prechtel 

K, Keller G, Hofler H (1998). Frequent loss of 

heterozygosity at chromosome 13q12-13 

with BRCA2 markers in sporadic male 

breast cancer. Diagn Mol Pathol 7: 57-62. 

2297. Prechtel K, Prechtel V (1997). [Breast 

carcinoma in the man. Current results from 

the viewpoint of clinic and pathology]. 

Pathologe 18: 45-52. 

2298. Prempree T, Tang CK, Hatef A, 

Forster S (1983). Angiosarcoma of the vagina: 

a clinicopathologic report. A reappraisal 

of the radiation treatment of 

angiosarcomas of the female genital tract. 

Cancer 51: 618-622. 

2299. Prendiville W, Cullimore J, Norman S 

(1989). Large loop excision of the transformation 

zone (LLETZ). A new method of 

management for women with cervical 

intraepithelial neoplasia. Br J Obstet 

Gynaecol 96: 1054-1060. 

2300. Press MF, Scully RE (1985). 

Endometrial "sarcomas" complicating 

ovarian thecoma, polycystic ovarian disease 

and estrogen therapy. Gynecol Oncol 

21: 135-154. 

2301. Pride GL, Schultz AE, Chuprevich TW, 

Buchler DA (1979). Primary invasive squamous 

carcinoma of the vagina. O b s t e t 

Gynecol 53: 218-225. 

2302. Pschera H, Wikstrom B (1991). 

Extraovarian Brenner tumor coexisting 

with serous cystadenoma. Case report. 


2303. Puget N, Gad S, Perrin-Vidoz L, 

Sinilnikova OM, Stoppa-Lyonnet D, Lenoir 

GM, Mazoyer S (2002). Distinct BRCA1 

rearrangements involving the BRCA1 

pseudogene suggest the existence of a 

recombination hot spot. Am J Hum Genet 

70: 858-865.

2304. Puls LE, Hamous J, Morrow MS, 

Schneyer A, MacLaughlin DT, Castracane 

VD (1994). Recurrent ovarian sex cord 

tumor with annular tubules: tumor marker 

and chemotherapy experience. Gynecol 

Oncol 54: 396-401. 

2305. Purola E, Savia E (1977). Cytology of 

gynecologic condyloma acuminatum. Acta 

Cytol 21: 26-31. 

2306. Pysher TJ, Hitch DC, Krous HF (1981). 

Bilateral juvenile granulosa cell tumors in 

a 4-month-old dysmorphic infant. A clinical, 

histologic, and ultrastructural study. 


2307. Qiao S, Nagasaka T, Harada T, 

Nakashima N (1998). p53, Bax and Bcl-2 

expression, and apoptosis in gestational 

trophoblast of complete hydatidiform mole. 

Placenta 19: 361-369. 

2308. Qizilbash AH (1976). Cystosarcoma 

phyllodes with liposarcomatous stroma. 


2309. Qizilbash AH, Patterson MC, Oliveira 

KF (1977). Adenoid cystic carcinoma of the 

breast. Light and electron microscopy and 

a brief review of the literature. Arch Pathol 

Lab Med 101: 302-306. 

2310. Quaglia MP, Brennan MF (2000). The 

clinical approach to desmoplastic small 

round cell tumor. Surg Oncol 9: 77-81. 

2 3 1 1 . Quigley JC, Hart WR (1981). 

Adenomatoid tumors of the uterus. Am J 


2312. Quincey C, Raitt N, Bell J, Ellis IO 

(1991). Intracytoplasmic lumina--a useful 

diagnostic feature of adenocarcinomas. 


2313. Quinn JM, McGee JO, Athanasou NA 

(1998). Human tumour-associated 

macrophages differentiate into osteoclastic 

bone-resorbing cells. J Pathol 184: 31- 

36. 

2314. Quinn MA (1997). Adenocarcinoma of 

the cervix--are there arguments for a different 

treatment policy? Curr Opin Obstet 

Gynecol 9: 21-24. 

2315. Quinn MA, Oster AO, Fortune D, 

Hudson B (1981). Sclerosing stromal 

tumour of the ovary case report with 

endocrine studies. Br J Obstet Gynaecol 

88: 555-558. 

2316. Raber G, Mempel V, Jackisch C, 

Hundeiker M, Heinecke A, Kurzl R, Glaubitz 

M, Rompel R, Schneider HP (1996). 

Malignant melanoma of the vulva. Report 

of 89 patients. Cancer 78: 2353-2358. 

2317. Radford DM, Fair KL, Phillips NJ, 

Ritter JH, Steinbrueck T, Holt MS, Donis- 

Keller H (1995). Allelotyping of ductal carcinoma 

in situ of the breast: deletion of loci 

on 8p, 13q, 16q, 17p and 17q. Cancer Res 

55: 3399-3405. 

2318. Radhi JM (2000). Immunohistochemical 

analysis of pleomorphic lobular carcinoma: 

higher expression of p53 and 

chromogranin and lower expression of ER 

and PgR. Histopathology 36: 156-160. 

2319. Radig K, Buhtz P, Roessner A (1998). 

Alveolar soft part sarcoma of the uterine 

corpus. Report of two cases and review of 

the literature. Pathol Res Pract 194: 59-63. 

2320. Ragnarsson-Olding BK, Nilsson BR, 

Kanter-Lewensohn LR, Lagerlof B, 

Ringborg UK (1999). Malignant melanoma 

of the vulva in a nationwide, 25-year study 

of 219 Swedish females: predictors of survival. 

Cancer 86: 1285-1293. 

2321. Rahilly MA, Williams AR, Krausz T, al 

Nafussi A (1995). Female adnexal tumour of 

probable Wolffian origin: a clinicopathological 

and immunohistochemical study of 

three cases. Histopathology 26: 69-74. 

2322. Rajakariar R, Walker RA (1995). 

Pathological and biological features of 

mammographically detected invasive 

breast carcinomas. Br J Cancer 71: 150- 

154. 

2323. Rajan JV, Marquis ST, Gardner HP, 

Chodosh LA (1997). Developmental expression 

of Brca2 colocalizes with Brca1 and is 

associated with proliferation and differentiation 

in multiple tissues. Dev Biol 184: 

385-401. 

2324. Rajkumar T, Franceschi S, Vaccarella 

S, Gajalakshmi V, Sharmila A, Snijders PJ, 

Munoz N, Meijer CJ, Herrero R (2003). Role 

of paan chewing and dietary habits in cer - 

vical carcinoma in Chennai, India. Br J 

Cancer 88: 1388-1393. 

2325. Raju U, Shah V, Perveen N, Linden M 

(2001). Evaluation of Breast Core Needle 

Biopsies with CK 5/6, E-cadherin and 

Calponin. Mod Pathol 14: 34A. 

2326. Raju U, Vertes D (1996). Breast papil - 

lomas with atypical ductal hyperplasia: a 

clinicopathologic study. Hum Pathol 2 7 : 

1231-1238. 

2327. Raju UB, Lee MW, Zarbo RJ, 

Crissman JD (1989). Papillary neoplasia of 

the breast: immunohistochemically 

defined myoepithelial cells in the diagnosis 

of benign and malignant papillary breast 

neoplasms. Mod Pathol 2: 569-576. 

2327 a. Ramachandra S, Machin L, Ashley 

S, Monaghan P, Gusterson BA (1990). 

Immunohistochemical distribution of cerbB-2 

in in situ breast carcinoma--a 

detailed morphological analysis. J Pathol 

161: 7-14. 

2328. Ramaswamy S, Ross KN, Lander ES, 

Golub TR (2003). A molecular signature of 

metastasis in primary solid tumors. Nat 

Genet 33: 49-54. 

2329. Ramesh V, Iyengar B (1990). 

Proliferating trichilemmal cysts over the 

vulva. Cutis 45: 187-189. 

2330. Ramos CV, Taylor HB (1974). Lipidrich 

carcinoma of the breast. A clinicopathologic 

analysis of 13 examples. 

Cancer 33: 812-819. 

2331. Ramsay J, Birrell G, Lavin M (1998). 

Testing for mutations of the ataxia telangiectasia 

gene in radiosensitive breast cancer 

patients. Radiother Oncol 47: 125-128. 

2332. Ramzy I (1976). Signet-ring stromal 

tumor of ovary. Histochemical, light, and 

electron microscopic study. Cancer 3 8 : 

166-172. 

2333. Randall ME, Kim JA, Mills SE, Hahn 

SS, Constable WC (1986). Uncommon variants 

of cervical carcinoma treated with 

radical irradiation. A clinicopathologic 


2334. Rapin V, Contesso G, Mouriesse H, 

Bertin F, Lacombe MJ, Piekarski JD, 

Travagli JP, Gadenne C, Friedman S (1988). 

Medullary breast carcinoma. A reevaluation 

of 95 cases of breast cancer with 

inflammatory stroma. Cancer 61: 2503- 

2510. 

2335. Rasbridge SA, Gillett CE, Millis RR 

(1993). Oestrogen and progesterone receptor 

expression in mammary fibromatosis. J 


2336. Rasbridge SA, Gillett CE, Sampson 

SA, Walsh FS, Millis RR (1993). Epithelial 

(E-) and placental (P-) cadherin cell adhesion 

molecule expression in breast carcinoma. 

J Pathol 169: 245-250. 

2336 a. Rasbridge SA, Millis RR (1995). 

Carcinoma in situ involving sclerosing 

adenosis: a mimic of invasive breast carcinoma. 


2337. Rasbridge SA, Millis RR, Sampson 

SA, Walsh FS (1992). Epithelial cadherin 

expression in breast carcinomas. J Pathol 

167: 149. 

2338. Rasmussen BB, Rose C, Thorpe SM, 

Andersen KW, Hou-Jensen K (1985). 

Argyrophilic cells in 202 human mucinous 

breast carcinomas. Relation to histopathologic 

and clinical factors. Am J Clin Pathol 

84: 737-740. 

2339. Rastkar G, Okagaki T, Twiggs LB, 

Clark BA (1982). Early invasive and in situ 

warty carcinoma of the vulva: clinical, his - 

tologic, and electron microscopic study 

with particular reference to viral association. 


2 3 4 0 . Rauscher FJ, III, Benjamin LE, 

Fredericks WJ, Morris JF (1994). Novel 

oncogenic mutations in the WT1 Wilms' 

tumor suppressor gene: a t(11;22) fuses the 

Ewing's sarcoma gene, EWS1, to WT1 in 

desmoplastic small round cell tumor. Cold 

Spring Harb Symp Quant Biol 59: 137-146. 

2341. Reardon W, Zhou XP, Eng C (2001). A 

novel germline mutation of the PTEN gene 

in a patient with macrocephaly, ventricular 

dilatation, and features of VATER association. 

J Med Genet 38: 820-823. 

2342. Rebbeck TR, Kantoff PW, Krithivas K, 

Neuhausen S, Blackwood MA, Godwin AK, 

Daly MB, Narod SA, Garber JE, Lynch HT, 

Weber BL, Brown M (1999). Modification of 

BRCA1-associated breast cancer risk by 

the polymorphic androgen-receptor CAG 

repeat. Am J Hum Genet 64: 1371-1377. 

2343. Rebbeck TR, Levin AM, Eisen A, 

Snyder C, Watson P, Cannon-Albright L, 

Isaacs C, Olopade O, Garber JE, Godwin 

AK, Daly MB, Narod SA, Neuhausen SL, 

Lynch HT, Weber BL (1999). Breast cancer 

risk after bilateral prophylactic oophorectomy 

in BRCA1 mutation carriers. J Natl 

Cancer Inst 91: 1475-1479. 

2344. Rebbeck TR, Lynch HT, Neuhausen 

SL, Narod SA, van't Veer L, Garber JE, 

Evans G, Isaacs C, Daly MB, Matloff E, 

Olopade OI, Weber BL (2002). Prophylactic 

oophorectomy in carriers of BRCA1 or 

BRCA2 mutations. N Engl J Med 346: 1616- 

1622. 

2345. Rebbeck TR, Wang Y, Kantoff PW, 

Krithivas K, Neuhausen SL, Godwin AK, 

Daly MB, Narod SA, Brunet JS, Vesprini D, 

Garber JE, Lynch HT, Weber BL, Brown M 

(2001). Modification of BRCA1- and 

BRCA2-associated breast cancer risk by 

AIB1 genotype and reproductive history. 

Cancer Res 61: 5420-5424. 

2346. Recht A, Rutgers EJ, Fentiman IS, 

Kurtz JM, Mansel RE, Sloane JP (1998). 

The fourth EORTC DCIS Consensus meeting 

(Chateau Marquette, Heemskerk, The 

Netherlands, 23-24 January 1998)--confer - 

ence report. Eur J Cancer 34: 1664-1669. 

2347. Reddy DB, Rao DB, Sarojini JS (1963). 

Extra-ovarian granulosa cell tumour. J 

Indian Med Assoc 41: 254-257. 

2348. Redline RW, Hassold T, Zaragoza MV 

(1998). Prevalence of the partial molar phenotype 

in triploidy of maternal and paternal 

origin. Hum Pathol 29: 505-511. 

2349. Reich O, Pickel H, Tamussino K, 

Winter R (2001). Microinvasive carcinoma 

of the cervix: site of first focus of invasion. 


2350. Reich O, Regauer S, Urdl W, 

Lahousen M, Winter R (2000). Expression 

of oestrogen and progesterone receptors 

in low-grade endometrial stromal sarcomas. 

Br J Cancer 82: 1030-1034. 

2351. Reiner A, Reiner G, Spona J, 

Schemper M, Holzner JH (1988). 

Histopathologic characterization of human 

breast cancer in correlation with estrogen 

receptor status. A comparison of immunocytochemical 

and biochemical analysis. 

Cancer 61: 1149-1154. 

2352. Reinfuss M, Stelmach A, Mitus J, Rys 

J, Duda K (1995). Typical medullary carcinoma 

of the breast: a clinical and pathological 

analysis of 52 cases. J Surg Oncol 

60: 89-94. 

2353. Reitamo JJ, Scheinin TM, Hayry P 

(1986). The desmoid syndrome. New 

aspects in the cause, pathogenesis and 

treatment of the desmoid tumor. Am J 

Surg 151: 230-237. 

2354. Renno SI, Moreland WS, Pettenati 

MJ, Beaty MW, Keung YK (2002). Primary 

malignant lymphoma of uterine corpus: 


Ann Hematol 81: 44-47. 

2355. Report of an Advisory Group on Nonionising 

Radiation (2001). Electromagnetic 

Fields and the Risk of Cancer. Doc NRBP, 

Vol. 12(1): 3-179. 

2356. Resnick M, Lester S, Tate JE, Sheets 

EE, Sparks C, Crum CP (1996). Viral and 

histopathologic correlates of MN and 

MIB-1 expression in cervical intraepithelial 

neoplasia. Hum Pathol 27: 234-239. 

2357. Resta L, Maiorano E, Piscitelli D, 

Botticella MA (1994). Lipomatous tumors of 

the uterus. Clinico-pathological features of 

10 cases with immunocytochemical study 

of histogenesis. Pathol Res Pract 190: 378- 

383. 

2358. Revillion F, Bonneterre J, Peyrat J 

(1998). ERBB2 oncogene in human breast 

cancer and its clinical significance. 

European Journal of Cancer 34: 791-808. 

2359. Reymundo C, Toro M, Morales C, 

Lopez-Beltran A, Nogales F, Nogales F Jr. 

(1993). Hyaline globules in uterine malignant 

mixed mullerian tumours. A diagnostic 

aid? Pathol Res Pract 189: 1063-1066. 

2 3 6 0 . Rhatigan RM, Mojadidi Q (1973). 

Adenosquamous carcinomas of the vulva 

and vagina. Am J Clin Pathol 60: 208-217. 

2361. Rhatigan RM, Nuss RC (1985). 

Keratoacanthoma of the vulva. Gynecol 

Oncol 21: 118-123. 

2361 a. Rhemtula H, Grayson W, van 

Iddekinge B, Tiltman A (2001). Large-cell 

neuroendocrine carcinoma of the uterine 

cervix--a clinicopathological study of five 

cases. S Afr Med J 91: 525-528. 

2362. Rhodes AR, Mihm MC Jr., Weinstock 

MA (1989). Dysplastic melanocytic nevi: a 

reproducible histologic definition emphasizing 

cellular morphology. Mod Pathol 2: 

306-319. 

2363. Ribeiro GG, Phillips HV, Skinner LG 

(1980). Serum oestradiol-17 beta, testosterone, 

luteinizing hormone and folliclestimulating 

hormone in males with breast 

cancer. Br J Cancer 41: 474-477. 

2364. Rice BF, Barclay DL, Sternberg WH 

(1969). Luteoma of pregnancy: steroidogenic 

and morphologic considerations. 


2365. Rice LW, Berkowitz RS, Lage JM, 

Goldstein DP, Bernstein MR (1990). 

Persistent gestational trophoblastic tumor 

after partial hydatidiform mole. Gynecol 

Oncol 36: 358-362. 

2366. Richard F, Pacyna-Gengelbach M, 

Schluns K, Fleige B, Winzer KJ, Szymas J, 

Dietel M, Petersen I, Schwendel A (2000). 

Patterns of chromosomal imbalances in 

invasive breast cancer. Int J Cancer 89: 

305-310. 


2367. Richardson WW (1956). Medullary 

carcinoma of the breast. A distinctive 

tumour type with a relatively good prognosis 

following radical mastectomy. Br J 

Cancer 10: 415-423. 

2368. Richart RM (1973). Cervical intraepithelial 

neoplasia. Pathol Annu 8: 301-328. 

2369. Ridley CM, Neill SM (1999). Noninfective 

cutaneous conditions of vulva in 

The Vulva. 2nd ed. Malden, MA Blackwell 

Science: Oxford. 

2370. Ridolfi RL, Rosen PP, Port A, Kinne D, 

Mike V (1977). Medullary carcinoma of the 

breast: a clinicopathologic study with 10 

year follow-up. Cancer 40: 1365-1385. 

2371. Riedel I, Czernobilsky B, Lifschitz- 

Mercer B, Roth LM, Wu XR, Sun TT, Moll R 

(2001). Brenner tumors but not transitional 

cell carcinomas of the ovary show urothe - 

lial differentiation: immunohistochemical 

staining of urothelial markers, including 

cytokeratins and uroplakins. V i r c h o w s 

Arch 438: 181-191. 

2372. Rigaud C, Theobald S, Noel P, 

Badreddine J, Barlier C, Delobelle A, 

Gentile A, Jacquemier J, Maisongrosse V, 

Peffault de Latour M, Trojani M, Zafrani B 

(1993). Medullary carcinoma of the breast. 

A multicenter study of its diagnostic consistency. 

Arch Pathol Lab Med 117: 1005- 

1008. 

2373. Riman T, Dickman PW, Nilsson S, 

Correia N, Nordlinder H, Magnusson CM, 

Weiderpass E, Persson IR (2002). Hormone 

replacement therapy and the risk of invasive 

epithelial ovarian cancer in Swedish 

women. J Natl Cancer Inst 94: 497-504. 

2374. Rimm DL, Sinard JH, Morrow JS 

(1995). Reduced alpha-catenin and E-cadherin 

expression in breast cancer. Lab 

Invest 72: 506-512. 

2375. Rio PG, Pernin D, Bay JO, Albuisson 

E, Kwiatkowski F, de Latour M, Bernard- 

Gallon DJ, Bignon YJ (1998). Loss of heterozygosity 

of BRCA1, BRCA2 and ATM 

genes in sporadic invasive ductal breast 

carcinoma. Int J Oncol 13: 849-853. 

2376. Riopel MA, Perlman EJ, Seidman JD, 

Kurman RJ, Sherman ME (1998). Inhibin 

and epithelial membrane antigen immunohistochemistry 

assist in the diagnosis of 

sex cord-stromal tumors and provide clues 

to the histogenesis of hypercalcemic small 

cell carcinomas. Int J Gynecol Pathol 17: 

46-53. 

2377. Riopel MA, Ronnett BM, Kurman RJ 

(1999). Evaluation of diagnostic criteria and 

behavior of ovarian intestinal-type mucinous 

tumors: atypical proliferative (borderline) 

tumors and intraepithelial, microinva - 

sive, invasive, and metastatic carcinomas. 


2378. Riopel MA, Spellerberg A, Griffin CA, 

Perlman EJ (1998). Genetic analysis of 

ovarian germ cell tumors by comparative 

genomic hybridization. Cancer Res 5 8 : 

3105-3110. 

2379. Rishi M, Howard LN, Bratthauer GL, 

Tavassoli FA (1997). Use of monoclonal 

antibody against human inhibin as a mark - 

er for sex cord-stromal tumors of the 

ovary. Am J Surg Pathol 21: 583-589. 

2380. Risinger JI, Berchuck A, Kohler MF, 

Boyd J (1994). Mutations of the E-cadherin 

gene in human gynecologic cancers. Nat 

Genet 7: 98-102. 

2381. Ro JY, Silva EG, Gallager HS (1987). 

Adenoid cystic carcinoma of the breast. 

Hum Pathol 18: 1276-1281. 


2382. Roa BB, Boyd AA, Volcik K, Richards 

CS (1996). Ashkenazi Jewish population 

frequencies for common mutations in 

BRCA1 and BRCA2. Nat Genet 14: 185-187. 

2383. Robbins GF, Berg JW (1964). Bilateral 

primary breast cancers. A propective clin - 

ico-pathological study. Cancer 17: 1502- 

1527. 

2384. Robbins GF, Shah J, Rosen P, Chu F, 

Taylor J (1974). Inflammatory carcinoma of 

the breast. Surg Clin North Am 54: 801-810. 

2385. Robbins P, Pinder S, de Klerk N, 

Dawkins H, Harvey J, Sterrett G, Ellis I, 

Elston C (1995). Histological grading of 

breast carcinomas: a study of interobserv - 

er agreement. Hum Pathol 26: 873-879. 

2386. Robboy SJ, Kaufman RH, Prat J, 

Welch WR, Gaffey T, Scully RE, Richart R, 

Fenoglio CM, Virata R, Tilley BC (1979). 

Pathologic findings in young women 

enrolled in the National Cooperative 

Diethylstilbestrol Adenosis (DESAD) project. 


2387. Robboy SJ, Krigman HR, Donohue J, 

Scully RE (1995). Prognostic indices in 

malignant struma ovarii: a clinicopathological 

analysis of 36 patients with 20-year follow 

up. Mod Pathol 8: 95A. 

2 3 8 8 . Robboy SJ, Norris HJ, Scully RE 

(1975). Insular carcinoid primary in the 

ovary. A clinicopathologic analysis of 48 

cases. Cancer 36: 404-418. 

2389. Robboy SJ, Scully RE (1970). Ovarian 

teratoma with glial implants on the peritoneum. 

An analysis of 12 cases. Hum 

Pathol 1: 643-653. 

2390. Robboy SJ, Scully RE (1980). Strumal 

carcinoid of the ovary: an analysis of 50 

cases of a distinctive tumor composed of 

thyroid tissue and carcinoid. Cancer 46: 

2019-2034. 

2391. Robboy SJ, Scully RE, Norris HJ 

(1974). Carcinoid metastatic to the ovary. A 

clinocopathologic analysis of 35 cases. 

Cancer 33: 798-811. 

2 3 9 2 . Robboy SJ, Scully RE, Norris HJ 

(1977). Primary trabecular carcinoid of the 

ovary. Obstet Gynecol 49: 202-207. 

2393. Robertson AJ, Brown RA, Cree IA, 

MacGillivray JB, Slidders W, Beck JS 

(1981). Prognostic value of measurement 

of elastosis in breast carcinoma. J Clin 

Pathol 34: 738-743. 

2394. Robles-Frias A, Severin CE, Robles- 

Frias MJ, Garrido JL (2001). Diffuse uterine 

leiomyomatosis with ovarian and parametrial 

involvement. Obstet Gynecol 97: 834- 

835. 

2395. Robles SC, White F, Peruga A (1996). 

Trends in cervical cancer mortality in the 

Americas. Bull Pan Am Health Organ 30: 

290-301. 

2396. Roca AN, Guajardo M, Estrada WJ 

(1980). Glial polyp of the cervix and 

endometrium. Report of a case and review 

of the literature. Am J Clin Pathol 73: 718- 

720. 

2397. Rodolakis A, Papaspyrou I, 

Sotiropoulou M, Markaki S, Michalas S 


of the endometrium. A report of 3 cases. 


2398. Rodriguez-Bigas MA, Boland CR, 

Hamilton SR, Henson DE, Jass JR, Khan 

PM, Lynch H, Perucho M, Smyrk T, Sobin L, 

Srivastava S (1997). A National Cancer 

Institute Workshop on Hereditary 

Nonpolyposis Colorectal Cancer 

Syndrome: meeting highlights and 

Bethesda guidelines. J Natl Cancer Inst 89: 

1758-1762. 

2399. Rodriguez C, Patel AV, Calle EE, 

Jacob EJ, Thun MJ (2001). Estrogen 

replacement therapy and ovarian cancer 

mortality in a large prospective study of US 

women. JAMA 285: 1460-1465. 

2400. Rodriguez HA, Ackerman LV (1968). 

Cellular blue nevus. Clinicopathologic 

study of forty-five cases. Cancer 21: 393- 

405. 

2401. Rodriguez IM, Prat J (2002). 

Mucinous tumors of the ovary: a clinicopathologic 

analysis of 75 borderline tumors 

(of intestinal type) and carcinomas. Am J 


2402. Rogers DA, Lobe TE, Rao BN, Fleming 

ID, Schropp KP, Pratt AS, Pappo AS (1994). 

Breast malignancy in children. J Pediatr 

Surg 29: 48-51. 

2402a. Rojansky N, Ophir E, Sharony A, 

Spira H, Suprun H (1985). Broad ligament 

adenocarcinoma--its origin and clinical 

behavior. A literature review and report of 

a case. Obstet Gynecol Surv 40: 665-671. 

2 4 0 3 . Rome RM, England PG (2000). 

Management of vaginal intraepithelial 

neoplasia: A series of 132 cases with longterm 

follow-up. Int J Gynecol Cancer 10: 

382-390. 

2404. Roncaroli F, Lamovec J, Zidar A, 

Eusebi V (1996). Acinic cell-like carcinoma 

of the breast. Virchows Arch 429: 69-74. 

2405. Roncaroli F, Riccioni L, Cerati M, 

Capella C, Calbucci F, Trevisan C, Eusebi V 

(1997). Oncocytic meningioma. Am J Surg 

Pathol 21: 375-382. 

2406. Ronnett BM, Kurman RJ, Shmookler 

BM, Sugarbaker PH, Young RH (1997). The 

morphologic spectrum of ovarian metastases 

of appendiceal adenocarcinomas: a 

clinicopathologic and immunohistochemical 

analysis of tumors often misinterpreted 

as primary ovarian tumors or metastatic 

tumors from other gastrointestinal sites. 


2407. Ronnett BM, Kurman RJ, Zahn CM, 

Shmookler BM, Jablonski KA, Kass ME, 

Sugarbaker PH (1995). Pseudomyxoma 

peritonei in women: a clinicopathologic 

analysis of 30 cases with emphasis on site 

of origin, prognosis, and relationship to 

ovarian mucinous tumors of low malignant 

potential. Hum Pathol 26: 509-524. 

2408. Ronnett BM, Shmookler BM, Diener- 

West M, Sugarbaker PH, Kurman RJ 

(1997). Immunohistochemical evidence 

supporting the appendiceal origin of 

pseudomyxoma peritonei in women. Int J 


2409. Ronnett BM, Zahn CM, Kurman RJ, 

Kass ME, Sugarbaker PH, Shmookler BM 

(1995). Disseminated peritoneal adenomucinosis 

and peritoneal mucinous carcinomatosis. 

A clinicopathologic analysis of 

109 cases with emphasis on distinguishing 

pathologic features, site of origin, prognosis, 

and relationship to "pseudomyxoma 

peritonei". Am J Surg Pathol 19: 1390-1408. 

2410. Rorat E, Wallach RC (1984). Mixed 

tumors of the vulva: clinical outcome and 

pathology. Int J Gynecol Pathol 3: 323-328. 

2411. Rosai J (1991). Borderline epithelial 

lesions of the breast. Am J Surg Pathol 15: 

209-221. 

2412. Rose PG, Arafah B, Abdul-Karim FW 

(1998). Malignant struma ovarii: recurrence 

and response to treatment monitored 

by thyroglobulin levels. G y n e c o l 

Oncol 70: 425-427. 

2413. Rosen PP (1983). Microglandular 

adenosis, a benign lesion simultating inva - 

sive mammary carcinoma. Am J Surg 

Pathol 7: 137-144. 

2414. Rosen PP (1983). Syringomatous adenoma 

of the nipple. Am J Surg Pathol 7: 

739-745. 

2415. Rosen PP (1983). Tumor emboli in 

intramammary lymphatics in breast carcinoma: 

pathologic criteria for diagnosis and 

clinical significance. Pathol Annu 18 Pt 

2:215-32.: 215-232. 

2416. Rosen PP (1985). Vascular tumors of 

the breast. III. Angiomatosis. Am J Surg 

Pathol 9: 652-658. 

2417. Rosen PP (1986). Mucocele-like 

tumors of the breast. Am J Surg Pathol 10: 

464-469. 

2418. Rosen PP (1987). Adenomyoepithelioma 

of the breast. Hum Pathol 18: 

1232-1237. 

2419. Rosen PP (1989). Adenoid cystic car - 

cinoma of the breast. A morphologically 

heterogeneous neoplasm. Pathol Annu 24 

Pt 2: 237-254. 

2420. Rosen PP (1997). Benign papillary 

tumors. In: Breast Pathology, PP Rosen 

(ed.), 1st ed. Lippincott-Raven: 

Philadelphia , pp. 67-104. 

2421. Rosen PP (1997). Carcinoma with 

metaplasia. In: Rosen's Breast Pathology, 

PP Rosen (ed.), Lippincott-Raven: 


2422. Rosen PP (1997). Glycogen-rich carcinoma. 

In: Breast Pathology, PP Rosen 

(ed.), Lipincott-Raven, ed., Philadelphia/ 

New York . 

2423. Rosen PP (1997). Mammary carcinoma 

with osteoclast-like giant cells. In: 

Breast Pathology, PP Rosen (ed.), 

Lippincott-Raven, ed., Philadelphia/New 

York . 

2424. Rosen PP (1997). Metastases in the 

breast from non-mammary malignant neoplasms. 

In: Breast Pathology, PP Rosen 

(ed.), Lippincott-Raven, ed., Philadelphia/ 

New York . 

2425. Rosen PP (1997). Rosen's Breast 

Pathology. Lippincott-Raven: Philadelphia. 


Pathology. 2nd ed. Philadelphia. 


Pathology. Lippincott Williams and Wilkins: 

Philadelphia. 

2428. Rosen PP, Braun DW Jr., Lyngholm B, 

Urban JA, Kinne DW (1981). Lobular carcinoma 

in situ of the breast: preliminary 

results of treatment by ipsilateral mastectomy 

and contralateral breast biopsy. 

Cancer 47: 813-819. 

2429. Rosen PP, Caicco JA (1986). Florid 

papillomatosis of the nipple. A study of 51 

patients, including nine with mammary 

carcinoma. Am J Surg Pathol 10: 87-101. 

2430. Rosen PP, Cranor ML (1991). 

Secretory carcinoma of the breast. Arch 


2431. Rosen PP, Ernsberger D (1987). Lowgrade 

adenosquamous carcinoma. A variant 

of metaplastic mammary carcinoma. 


2432. Rosen PP, Ernsberger D (1989). 

Mammary fibromatosis. A benign spindlecell 

tumor with significant risk for local 


2433. Rosen PP, Groshen S, Kinne DW, 

Norton L (1993). Factors influencing prognosis 

in node-negative breast carcinoma: 

analysis of 767 T1N0M0/T2N0M0 patients 

with long-term follow-up. J Clin Oncol 11: 

2090-2100.

2 4 3 4 . Rosen PP, Groshen S, Saigo PE, 

Kinne DW, Hellman S (1989). Pathological 

prognostic factors in stage I (T1N0M0) and 

stage II (T1N1M0) breast carcinoma: a 

study of 644 patients with median followup 

of 18 years. J Clin Oncol 7: 1239-1251. 

2435. Rosen PP, Jozefczyk MA, Boram LH 

(1985). Vascular tumors of the breast. IV. 

The venous hemangioma. Am J Surg 

Pathol 9: 659-665. 

2436. Rosen PP, Kimmel M, Ernsberger D 

(1988). Mammary angiosarcoma. The prognostic 

significance of tumor differentiation. 

Cancer 62: 2145-2151. 

2437. Rosen PP, Kinne DW, Lesser M, 

Hellman S (1986). Are prognostic factors 

for local control of breast cancer treated 

by primary radiotherapy significant for 

patients treated by mastectomy? Cancer 

57: 1415-1420. 

2438. Rosen PP, Kosloff C, Lieberman PH, 

Adair F, Braun DW Jr. (1978). Lobular carcinoma 

in situ of the breast. Detailed 

analysis of 99 patients with average follow-up 

of 24 years. Am J Surg Pathol 2: 

225-251. 

2439. Rosen PP, Lesser ML, Arroyo CD, 

Cranor M, Borgen P, Norton L (1995). 

Immunohistochemical detection of 

HER2/neu in patients with axillary lymph 

node negative breast carcinoma. A study 

of epidemiologic risk factors, histologic 

features, and prognosis. Cancer 75: 1320- 

1326. 

2440. Rosen PP, Lesser ML, Arroyo CD, 

Cranor M, Borgen P, Norton L (1995). p53 in 

node-negative breast carcinoma: an 

immunohistochemical study of epidemiologic 

risk factors, histologic features, and 

prognosis. J Clin Oncol 13: 821-830. 

2441. Rosen PP, Lesser ML, Senie RT, 

Kinne DW (1982). Epidemiology of breast 

carcinoma III: relationship of family history 

to tumor type. Cancer 50: 171-179. 

2442. Rosen PP, Oberman HA (1993). Atlas 

of Tumour Pathology. Tumour of the 

Mammary Gland. Washington,D.C. 

2443. Rosen PP, Ridolfi RL (1977). The perilobular 

hemangioma. A benign microscopic 

vascular lesion of the breast. Am J Clin 

Pathol 68: 21-23. 

2444. Rosen PP, Saigo PE, Braun DW Jr., 

Weathers E, Kinne DW (1981). Prognosis in 

stage II (T1N1M0) breast cancer.Ann Surg 

194: 576-584. 

2445. Rosen PP, Saigo PE, Braun DW Jr., 

Weathers E, DePalo A (1981). Predictors of 

recurrence in stage I (T1N0M0) breast carcinoma. 

Ann Surg 193: 15-25. 

2446. Rosen PP, Senie R, Schottenfeld D, 

Ashikari R (1979). Noninvasive breast carcinoma: 

frequency of unsuspected invasion 

and implications for treatment. Ann 

Surg 189: 377-382. 

2447. Rosen PP, Wang T-Y (1980). Colloid 

carcinoma of the breast. Analysis of 64 

patients with long term followup. Am J Clin 

Pathol 73: 304. 

2448. Rosenberg CR, Pasternack BS, Shore 

RE, Koenig KL, Toniolo PG (1994). 

Premenopausal estradiol levels and the 

risk of breast cancer: a new method of 

controlling for day of the menstrual cycle. 


2449. Rosenblatt KA, Thomas DB, 

McTiernan A, Austin MA, Stalsberg H, 

Stemhagen A, Thompson WD, Curnen MG, 

Satariano W, Austin DF, et al. (1991). 

Breast cancer in men: aspects of familial 

aggregation. J Natl Cancer Inst 83: 849- 

854. 

2450. Rosenblatt KA, Weiss NS, Schwartz 

SM (1989). Incidence of malignant fallopian 

tube tumors. Gynecol Oncol 35: 236-239. 

2451. Rosenfeld WD, Rose E, Vermund SH, 

Schreiber K, Burk RD (1992). Follow-up 

evaluation of cervicovaginal human papillomavirus 

infection in adolescents. J 

Pediatr 121: 307-311. 

2452. Roses DF, Bell DA, Flotte TJ, Taylor R, 

Ratech H, Dubin N (1982). Pathologic predictors 

of recurrence in stage 1 (TINOMO) 

breast cancer. Am J Clin Pathol 78: 817- 

820. 

2453. Rosner D, Lane WW, Penetrante R 

(1991). Ductal carcinoma in situ with 

microinvasion. A curable entity using surgery 

alone without need for adjuvant therapy. 

Cancer 67: 1498-1503. 

2454. Ross JC, Eifel PJ, Cox RS, Kempson 

RL, Hendrickson MR (1983). Primary mucinous 

adenocarcinoma of the endometrium. 

A clinicopathologic and histochemical 

study. Am J Surg Pathol 7: 715-729. 

2455. Ross LD (1984). Hilus cell tumour of 

the ovary with an associated endometrial 

carcinoma, presenting with male pattern 

baldness and postmenopausal bleeding. 

Case report. Br J Obstet Gynaecol 91: 1266- 

1268. 

2456. Ross MJ, Welch WR, Scully RE 

(1989). Multilocular peritoneal inclusion 

cysts (so-called cystic mesotheliomas). 

Cancer 64: 1336-1346. 

2457. Rossi G, Bonacorsi G, Longo L, Artusi 

T, Rivasi F (2001). Primary high-grade 

mucosa-associated lymphoid tissue-type 

lymphoma of the cervix presenting as a 

common endocervical polyp. Arch Pathol 

Lab Med 125: 537-540. 

2458. Rossing MA, Daling JR, Weiss NS, 

Moore DE, Self SG (1994). Ovarian tumors 

in a cohort of infertile women. N Engl J 

Med 331: 771-776. 

2459. Roth LM, Anderson MC, Govan AD, 

Langley FA, Gowing NF, Woodcock AS 

(1981). Sertoli-Leydig cell tumors: a clinicopathologic 

study of 34 cases. Cancer 48: 

187-197. 

2460. Roth LM, Czernobilsky B (1985). 

Ovarian Brenner tumors. II. Malignant. 

Cancer 56: 592-601. 

2461. Roth LM, Dallenbach-Hellweg G, 

Czernobilsky B (1985). Ovarian Brenner 

tumors. I. Metaplastic, proliferating, and of 

low malignant potential. Cancer 56: 582- 

591. 

2462. Roth LM, Davis MM, Sutton GP 

(1996). Steroid cell tumor of the broad liga - 

ment arising in an accessory ovary. Arch 


2463. Roth LM, Deaton RL, Sternberg WH 

(1979). Massive ovarian edema. A clinicopathologic 

study of five cases including 

ultrastructural observations and review of 

the literature. Am J Surg Pathol 3: 11-21. 

2464. Roth LM, Gersell DJ, Ulbright TM 

(1993). Ovarian Brenner tumors and transi - 

tional cell carcinoma: recent developments. 


2465. Roth LM, Gersell DJ, Ulbright TM 

(1996). Transitional cell carcinoma and 

other transitional cell tumors of the ovary. 

Anat Pathol 1: 179-191. 

2466. Roth LM, Liban E, Czernobilsky B 

(1982). Ovarian endometrioid tumors mimicking 

Sertoli and Sertoli-Leydig cell 

tumors: Sertoliform variant of endometrioid 


2467. Roth LM, Look KY (2000). Inverted follicular 

keratosis of the vulvar skin: a lesion 

that can be confused with squamous cell 

carcinoma. Int J Gynecol Pathol 19: 369- 

373. 

2468. Roth LM, Nicholas TR, Ehrlich CE 

(1979). Juvenile granulosa cell tumor: a 

clinicopathologic study of three cases with 

ultrastructural observations. Cancer 4 4 : 

2194-2205. 

2469. Roth LM, Reed RJ (1999). Dissecting 

leiomyomas of the uterus other than 

cotyledonoid dissecting leiomyomas: a 

report of eight cases. Am J Surg Pathol 23: 

1032-1039. 

2470. Roth LM, Reed RJ, Sternberg WH 

(1996). Cotyledonoid dissecting leiomyoma 

of the uterus. The Sternberg tumor. Am J 

Surg Pathol 20: 1455-1461. 

2471. Roth LM, Slayton RE, Brady LW, 

Blessing JA, Johnson G (1985). Retiform 

differentiation in ovarian Sertoli-Leydig 

cell tumors. A clinicopathologic study of 

six cases from a Gynecologic Oncology 

Group study. Cancer 55: 1093-1098. 

2472. Roth LM, Sternberg WH (1973). 

Ovarian stromal tumors containing Leydig 

cells. II. Pure Leydig cell tumor, non-hilar 

type. Cancer 32: 952-960. 

2473. Rothbard MJ, Markham EH (1974). 

Leiomyosarcoma of the cervix: report of a 

case. Am J Obstet Gynecol 120: 853-854. 

2474. Royar J, Becher H, Chang-Claude J 

(2001). Low-dose oral contraceptives: protective 

effect on ovarian cancer risk. Int J 

Cancer 95: 370-374. 

2475. Roylance R, Gorman P, Hanby A, 

Tomlinson I (2002). Allelic imbalance 

analysis of chromosome 16q shows that 

grade I and grade III invasive ductal breast 

cancers follow different genetic pathways. 

J Pathol 196: 32-36. 

2476. Roylance R, Gorman P, Harris W, 

Liebmann R, Barnes D, Hanby A, Sheer D 

(1999). Comparative genomic hybridization 

of breast tumors stratified by histological 

grade reveals new insights into the biological 

progression of breast cancer. Cancer 

Res 59: 1433-1436. 

2477. Rozan S, Vincent-Salomon A, Zafrani 

B, Validire P, de Cremoux P, Bernoux A, 

Nieruchalski M, Fourquet A, Clough K, 

Dieras V, Pouillart P, Sastre-Garau X 

(1998). No significant predictive value of cerbB-2 

or p53 expression regarding sensitivity 

to primary chemotherapy or radiotherapy 

in breast cancer. Int J Cancer 79: 

27-33. 

2478. Rubens JR, Lewandrowski KB, 

Kopans DB, Koerner FC, Hall DA, McCarthy 

KA (1990). Medullary carcinoma of the 

breast. Overdiagnosis of a prognostically 

favorable neoplasm. Arch Surg 125: 601- 

604. 

2479. Rubin SC, Benjamin I, Behbakht K, 

Takahashi H, Morgan MA, LiVolsi VA, 

Berchuck A, Muto MG, Garber JE, Weber 

BL, Lynch HT, Boyd J (1996). Clinical and 

pathological features of ovarian cancer in 

women with germ-line mutations of 

BRCA1. N Engl J Med 335: 1413-1416. 

2480. Rubin SC, Young J, Mikuta JJ (1985). 

Squamous carcinoma of the vagina: treatment, 

complications, and long-term followup. 


2481. Rubio IT, Korourian S, Brown H, 

Cowan C, Klimberg VS (1998). Carcinoid 

tumor metastatic to the breast. Arch Surg 

133: 1117-1119. 

2482. Rudan I, Rudan N, Skoric T, Sarcevic 

B (1996). Fibromatosis of male breast. Acta 

Med Croatica 50: 157-159. 

2483. Rudas M, Neumayer R, Gnant MF, 

Mittelbock M, Jakesz R, Reiner A (1997). 

p53 protein expression, cell proliferation 

and steroid hormone receptors in ductal 

and lobular in situ carcinomas of the 

breast. Eur J Cancer 33: 39-44. 

2484. Rudas M, Schmidinger M, Wenzel C, 

Okamoto I, Budinsky A, Fazeny B, Marosi C 

(2000). Karyotypic findings in two cases of 

male breast cancer. Cancer Genet 

Cytogenet 121: 190-193. 

2485. Ruffolo EF, Koerner FC, Maluf HM 

(1997). Metaplastic carcinoma of the 

breast with melanocytic differentiation. 

Mod Pathol 10: 592-596. 

2486. Ruggieri AM, Brody JM, Curhan RP 

(1996). Vaginal leiomyoma. A case report 

with imaging findings. J Reprod Med 41: 

875-877. 

2487. Runnebaum IB, Wang-Gohrke S, 

Vesprini D, Kreienberg R, Lynch H, Moslehi 

R, Ghadirian P, Weber B, Godwin AK, Risch 

H, Garber J, Lerman C, Olopade OI, Foulkes 

WD, Karlan B, Warner E, Rosen B, 

Rebbeck T, Tonin P, Dube MP, Kieback DG, 

Narod SA (2001). Progesterone receptor 

variant increases ovarian cancer risk in 

BRCA1 and BRCA2 mutation carriers who 

were never exposed to oral contraceptives. 

Pharmacogenetics 11: 635-638. 

2488. Rush DS, Tan J, Baergen RN, Soslow 

RA (2001). h-Caldesmon, a novel smooth 

muscle-specific antibody, distinguishes 

between cellular leiomyoma and endometrial 

stromal sarcoma. Am J Surg Pathol 25: 

253-258. 

2489. Russell P (1979). The pathological 

assessment of ovarian neoplasms. I: 

Introduction to the common 'epithelial' 

tumours and analysis of benign 'epithelial' 

tumours. Pathology 11: 5-26. 

2490. Russell P (1979). The pathological 

assessment of ovarian neoplasms. II: The 

proliferating 'epithelial' tumours. 

Pathology 11: 251-282. 

2491. Russell P, Merkur H (1979). 

Proliferating ovarian "epithelial" tumours: a 

clinico-pathological analysis of 144 cases. 

Aust N Z J Obstet Gynaecol 19: 45-51. 

2492. Russell P, Wills EJ, Watson G, Lee J, 

Geraghty T (1995). Monomorphic (basal 

cell) salivary adenoma of ovary: report of a 

case. Ultrastruct Pathol 19: 431-438. 

2493. Russell PA, Pharoah PD, De Foy K, 

Ramus SJ, Symmonds I, Wilson A, Scott I, 

Ponder BA, Gayther SA (2000). Frequent 

loss of BRCA1 mRNA and protein expression 

in sporadic ovarian cancers. Int J 

Cancer 87: 317-321. 

2494. Russo L, Woolmough E, Heatley MK 

(2000). Structural and cell surface antigen 

expression in the rete ovarii and 

epoophoron differs from that in the 

Fallopian tube and in endometriosis. 


2495. Rutgers JL, Scully RE (1988). Cysts 

(cystadenomas) and tumors of the rete 

ovarii. Int J Gynecol Pathol 7: 330-342. 

2496. Rutgers JL, Scully RE (1988). Ovarian 

mixed-epithelial papillary cystadenomas of 

borderline malignancy of mullerian type. A 

clinicopathologic analysis. Cancer 61: 546- 

554. 

2497. Rutgers JL, Scully RE (1988). Ovarian 

mullerian mucinous papillary cystadenomas 

of borderline malignancy. A clinicopathologic 

analysis. Cancer 61: 340-348. 

2498. Rutgers JL, Scully RE (1991). The 

androgen insensitivity syndrome (testicular 

feminization): a clinicopathologic study 


144. 


2499. Rutledge F (1967). Cancer of the vagina. 


2500. Rutqvist LE, Wallgren A (1983). 

Influence of age on outcome in breast carcinoma. 

Acta Radiol Oncol 22: 289-294. 

2501. Rywlin AM, Simmons RJ, Robinson 

MJ (1969). Leiomyoma of vagina recurrent 

in pregnancy: a case with apparent hormone 

dependency. South Med J 62: 1449- 

1451. 

2502. Sabini G, Chumas JC, Mann WJ 

(1992). Steroid hormone receptors in 

endometrial stromal sarcomas. A biochemical 

and immunohistochemical study. 


2503. Safe SH (1997). Xenoestrogens and 

breast cancer. N Engl J Med 337: 1303- 

1304. 

2504. Saffos RO, Rhatigan RM, Scully RE 

(1980). Metaplastic papillary tumor of the 

fallopian tube--a distinctive lesion of preg - 

nancy. Am J Clin Pathol 74: 232-236. 

2505. Sagebiel R.W. (1969). Ultrastructural 

observations on epidermal cells in Paget's 

disease of the breast. Am J Pathol 1: 49-64. 

2506. Sahin A, Benda JA (1988). Primary 

ovarian Wilms' tumor. Cancer 61: 1460- 

1463. 

2507. Sahin AA, Silva EG, Ordonez NG 

(1989). Alveolar soft part sarcoma of the 

uterine cervix. Mod Pathol 2: 676-680. 

2508. Saigo PE, Rosen PP (1981). Mammary 

carcinoma with "choriocarcinomatous" 

features. Am J Surg Pathol 5: 773-778. 

2509. Sainsbury JR, Farndon JR, Needham 

GK, Malcolm AJ, Harris AL (1987). 

Epidermal-growth-factor receptor status 

as predictor of early recurrence of and 

death from breast cancer. Lancet 1: 1398- 

1402. 

2510. Saint Aubain SN, Larsimont D, 

Cluydts N, Heymans O, Verhest A (1997). 

Pseudoangiomatous hyperplasia of mammary 

stroma in an HIV patient. Gen Diagn 

Pathol 143: 251-254. 

2511. Sainz dlC, Eichhorn JH, Rice LW, 

Fuller AF Jr., Nikrui N, Goff BA (1996). 

Histologic transformation of benign 

endometriosis to early epithelial ovarian 

cancer. Gynecol Oncol 60: 238-244. 

2512. Saitoh A, Tsutsumi Y, Osamura RY, 

Watanabe K (1989). Sclerosing stromal 

tumor of the ovary. Immunohistochemical 

and electron-microscopic demonstration 

of smooth-muscle differentiation. A r c h 


2513. Sakamoto A, Sasaki H, Furusato M, 

Suzuki M, Hirai Y, Tsugane S, Fukushima 

M, Terashima Y (1994). Observer disagree - 

ment in histological classification of ovari - 

an tumors in Japan. Gynecol Oncol 54: 54- 

58. 

2514. Sakuragi N, Satoh C, Takeda N, 

Hareyama H, Takeda M, Yamamoto R, 

Fujimoto T, Oikawa M, Fujino T, Fujimoto S 

(1999). Incidence and distribution pattern 

of pelvic and paraaortic lymph node 

metastasis in patients with Stages IB, IIA, 

and IIB cervical carcinoma treated with 

radical hysterectomy. Cancer 85: 1547- 

1554. 

2515. Salazar H, Kanbour A, Tobon H, 

Gonzalez-Angulo A (1974). Endoderm cell 

derivatives in embryonal carcinoma of the 

ovary: an electron microscopic study of 

two cases. Am J Pathol 74: 108 A. 


2516. Salovaara R, Loukola A, Kristo P, 

Kaariainen H, Ahtola H, Eskelinen M, 

Harkonen N, Julkunen R, Kangas E, Ojala 

S, Tulikoura J, Valkamo E, Jarvinen H, 

Mecklin JP, Aaltonen LA, de la CA (2000). 

Population-based molecular detection of 

hereditary nonpolyposis colorectal cancer. 

J Clin Oncol 18: 2193-2200. 

2517. Saltzstein SL (1974). Clinically occult 

inflammatory carcinoma of the breast. 

Cancer 34: 382-388. 

2518. Salvesen HB, MacDonald N, Ryan A, 

Iversen OE, Jacobs IJ, Akslen LA, Das S 

(2000). Methylation of hMLH1 in a population-based 

series of endometrial carcinomas. 


2519. Samanth KK, Black WC, III (1970). 

Benign ovarian stromal tumors associated 

with free peritoneal fluid. Am J Obstet 

Gynecol 107: 538-545. 

2520. Samuels TH, Miller NA, Manchul LA, 

DeFreitas G, Panzarella T (1996). 

Squamous cell carcinoma of the breast. 

Can Assoc Radiol J 47: 177-182. 

2521. Sanchez AG, Villanueva AG, Redondo 

C (1986). Lobular carcinoma of the breast in 

a patient with Klinefelter's syndrome. A 

case with bilateral, synchronous, histolog - 

ically different breast tumors. Cancer 57: 

1181-1183. 

2522. Sander CM (1993). Angiomatous malformation 

of placental chorionic stem ves - 

sels and pseudo-partial molar placentas: 

report of five cases. Pediatr Pathol 13: 621- 

633. 

2523. Sangwan K, Khosla AH, Hazra PC 

(1996). Leiomyoma of the vagina. Aust N Z 


2524. Sanjeevi CB, Hjelmstrom P, Hallmans 

G, Wiklund F, Lenner P, Angstrom T, Dillner 

J, Lernmark A (1996). Different HLA-DR-DQ 

haplotypes are associated with cervical 

intraepithelial neoplasia among human 

papillomavirus type-16 seropositive and 

seronegative Swedish women. Int J 

Cancer 68: 409-414. 

2525. Sankaranarayanan R, Black RJ, 

Parkin DM (1998). Cancer Survival in 

Developing Countries. IARC: Lyon. 

2526. Sankila R, Aaltonen LA, Jarvinen HJ, 

Mecklin JP (1996). Better survival rates in 

patients with MLH1-associated hereditary 

colorectal cancer. Gastroenterology 110: 

682-687. 

2527. Sano T, Oyama T, Kashiwabara K, 

Fukuda T, Nakajima T (1998). Expression 

status of p16 protein is associated with 

human papillomavirus oncogenic potential 

in cervical and genital lesions. Am J 

Pathol 153: 1741-1748. 

2528. Santesson L, Kottmeier HL (1968). 

General classification of ovarian tumours. 

In: Ovarian Cancer, Gentil F, Junquiera AC, 

eds., Springer-Verlag: New York , pp. 1-8. 

2529. Santeusanio G, Schiaroli S, Anemona 

L, Sesti F, Valli E, Piccione E, Spagnoli LG 

(1991). Carcinoma of the vulva with sarcomatoid 

features: a case report with 

immunohistochemical study. G y n e c o l 

Oncol 40: 160-163. 

2530. Santini D, Gelli MC, Mazzoleni G, 

Ricci M, Severi B, Pasquinelli G, Pelusi G, 

Martinelli G (1989). Brenner tumor of the 

ovary: a correlative histologic, histochemical, 

immunohistochemical, and ultrastructural 

investigation. Hum Pathol 20: 787-795. 

2531. Santos MJ, Gonzalez SS, Carretero 

AL (2000). Breast metastases from embryonal 

rhabdomyosarcoma: apropos 2 cases 

and a review of the literature. Rev Clin Esp 

200: 21-25. 

2532. Sanz-Ortega J, Chuaqui R, Zhuang Z, 

Sobel ME, Sanz-Esponera J, Liotta LA, 

Emmert-Buck MR, Merino MJ (1995). Loss 

of heterozygosity on chromosome 11q13 in 

microdissected human male breast carcinomas. 


2 5 3 3 . Sapino A, Bussolati G (2002). Is 

detection of endocrine cells in breast ade - 

nocarcinoma of diagnostic and clinical 

significance? Histopathology 40: 211-214. 

2534. Sapino A, Frigerio A, Peterse JL, 

Arisio R, Coluccia C, Bussolati G (2000). 

Mammographically detected in situ lobular 

carcinomas of the breast. Virchows Arch 

436: 421-430. 

2535. Sapino A, Righi L, Cassoni P, Papotti 

M, Gugliotta P, Bussolati G (2001). 

Expression of apocrine differentiation 

markers in neuroendocrine breast carcinomas 

of aged women. Mod Pathol 14: 

768-776. 

2536. Sapino A, Righi L, Cassoni P, Papotti 

M, Pietribiasi F, Bussolati G (2000). 

Expression of the neuroendocrine phenotype 

in carcinomas of the breast. Semin 

Diagn Pathol 17: 127-137. 

2536 a. Sartwell PE, Arthes FG, Tonascia 

JA (1978). Benign and malignant breast 

tumours: epidemiological similarities. Int J 


2537. Sasano H, Mason JI, Sasaki E, Yajima 

A, Kimura N, Namiki T, Sasano N, Nagura 

H (1990). Immunohistochemical study of 3 

beta-hydroxysteroid dehydrogenase in sex 

cord-stromal tumors of the ovary. Int J 


2538. Sasano H, Sato S, Yajima A, Akama J, 

Nagura H (1997). Adrenal rest tumor of the 

broad ligament: case report with immunohistochemical 

study of steroidogenic 

enzymes. Pathol Int 47: 493-496. 

2539. Sasco AJ, Lowenfels AB, Pasker-de 

Jong P (1993). Epidemiology of male breast 

cancer. A meta-analysis of published 

case-control studies and discussion of 

selected aetiological factors. Int J Cancer 

53: 538-549. 

2540. Sashiyama H, Abe Y, Miyazawa Y, 

Nagashima T, Hasegawa M, Okuyama K, 

Kuwahara T, Takagi T (1999). Primary Non- 

Hodgkin's Lymphoma of the Male Breast: 

A Case Report. Breast Cancer 6: 55-58. 

2541. Sastre-Garau X, Jouve M, Asselain 

B, Vincent-Salomon A, Beuzeboc P, Dorval 

T, Durand JC, Fourquet A, Pouillart P 

(1996). Infiltrating lobular carcinoma of the 

breast. Clinicopathologic analysis of 975 

cases with reference to data on conservative 

therapy and metastatic patterns. 

Cancer 77: 113-120. 

2 5 4 2 . Satake T, Matsuyama M (1991). 

Endocrine cells in a normal breast and 

non-cancerous breast lesion. Acta Pathol 

Jpn 41: 874-878. 

2 5 4 3 . Sato N, Tsunoda H, Nishida M, 

Morishita Y, Takimoto Y, Kubo T, Noguchi 

M (2000). Loss of heterozygosity on 10q23.3 

and mutation of the tumor suppressor gene 

PTEN in benign endometrial cyst of the 

ovary: possible sequence progression 

from benign endometrial cyst to 

endometrioid carcinoma and clear cell 

carcinoma of the ovary. Cancer Res 60: 

7052-7056. 

2544. Sau P, Solis J, Lupton GP, James WD 

(1989). Pigmented breast carcinoma. A 

clinical and histopathologic simulator of 

malignant melanoma. Arch Dermatol 125: 

536-539. 

2545. Savey L, Lasser P, Castaigne D, 

Michel G, Bognel C, Colau JC (1996). 

[Krukenberg tumors. Analysis of a series of 

28 cases]. J Chir (Paris) 133: 427-431. 

2546. Savitsky K, Bar-Shira A, Gilad S, 

Rotman G, Ziv Y, Vanagaite L, Tagle DA, 

Smith S, Uziel T, Sfez S, Ashkenazi M, 

Pecker I, frydman M, Harnik R, Patanjali 

SR, Simmons A, Clines GA, Sartiel A, Gatti 

RA, Chessa L, Sanal O, Lavin MF, Jaspers 

NGJ, Malcolm A, Taylor R, Arlett CF, Miki T, 

Weissman SM, Lovett M, Collins FS, Shiloh 

H. (1995). A single ataxia telangiectasia 

gene with a product similar to PI-3 kinase. 

Science 268: 1749-1753. 

2547. Savitsky K, Platzer M, Uziel T, Gilad S, 

Sartiel A, Rosenthal A, Elroy-Stein O, 

Shiloh Y, Rotman G (1997). Ataxia-telangiectasia: 

structural diversity of untranslated 

sequences suggests complex posttranscriptional 

regulation of ATM gene 

expression. Nucleic Acids Res 25: 1678- 

1684. 

2 5 4 8 . Scarff RW, Torloni H (1968). 

International Histological Classification of 

Tumours, n°2. Histological Typing of 

Breast Tumours. World Health 

Organization: Geneva. 

2549. Scatarige JC, Hsiu JG, de la TR, 

Cramer MS, Siddiky MA, Jaffe AH (1987). 

Acoustic shadowing in benign granular 

cell tumor (myoblastoma) of the breast. J 

Ultrasound Med 6: 545-547. 

2550. Schammel DP, Silver SA, Tavassoli 

FA (1999). Combined endometrial stromal/smooth 

muscle neoplasms of the 

uterus: clinicopathologic study of 38 

cases. Mod Pathol 12: 124A. 

2551. Schammel DP, Tavassoli FA (1998). 

Uterine angiosarcomas: a morphologic 

and immunohistochemical study of four 


2552. Scheidbach H, Dworak O, 

Schmucker B, Hohenberger W (2000). 

Lobular carcinoma of the breast in an 85year-old 

man. Eur J Surg Oncol 26: 319-321. 

2553. Scheistroen M, Trope C, Kaern J, 

Pettersen EO, Alfsen GC, Nesland JM 

(1997). DNA ploidy and expression of p53 

and C-erbB-2 in extramammary Paget's 

disease of the vulva. Gynecol Oncol 64: 88- 

92. 

2554. Scheithauer B, Woodruff JM (1999). 

Tumours of the Peripheral Nervous 

System. AFIP: Washington, DC. 

2555. Schell SR, Montague ED, Spanos WJ 

Jr., Tapley ND, Fletcher GH, Oswald MJ 

(1982). Bilateral breast cancer in patients 

with initial stage I and II disease. Cancer 

50: 1191-1194. 

2556. Schernhammer ES, Laden F, Speizer 

FE, Willett WC, Hunter DJ, Kawachi I, 

Colditz GA (2001). Rotating night shifts and 

risk of breast cancer in women participating 

in the nurses' health study. J Natl 

Cancer Inst 93: 1563-1568. 

2556a. Schildkraut JM, Risch N, Thompson 

WD (1989). Evaluating genetic association 

among ovarian, breast, and endometrial 

cancer: evidence for a breast/ovarian cancer 

relationship. Am J Hum Genet 45: 521- 

529. 

2 5 5 7 . Schildkraut JM, Thompson WD 

(1988). Familial ovarian cancer: a population-based 

case-control study. Am J 

Epidemiol 128: 456-466. 

2558. Schlesinger C, Kamoi S, Ascher SM, 

Kendell M, Lage JM, Silverberg SG (1998). 

Endometrial polyps: a comparison study of 

patients receiving tamoxifen with two control 

groups. Int J Gynecol Pathol 17: 302- 

311.

2559. Schlesinger C, Silverberg SG (1999). 

Endocervical adenocarcinoma in situ of 

tubal type and its relation to atypical tubal 

metaplasia. Int J Gynecol Pathol 18: 1-4. 

2560. Schmidt-Kittler O, Ragg T, Daskalakis 

A, Granzow M, Ahr A, Blankenstein TJ, 

Kaufmann M, Diebold J, Arnholdt H, Muller 

P, Bischoff J, Harich D, Schlimok G, 

Riethmuller G, Eils R, Klein CA (2003). From 

latent disseminated cells to overt metastasis: 

genetic analysis of systemic breast 

cancer progression. Proc Natl Acad Sci 

USA 100: 7737-7742. 

2561. Schmitt FC, Ribeiro CA, Alvarenga S, 

Lopes JM (2000). Primary acinic cell-like 

carcinoma of the breast--a variant with 

good prognosis? Histopathology 36: 286- 

289. 

2562. Schmitz MJ, Hendricks DT, Farley J, 

Taylor RR, Geradts J, Rose GS, Birrer MJ 

(2000). p27 and cyclin D1 abnormalities in 

uterine papillary serous carcinoma. 


2563. Schmutte C, Marinescu RC, Copeland 

NG, Jenkins NA, Overhauser J, Fishel R 

(1998). Refined chromosomal localization 

of the mismatch repair and hereditary nonpolyposis 

colorectal cancer genes hMSH2 

and hMSH6. Cancer Res 58: 5023-5026. 

2564. Schnarkowski P, Kessler M, Arnholdt 

H, Helmberger T (1997). Angiosarcoma of 

the breast: mammographic, sonographic, 

and pathological findings. Eur J Radiol 24: 

54-56. 

2 5 6 5 . Schneider A, de Villiers EM, 

Schneider V (1987). Multifocal squamous 

neoplasia of the female genital tract: significance 

of human papillomavirus infection 

of the vagina after hysterectomy. 


2566. Schneider C, Wight E, Perucchini D, 

Haller U, Fink D (2000). Primary carcinoma 

of the fallopian tube. A report of 19 cases 

with literature review. Eur J Gynaecol 

Oncol 21: 578-582. 

2567. Schneider JA (1989). Invasive papillary 

breast carcinoma: mammographic and 

sonographic appearance. Radiology 171: 

377-379. 

2568. Schneider V, Zimberg ST, Kay S 

(1981). The pigmented portio: benign lentigo 

of the uterine cervix. Diagn Gynecol 

Obstet 3: 269-272. 

2569. Schnitt SJ (1997). Morphologic risk 

factors for local recurrence in patients 

with invasive breast cancer treated with 

conservative surgery and radiation therapy. 

Breast J. 3: 261-266. 

2570. Schnitt SJ, Connolly JL, Recht A, 

Silver B, Harris JR (1989). Influence of infiltrating 

lobular histology on local tumor 

control in breast cancer patients treated 

with conservative surgery and radiotherapy. 

Cancer 64: 448-454. 

2571. Schnitt SJ, Connolly JL, Tavassoli FA, 

Fechner RE, Kempson RL, Gelman R, Page 

DL (1992). Interobserver reproducibility in 

the diagnosis of ductal proliferative breast 

lesions using standardized criteria. Am J 

Surg Pathol 16: 1133-1143. 

2 5 7 2 . Schnuch A (1993). [Post hoc or 

propter hoc? On the heuristics of sideeffects 

in the example of gynecomastia]. 

Dtsch Med Wochenschr 118: 796-803. 

2 5 7 3 . Schorge JO, Lee KR, Sheets EE 

(2000). Prospective management of stage 

IA(1) cervical adenocarcinoma by conization 

alone to preserve fertility: a preliminary 

report. Gynecol Oncol 78: 217-220. 

2574. Schorge JO, Miller YB, Qi LJ, Muto 

MG, Welch WR, Berkowitz RS, Mok SC 

(2000). Genetic alterations of the WT1 gene 

in papillary serous carcinoma of the peritoneum. 


2575. Schorge JO, Muto MG, Lee SJ, 

Huang LW, Welch WR, Bell DA, Keung EZ, 

Berkowitz RS, Mok SC (2000). BRCA1-related 

papillary serous carcinoma of the peritoneum 

has a unique molecular pathogen - 

esis. Cancer Res 60: 1361-1364. 

2576. Schorge JO, Muto MG, Welch WR, 

Bandera CA, Rubin SC, Bell DA, Berkowitz 

RS, Mok SC (1998). Molecular evidence for 

multifocal papillary serous carcinoma of 

the peritoneum in patients with germline 

BRCA1 mutations. J Natl Cancer Inst 90: 

841-845. 

2577. Schottenfeld D, Lilienfeld AM, 

Diamond H (1963). Some observations on 

the epidemiology of breast cancer among 

males. Am J Publ Hlth 53: 890-897. 

2578. Schrager CA, Schneider D, Gruener 

AC, Tsou HC, Peacocke M (1998). Clinical 

and pathological features of breast disease 

in Cowden's syndrome: an underrec - 

ognized syndrome with an increased risk 

of breast cancer. Hum Pathol 29: 47-53. 

2579. Schuh ME, Nemoto T, Penetrante RB, 

Rosner D, Dao TL (1986). Intraductal carci - 

noma. Analysis of presentation, pathologic 

findings, and outcome of disease. Arch 

Surg 121: 1303-1307. 

2580. Schultz DM (1957). A malignant, melonotic 

neoplasm of the uterus, resembling 

the "retinal anlage" tumours. Arch Pathol 

28: 524-532. 

2581. Schurch W, Potvin C, Seemayer TA 

(1985). Malignant myoepithelioma (myoep - 

ithelial carcinoma) of the breast: an ultrastructural 

and immunocytochemical study. 


2582. Schuuring E, Verhoeven E, van 

Tinteren H, Peterse JL, Nunnink B, 

Thunnissen FB, Devilee P, Cornelisse CJ, 

Van de Vijver MJ, Mooi WJ, Michalides 

RJAM. (1992). Amplification of genes with - 

in the chromosome 11q13 region is indicative 

of poor prognosis in patients with 

operable breast cancer. Cancer Res 52: 

5229-5234. 

2583. Schwartz GF, Feig SA, Rosenberg AL, 

Patchefsky AS, Schwartz AB (1984). 

Staging and treatment of clinically occult 


2584. Schwartz GF, Patchefsky AS, 

Finklestein SD, Sohn SH, Prestipino A, Feig 

SA, Singer JS (1989). Nonpalpable in situ 

ductal carcinoma of the breast. Predictors 

of multicentricity and microinvasion and 

implications for treatment. Arch Surg 124: 

29-32. 

2585. Schwartz IS, Strauchen JA (1990). 

Lymphocytic mastopathy. An autoimmune 

disease of the breast? Am J Clin Pathol 93: 

725-730. 

2586. Schwartz PE (2000). Surgery of germ 

cell tumours of the ovary. Forum (Genova) 

10: 355-365. 

2587. Schwartz PE, Chambers SK, 

Chambers JT, Kohorn E, McIntosh S (1992). 

Ovarian germ cell malignancies: the Yale 

University experience. Gynecol Oncol 45: 

26-31. 

2588. Schwartz PE, Smith JP (1976). 

Treatment of ovarian stromal tumors. Am J 


2589. Schweizer P, Moisio AL, Kuismanen 

SA, Truninger K, Vierumaki R, Salovaara R, 

Arola J, Butzow R, Jiricny J, Peltomaki P, 

Nystrom-Lahti M (2001). Lack of MSH2 and 

MSH6 characterizes endometrial but not 

colon carcinomas in hereditary nonpolyposis 

colorectal cancer. Cancer Res 61: 2813- 

2815. 

2590. Scopsi L, Andreola S, Pilotti S, 

Bufalino R, Baldini MT, Testori A, Rilke F 

(1994). Mucinous carcinoma of the breast. 

A clinicopathologic, histochemical, and 

immunocytochemical study with special 

reference to neuroendocrine differentiation. 


2591. Scopsi L, Andreola S, Saccozzi R, 

Pilotti S, Boracchi P, Rosa P, Conti AR, 

Manzari A, Huttner WB, Rilke F (1991). 

Argyrophilic carcinoma of the male breast. 

A neuroendocrine tumor containing predominantly 

chromogranin B (secretogranin 

I). Am J Surg Pathol 15: 1063-1071. 

2592. Scott SP, Bendix R, Chen P, Clark R, 

Dork T, Lavin MF (2002). Missense mutations 

but not allelic variants alter the func - 

tion of ATM by dominant interference in 

patients with breast cancer. Proc Natl 

Acad Sci USA 99: 925-930. 

2593. Scully R, Anderson SF, Chao DM, Wei 

W, Ye L, Young RA, Livingston DM, Parvin 

JD (1997). BRCA1 is a component of the 

RNA polymerase II holoenzyme. Proc Natl 

Acad Sci USA 94: 5605-5610. 

2594. Scully R, Chen J, Ochs RL, Keegan K, 

Hoekstra M, Feunteun J, Livingston DM 

(1997). Dynamic changes of BRCA1 subnu - 

clear location and phosphorylation state 

are initiated by DNA damage. Cell 90: 425- 

435. 

2595. Scully R, Chen J, Plug A, Xiao Y, 

Weaver D, Feunteun J, Ashley T, 

Livingston DM (1997). Association of 

BRCA1 with Rad51 in mitotic and meiotic 

cells. Cell 88: 265-275. 

2596. Scully R, Ganesan S, Brown M, De 

Caprio JA, Cannistra SA, Feunteun J, 

Schnitt S, Livingston DM (1996). Location of 

BRCA1 in human breast and ovarian cancer 

cells. Science 272: 123-126. 

2597. Scully R, Ganesan S, Vlasakova K, 

Chen J, Socolovsky M, Livingston DM 

(1999). Genetic analysis of BRCA1 function 

in a defined tumor cell line. Mol Cell 4: 

1093-1099. 

2598. Scully RE (1970). Gonadoblastoma. A 

review of 74 cases. Cancer 25: 1340-1356. 

2599. Scully RE (1970). Sex cord tumor with 

annular tubules a distinctive ovarian tumor 

of the Peutz-Jeghers syndrome. Cancer 25: 

1107-1121. 

2600. Scully RE, Bell DA, Abu-Jawdeh GM 

(1995). Update on early ovarian cancer and 

cancer developing in benign ovarian 

tumors. In: Ovarian Cancer 3, P Mason, F 

Sharp, T Blackett, J Berek (eds.), 

Chapman and Hall: London, pp. 139-144. 

2601. Scully RE, Bonfiglio TA, Kurman RJ, 

Silverberg SG, Wilkinson EJ (1994). World 

Health Organization: Histological Typing of 

Female Tract Tumours. 2nd ed. Springer- 

Verlag: Berlin. 

2602. Scully RE, Bonfiglio TA, Kurman RJ, 

Silverberg SG, Wilkinson EJ (1994). Uterine 

corpus. In: World Health Organization: 

Histological Typing of Female Genital 

Tract Tumors, Springer-Verlag: New York , 

pp. 13-31. 

2603. Scully RE, Galdabini JJ, McNeely BU 

(1976). Case records of the Massachusetts 

General Hospital. Weekly clinicopathological 

exercises. Case 14-1976. N Engl J Med 

294: 772-777. 

2604. Scully RE, Sobin LH (1999). World 

Health Organization: Histological Typing of 

Ovarian Tumours. 2nd ed. Spinger-Verlag: 

Berlin. 

2605. Scully RE, Young RH, Clement PB 

(1998). Atlas of Tumor Pathology Tumors 

of the Ovary, Maldeveloped Gonads, 

Fallopian Tube, and Broad Ligament. 3rd 

ed. AFIP: Washington,D.C. 

2606. Scurry J, Beshay V, Cohen C, Allen D 

(1998). Ki67 expression in lichen sclerosus 

of vulva in patients with and without associated 

squamous cell carcinoma. 


2607. Scurry J, Brand A, Planner R, 

Dowling J, Rode J (1996). Vulvar Merkel 

cell tumor with glandular and squamous 

differentiation. Gynecol Oncol 62: 292-297. 

2608. Scurry J, Craighead P, Duggan M 

(2000). Histologic study of patterns of cervical 

involvement in FIGO stage II endometrial 

carcinoma. Int J Gynecol Cancer 10: 

497-502. 

2609. Scurry J, Planner R, Grant P (1991). 

Unusual variants of vaginal adenosis: a 

challenge for diagnosis and treatment. 


2610. Scurry JP, Brown RW, Jobling T 

(1996). Combined ovarian serous papillary 

and hepatoid carcinoma. Gynecol Oncol 

63: 138-142. 

2611. Sebek BA (1984). Cavernous hemangioma 

of the female breast. Cleve Clin Q 51: 

471-474. 

2612. Seckl MJ, Mulholland PJ, Bishop AE, 

Teale JD, Hales CN, Glaser M, Watkins S, 

Seckl JR (1999). Hypoglycemia due to an 

insulin-secreting small-cell carcinoma of 

the cervix. N Engl J Med 341: 733-736. 

2613. Secreto G, Zumoff B (1994). Abnormal 

production of androgens in women with 

breast cancer. Anticancer Res 14: 2113- 

2117. 

2614. Sedlis A (1961). Primary carcinoma of 

the Fallopian tube. Obstet Gynecol Surv 16: 

209-226. 

2615. Segal GH, Hart WR (1992). Ovarian 

serous tumors of low malignant potential 

(serous borderline tumors). The relationship 

of exophytic surface tumor to peritoneal 

"implants". Am J Surg Pathol 16: 577- 

583. 

2616. Segawa T, Sasagawa T, Yamazaki H, 

Sakaike J, Ishikawa H, Inoue M (1999). 

Fragile histidine triad transcription abnormalities 

and human papillomavirus E6-E7 

mRNA expression in the development of 

cervical carcinoma. Cancer 85: 2001-2010. 

2617. Seidman JD (1994). Mucinous lesions 

of the fallopian tube. A report of seven 


2618. Seidman JD (1996). Prognostic 

importance of hyperplasia and atypia in 

endometriosis. Int J Gynecol Pathol 15: 1-9. 

2619. Seidman JD (1996). Unclassified 

ovarian gonadal stromal tumors. A clinicopathologic 

study of 32 cases. Am J Surg 

Pathol 20: 699-706. 

2620. Seidman JD, Abbondanzo SL, 

Bratthauer GL (1995). Lipid cell (steroid 

cell) tumor of the ovary: immunophenotype 

with analysis of potential pitfall due to 

endogenous biotin-like activity. Int J 


2621. Seidman JD, Ashton M, Lefkowitz M 

(1996). Atypical apocrine adenosis of the 

breast: a clinicopathologic study of 37 

patients with 8.7-year follow-up. Cancer 

77: 2529-2537. 


2622. Seidman JD, Borkowski A, Aisner SC, 

Sun CC (1993). Rapid growth of pseudoangiomatous 

hyperplasia of mammary stroma 

in axillary gynecomastia in an immunosuppressed 

patient. Arch Pathol Lab Med 

117: 736-738. 

2623. Seidman JD, Elsayed AM, Sobin LH, 

Tavassoli FA (1993). Association of mucinous 

tumors of the ovary and appendix. A 



2624. Selim AG, Wells CA (1999). 

Immunohistochemical localisation of 

androgen receptor in apocrine metaplasia 

and apocrine adenosis of the breast: relation 

to oestrogen and progesterone receptors. 


2625. Seltzer VL, Levine A, Spiegel G, 

Rosenfeld D, Coffey EL (1990). 

Adenofibroma of the uterus: multiple 

recurrences following wide local excision. 


2626. Seltzer VL, Molho L, Fougner A, Hong 

P, Kereszti B, Gero M, Spitzer M (1988). 

Parovarian cystadenocarcinoma of lowmalignant 

potential. Gynecol Oncol 30: 216- 

221. 

2627. Semczuk A, Baranowski W, Berbec 

H, Marzec B, Skomra D, Miturski R (1999). 

Analysis of p53 and K-ras genes and their 

proteins in a sarcoma botryoides of the 

uterine cervix. Eur J Gynaecol Oncol 20: 

311-314. 

2628. Sengupta BS (1981). Vulval cancer 

following or co-existing with chronic granulomatous 

diseases of vulva. An analysis 

of its natural history, clinical manifestation 

and treatment. Trop Doct 11: 110-114. 

2629. Senzaki H, Kiyozuka Y, Mizuoka H, 

Yamamoto D, Ueda S, Izumi H, Tsubura A 

(1999). An autopsy case of hepatoid carcinoma 

of the ovary with PIVKA-II production: 

immunohistochemical study and liter - 

ature review. Pathol Int 49: 164-169. 

2630. Seong C, Kirby RW (1987). Leydig-cell 

tumour of the ovary en a multiple 

endocrine neoplasia syndrome. J Obstet 

Gynaecol 7: 295-296. 

2631. Serova OM, Mazoyer S, Puget N, 

Dubois V, Tonin P, Shugart YY, Goldgar D, 

Narod SA, Lynch HT, Lenoir GM (1997). 

Mutations in BRCA1 and BRCA2 in breast 

cancer families: are there more breast 

cancer-susceptibility genes? Am J Hum 

Genet 60: 486-495. 

2632. Shabb NS, Tawil A, Mufarrij A, Obeid 

S, Halabi J (1997). Mammary carcinoma 

with osteoclastlike giant cells cytologically 

mimicking benign breast disease. A case 

report. Acta Cytol 41: 1284-1288. 

2633. Shanks JH, Harris M, Banerjee SS, 

Eyden BP, Joglekar VM, Nicol A, Hasleton 

PS, Nicholson AG (2000). Mesotheliomas 

with deciduoid morphology: a morphologic 

spectrum and a variant not confined to 

young females. Am J Surg Pathol 24: 285- 

294. 

2634. Sharma A, Pratap M, Sawhney VM, 

Khan IU, Bhambhani S, Mitra AB (1999). 

Frequent amplification of C-erbB2 (HER- 

2/Neu) oncogene in cervical carcinoma as 

detected by non-fluorescence in situ 

hybridization technique on paraffin sections. 

Oncology 56: 83-87. 

2635. Shashi V, Golden WL, Kap-Herr C, 

Andersen WA, Gaffey MJ (1994). 

Interphase fluorescence in situ hybridization 

for trisomy 12 on archival ovarian sex 

cord-stromal tumors. Gynecol Oncol 55: 

349-354. 


2636. Shatz P, Bergeron C, Wilkinson EJ, 

Arseneau J, Ferenczy A (1989). Vulvar 

intraepithelial neoplasia and skin 

appendage involvement. Obstet Gynecol 

74: 769-774. 

2637. Shaw JA, Dabbs DJ, Geisinger KR 

(1992). Sclerosing stromal tumor of the 

ovary: an ultrastructural and immunohistochemical 

analysis with histogenetic considerations. 


2638. Sheikh MS, Rochefort H, Garcia M 

(1995). Overexpression of p21WAF1/CIP1 

induces growth arrest, giant cell formation 

and apoptosis in human breast carcinoma 

cell lines. Oncogene 11: 1899-1905. 

2639. Shen JT, d'Ablaing G, Morrow CP 

(1982). Alveolar soft part sarcoma of the 

vulva: report of first case and review of lit - 

erature. Gynecol Oncol 13: 120-128. 

2640. Shen T, Zhuang Z, Gersell DJ, 

Tavassoli FA (2000). Allelic Deletion of VHL 

Gene Detected in Papillary Tumors of the 

Broad Ligament, Epididymis, and 

Retroperitoneum in von Hippel-Lindau 

Disease Patients. Int J Surg Pathol 8: 207- 

212. 

2641. Shenson DL, Gallion HH, Powell DE, 

Pieretti M (1995). Loss of heterozygosity 

and genomic instability in synchronous 

endometrioid tumors of the ovary and 

endometrium. Cancer 76: 650-657. 

2642. Shepherd JH (1989). Revised FIGO 

staging for gynaecological cancer. Br J 


2643. Shepherd JJ, Wright DH (1967). 

Burkitt's tumour presenting as bilateral 

swelling of the breast in women of childbearing 

age. Br J Surg 54: 776-780. 

2644. Sheppard DG, Libshitz HI (2001). Postradiation 

sarcomas: a review of the clinical 

and imaging features in 63 cases. Clin 

Radiol 56: 22-29. 

2645. Sherman JE, Smith JW (1981). 

Neurofibromas of the breast and nippleareolar 

area. Ann Plast Surg 7: 302-307. 

2646. Sherman ME, Bitterman P, 

Rosenshein NB, Delgado G, Kurman RJ 

(1992). Uterine serous carcinoma. A morphologically 

diverse neoplasm with unifying 

clinicopathologic features. Am J Surg 

Pathol 16: 600-610. 

2647. Sherman ME, Bur ME, Kurman RJ 

(1995). p53 in endometrial cancer and its 

putative precursors: evidence for diverse 

pathways of tumorigenesis. Hum Pathol 26: 

1268-1274. 

2648. Sherman ME, Sturgeon S, Brinton LA, 

Potischman N, Kurman RJ, Berman ML, 

Mortel R, Twiggs LB, Barrett RJ, Wilbanks 

GD (1997). Risk factors and hormone levels 

in patients with serous and endometrioid 

uterine carcinomas. Mod Pathol 10: 963- 

968. 

2649. Sheth NA, Saruiya JN, Ranadive KJ, 

Sheth AR (1974). Ectopic production of 

human chorionic gonadotrophin by human 

breast tumours. Br J Cancer 30: 566-570. 

2650. Sheth S, Hamper UM, Kurman RJ 

(1993). Thickened endometrium in the postmenopausal 

woman: sonographic-pathologic 

correlation. Radiology 187: 135-139. 

2651. Sheu BC, Lin HH, Chen CK, Chao KH, 

Shun CT, Huang SC (1995). Synchronous 

primary carcinomas of the endometrium 

and ovary. Int J Gynaecol Obstet 51: 141- 

146. 

2652. Shevchuk MM, Fenoglio CM, Lattes 

R, Frick HC, Richart RM (1978). Malignant 

mixed tumor of the vagina probably arising 

in mesonephric rests. Cancer 42: 214-223. 

2653. Sheyn I, Mira JL, Bejarano PA, 

Husseinzadeh N (2000). Metastatic female 

adnexal tumor of probable Wolffian origin: 

a case report and review of the literature. 


2654. Shidara Y, Karube A, Watanabe M, 

Satou E, Uesaka Y, Matsuura T, Tanaka T 

(2000). A case report: verrucous carcinoma 

of the endometrium--the difficulty of 

diagnosis, and a review of the literature. J 

Obstet Gynaecol Res 26: 189-192. 

2655. Shigematsu T, Kamura T, Arima T, 

Wake N, Nakano H (2000). DNA polymorphism 

analysis of a pure non-gestational 

choriocarcinoma of the ovary: case report. 


2656. Shigeta H, Taga M, Kurogi K, 

Kitamura H, Motoyama T, Gorai I (1999). 

Ovarian strumal carcinoid with severe 

constipation: immunohistochemical and 

mRNA analyses of peptide YY. Hum Pathol 

30: 242-246. 

2657. Shih HA, Couch FJ, Nathanson KL, 

Blackwood MA, Rebbeck TR, Armstrong 

KA, Calzone K, Stopfer J, Seal S, Stratton 

MR, Weber BL (2002). BRCA1 and BRCA2 

mutation frequency in women evaluated in 

a breast cancer risk evaluation clinic. J 

Clin Oncol 20: 994-999. 

2 6 5 8 . Shih IM, Kurman RJ (1998). 

Epithelioid trophoblastic tumor: a neoplasm 

distinct from choriocarcinoma and 

placental site trophoblastic tumor simulat - 

ing carcinoma. Am J Surg Pathol 22: 1393- 

1403. 

2659. Shih IM, Kurman RJ (2001). The 

pathology of intermediate trophoblastic 

tumors and tumor-like lesions. Int J 


2660. Shiloh Y, Kastan MB (2001). ATM: 

genome stability, neuronal development, 

and cancer cross paths. Adv Cancer Res 

83: 209-254. 

2 6 6 1 . Shin SJ, DeLellis RA, Rosen PP 

(2001). Small cell carcinoma of the breast- 

-additional immunohistochemical studies. 


2662. Shin SJ, DeLellis RA, Ying L, Rosen 

PP (2000). Small cell carcinoma of the 

breast: a clinicopathologic and immunohistochemical 

study of nine patients. Am J 

Surg Pathol 24: 1231-1238. 

2663. Shin SJ, Kanomata N, Rosen PP 

(2000). Mammary carcinoma with prominent 

cytoplasmic lipofuscin granules mim - 

icking melanocytic differentiation. 


2664. Shivas AA, Douglas JG (1972). The 

prognostic significance of elastosis in 

breast carcinoma. J R Coll Surg Edinb 17: 

315-320. 

2665. Shokeir MO, Noel SM, Clement PB 

(1996). Malignant mullerian mixed tumor of 

the uterus with a prominent alpha-fetoprotein-producing 

component of yolk sac 

tumor. Mod Pathol 9: 647-651. 

2666. Shoker BS, Jarvis C, Clarke RB, 

Anderson E, Munro C, Davies MP, Sibson 

DR, Sloane JP (2000). Abnormal regulation 

of the oestrogen receptor in benign breast 

lesions. J Clin Pathol 53: 778-783. 

2667. Shoker BS, Jarvis C, Sibson DR, 

Walker C, Sloane JP (1999). Oestrogen 

receptor expression in the normal and precancerous 

breast. J Pathol 188: 237-244. 

2668. Shousha S, Backhous CM, 

Alaghband-Zadeh J, Burn I (1986). Alveolar 

variant of invasive lobular carcinoma of 

the breast. A tumor rich in estrogen receptors. 


2669. Shousha S, Coady AT, Stamp T, 

James KR, Alaghband-Zadeh J (1989). 

Oestrogen receptors in mucinous carcinoma 

of the breast: an immunohistological 

study using paraffin wax sections. J Clin 

Pathol 42: 902-905. 

2670. Shousha S, Schoenfeld A, Moss J, 

Shore I, Sinnett HD (1994). Light and electron 

microscopic study of an invasive cribriform 

carcinoma with extensive microcalcification 

developing in a breast with 

silicone augmentation. Ultrastruct Pathol 

18: 519-523. 

2671. Sieinski W (1989). Lipomatous 

neometaplasia of the uterus. Report of 11 

cases with discussion of histogenesis and 

pathogenesis. Int J Gynecol Pathol 8: 357- 

363. 

2 6 7 2 . Sigurdsson K, Hrafnkelsson J, 

Geirsson G, Gudmundsson J, Salvarsdottir 

A (1991). Screening as a prognostic factor 

in cervical cancer: analysis of survival and 

prognostic factors based on Icelandic 

population data, 1964-1988. Gynecol Oncol 

43: 64-70. 

2673. Sijmons RH, Kiemeney LA, Witjes JA, 

Vasen HF (1998). Urinary tract cancer and 

hereditary nonpolyposis colorectal cancer: 

risks and screening options. J Urol 

160: 466-470. 

2674. Sillman FH, Fruchter RG, Chen YS, 

Camilien L, Sedlis A, McTigue E (1997). 

Vaginal intraepithelial neoplasia: risk factors 

for persistence, recurrence, and invasion 

and its management. Am J Obstet 

Gynecol 176: 93-99. 

2675. Silva EG, Jenkins R (1990). Serous 

carcinoma in endometrial polyps. M o d 

Pathol 3: 120-128. 

2676. Silva EG, Robey-Cafferty SS, Smith 

TL, Gershenson DM (1990). Ovarian carcinomas 

with transitional cell carcinoma 

pattern. Am J Clin Pathol 93: 457-465. 

2677. Silva EG, Tornos C, Bailey MA, Morris 

M (1991). Undifferentiated carcinoma of 

the ovary. Arch Pathol Lab Med 115: 377- 

381. 

2678. Silver SA, Cheung AN, Tavassoli FA 

(1999). Oncocytic metaplasia and carcinoma 

of the endometrium: an immunohistochemical 

and ultrastructural study. Int J 


2679. Silver SA, Devouassoux-Shisheboran 

M, Mezzetti TP, Tavassoli FA (2001). 

Mesonephric adenocarcinomas of the 

uterine cervix: a study of 11 cases with 

immunohistochemical findings. Am J Surg 

Pathol 25: 379-387. 

2680. Silver SA, Tavassoli FA (1998). 

Mammary ductal carcinoma in situ with 

microinvasion. Cancer 82: 2382-2390. 

2 6 8 1 . Silver SA, Tavassoli FA (1998). 

Primary osteogenic sarcoma of the breast: 

a clinicopathologic analysis of 50 cases. 


2 6 8 2 . Silver SA, Tavassoli FA (2000). 

Glomus tumor arising in a mature teratoma 

of the ovary: report of a case simulating a 

metastasis from cervical squamous carcinoma. 


2683. Silver SA, Tavassoli FA (2000). 

Pleomorphic carcinoma of the breast: clinicopathological 

analysis of 26 cases of an 

unusual high-grade phenotype of ductal 

carcinoma. Histopathology 36: 505-514. 

2684. Silver SA, Wiley JM, Perlman EJ 

(1994). DNA ploidy analysis of pediatric 

germ cell tumors. Mod Pathol 7: 951-956. 

2685. Silverberg SG (1971). Brenner tumor 

of the ovary. A clinicopathologic study of 

60 tumors in 54 women. Cancer 28: 588- 

596.

2686. Silverberg SG (1999). Protocol for the 

examination of specimens from patients 

with carcinomas of the endometrium: a 

basis for checklists. Cancer Committee, 

College of American Pathologists. Arch 


2687. Silverberg SG (2000). Histopathologic 

grading of ovarian carcinoma: a review 

and proposal. Int J Gynecol Pathol 19: 7-15. 

2688. Silverberg SG (2000). Problems in the 

differential diagnosis of endometrial 

hyperplasia and carcinoma. Mod Pathol 

13: 309-327. 

2689. Silverberg SG, Chitale AR (1973). 

Assessment of significance of proportions 

of intraductal and infiltrating tumor growth 

in ductal carcinoma of the breast. Cancer 

32: 830-837. 

2690. Silverberg SG, Kay S, Koss LG (1971). 

Postmastectomy lymphangiosarcoma: 

ultrastructural observations. Cancer 27: 

100-108. 

2691. Silverberg SG, Kurman RJ (1992). 

Atlas of Tumour Pathology. Tumours of the 

uterine corpus and gestational trophoblastic 

disease, AFIP: Washington DC. 

2692. Silverberg SG, Major FJ, Blessing JA, 

Fetter B, Askin FB, Liao SY, Miller A (1990). 

Carcinosarcoma (malignant mixed mesodermal 

tumor) of the uterus. A Gynecologic 

Oncology Group pathologic study of 203 


2693. Silverberg SG, Willson MA, Board JA 

(1971). Hemangiopericytoma of the uterus: 

an ultrastructural study. Am J Obstet 

Gynecol 110: 397-404. 

2694. Silverman EM, Oberman HA (1974). 

Metastatic neoplasms in the breast. Surg 


2695. Silverstein MJ, Gierson ED, Colburn 

WJ, Rosser RJ, Waisman JR, Gamagami P 

(1991). Axillary lymphadenectomy for intraductal 

carcinoma of the breast. S u r g 


2696. Silverstein MJ, Lewinsky BS, 

Waisman JR, Gierson ED, Colburn WJ, 

Senofsky GM, Gamagami P (1994). 

Infiltrating lobular carcinoma. Is it different 

from infiltrating duct carcinoma? Cancer 

73: 1673-1677. 

2697. Simkin PH, Ramirez LA, Zweizig SL, 

Afonso SA, Fraire AE, Khan A, Dunn AD, 

Dunn JT, Braverman LE (1999). 

Monomorphic teratoma of the ovary: a rare 

cause of triiodothyronine toxicosis. 

Thyroid 9: 949-954. 

2698. Simpson JF, Page DL, Dupont WD 

(1990). Apocrine adenosis - a mimmic of 

mammary carcinoma. Surgical Pathology 

3: 289-299. 

2699. Simpson JF, Page DL, Dupont WD 

(1990). Apocrine adenosis - an occasional 

mimicker of breast carcinoma. Mod Pathol 

3. 

2700. Simpson JF, Quan DE, O'Malley F, 

Odom-Maryon T, Clarke PE (1997). 

Amplification of CCND1 and expression of 

its protein product, cyclin D1, in ductal carcinoma 

in situ of the breast. Am J Pathol 

151: 161-168. 

2701. Simpson JL, Michael H, Roth LM 

(1998). Unclassified sex cord-stromal 

tumors of the ovary: a report of eight 

cases. Arch Pathol Lab Med 122: 52-55. 

2702. Simpson RH, Cope N, Skalova A, 

Michal M (1998). Malignant adenomyoepithelioma 

of the breast with mixed 

osteogenic, spindle cell, and carcinomatous 

differentiation. Am J Surg Pathol 22: 

631-636. 

2703. Simpson T, Thirlby RC, Dail DH (1992). 

Surgical treatment of ductal carcinoma in 

situ of the breast. 10- to 20-year follow-up. 

Arch Surg 127: 468-472. 

2704. Simsek T, Trak B, Tunc M, Karaveli S, 

Uner M, Sonmez C (1998). Primary pure 

choriocarcinoma of the ovary in reproduc - 

tive ages: a case report. Eur J Gynaecol 

Oncol 19: 284-286. 

2705. Singer A, Monaghan J (2000). Lower 

Genital Tract Precancer. Colposcopy, 

Pathology and Treatment. 2nd ed. 

Blackwell Science Ltd: Oxford. 

2706. Singer G, Kurman RJ, Chang HW, Cho 

SK, Shih I (2002). Diverse tumorigenic pathways 

in ovarian serous carcinoma. Am J 

Pathol 160: 1223-1228. 

2707. Singer G, Oldt R, III, Cohen Y, Wang 

BG, Sidransky D, Kurman RJ, Shih I (2003). 

Mutations in BRAF and KRAS characterize 

the development of low-grade ovarian 

serous carcinoma. J Natl Cancer Inst 95: 

484-486. 

2708. Singh TT, Hopkins MP, Price J, 

Schuen R (1992). Myxoid liposarcoma of 

the broad ligament. Int J Gynecol Cancer 2: 

220-223. 

2709. Singhal S, Sharma S, De S, Kumar L, 

Chander S, Rath GK, Gupta SD (1990). Adult 

embryonal rhabdomyosarcoma of the vagina 

complicating pregnancy: a case report 

and review of the literature. Asia Oceania 


2710. Sinkre P, Albores-Saavedra J, Miller 

DS, Copeland LJ, Hameed A (2000). 

Endometrial endometrioid carcinomas 

associated with Ewing sarcoma/peripheral 

primitive neuroectodermal tumor. Int J 


2711. Sinkre P, Miller DS, Milchgrub S, 

Hameed A (2000). Adenomyofibroma of the 

endometrium with skeletal muscle differentiation. 


2712. Sinniah R, O'Brien FV (1973). 

Pigmented progonoma in a dermoid cyst of 

the ovary. J Pathol 109: 357-359. 

2713. Siriaunkgul S, Robbins KM, 

McGowan L, Silverberg SG (1995). Ovarian 

mucinous tumors of low malignant potential: 

a clinicopathologic study of 54 tumors 

of intestinal and mullerian type. Int J 


2714. Sirota RL, Dickersin GR, Scully RE 

(1981). Mixed tumors of the vagina. A clini - 

copathological analysis of eight cases.Am 


2715. Sit AS, Price FV, Kelley JL, Comerci 

JT, Kunschner AJ, Kanbour-Shakir A, 

Edwards RP (2000). Chemotherapy for 

malignant mixed Mullerian tumors of the 

ovary. Gynecol Oncol 79: 196-200. 

2 7 1 6 . Sjostedt S, Whalen T (1961). 

Prognosis of granulosa cell tumours. Acta 

Obstet Gynecol Scand 40(suppl 6): 3-26. 

2717. Skelton H, Smith KJ (2001). Spindle 

cell epithelioma of the vagina shows 

immunohistochemical staining supporting 

its origin from a primitive/progenitor cell 

population. Arch Pathol Lab Med 125: 547- 

550. 

2718. Skinnider BF, Clement PB, 

MacPherson N, Gascoyne RD, Viswanatha 

DS (1999). Primary non-Hodgkin's lymphoma 

and malakoplakia of the vagina: a 

case report. Hum Pathol 30: 871-874. 

2719. Slamon DJ, Clark GM, Wong SG, 

Levin WJ, Ullrich A, McGuire WL (1987). 

Human breast cancer: correlation of 

relapse and survival with amplification of 

the HER-2/neu oncogene. Science 2 3 5 : 

177-182. 

2720. Slanetz PJ, Whitman GJ, Halpern EF, 

Hall DA, McCarthy KA, Simeone JF (1997). 

Imaging of fallopian tube tumors. AJR Am 

J Roentgenol 169: 1321-1324. 

2720a. Slattery ML, Kerber RA (1993). A 

comprehensive evaluation of family history 

and breast cancer risk. The Utah 

Population Database. JAMA 270: 1563- 

1568. 

2721. Sloan D (1988). Diagnosis of a tumor 

with an unusual presentation in the pelvis. 


2722. Sloane JP (2001). Biopsy Pathology 

of the Breast. 2nd ed. Arnold: London. 

2723. Sloane JP, Amendoeira I, 



Connolly CE, Dervan P, Eusebi V, De 

Miguel C, Drijkoningen M, Elston CW, 

Faverley D, Gad A, Jacquemier J, Lacerda 

M, Martinez-Penuela J, Munt C, Peterse 

JL, Rank F, Sylvan M, Tsakraklides V, 

Zafrani B (1998). Consistency achieved by 

23 European pathologists in categorizing 

ductal carcinoma in situ of the breast 

using five classifications. European 

Commission Working Group on Breast 

Screening Pathology. Hum Pathol 29: 1056- 

1062. 

2724. Sloane JP, Amendoeira I, 



Connolly CE, Eusebi V, De Miguel C, 

Dervan P, Drijkoningen R, Elston CW, 

Faverly D, Gad A, Jacquemier J, Lacerda 

M, Martinez-Penuela J, Munt C, Peterse 

JL, Rank F, Sylvan M, Tsakraklides V, 

Zafrani B (1999). Consistency achieved by 

23 European pathologists from 12 countries 

in diagnosing breast disease and 

reporting prognostic features of carcinomas. 

European Commission Working 

Group on Breast Screening Pathology. 


2725. Sloane JP, Mayers MM (1993). 

Carcinoma and atypical hyperplasia in 

radial scars and complex sclerosing 

lesions: importance of lesion size and 

patient age. Histopathology 23: 225-231. 

2726. Sloboda J, Zaviacic M, Jakubovsky J, 

Hammar E, Johnsen J (1998). 

Metastasizing adenocarcinoma of the 

female prostate (Skene's paraurethral 

glands). Histological and immunohistochemical 

prostate markers studies and 

first ultrastructural observation. P a t h o l 

Res Pract 194: 129-136. 

2727. Slomovitz BM, Caputo TA, Gretz HF, 

III, Economos K, Tortoriello DV, 

Schlosshauer PW, Baergen RN, Isacson C, 

Soslow RA (2002). A comparative analysis 

of 57 serous borderline tumors with and 

without a noninvasive micropapillary com - 

ponent. Am J Surg Pathol 26: 592-600. 

2728. Smit VT, Cornelisse CJ, De Jong D, 

Dijkshoorn NJ, Peters AA, Fleuren GJ 

(1988). Analysis of tumor heterogeneity in a 

patient with synchronously occurring 

female genital tract malignancies by DNA 

flow cytometry, DNA fingerprinting, and 

immunohistochemistry. Cancer 62: 1146- 

1152. 

2 7 2 9 . Smith-Warner SA, Spiegelman D, 

Yaun SS, van den Brandt PA, Folsom AR, 

Goldbohm RA, Graham S, Holmberg L, 

Howe GR, Marshall JR, Miller AB, Potter 

JD, Speizer FE, Willett WC, Wolk A, Hunter 

DJ (1998). Alcohol and breast cancer in 

women: a pooled analysis of cohort studies. 

JAMA 279: 535-540. 

2 7 3 0 . Smith BH, Taylor HB (1969). The 

occurrence of bone and cartilage in mammary 

tumors. Am J Clin Pathol 51: 610-618. 

2 7 3 1 . Smith DR, Ji CY, Goh HS (1996). 

Prognostic significance of p53 overexpression 

and mutation in colorectal adenocarcinomas. 

Br J Cancer 74: 216-223. 

2732. Smith HO, Qualls CR, Romero AR, 

Webb JC, Dorin MH, Padilla LA, Key CR 

(2002). Is there a difference in survival for 

IA1 and IA2 adenocarcinoma of the uterine 

cervix? Gynec Oncol 85: 229-241. 

2733. Smith J, Munoz N, Herrero R, Eluf- 

Neto J, Ngelangel C, Franceschi S, Bosch 

FX, Walboomers JM, Peeling RW (2002). 

Evidence for Chlamydia trachomatis as a 

human papillomavirus cofactor in the etiology 

of invasive cervical cancer in Brazil 

and the Philippines. J Infect Dis 185: 324- 

331. 

2734. Smith JS, Herrero R, Bosetti C, 

Munoz N, Bosch FX, Eluf-Neto J, 

Castellsague X, Meijer CJ, van den Brule 

AJ, Franceschi S, Ashley R (2002). Herpes 

simplex virus-2 as a human papillomavirus 

cofactor in the etiology of invasive cervical 

cancer. J Natl Cancer Inst 94: 1604-1613. 

2735. Smith TM, Lee MK, Szabo CI, Jerome 

N, McEuen M, Taylor M, Hood L, King MC 

(1996). Complete genomic sequence and 

analysis of 117 kb of human DNA containing 

the gene BRCA1. Genome Res 6: 1029- 

1049. 

2736. Smith YR, Quint EH, Hinton EL (1998). 

Recurrent benign mullerian papilloma of 

the cervix. J Pediatr Adolesc Gynecol 11: 

29-31. 

2737. Snyder RR, Norris HJ, Tavassoli F 

(1988). Endometrioid proliferative and low 

malignant potential tumors of the ovary. A 



2738. Soares J, Tomasic G, Bucciarelli E, 

Eusebi V (1994). Intralobular growth of 

myoepithelial cell carcinoma of the breast. 


2739. Sobin LH, Wittekind CH (1997). Breast 

Tumours in TNM. 5th ed. Wiley-Liss: New 

York. 

2740. Sodha N, Houlston RS, Bullock SL, 

Yuille MA, Chu C, Turner G, Eeles RA 

(2002). Increasing evidence that germline 

mutations in CHEK2 do not cause Li- 

Fraumeni syndrome. Hum Mutat 20: 460- 

462. 

2741. Sodha N, Houlston RS, Williams R, 

Yuille MA, Mangion J, Eeles RA (2002). A 

robust method for detecting CHK2/RAD53 

mutations in genomic DNA. Hum Mutat 19: 

173-177. 

2742. Sodha N, Williams R, Mangion J, 

Bullock SL, Yuille MR, Eeles RA (2000). 

Screening hCHK2 for mutations. Science 

289: 359. 

2743. Soga J, Osaka M, Yakuwa Y (2000). 

Carcinoids of the ovary: an analysis of 329 

reported cases. J Exp Clin Cancer Res 19: 

271-280. 

2 7 4 4 . Solin LJ, Fowble BL, Yeh IT, 

Kowalyshyn MJ, Schultz DJ, Weiss MC, 

Goodman RL (1992). Microinvasive ductal 

carcinoma of the breast treated with 

breast-conserving surgery and definitive 

irradiation. Int J Radiat Oncol Biol Phys 23: 

961-968. 

2745. Somasundaram K, Zhang H, Zeng YX, 

Houvras Y, Peng Y, Zhang H, Wu GS, Licht 

JD, Weber BL, El Deiry WS (1997). Arrest of 

the cell cycle by the tumour-suppressor 

BRCA1 requires the CDK-inhibitor 

p21WAF1/CiP1. Nature 389: 187-190. 


2746. Somerville JE, Clarke LA, Biggart JD 

(1992). c-erbB-2 overexpression and histological 

type of in situ and invasive breast 

carcinoma. J Clin Pathol 45: 16-20. 

2747. Sonnendecker HE, Cooper K, Kalian 

KN (1994). Primary fallopian tube adenocarcinoma 

in situ associated with adjuvant 

tamoxifen therapy for breast carcinoma. 


2748. Sonoda Y, Saigo PE, Federici MG, 

Boyd J (2000). Carcinosarcoma of the 

ovary in a patient with a germline BRCA2 

mutation: evidence for monoclonal origin. 


2749. Sood AK, Sorosky JI, Gelder MS, 

Buller RE, Anderson B, Wilkinson EJ, 

Benda JA, Morgan LS (1998). Primary ovarian 

sarcoma: analysis of prognostic variables 

and the role of surgical cytoreduction. 

Cancer 82: 1731-1737. 

2 7 5 0 . Soomro S, Shousha S, Taylor P, 

Shepard HM, Feldmann M (1991). c-erbB-2 

expression in different histological types of 

invasive breast carcinoma. J Clin Pathol 

44: 211-214. 

2751. Sorbe B, Risberg B, Thornthwaite J 

(1994). Nuclear morphometry and DNA 

flow cytometry as prognostic methods for 

endometrial carcinoma. Int J Gynecol 

Cancer 4: 94-100. 

2752. Sordillo PP, Chapman R, Hajdu SI, 

Magill GB, Golbey RB (1981). Lymphangiosarcoma. 

Cancer 48: 1674-1679. 

2753. Soreide JA, Anda O, Eriksen L, Holter 

J, Kjellevold KH (1988). Pleomorphic adenoma 

of the human breast with local 


2754. Sorensen FB, Paulsen SM (1987). 

Glycogen-rich clear cell carcinoma of the 

breast: a solid variant with mucus. A light 

microscopic, immunohistochemical and 

ultrastructural study of a case. 


2755. Sorensen HT, Friis S, Olsen JH, 

Thulstrup AM, Mellemkjaer L, Linet M, 

Trichopoulos D, Vilstrup H, Olsen J (1998). 

Risk of breast cancer in men with liver cir - 

rhosis. Am J Gastroenterol 93: 231-233. 

2756. Sorlie T, Perou CM, Tibshirani R, Aas 

T, Geisler S, Johnsen H, Hastie T, Eisen 

MB, van de Rijn M, Jeffrey SS, Thorsen T, 

Quist H, Matese JC, Brown PO, Botstein D, 

Eystein LP, Borresen-Dale AL (2001). Gene 

expression patterns of breast carcinomas 

distinguish tumor subclasses with clinical 

implications. Proc Natl Acad Sci USA 98: 

10869-10874. 

2757. Sorlie T, Tibshirani R, Parker J, Hastie 

T, Marron JS, Nobel A, Deng S, Johnsen H, 

Pesich R, Geisler S, Demeter J, Perou CM, 

Lonning PE, Brown PO, Borresen-Dale AL, 

Botstein D (2003). Repeated observation of 

breast tumor subtypes in independent 

gene expression data sets. Proc Natl Acad 

Sci USA 100: 8418-8423. 

2758. Soslow RA, Rouse RV, Hendrickson 

MR, Silva EG, Longacre TA (1996). 

Transitional cell neoplasms of the ovary 

and urinary bladder: a comparative 

immunohistochemical analysis. Int J 


2759. Soussi T (1996). The p53 tumour suppressor 

gene: a model for molecular epidemiology 

of human cancer. Mol Med 

Today 2: 32-37. 

2760. Soussi T, Beroud C (2001). Assessing 

TP53 status in human tumours to evaluate 

clinical outcome. Nat Rev Cancer 1: 233- 

240. 


2761. Soussi T, Dehouche K, Beroud C 

(2000). p53 website and analysis of p53 

gene mutations in human cancer: forging a 

link between epidemiology and carcinogenesis. 

Hum Mutat 15: 105-113. 

2762. Spagnolo DV, Shilkin KB (1983). 

Breast neoplasms containing bone and 

cartilage. Virchows Arch A Pathol Anat 


2763. Spatz A, Bouron D, Pautier P, 

Castaigne D, Duvillard P (1998). Primary 

yolk sac tumor of the endometrium: a case 



2764. Spiegel GW (1995). Endometrial carcinoma 

in situ in postmenopausal women. 


2765. Spitz DJ, Reddy VB, Gattuso P (1999). 

Fine-needle aspiration of pseudoangioma - 

tous stromal hyperplasia of the breast. 

Diagn Cytopathol 20: 323-324. 

2766. Spitzer M (1999). Lower genital tract 

intraepithelial neoplasia in HIV-infected 

women: guidelines for evaluation and 

management. Obstet Gynecol Surv 54: 131- 

137. 

2767. Sreenan JJ, Hart WR (1995). 

Carcinosarcomas of the female genital 

tract. A pathologic study of 29 metastatic 

tumors: further evidence for the dominant 

role of the epithelial component and the 

conversion theory of histogenesis. Am J 


2768. Srigley JR, Colgan TJ (1988). 

Multifocal and diffuse adenomatoid tumor 

involving uterus and fallopian tube. 


2769. Srivatsa PJ, Keeney GL, Podratz KC 

(1994). Disseminated cervical adenoma 

malignum and bilateral ovarian sex cord 

tumors with annular tubules associated 

with Peutz-Jeghers syndrome. G y n e c o l 

Oncol 53: 256-264. 

2 7 7 0 . Ssali JC, Gakwaya A, Katongole- 

Mbidde F (1995). Risk factors for breast 

cancer in Ugandan women: a case-control 

study. East Central Afr J Surg 1: 9-13. 

2771. Staebler A, Heselmeyer-Haddad K, 

Bell K, Riopel M, Perlman E, Ried T, 

Kurman RJ (2002). Micropapillary serous 

carcinoma of the ovary has distinct patterns 

of chromosomal imbalances by comparative 

genomic hybridization compared 

with atypical proliferative serous tumors 

and serous carcinomas. Hum Pathol 33: 47- 

59. 

2772. Staebler A, Lax SF, Ellenson LH 

(2000). Altered expression of hMLH1 and 

hMSH2 protein in endometrial carcinomas 

with microsatellite instability. Hum Pathol 

31: 354-358. 

2773. Stalsberg H, Blom PE, Bostad LH, 

Westgaard G (1983). An International 

Survey of Distributions of Histologic Types 

of Tumours of the Testis and Ovary 

(Ovarian tumours and endometriosis in 

Norway General Hospital material). UICC: 

Geneva. 

2774. Stambolic V, Suzuki A, de la Pompa 

JL, Brothers GM, Mirtsos C, Sasaki T, 

Ruland J, Penninger JM, Siderovski DP, 

Mak TW (1998). Negative regulation of 

PKB/Akt-dependent cell survival by the 

tumor suppressor PTEN. Cell 95: 29-39. 

2775. Stankovic T, Kidd AM, Sutcliffe A, 

McGuire GM, Robinson P, Weber P, 

Bedenham T, Bradwell AR, Easton DF, 

Lennox GG, Haites N, Byrd PJ, Taylor AM 

(1998). ATM mutations and phenotypes in 

ataxia-telangiectasia families in the British 

Isles: expression of mutant ATM and the 

risk of leukemia, lymphoma, and breast 

cancer. Am J Hum Genet 62: 334-345. 

2775a. Stapleton JJ, Holser MH, Linder LE 

(1981). Paramesonephric papillary serous 

cystadenocarcinoma. A case report with 

scanning electron microscopy. Acta Cytol 

25: 310-316. 

2776. Starink TM, van der Veen JP, Arwert 

F, de Waal LP, de Lange GG, Gille JJ, 

Eriksson AW (1986). The Cowden syndrome: 

a clinical and genetic study in 21 

patients. Clin Genet 29: 222-233. 

2777. Steck PA, Pershouse MA, Jasser SA, 

Yung WK, Lin H, Ligon AH, Langford LA, 

Baumgard ML, Hattier T, Davis T, Frye C, 

Hu R, Swedlund B, Teng DH, Tavtigian SV 

(1997). Identification of a candidate tumour 

suppressor gene, MMAC1, at chromosome 

10q23.3 that is mutated in multiple 

advanced cancers. Nat Genet 15: 356-362. 

2778. Steeper TA, Piscioli F, Rosai J (1983). 

Squamous cell carcinoma with sarcomalike 

stroma of the female genital tract. 

Clinicopathologic study of four cases. 

Cancer 52: 890-898. 

2779. Steeper TA, Rosai J (1983). 

Aggressive angiomyxoma of the female 

pelvis and perineum. Report of nine cases 

of a distinctive type of gynecologic soft-tissue 

neoplasm. Am J Surg Pathol7: 463-475. 

2780. Steeper TA, Wick MR (1986). Minimal 

deviation adenocarcinoma of the uterine 

cervix ("adenoma malignum"). An immunohistochemical 

comparison with microglandular 

endocervical hyperplasia and conventional 

endocervical adenocarcinoma. 

Cancer 58: 1131-1138. 

2781. Stefani M, Speranza N (1970). [A case 

of cylindroma of the vagina]. Riv Anat 

Patol Oncol 36: 77-105. 

2782. Stehman FB, Bundy BN, Disaia PJ, 

Keys HM, Larson JE, Fowler WC (1991). 

Carcinoma of the cervix treated with radiation 

therapy. I. A multi-variate analysis of 

prognostic variables in the Gynecologic 

Oncology Group. Cancer 67: 2776-2785. 

2783. Stehman FB, Bundy BN, Dvoretsky 

PM, Creasman WT (1992). Early stage I 

carcinoma of the vulva treated with ipsilateral 

superficial inguinal lymphadenectomy 

and modified radical hemivulvectomy: a 

prospective study of the Gynecologic 

Oncology Group. Obstet Gynecol 79: 490- 

497. 

2784. Steingaszner LC, Enzinger FM, Taylor 

HB (1965). Hemangiosarcoma of the 


2785. Stenkvist B, Bengtsson E, Dahlqvist 

B, Eklund G, Eriksson O, Jarkrans T, Nordin 

B (1982). Predicting breast cancer recurrence. 

Cancer 50: 2884-2893. 

2786. Stenwig JT, Hazekamp JT, Beecham 

JB (1979). Granulosa cell tumors of the 

ovary. A clinicopathological study of 118 

cases with long-term follow-up. Gynecol 

Oncol 7: 136-152. 

2787. Stephenson TJ, Mills PM (1986). 

Adenomatoid tumours: an immunohistochemical 

and ultrastructural appraisal of 

their histogenesis. J Pathol 148: 327-335. 

2788. Sternberg WH, Barclay DL (1966). 

Luteoma of pregnancy. Am J Obstet 

Gynecol 95: 165-184. 

2789. Sternberg WH, Roth LM (1973). 

Ovarian stromal tumors containing Leydig 

cells. I. Stromal-Leydig cell tumor and nonneoplastic 

transformation of ovarian stroma 

to Leydig cells. Cancer 32: 940-951. 

2790. Stettner AR, Hartenbach EM, Schink 

JC, Huddart R, Becker J, Pauli R, Long R, 

Laxova R (1999). Familial ovarian germ cell 

cancer: report and review. Am J Med 

Genet 84: 43-46. 

2791. Stevens RG (1987). Electric power 

use and breast cancer: a hypothesis. Am J 

Epidemiol 125: 556-561. 

2792. Stewart CJ, Nandini CL, Richmond JA 

(2000). Value of A103 (melan-A) immunostaining 

in the differential diagnosis of ovarian 

sex cord stromal tumours.J Clin Pathol 

53: 206-211. 

2793. Stewart FW, Treves N (1949). 

Lymphangiosarcoma in postmastectomy 

lymphedema. A report of six cases of elephantiasis 

chirurgica. Cancer 1: 64-81. 

2794. Stock RJ, Zaino R, Bundy BN, Askin 

FB, Woodward J, Fetter B, Paulson JA, 

Disaia PJ, Stehman FB (1994). Evaluation 

and comparison of histopathologic grading 

systems of epithelial carcinoma of the 

uterine cervix: Gynecologic Oncology 

Group studies. Int J Gynecol Pathol 13: 99- 

108. 

2795. Stocks LH, Patterson FM (1976). 

Inflammatory carcinoma of the breast. 


2796. Stomper PC, Connolly JL (1992). 

Ductal carcinoma in situ of the breast: correlation 

between mammographic calcification 

and tumor subtype. AJR Am J 

Roentgenol 159: 483-485. 

2797. Stone GC, Bell DA, Fuller A, Dickersin 

GR, Scully RE (1986). Malignant schwannoma 

of the ovary. Report of a case. Cancer 

58: 1575-1582. 

2798. Storm HH, Jensen OM (1986). Risk of 

contralateral breast cancer in Denmark 

1943-80. Br J Cancer 54: 483-492. 

2799. Storm HH, Olsen J (1999). Risk of 

breast cancer in offspring of male breastcancer 

patients. Lancet 353: 209. 

2800. Stratton JF, Gayther SA, Russell P, 

Dearden J, Gore M, Blake P, Easton D, 

Ponder BA (1997). Contribution of BRCA1 

mutations to ovarian cancer. N Engl J Med 

336: 1125-1130. 

2801. Stratton JF, Pharoah P, Smith SK, 

Easton D, Ponder BA (1998). A systematic 

review and meta-analysis of family history 

and risk of ovarian cancer. Br J Obstet 

Gynaecol 105: 493-499. 

2802. Stratton JF, Thompson D, Bobrow L, 

Dalal N, Gore M, Bishop DT, Scott I, Evans 

G, Daly P, Easton DF, Ponder BA (1999). 

The genetic epidemiology of early-onset 

epithelial ovarian cancer: a populationbased 

study. Am J Hum Genet 65: 1725- 

1732. 

2803. Straughn JM Jr., Richter HE, Conner 

MG, Meleth S, Barnes MN (2001). 

Predictors of outcome in small cell carcinoma 

of the cervix--a case series. 


2804. Sturgeon SR, Brinton LA, Devesa SS, 

Kurman RJ (1992). In situ and invasive vulvar 

cancer incidence trends (1973 to 1987). 


2805. Sturgeon SR, Sherman ME, Kurman 

RJ, Berman ML, Mortel R, Twiggs LB, 

Barrett RJ, Wilbanks GD, Brinton LA (1998). 

Analysis of histopathological features of 

endometrioid uterine carcinomas and epidemiologic 

risk factors. Cancer Epidemiol 

Biomarkers Prev 7: 231-235.

2806. Stutz JA, Evans AJ, Pinder S, Ellis IO, 

Yeoman LJ, Wilson AR, Sibbering DM 

(1994). The radiological appearances of 

invasive cribriform carcinoma of the 

breast. Nottingham Breast Team. C l i n 

Radiol 49: 693-695. 

2807. Su TH, Wang JC, Tseng HH, Chang 

CP, Chang TA, Wei HJ, Chang JG (1998). 

Analysis of FHIT transcripts in cervical and 

endometrial cancers. Int J Cancer 76: 216- 

222. 

2808. Su Y, Swift M (2000). Mortality rates 

among carriers of ataxia-telangiectasia 

mutant alleles. Ann Intern Med 133: 770- 

778. 

2809. Su Y, Swift M (2001). Outcomes of 

adjuvant radiation therapy for breast cancer 

in women with ataxia-telangiectasia 

mutations. JAMA 286: 2233-2234. 

2810. Su YN, Cheng WF, Chen CA, Lin TY, 

Hsieh FJ, Cheng SP, Hsieh CY (1999). 

Pregnancy with primary tubal placental 

site trophoblastic tumor--A case report 

and literature review. Gynecol Oncol 73: 

322-325. 

2811. Suarez A, Palacios J, Burgos E, 

Gamallo C (1993). Signet-ring stromal 

tumor of the ovary: a histochemical, 


study. Virchows Arch A Pathol Anat 


2812. Suarez VD, Gimenez PA, Rio SM 

(1990). Vaginal rhabdomyoma and adenosis. 


2813. Sugiyama T, Ohta S, Nishida T, Okura 

N, Tanabe K, Yakushiji M (1998). Two cases 

of endometrial adenocarcinoma arising 

from atypical polypoid adenomyoma. 


2814. Sullivan JJ, Magee HR, Donald KJ 

(1977). Secretory (juvenile) carcinoma of 

the breast. Pathology 9: 341-346. 

2815. Sumpio BE, Jennings TA, Merino MJ, 

Sullivan PD (1987). Adenoid cystic carcinoma 

of the breast. Data from the 

Connecticut Tumor Registry and a review 

of the literature. Ann Surg 205: 295-301. 

2816. Suster S, Moran CA, Hurt MA (1991). 

Syringomatous squamous tumors of the 


2817. Suzuki A, de la Pompa JL, Stambolic 

V, Elia AJ, Sasaki T, del Barco Barrantes I, 

Ho A, Wakeham A, Itie A, Khoo W, 

Fukumoto M, Mak TW (1998). High cancer 

susceptibility and embryonic lethality 

associated with mutation of the PTEN 

tumor suppressor gene in mice. Curr Biol 8: 

1169-1178. 

2818. Swanson GP, Dobin SM, Arber JM, 

Arber DA, Capen CV, Diaz JA (1997). 

Chromosome 11 abnormalities in Bowen 

disease of the vulva. Cancer Genet 

Cytogenet 93: 109-114. 

2819. Swift M, Morrell D, Massey RB, 

Chase CL (1991). Incidence of cancer in 161 

families affected by ataxia-telangiectasia. 

N Engl J Med 325: 1831-1836. 

2820. Swift M, Reitnauer PJ, Morrell D, 

Chase CL (1987). Breast and other cancers 

in families with ataxia-telangiectasia. N 

Engl J Med 316: 1289-1294. 

2821. Switzer JM, Weckstein ML, Campbell 

LF, Curtis KL, Powaser JT (1984). Ovarian 

hydatidiform mole. J Ultrasound Med 3: 

471-473. 

2822. Sworn MJ, Hammond GT, Buchanan 

R (1979). Mixed mesenchymal sarcoma of 

the broad ligament: case report. Br J 


2823. Symonds RP, Habeshaw T, Paul J, 

Kerr DJ, Darling A, Burnett RA, Sotsiou F, 

Linardopoulos S, Spandidos DA (1992). No 

correlation between ras, c-myc and c-jun 

proto-oncogene expression and prognosis 

in advanced carcinoma of cervix. Eur J 

Cancer 28A: 1615-1617. 

2824. Szabo CI, King MC (1997). Population 

genetics of BRCA1 and BRCA2. Am J Hum 

Genet 60: 1013-1020. 

2825. Szabo CI, Wagner LA, Francisco LV, 

Roach JC, Argonza R, King MC, Ostrander 

EA (1996). Human, canine and murine 

BRCA1 genes: sequence comparison 

among species. Hum Mol Genet 5: 1289- 

1298. 

2 8 2 6 . Szarewski A, Cuzick J (1998). 

Smoking and cervical neoplasia: a review 

of the evidence. J Epidem Biostat 3: 229- 

256. 

2827. Szukala SA, Marks JR, Burchette JL, 

Elbendary AA, Krigman HR (1999). Coexpression 

of p53 by epithelial and stromal 

elements in carcinosarcoma of the female 

genital tract: an immunohistochemical 

study of 19 cases. Int J Gynecol Cancer 9: 

131-136. 

2828. Szulman AE, Surti U (1978). The syndromes 

of hydatidiform mole. I. 

Cytogenetic and morphologic correlations. 


2829. Szulman AE, Surti U (1978). The syndromes 

of hydatidiform mole. II. 

Morphologic evolution of the complete and 

partial mole. Am J Obstet Gynecol 132: 20- 

27. 

2830. Szych C, Staebler A, Connolly DC, Wu 

R, Cho KR, Ronnett BM (1999). Molecular 

genetic evidence supporting the clonality 

and appendiceal origin of Pseudomyxoma 

peritonei in women. Am J Pathol 154: 1849- 

1855. 

2831. Szyfelbein WM, Young RH, Scully RE 

(1994). Cystic struma ovarii: a frequently 

unrecognized tumor. A report of 20 cases. 


2832. Szyfelbein WM, Young RH, Scully RE 

(1995). Struma ovarii simulating ovarian 

tumors of other types. A report of 30 cases. 


2833. Tagaya N, Kodaira H, Kogure H, 

Shimizu K (1999). A case of phyllodes tumor 

with bloody nipple discharge in juvenile 

patient. Breast Cancer 6: 207-210. 

2834. Tai LH, Tavassoli FA (2002). 

Endometrial polyps with atypical (bizarre) 

stromal cells. Am J Surg Pathol 26: 505-509. 

2835. Takahashi M, Kigawa J, Ishihara K, 

Shimada M, Kamei T, Terakawa N (2002). 

Hydrotubation for diagnosing carcinoma in 

situ of the fallopian tube. A case report. 

Acta Cytol 46: 735-737. 

2836. Takahashi O, Shibata S, Hatazawa J, 

Takisawa J, Sato H, Ota H, Tanaka T (1998). 

Mature cystic teratoma of the uterine corpus. 

Acta Obstet Gynecol Scand 77: 936- 

938. 

2837. Takahashi T, Moriki T, Hiroi M, 

Nakayama H (1998). Invasive lobular carcinoma 

of the breast with osteoclastlike 

giant cells. A case report. Acta Cytol 42: 

734-741. 

2838. Takemori M, Nishimura R, Yasuda D, 

Sugimura K (1997). Carcinosarcoma of the 

uterus: magnetic resonance imaging. 


2839. Takeshima N, Tabata T, Nishida H, 

Furuta N, Tsuzuku M, Hirai Y, Hasumi K 

(2001). Peripheral primitive neuroectodermal 

tumor of the vulva: report of a case 

with imprint cytology. Acta Cytol 45: 1049- 

1052. 

2840. Takeuchi K, Murata K, Funaki K, Fujita 

I, Hayakawa Y, Kitazawa S (2000). 

Liposarcoma of the uterine cervix: case 

report. Eur J Gynaecol Oncol 21: 290-291. 

2841. Takeuchi S (1982). Nature of invasive 

mole and its rational management. Semin 

Oncol 9: 181-186. 

2842. Takeuchi S, Ishihara N, Ohbayashi C, 

Itoh H, Maruo T (1999). Stromal Leydig cell 

tumor of the ovary. Case report and literature 

review. Int J Gynecol Pathol 18: 178- 

182. 

2843. Talamonti MS (1996). Management of 

ductal carcinoma in situ. Semin Surg 

Oncol 12: 300-313. 

2 8 4 4 . Talerman A (1972). A distinctive 

gonadal neoplasm related to gonadoblastoma. 

Cancer 30: 1219-1224. 

2845. Talerman A (1972). A mixed germ 

cell-sex cord stroma tumor of the ovary in 

a normal female infant. Obstet Gynecol 40: 

473-478. 

2846. Talerman A (1974). Gonadoblastoma 

associated with embryonal carcinoma. 


2847. Talerman A (1980). The pathology of 

gonadal neoplasms composed of germ 

cells and sex cord stroma derivatives. 


2848. Talerman A (1994). Germ cell tumours 

of the ovary. In: Blaustein's Pathology of 

the Female Genital Tract, RJ Kurman (ed.), 

4th ed. Springer-Verlag: New York, pp. 

849-914. 

2849. Talerman A (2002). Mixed germ cellsex 

cord stromal tumours. In: Haines and 

Taylor, Gynaecological and Obstetrical 

Pathology, 5th ed. Churchill Livingstone: 

Edingburgh. 

2850. Talerman A (2002). Mixed germ cell 

tumors of the ovary. In: Blaustein's 

Pathology of the Female Genital Tract, RJ 

Kurman, A Blaustein (eds.), 5th ed. 

Springer Verlag: New York. 

2851. Talerman A, Auerbach WM, van 

Meurs AJ (1981). Primary chondrosarcoma 

of the ovary. Histopathology 5: 319-324. 

2852. Talerman A, van der Harten JJ (1977). 

Mixed germ cell-sex cord stroma tumor of 

the ovary associated with isosexual precocious 

puberty in a normal girl. Cancer 40: 

889-894. 

2853. Tallini G, Price FV, Carcangiu ML 

(1993). Epithelioid angiosarcoma arising in 

uterine leiomyomas. Am J Clin Pathol 100: 

514-518. 

2 8 5 4 . Tallini G, Vanni R, Manfioletti G, 

Kazmierczak B, Faa G, Pauwels P, 

Bullerdiek J, Giancotti V, Van den Berghe 

H, Dal Cin P (2000). HMGI-C and HMGI(Y) 

immunoreactivity correlates with cytogenetic 

abnormalities in lipomas, pulmonary 

chondroid hamartomas, endometrial 

polyps, and uterine leiomyomas and is 

compatible with rearrangement of the 

HMGI-C and HMGI(Y) genes. Lab Invest 

80: 359-369. 

2855. Talwar S, Prasad N, Gandhi S, Prasad 

P (1999). Haemangiopericytoma of the 

adult male breast. Int J Clin Pract 53: 485- 

486. 

2856. Tambouret R, Bell DA, Young RH 

(2000). Microcystic endocervical adenocarcinomas: 

a report of eight cases. Am J 


2 8 5 7 . Tamimi HK, Bolen JW (1984). 

Enchondromatosis (Ollier's disease) and 

ovarian juvenile granulosa cell tumor. 

Cancer 53: 1605-1608. 

2858. Tamura S, Enjoji M (1988). Elastosis in 

neoplastic and non-neoplastic tissues 

from patients with mammary carcinoma. 

Acta Pathol Jpn 38: 1537-1546. 

2859. Tanaka Y, Sasaki Y, Nishihira H, 

Izawa T, Nishi T (1992). Ovarian juvenile 

granulosa cell tumor associated with 

Maffucci's syndrome. Am J Clin Pathol 97: 

523-527. 

2860. Tang CK, Toker C, Ances IG (1979). 

Stromomyoma of the uterus. Cancer 43: 

308-316. 

2861. Tariel D, Body G, Fetissof F, Menard 

F, Lansac J (1986). [Postoperative vaginal 

pseudosarcoma. Apropos of a case]. J 

Gynecol Obstet Biol Reprod (Paris) 15: 769- 

771. 

2862. Taruscio D, Carcangiu ML, Ward DC 

(1993). Detection of trisomy 12 on ovarian 

sex cord stromal tumors by fluorescence 

in situ hybridization. Diagn Mol Pathol 2: 

94-98. 

2 8 6 3 . Tashiro H, Isacson C, Levine R, 

Kurman RJ, Cho KR, Hedrick L (1997). p53 

gene mutations are common in uterine 

serous carcinoma and occur early in their 

pathogenesis. Am J Pathol 150: 177-185. 

2864. Tasseron EW, van der Esch EP, Hart 

AA, Brutel de la Riviere G, Aartsen EJ 

(1992). A clinicopathological study of 30 

melanomas of the vulva. Gynecol Oncol 46: 

170-175. 

2 8 6 5 . Tateno H, Sasano N (1983). An 

International Survey of Distribution of 

Histologic Types Tumours of the Testis and 

Ovary (Ovarian Tumours in Sendai Japan. 

General Hospital Material). UICC 

Technical Report Series: Genova. 

2866. Tavassoli FA (1986). Melanotic paraganglioma 

of the uterus. Cancer 58: 942- 

948. 

2867. Tavassoli FA (1988). Serous tumor of 

low malignant potential with early stromal 

invasion (serous LMP with microinvasion). 

Mod Pathol 1: 407-414. 

2868. Tavassoli FA (1991). Myoepithelial 

lesions of the breast. Myoepitheliosis, adenomyoepithelioma, 

and myoepithelial carcinoma. 


2869. Tavassoli FA (1992). Carcinoma with 

osteoclastic giant cells. In: Pathology of 

the Breast, Appleton and Lange: Norwalk, 

Connecticut. 

2870. Tavassoli FA (1992). Glycogen-rich 

(clear-cell) carcinoma. In: Pathology of 

the Breast, Appleton and Lange: Norwalk, 

Connecticut . 

2871. Tavassoli FA (1992). Mesenchymal 

lesions. In: Pathology of the Breast, 

Tavassoli FA, ed., First edition ed. 

Appleton and Lange: Norwalk , pp. 557-558. 

2872. Tavassoli FA (1992). Metastatic carcinoma. 

In: Pathology of the Breast, 

Appleton and Lange: Norwalk, 

Connecticut. 

2873. Tavassoli FA (1992). Papillary lesions. 

In: Pathology of the Breast, Appleton and 

Lange: Stamford , pp. 193-228. 

2874. Tavassoli FA (1992). Pathology of the 

Breast. Appleton and Lange: Stanford. 

2875. Tavassoli FA (1999). Myoepithelial 

lesions. In: Pathology of the Breast, 2nd ed. 

Appleton and Lange: Hartford, pp. 763-791. 

2876. Tavassoli FA (1999). Pathology of the 

Breast. 2nd ed. Appleton-Lange: Stamford. 

2877. Tavassoli FA, Andrade R, Merino M 

(1990). Retiform wolffian adenoma. In: 

Progress in Surgical Pathology, C M 

Fenoglio-Preiser, M Wolfe, F Rilke (eds.), 

Field & Wood Medica Publishers inc: New 

York, pp. 121-136. 


2878. Tavassoli FA, Andradre R, Merino M 

(1990). Retiform wolffian adenoma. 

Progress in Surgical Pathology. Field & 

Wood Medical Publishers: New York. 

2879. Tavassoli FA, Norris HJ (1979). 

Smooth muscle tumors of the vagina. 


2 8 8 0 . Tavassoli FA, Norris HJ (1979). 

Smooth muscle tumors of the vulva. Obstet 

Gynecol 53: 213-217. 


Secretory carcinoma of the breast.Cancer 

45: 2404-2413. 

2882. Tavassoli FA, Norris HJ (1980). Sertoli 

tumors of the ovary. A clinicopathologic 

study of 28 cases with ultrastructural 

observations. Cancer 46: 2281-2297. 


Mesenchymal tumours of the uterus. VII. A 

clinicopathological study of 60 endometrial 

stromal nodules. Histopathology 5: 1-10. 


Microglandular adenosis of the breast. A 

clinicopathologic study of 11 cases with 

ultrastructural observations. Am J Surg 

Pathol 7: 731-737. 


Mammary adenoid cystic carcinoma with 

sebaceous differentiation. A morphologic 

study of the cell types. Arch Pathol Lab 

Med 110: 1045-1053. 

2886. Tavassoli FA, Norris HJ (1990). A 

comparison of the results of long-term follow-up 

for atypical intraductal hyperplasia 

and intraductal hyperplasia of the breast. 

Cancer 65: 518-529. 


Intraductal apocrine carcinoma: a clinicopathologic 

study of 37 cases.Mod Pathol 7: 

813-818. 

2888. Tavassoli FA, Purcell CA, Bratthauer 

GL, Man Y (1996). Androgen receptor 

expression along with loss of bcl-2, ER and 

PR expression in benign and malignant 

apocrine lesions of the breast: implications 

for therapy. Breast Jour 2: 261-269. 

2 8 8 9 . Tavassoli FA, Weiss S (1981). 

Hemangiopericytoma of the breast. Am J 


2890. Tavassoli FA, Yeh IT (1988). Surgical 

pathology of the ovary: a review of selected 

tumors. Mod Pathol 1: 140-167. 

2891. Tavtigian SV, Simard J, Rommens J, 

Couch F, Shattuck-Eidens D, Neuhausen S, 

Merajver S, Thorlacius S, Offit K, Stoppa- 

Lyonnet D, Belanger C, Bell R, Berry S, 

Bogden R, Chen Q, Davis T, Dumont M, 

Frye C, Hattier T, Jammulapati S, Janecki 

T, Jiang P, Kehrer R, Leblanc JF, Mitchell 

JT, McArthur Morrisson J, Nguyen K, Peng 

Y, Samson C, Shroeder M, Snyder SC, 

Steele L, Stringfellow M, Stroup C, 

Swedlund B, Swensen J, Teng D, Thomas 

A, Tran T, Tran T, Tranchant M, Weaver 

Feldhaus J, Wong AKC, Shizuya H, Eyfjord 

JE, Cannon Albright L, Labrie F, Skolnick 

MH, Weber B, Kamb A, Goldgar DE (1996). 

The complete BRCA2 gene and mutations 

in chromosome 13q-linked kindreds. Nat 

Genet 12: 333-337. 

2892. Taxy JB, Trujillo YP (1994). Breast 

cancer metastatic to the uterus. Clinical 

manifestations of a rare event. A r c h 


2893. Taylor CE, Tuttle HK (1944). 

Melanocarcinoma of the cervix uteri and 

vaginal vault. Arch Pathol 38: 60-61. 

2894. Taylor HB, Robertson A.G. (1965). 

Adenomas of the nipple. Cancer 18: 995- 

1002. 


2894a. Taylor HCJ (1929). Malignant and 

semimalignant tumors of the ovary. Surg 


2895. Taylor RN, Lacey CG, Shuman MA 

(1985). Adenocarcinoma of Skene's duct 

associated with a systemic coagulopathy. 


2896. Teilum G (1965). Endodermal sinus of 

the ovary and testis: comparative morpho - 

genesis of the so-called mesonephroma 

ovarii (Schiller) and extraembryonic (yolk 

sac allantoic) structures of the rat's palcenta. 

Cancer 12: 1091-1105. 

2897. Teixeira MR, Kristensen GB, Abeler 

VM, Heim S (1999). Karyotypic findings in 

tumors of the vulva and vagina. Cancer 

Genet Cytogenet 111: 87-91. 

2898. Tempany CM, Zou KH, Silverman SG, 

Brown DL, Kurtz AB, McNeil BJ (2000). 

Staging of advanced ovarian cancer: comparison 

of imaging modalities--report from 

the Radiological Diagnostic Oncology 

Group. Radiology 215: 761-767. 

2899. Terada S, Suzuki N, Uchide K, Shozu 

M, Akasofu K (1993). Parovarian fibroma 

with heterotopic bone formation of probable 

wolffian origin. Gynecol Oncol 50: 115- 

118. 

2900. Terzakis JA, Opher E, Melamed J, 

Santagada E, Sloan D (1990). Pigmented 

melanocytic schwannoma of the uterine 

cervix. Ultrastruct Pathol 14: 357-366. 

2901. Tetu B, Bonenfant JL (1991). Ovarian 

myxoma. A study of two cases with longterm 

follow-up. Am J Clin Pathol 95: 340- 

346. 

2902. Tetu B, Silva EG, Gershenson DM 

(1987). Squamous cell carcinoma of the 

ovary. Arch Pathol Lab Med 111: 864-866. 

2903. Tewari K, Cappuccini F, Disaia PJ, 

Berman ML, Manetta A, Kohler MF (2000). 

Malignant germ cell tumors of the ovary. 


2904. Thakur S, Zhang HB, Peng Y, Le H, 

Carroll B, Ward T, Yao J, Farid LM, Couch 

FJ, Wilson RB, Weber BL (1997). 

Localization of BRCA1 and a splice variant 

identifies the nuclear localization signal. 

Mol Cell Biol 17: 444-452. 

2905. The European Commission (1996). 

European Guidelines for Quality 

Assurance in Mammography Screening. 

2nd ed. The European Commission: 

Luxembourg. 

2906. Thomas DB, Jimenez LM, McTiernan 

A, Rosenblatt K, Stalsberg H, Stemhagen 

A, Thompson WD, Curnen MG, Satariano 

W, Austin DF, et al. (1992). Breast cancer in 

men: risk factors with hormonal implications. 


2907. Thomas EJ, Campbell IG (2000). 

Molecular genetic defects in endometriosis. 

Gynecol Obstet Invest 50 Suppl 1: 44- 

50. 

2908. Thomas GM (2000). Concurrent 

chemotherapy and radiation for locally 

advanced cervical cancer: the new standard 

of care. Semin Radiat Oncol 10: 44-50. 

2909. Thomas HV, Key TJ, Allen DS, Moore 

JW, Dowsett M, Fentiman IS, Wang DY 

(1997). A prospective study of endogenous 

serum hormone concentrations and breast 

cancer risk in premenopausal women on 

the island of Guernsey. Br J Cancer 75: 

1075-1079. 

2910. Thomas JP, Timbal Y, Wannin G, 

Dumurgier C (1973). [Schwannoglioma of 

the broad ligament]. J Urol Nephrol (Paris) 

79: 933-935. 

2911. Thomas M, Pim D, Banks L (1999). 

The role of the E6-p53 interaction in the 

molecular pathogenesis of HPV. 

Oncogene 18: 7690-7700. 

2912. Thomas NA, Choong DY, Jokubaitis 

VJ, Neville PJ, Campbell IG (2001). 

Mutation of the ST7 tumor suppressor 

gene on 7q31.1 is rare in breast, ovarian 

and colorectal cancers. Nat Genet 29: 379- 

380. 

2912a. Thomason RW, Rush W, Dave H 

(1995). Transitional cell carcinoma arising 

within a paratubal cyst: report of a case. 


2913. Thompson D, Easton D (2001). 

Variation in cancer risks, by mutation position, 

in BRCA2 mutation carriers. Am J 

Hum Genet 68: 410-419. 

2914. Thompson D, Easton D (2002). 

Variation in BRCA1 cancer risks by mutation 

position. Cancer Epidemiol Biomarkers 

Prev 11: 329-336. 

2915. Thompson D, Easton DF (2002). 

Cancer incidence in BRCA1 mutation carriers. 


2916. Thompson M, Husemeyer R (1981). 

Carcinofibroma--a variant of the mixed 

Mullerian tumour. Case report. Br J Obstet 

Gynaecol 88: 1151-1155. 

2917. Thompson ME, Jensen RA, 

Obermiller PS, Page DL, Holt JT (1995). 

Decreased expression of BRCA1 accelerates 

growth and is often present during 

sporadic breast cancer progression. Nat 

Genet 9: 444-450. 

2918. Thompson WD, Schildkraut JM 

(1991). Family history of gynaecological 

cancers: relationships to the incidence of 

breast cancer prior to age 55. Int J 

Epidemiol 20: 595-602. 

2919. Thor AD, Young RH, Clement PB 

(1991). Pathology of the fallopian tube, 

broad ligament, peritoneum, and pelvic 

soft tissues. Hum Pathol 22: 856-867. 

2920. Thorlacius S, Sigurdsson S, 

Bjarnadottir H, Olafsdottir G, Jonasson JG, 

Tryggvadottir L, Tulinius H, Eyfjord JE 

(1997). Study of a single BRCA2 mutation 

with high carrier frequency in a small pop - 

ulation. Am J Hum Genet 60: 1079-1084. 

2921. Thorlacius S, Struewing JP, Hartge P, 

Olafsdottir GH, Sigvaldason H, 

Tryggvadottir L, Wacholder S, Tulinius H, 

Eyfjord JE (1998). Population-based study 

of risk of breast cancer in carriers of 

BRCA2 mutation. Lancet 352: 1337-1339. 

2922. Thurlbeck WM, Scully RE (1960). 

Solid teratoma of the ovary. A clinicopathological 


13: 804-811. 

2923. Tietze L, Gunther K, Horbe A, Pawlik 

C, Klosterhalfen B, Handt S, Merkelbach- 

Bruse S (2000). Benign metastasizing 

leiomyoma: a cytogenetically balanced but 

clonal disease. Hum Pathol 31: 126-128. 

2924. Tiltman AJ (1980). Adenomatoid 

tumours of the uterus. Histopathology 4: 

437-443. 

2925. Tiltman AJ (1998). Leiomyomas of the 

uterine cervix: a study of frequency. Int J 


2926. Tiltman AJ, Allard U (2001). Female 

adnexal tumours of probable Wolffian origin: 

an immunohistochemical study comparing 

tumours, mesonephric remnants 

and paramesonephric derivatives. 


2927. Tirkkonen M, Kainu T, Loman N, 

Johannsson OT, Olsson H, Barkardottir RB, 

Kallioniemi OP, Borg A (1999). Somatic 

genetic alterations in BRCA2-associated 

and sporadic male breast cancer. Genes 


2928. Tjarks M, Van Voorhis BJ (2000). 

Treatment of endometrial polyps. Obstet 

Gynecol 96: 886-889. 

2929. Tobon H, Murphy AI (1977). Benign 

blue nevus of the vagina. Cancer 40: 3174- 

3176. 

2930. Todorov S (1980). Polyposis of the 

uterine cervix. Jugosl Ginekol Opstet 19: 

183-186. 

2931. Tohya T, Katabuchi H, Fukuma K, 

Fujisaki S, Okamura H (1991). Angiosarcoma 

of the vagina. A light and electronmicroscopy 

study. Acta Obstet 

Gynecol Scand 70: 169-172. 

2932. Toikkanen S (1981). Primary squamous 

cell carcinoma of the breast. Cancer 

48: 1629-1632. 

2933. Toikkanen S, Eerola E, Ekfors TO 

(1988). Pure and mixed mucinous breast 

carcinomas: DNA stemline and prognosis. 


2934. Toikkanen S, Kujari H (1989). Pure 

and mixed mucinous carcinomas of the 

breast: a clinicopathologic analysis of 61 

cases with long-term follow-up. H u m 

Pathol 20: 758-764. 

2935. Toikkanen S, Pylkkanen L, Joensuu H 

(1997). Invasive lobular carcinoma of the 

breast has better short- and long-term survival 

than invasive ductal carcinoma. Br J 

Cancer 76: 1234-1240. 

2936. Toki T, Kurman RJ, Park JS, Kessis T, 

Daniel RW, Shah KV (1991). Probable nonpapillomavirus 

etiology of squamous cell 

carcinoma of the vulva in older women: a 

clinicopathologic study using in situ 

hybridization and polymerase chain reaction. 


2937. Toki T, Zhai Y-L, Park JS, Fujii S 

(1999). Infrequent occurence of high-risk 

human papillomavirus and of p53 mutation 

in minimal deviation adenocarcinoma of 

the cervix. Int J Gynecol Pathol 18: 215-219. 

2938. Tokunaga M, Land CE, Yamamoto T, 

Asano M, Tokuoka S, Ezaki H, Nishimori I 

(1987). Incidence of female breast cancer 

among atomic bomb survivors, Hiroshima 

and Nagasaki, 1950-1980. Radiat Res 112: 

243-272. 

2938a. Tommasino M (2001). Early genes of 

human papillomaviruses. In: Encyclopedic 

Reference of Cancer. Springer-Verlag: 

Heidelberg, p. 270. 

2939. Tonin P, Moslehi R, Green R, Rosen 

B, Cole D, Boyd N, Cutler C, Margolese R, 

Carter R, McGillivray B, Ives E, Labrie F, 

Gilchrist D, Morgan K, Simard J, Narod SA. 

(1995). Linkage analysis of 26 Canadian 

breast and breast-ovarian cancer families. 

Hum Genet 95: 545-550. 

2940. Topalovski M, Crisan D, Mattson JC 

(1999). Lymphoma of the breast. A clinicopathologic 

study of primary and secondary 

cases. Arch Pathol Lab Med 123: 1208- 

1218. 

2941. Tornos C, Silva EG, Khorana SM, 

Burke TW (1994). High-stage endometrioid 

carcinoma of the ovary. Prognostic significance 

of pure versus mixed histologic 

types. Am J Surg Pathol 18: 687-693.

2942. Tornos C, Silva EG, Ordonez NG, 

Gershenson DM, Young RH, Scully RE 

(1995). Endometrioid carcinoma of the 

ovary with a prominent spindle-cell component, 

a source of diagnostic confusion. 

A report of 14 cases. Am J Surg Pathol 19: 

1343-1353. 

2943. Tot T (2000). The cytokeratin profile of 

medullary carcinoma of the breast. 


2944. Towfighi J, Simmonds MA, Davidson 

EA (1983). Mucin and fat emboli in mucinous 

carcinomas. Cause of hemorrhagic 

cerebral infarcts. Arch Pathol Lab Med 

107: 646-649. 

2945. Traiman P, Bacchi CE, De Luca LA, 

Uemura G, Nahas NJ, Nahas EA, Pontes A 

(1999). Vulvar carcinoma in young patients 

and its relationship with genital warts. Eur 


2946. Treffers PE, Hanselaar AG, 

Helmerhorst TJ, Koster ME, van Leeuwen 

FE (2001). [Consequences of diethylstilbestrol 

during pregnancy; 50 years later still a 

significant problem]. Ned Tijdschr 

Geneeskd 145: 675-680. 

2947. Treilleux T, Mignotte H, Clement- 

Chassagne C, Guastalla P, Bailly C (1999). 

Tamoxifen and malignant epithelial-nonepithelial 

tumours of the endometrium: report 

of six cases and review of the literature. 

Eur J Surg Oncol 25: 477-482. 

2 9 4 8 . Tremblay G, Pearse AGE (2001). 

Histochemistry of oxidative enzyme systems 

in human thyroid with special reference 

to Askanazy cells. J Pathol Bacteriol 

80: 353-358. 

2949. Trimble EL (1996). Melanomas of the 

vulva and vagina. Oncology (Huntingt) 10: 

1017-1023. 

2950. Trimble EL, Lewis JL Jr., Williams LL, 

Curtin JP, Chapman D, Woodruff JM, Rubin 

SC, Hoskins WJ (1992). Management of 

vulvar melanoma. Gynecol Oncol 45: 254- 

258. 

2951. Trivedi P, Dave K, Shah M, Karelia N, 

Patel D, Wadhwa M (1998). Hepatoid carcinoma 

of the ovary--a case report. Eur J 


2952. Trojani M, De Mascarel I, Coquet M, 

Coindre JM, De Mascarel A (1989). 

[Osteoclastic type giant cell carcinoma of 

the breast]. Ann Pathol 9: 189-194. 

2953. Trojani M, Guiu M, Trouette H, De 

Mascarel I, Cocquet M (1992). Malignant 

adenomyoepithelioma of the breast. An 

immunohistochemical, cytophotometric, 

and ultrastructural study of a case with 

lung metastases. Am J Clin Pathol 98: 598- 

602. 

2954. Troncone G, Martinez JC, Palombini 

L, De Rosa G, Mugica C, Rodriguez JA, 

Zeppa P, Di Vizio D, Lucariello A, Piris MA 

(1998). Immunohistochemical expression 

of mdm2 and p21WAF1 in invasive cervical 

cancer: correlation with p53 protein and 

high risk HPV infection. J Clin Pathol 51: 

754-760. 

2955. Tsang WY, Chan JK (1996). Endocrine 

ductal carcinoma in situ (E-DCIS) of the 

breast: a form of low-grade DCIS with distinctive 

clinicopathologic and biologic 

characteristics. Am J Surg Pathol 20: 921- 

943. 

2956. Tsang WYW, Chan JKC (1996). 

Endocrine ductal carcinoma in situ (E- 

DCIS) of the breast: a form of low-grade 

DCIS with distinctive clinicopathologic and 

biologic characteristics. Am J Surg Pathol 

20: 921-943. 

2957. Tseng CJ, Pao CC, Tseng LH, Chang 

CT, Lai CH, Soong YK, Hsueh S, Jyu-Jen H 

(1997). Lymphoepithelioma-like carcinoma 

of the uterine cervix: association with 

Epstein-Barr virus and human papillomavirus. 

Cancer 80: 91-97. 

2958. Tsongalis GJ, Ried A Jr. (2001). HER2: 

the neu prognostic marker for breast cancer. 

Crit Rev Clin Lab Sci 38: 167-182. 

2959. Tsou HC, Teng DH, Ping XL, 

Brancolini V, Davis T, Hu R, Xie XX, 

Gruener AC, Schrager CA, Christiano AM, 

Eng C, Steck P, Ott J, Tavtigian SV, 

Peacocke M (1997). The role of MMAC1 

mutations in early-onset breast cancer: 

causative in association with Cowden syndrome 

and excluded in BRCA1-negative 

cases. Am J Hum Genet 61: 1036-1043. 

2 9 6 0 . Tsuda H, Callen DF, Fukutomi T, 

Nakamura Y, Hirohashi S (1994). Allele loss 

on chromosome 16q24.2-qter occurs frequently 

in breast cancers respectively of 

differences in phenotype and extent of 

spread. Cancer Res 54: 513-517. 

2961. Tsuda H, Takarabe T, Susumu N, 

Inazawa J, Okada S, Hirohashi S (1997). 

Detection of numerical and structural 

alterations and fusion of chromosomes 16 

and 1 in low-grade papillary breast carcinoma 

by fluorescence in situ hybridization. 

Am J Pathol 151: 1027-1034. 

2962. Tsuda HH (2001). Prognostic and predictive 

value of c-erbB-2 (HER-2/neu) gene 

amplification in human breast cancer. 

Breast Cancer 8: 38-44. 

2963. Tsuji T, Kawauchi S, Utsunomiya T, 

Nagata Y, Tsuneyoshi M (1997). 

Fibrosarcoma versus cellular fibroma of 

the ovary: a comparative study of their proliferative 

activity and chromosome aberrations 

using MIB-1 immunostaining, DNA 

flow cytometry, and fluorescence in situ 

hybridization. Am J Surg Pathol 21: 52-59. 

2964. Tsukamoto N, Nakamura M, 

Ishikawa H (1976). Case report: sclerosing 

stromal tumor of the ovary. Gynecol Oncol 

4: 335-339. 

2965. Tsuura Y, Hiraki H, Watanabe K, 

Igarashi S, Shimamura K, Fukuda T, Suzuki 

T, Seito T (1994). Preferential localization of 

c-kit product in tissue mast cells, basal 

cells of skin, epithelial cells of breast, small 

cell lung carcinoma and seminoma/dysgerminoma 

in human: immunohistochemical 

study on formalin-fixed, paraffinembedded 

tissues. Virchows Arch 4 2 4 : 

135-141. 

2966. Tuncer ZS, Vegh GL, Fulop V, Genest 

DR, Mok SC, Berkowitz RS (2000). 

Expression of epidermal growth factor 

receptor-related family products in gestational 

trophoblastic diseases and normal 

placenta and its relationship with development 

of postmolar tumor. Gynecol Oncol 

77: 389-393. 

2967. Twiggs LB, Okagaki T, Phillips GL, 

Stroemer JR, Adcock LL (1981). 

Trophoblastic pseudotumor-evidence of 

malignant disease potential. G y n e c o l 

Oncol 12: 238-248. 

2968. Tyagi SP, Saxena K, Rizvi R, Langley 

FA (1979). Foetal remnants in the uterus 

and their relation to other uterine heterotopia. 


2969. Uchiyama M, Iwasaka T, Matsuo N, 

Hachisuga T, Mori M, Sugimori H (1997). 

Correlation between human papillomavirus 

positivity and p53 gene overexpression 

in adenocarcinoma of the uterine 


2970. Ueda G, Fujita M, Ogawa H, Sawada 

M, Inoue M, Tanizawa O (1993). 

Adenocarcinoma in a benign cystic teratoma 

of the ovary: report of a case with a 

long survival period. Gynecol Oncol 48: 

259-263. 

2971. Ueda H, Togashi K, Konishi I, Kataoka 

ML, Koyama T, Fujiwara T, Kobayashi H, 

Fujii S, Konishi J (1999). Unusual appearances 

of uterine leiomyomas: MR imaging 

findings and their histopathologic backgrounds. 

Radiographics 19 Spec No: S131- 

S145. 

2972. Uehara T, Izumo T, Kishi K, Takayama 

S, Kasuga T (1991). Stromal melanocytic 

foci ("blue nevus") in step sections of the 

uterine cervix. Acta Pathol Jpn 41: 751-756. 

2973. Uehara T, Takayama S, Takemura T, 

Kasuga T (1991). Foci of stromal 

melanocytes (so-called blue naevus) of the 

uterine cervix in Japanese women. 


418: 327-331. 

2974. Uehira K, Hashimoto H, Tsuneyoshi 

M, Enjoji M (1993). Transitional cell carcinoma 

pattern in primary carcinoma of the 

fallopian tube. Cancer 72: 2447-2456. 

2975. Ueki M, Sano T, Okamura S, Iito Y, 

Kitsuki K, Sugimoto O (1982). [Clinical diagnosis 

of well differentiated cervical adenocarcinoma 

with plentiful mucous secretion]. 

Nippon Sanka Fujinka Gakkai Zasshi 

34: 1846-1852. 

2976. UICC (2002). TNM classification of 

malignant tumors. Sixth ed. John Wiley & 

Sons: New York. 

2977. Ulbright TM, Alexander RW, Kraus FT 

(1981). Intramural papilloma of the vagina: 

evidence of Mullerian histogenesis. 

Cancer 48: 2260-2266. 

2978. Ulbright TM, Roth LM (1985). 

Metastatic and independent cancers of 

the endometrium and ovary: a clinicopathologic 

study of 34 cases. Hum Pathol 

16: 28-34. 

2979. Ulbright TM, Roth LM, Brodhecker 

CA (1986). Yolk sac differentiation in germ 

cell tumors. A morphologic study of 50 

cases with emphasis on hepatic, enteric, 

and parietal yolk sac features. Am J Surg 

Pathol 10: 151-164. 

2980. Ulbright TM, Roth LM, Stehman FB 

(1984). Secondary ovarian neoplasia. A 

clinicopathologic study of 35 cases. 

Cancer 53: 1164-1174. 

2981. Underwood PB Jr., Smith RT (1971). 

Carcinoma of the vagina. JAMA 217: 46-52. 

2982. Unkila-Kallio L, Tiitinen A, Wahlstrom 

T, Lehtovirta P, Leminen A (2000). 

Reproductive features in women developing 

ovarian granulosa cell tumour at a fertile 

age. Hum Reprod 15: 589-593. 

2983. Uziel T, Savitsky K, Platzer M, Ziv Y, 

Helbitz T, Nehls M, Boehm T, Rosenthal A, 

Shiloh Y, Rotman G (1996). Genomic 

Organization of the ATM gene. Genomics 

33: 317-320. 

2984. Vahteristo P, Bartkova J, Eerola H, 

Syrjakoski K, Ojala S, Kilpivaara O, 

Tamminen A, Kononen J, Aittomaki K, 

Heikkila P, Holli K, Blomqvist C, Bartek J, 

Kallioniemi OP, Nevanlinna H (2002). A 

CHEK2 genetic variant contributing to a 

substantial fraction of familial breast cancer. 

Am J Hum Genet 71: 432-438. 

2985. Vaizey C, Burke M, Lange M (1999). 

Carcinoma of the male breast - a review of 

91 patients from the Johannesburg 

Hospital breast clinics. S Afr J Surg 37: 6-8. 

2986. van't Veer LJ, Dai H, Van de Vijver 

MJ, He YD, Hart AA, Mao HL, van der Kooy 

K, Marton MJ, Witteveen AT, Schreiber 

GJ, Kerkhoven RM, Roberts C, Linsley PS, 

Bernards R, Friend SH (2002). Gene expression 

profiling predicts clinical outcome of 

breast cancer. Nature 415: 530-536. 

2987. van Belzen MJ, Hiel JA, Weemaes 

CM, Gabreels FJ, van Engelen BG, Smeets 

DF, van den Heuvel LP (1998). A double 

missense mutation in the ATM gene of a 

Dutch family with ataxia telangiectasia. 

Hum Genet 102: 187-191. 

2988. Van Bogaert LJ, Maldague P (1977). 

Histologic variants of lipid-secreting carcinoma 

of the breast. Virchows Arch A 

Pathol Anat 375: 345-353. 

2989. Van de Vijver MJ (1999). The pathology 

of familial breast cancer: The pre- 

BRCA1/BRCA2 era: historical perspectives. 

Breast Cancer Res 1: 27-30. 

2990. Van de Vijver MJ, He YD, van't Veer 

LJ, Dai H, Hart AA, Voskuil DW, Schreiber 

GJ, Peterse JL, Roberts C, Marton MJ, 

Parrish M, Atsma D, Witteveen A, Glas A, 

Delahaye L, van der Velde T, Bartelink H, 

Rodenhuis S, Rutgers ET, Friend SH, 

Bernards R (2002). A gene-expression signature 

as a predictor of survival in breast 


2991. van der Putte SC (1994). Mammarylike 

glands of the vulva and their disorders. 


2992. van der Putte SC, van Gorp LH (1994). 

Adenocarcinoma of the mammary-like 

glands of the vulva: a concept unifying 

sweat gland carcinoma of the vulva, carcinoma 

of supernumerary mammary glands 

and extramammary Paget's disease. J 

Cutan Pathol 21: 157-163. 

2993. van Diest PJ, Baak JPA (1991). The 

morphometric prognostic index is the 

strongest prognosticator in premenopausal 

lymph node-negative and 

lymph node-positive breast cancer 

patients. Hum Pathol 22: 326-330. 

2994. Van Dorpe J, De Pauw A, Moerman P 

(1998). Adenoid cystic carcinoma arising in 

an adenomyoepithelioma of the breast. 


2995. Van Hoeven KH, Drudis T, Cranor ML, 

Erlandson RA, Rosen PP (1993). Low-grade 

adenosquamous carcinoma of the breast. 

A clinocopathologic study of 32 cases with 

ultrastructural analysis. Am J Surg Pathol 

17: 248-258. 

2996. van Ingen G, Schoemaker J, Baak JP 

(1991). A testosterone-producing tumour in 

the mesovarium. Pathol Res Pract 187: 362- 

370. 

2997. Vanderstichele S, Elhage A, Verbert- 

Scherrer A, Robert Y, Querleu D, Crepin G 

(1996). [Granulosa cell tumors: a case 

located in the broad ligament of the uterus 

with normal ovaries]. J Gynecol Obstet 

Biol Reprod (Paris) 25: 47-52. 

2998. Vang R, Kempson RL (2002). 

Perivascular epithelioid cell tumor 

('PEComa') of the uterus: a subset of HMB- 

45-positive epithelioid mesenchymal neoplasms 

with an uncertain relationship to 

pure smooth muscle tumors. Am J Surg 

Pathol 26: 1-13. 

2999. Vang R, Medeiros LJ, Fuller GN, 

Sarris AH, Deavers M (2001). Non- 

Hodgkin's lymphoma involving the gynecologic 

tract: a review of 88 cases. Adv Anat 

Pathol 8: 200-217. 

3000. Vang R, Medeiros LJ, Ha CS, Deavers 

M (2000). Non-Hodgkin's lymphomas 

involving the uterus: a clinicopathologic 

analysis of 26 cases. Mod Pathol 13: 19-28. 


3001. Vang R, Medeiros LJ, Silva EG, 

Gershenson DM, Deavers M (2000). Non- 

Hodgkin's lymphoma involving the vagina: 

a clinicopathologic analysis of 14 patients. 


3002. Vang R, Taubenberger JK, Mannion 

CM, Bijwaard K, Malpica A, Ordonez NG, 

Tavassoli FA, Silver SA (2000). Primary vulvar 

and vaginal extraosseous Ewing's sar - 

coma/peripheral neuroectodermal tumor: 

diagnostic confirmation with CD99 

immunostaining and reverse transcriptase-polymerase 

chain reaction. Int J 


3003. Vang R, Whitaker BP, Farhood AI, 

Silva EG, Ro JY, Deavers MT (2001). 

Immunohistochemical analysis of clear 

cell carcinoma of the gynecologic tract. 


3004. Vanni R, Faa G, Dettori T, Melis GB, 

Dumanski JP, O'Brien KP (2000). A case of 

dermatofibrosarcoma protuberans of the 

vulva with a COL1A1/PDGFB fusion identical 

to a case of giant cell fibroblastoma. 


3005. Vardi JR, Tovell HM (1980). 

Leiomyosarcoma of the uterus: clinicopathologic 

study. Obstet Gynecol 56: 428- 

434. 

3006. Varga Z, Kolb SA, Flury R, Burkhard R, 

Caduff R (2000). Sebaceous carcinoma of 

the breast. Pathol Int 50: 63-66. 

3007. Vasen HF (2000). Clinical diagnosis 

and management of hereditary colorectal 

cancer syndromes. J Clin Oncol 18: 81S- 

92S. 

3008. Vasen HF, Mecklin JP, Khan PM, 

Lynch HT (1991). The International 

Collaborative Group on Hereditary Non- 

Polyposis Colorectal Cancer (ICG-HNPCC). 

Dis Colon Rectum 34: 424-425. 

3009. Vasen HF, Stormorken A, Menko FH, 

Nagengast FM, Kleibeuker JH, Griffioen G, 

Taal BG, Moller P, Wijnen JT (2001). MSH2 

mutation carriers are at higher risk of can - 

cer than MLH1 mutation carriers: a study 

of hereditary nonpolyposis colorectal cancer 

families. J Clin Oncol 19: 4074-4080. 

3010. Vasen HF, Watson P, Mecklin JP, 

Lynch HT (1999). New clinical criteria for 

hereditary nonpolyposis colorectal cancer 

(HNPCC, Lynch syndrome) proposed by the 

International Collaborative group on 

HNPCC. Gastroenterology 116: 1453-1456. 

3011. Vasen HF, Wijnen JT, Menko FH, 

Kleibeuker JH, Taal BG, Griffioen G, 

Nagengast FM, Meijers-Heijboer EH, 

Bertario L, Varesco L, Bisgaard ML, Mohr 

J, Fodde R, Khan PM (1996). Cancer risk in 

families with hereditary nonpolyposis colorectal 

cancer diagnosed by mutation 

analysis. Gastroenterology 110: 1020-1027. 

3012. Vaughn JP, Cirisano FD, Huper G, 

Berchuck A, Futreal PA, Marks JR, Iglehart 

JD (1996). Cell cycle control of BRCA2. 

Cancer Res 56: 4590-4594. 

3013. Vega de la G. (1976). Signet ring cell 

carcinoma of the uterine cervix. Patologia 

14: 193-196. 

3014. Vegh GL, Fulop V, Liu Y, Ng SW, 

Tuncer ZS, Genest DR, Paldi-Haris P, Foldi 

J, Mok SC, Berkowitz RS (1999). 

Differential gene expression pattern 

between normal human trophoblast and 

choriocarcinoma cell lines: downregulation 

of heat shock protein-27 in choriocarcinoma 

in vitro and in vivo. Gynecol Oncol 

75: 391-396. 


3015. Velasco-Oses A, Alonso-Alvaro A, 

Blanco-Pozo A, Nogales FF Jr. (1988). 

Ollier's disease associated with ovarian 

juvenile granulosa cell tumor. Cancer 62: 

222-225. 

3016. Veliath AJ, Hannah P, Ratnakar C, 

Jayanthi K, Aurora AL (1978). Primary 

liposarcoma of the cervix: a case report. 

Int J Gynaecol Obstet 16: 75-79. 

3017. Venable JG, Schwartz AM, 

Silverberg SG (1990). Infiltrating cribriform 

carcinoma of the breast: a distinctive clinicopathologic 

entity. Hum Pathol 21: 333- 

338. 

3018. Venkitaraman AR (2002). Cancer susceptibility 

and the functions of BRCA1 and 

BRCA2. Cell 108: 171-182. 

3019. Venkitaraman AR (2003). A growing 

network of cancer-susceptibility genes. N 

Engl J Med 348: 1917-1919. 

3020. Vergier B, Trojani M, De Mascarel I, 

Coindre JM, Le Treut A (1991). Metastases 

to the breast: differential diagnosis from 

primary breast carcinoma. J Surg Oncol 

48: 112-116. 

3021. Verhest A, Nedoszytko B, Noel JC, 

Dangou JM, Simon P, Limon J (1992). 

Translocation (6;16) in a case of granulosa 

cell tumor of the ovary. Cancer Genet 


3022. Verhoog LC, Brekelmans CT, 

Seynaeve C, van den Bosch LM, Dahmen 

G, van Geel AN, Tilanus-Linthorst MM, 

Bartels CC, Wagner A, van den Ouweland 

A, Devilee P, Meijers-Heijboer EJ, Klijn JG 

(1998). Survival and tumour characteristics 

of breast-cancer patients with germline 

mutations of BRCA1. Lancet 351: 316-321. 

3023. Verhoog LC, van den Ouweland AM, 

Berns E, Veghel-Plandsoen MM, van 

Staveren IL, Wagner A, Bartels CC, 

Tilanus-Linthorst MM, Devilee P, 

Seynaeve C, Halley DJ, Niermeijer MF, 

Klijn JG, Meijers-Heijboer H (2001). Large 

regional differences in the frequency of 

distinct BRCA1/BRCA2 mutations in 517 

Dutch breast and/or ovarian cancer families. 

Eur J Cancer 37: 2082-2090. 

3024. Veridiano NP, Gal D, Delke I, Rosen Y, 

Tancer ML (1980). Gestational choriocarcinoma 

of the ovary. Gynecol Oncol 10: 235- 

240. 

3025. Viacava P, Naccarato AG, Nardini V, 

Bevilacqua G (1995). Breast carcinoma 

with osteoclast-like giant cells: immunohistochemical 

and ultrastructural study of 

a case and review of the literature. Tumori 

81: 135-141. 

3026. Vicandi B., Jimenez-Hefferman J.A., 

Lopez-Ferrer P., Ortega L., Viguer J.M. 

(1998). Nodular pseudoangiomatous stromal 

hyperplasia of the breast. Cytologic 

features. Acta Cytol 42: 335-341. 

3027. Vivian JB, Tan EG, Frayne JR, Waters 

ED (1993). Bilateral liposarcoma of the 

breast. Aust N Z J Surg 63: 658-659. 

3028. Vizcaino AP, Moreno V, Bosch FX, 

Munoz N, Barros-Dios XM, Parkin DM 

(1998). International trends in the incidence 

of cervical cancer: I. Adenocarcinoma 

and adenosquamous cell carcinomas. 

Int J Cancer 75: 536-545. 

3029. Vizcaino I, Torregrossa AHV, Morote 

V, Crenades A, Torres V, Olmos S, Molins C 

(2001). Metastasis to the breast from extramammary 

malignancies: a report of four 

cases and a review of literature. E u r 

Radiol 11: 802-806. 

3030. Vleminckx K, Vakaet L Jr., Mareel M, 

Fiers W, van Roy F (1991). Genetic manipulation 

of E-cadherin expression by epithelial 

tumor cells reveals an invasion suppressor 

role. Cell 66: 107-119. 

3031. Voet RL, Lifshitz S (1982). Primary 

clear cell adenocarcinoma of the fallopian 

tube: light microscopic and ultrastructural 

findings. Int J Gynecol Pathol 1: 292-298. 

3032. Vortmeyer AO, Devouassoux- 

Shisheboran M, Li G, Mohr V, Tavassoli F, 

Zhuang Z (1999). Microdissection-based 

analysis of mature ovarian teratoma. Am J 

Pathol 154: 987-991. 

3033. Vos A, Oosterhuis JW, de Jong B, 

Castedo SM, Hollema H, Buist J, Aalders 

JG (1990). Karyotyping and DNA flow 

cytometry of metastatic ovarian yolk sac 

tumor. Cancer Genet Cytogenet 44: 223- 

228. 

3034. Vos CB, Cleton-Jansen AM, Berx G, 

de Leeuw WJ, ter Haar NT, van Roy F, 

Cornelisse CJ, Peterse JL, Van de Vijver 

MJ (1997). E-cadherin inactivation in lobular 

carcinoma in situ of the breast: an early 

event in tumorigenesis. Br J Cancer 76: 

1131-1133. 

3035. Vos CB, ter Haar NT, Peterse JL, 

Cornelisse CJ, Van de Vijver MJ (1999). 

Cyclin D1 gene amplification and overexpression 

are present in ductal carcinoma 

in situ of the breast. J Pathol 187: 279-284. 

3036. Vos CB, ter Haar NT, Rosenberg C, 

Peterse JL, Cleton-Jansen AM, Cornelisse 

CJ, Van de Vijver MJ (1999). Genetic alterations 

on chromosome 16 and 17 are 

important features of ductal carcinoma in 

situ of the breast and are associated with 

histologic type. Br J Cancer 81: 1410-1418. 

3037. Vuitch MF, Rosen PP, Erlandson RA 

(1986). Pseudoangiomatous hyperplasia of 

mammary stroma. Hum Pathol 17: 185-191. 

3038. Wadhwa J, Dawar R, Kumar L (1999). 

Ovarian carcinoma metastatic to the 

breast. Clin Oncol (R Coll Radiol ) 11: 419- 

421. 

3039. Wagner A, Hendriks Y, Meijers- 

Heijboer EJ, de Leeuw WJ, Morreau H, 

Hofstra R, Tops C, Bik E, Brocker-Vriends 

AH, van der Meer C, Lindhout D, Vasen HF, 

Breuning MH, Cornelisse CJ, van Krimpen 

C, Niermeijer MF, Zwinderman AH, Wijnen 

J, Fodde R (2001). Atypical HNPCC owing 

to MSH6 germline mutations: analysis of a 

large Dutch pedigree. J Med Genet 38: 318- 

322. 

3040. Wagner I, Bettendorf U (1980). 

Extraovarian Brenner tumor. Case report 

and review. Arch Gynecol 229: 191-196. 

3041. Waha A, Sturne C, Kessler A, Koch A, 

Kreyer E, Fimmers R, Wiestler OD, von 

Deimling A, Krebs D, Schmutzler RK (1998). 

Expression of the ATM gene is significant - 

ly reduced in sporadic breast carcinomas. 

Int J Cancer 78: 306-309. 

3042. Wahner-Roedler DL, Sebo TJ, 

Gisvold JJ (2001). Hamartomas of the 

breast: clinical, radiologic, and pathologic 

manifestations. Breast J 7: 101-105. 

3043. Waite KA, Eng C (2002). Protean 

PTEN: form and function. Am J Hum Genet 

70: 829-844. 

3044. Walboomers JM, Jacobs MV, Manos 

MM, Bosch FX, Kummer JA, Shah KV, 

Snijders PJ, Peto J, Meijer CJ, Munoz N 

(1999). Human papillomavirus is a necessary 

cause of invasive cervical cancer 

worldwide. J Pathol 189: 12-19. 

3045. Waldman FM, Devries S, Chew KL, 

Moore DH, Kerlikowske K, Ljung BM 

(2000). Chromosomal alterations in ductal 

carcinomas in situ and their in situ recurrences. 


3046. Waldman FM, Hwang ES, Etzell J, 

Eng C, Devries S, Bennington J, Thor A 

(2001). Genomic alterations in tubular 

breast carcinomas. Hum Pathol 32: 222- 

226. 

3047. Walford N, ten Velden J (1989). 

Histiocytoid breast carcinoma: an apocrine 

variant of lobular carcinoma. 


3048. Walker RA, Jones JL, Chappell S, 

Walsh T, Shaw JA (1997). Molecular 

pathology of breast cancer and its application 

to clinical management. C a n c e r 

Metastasis Rev 16: 5-27. 

3049. Walsh MM, Bleiweiss IJ (2001). 

Invasive micropapillary carcinoma of the 

breast: eighty cases of an underrecognized 

entity. Hum Pathol 32: 583-589. 

3050. Walt H, Hornung R, Fink D, Dobler- 

Girdziunaite D, Stallmach T, Spycher MA, 

Maly F, Haller U, Burki N (2001). 

Hypercalcemic-type of small cell carcinoma 

of the ovary: characterization of a new 

tumor line. Anticancer Res 21: 3253-3259. 

3051. Walter A (1982). Benign teratoma of 

the Fallopian tube. Aust N Z J Obstet 

Gynaecol 22: 245-247. 

3052. Wang H, Douglas W, Lia M, 

Edelmann W, Kucherlapati R, Podsypanina 

K, Parsons R, Ellenson LH (2002). DNA mismatch 

repair deficiency accelerates 

endometrial tumorigenesis in Pten heterozygous 

mice. Am J Pathol 160: 1481- 

1486. 

3053. Wang WW, Spurdle AB, Kolachana 

P, Bove B, Modan B, Ebbers SM, Suthers 

G, Tucker MA, Kaufman DJ, Doody MM, 

Tarone RE, Daly M, Levavi H, Pierce H, 

Chetrit A, Yechezkel GH, Chenevix-Trench 

G, Offit K, Godwin AK, Struewing JP (2001). 

A single nucleotide polymorphism in the 5' 

untranslated region of RAD51 and risk of 

cancer among BRCA1/2 mutation carriers. 

Cancer Epidemiol Biomarkers Prev 10: 955- 

960. 

3054. Wang Y, Cortez D, Yazdi P, Neff N, 

Elledge SJ, Qin J (2000). BASC, a super 

complex of BRCA1-associated proteins 

involved in the recognition and repair of 

aberrant DNA structures. Genes Dev 14: 

927-939. 

3055. Ward BA, McKhann CF, Ravikumar 

TS (1992). Ten-year follow-up of breast 

carcinoma in situ in Connecticut. A r c h 

Surg 127: 1392-1395. 

3056. Ward BE, Cooper PH, Subramony C 

(1989). Syringomatous tumor of the nipple. 


3057. Ward BE, Saleh AM, Williams JV, Zitz 

JC, Crum CP (1992). Papillary immature 

metaplasia of the cervix: a distinct subset 

of exophytic cervical condyloma associat - 

ed with HPV-6/11 nucleic acids. M o d 

Pathol 5: 391-395. 

3058. Ward RM, Evans HL (1986). 

Cystosarcoma phyllodes. A clinicopathologic 

study of 26 cases. Cancer 58: 2282- 

2289. 

3059. Wargotz ES, Deos PH, Norris HJ 

(1989). Metaplastic carcinomas of the 

breast. II. Spindle cell carcinoma. Hum 

Pathol 20: 732-740. 

3060. Wargotz ES, Norris HJ (1989). 

Metaplastic carcinomas of the breast. I. 

Matrix-producing carcinoma. Hum Pathol 

20: 628-635.


Metaplastic carcinomas of the breast. IV. 

Squamous cell carcinoma of ductal origin. 

Cancer 65: 272-276. 


Metaplastic carcinomas of the breast: V. 

Metaplastic carcinoma with osteoclastic 

giant cells. Hum Pathol 21: 1142-1150. 

3063. Wargotz ES, Norris HJ, Austin RM, 

Enzinger FM (1987). Fibromatosis of the 

breast. A clinical and pathological study of 


3064. Wargotz ES, Silverberg SG (1988). 

Medullary carcinoma of the breast: a clinicopathologic 

study with appraisal of current 

diagnostic criteria. Hum Pathol 19: 

1340-1346. 

3065. Warner E, Foulkes W, Goodwin P, 

Meschino W, Blondal J, Paterson C, 

Ozcelik H, Goss P, Allingham-Hawkins D, 

Hamel N, Di Prospero L, Contiga V, Serruya 

C, Klein M, Moslehi R, Honeyford J, Liede 

A, Glendon G, Brunet JS, Narod S (1999). 

Prevalence and penetrance of BRCA1 and 

BRCA2 gene mutations in unselected 

Ashkenazi Jewish women with breast cancer. 


3066. Warner NE (1969). Lobular carcinoma 


3067. Watanabe Y, Nakajima H, Nozaki K, 

Ueda H, Obata K, Hoshiai H, Noda K (2001). 

Clinicopathologic and immunohistochemical 

features and microsatellite status of 

endometrial cancer of the uterine isthmus. 


3068. Waterhouse J, Muir CS, Correa P, 

Powell J (1976). Cancer Incidence in Five 

Continents (IARC Scientific Publications 

n°15). IARC: Lyon. 

3069. Watkin W, Silva EG, Gershenson DM 

(1992). Mucinous carcinoma of the ovary. 

Pathologic prognostic factors. Cancer 69: 

208-212. 

3070. Watson P, Lin KM, Rodriguez-Bigas 

MA, Smyrk T, Lemon S, Shashidharan M, 

Franklin B, Karr B, Thorson A, Lynch HT 

(1998). Colorectal carcinoma survival 

among hereditary nonpolyposis colorectal 

carcinoma family members. Cancer 8 3 : 

259-266. 

3071. Watson P, Vasen HF, Mecklin JP, 

Jarvinen H, Lynch HT (1994). The risk of 

endometrial cancer in hereditary nonpolyposis 

colorectal cancer. Am J Med 96: 516- 

520. 

3072. Watt AC, Haggar AM, Krasicky GA 

(1984). Extraosseous osteogenic sarcoma 

of the breast: mammographic and pathologic 

findings. Radiology 150: 34. 

3073. Waxman M (1979). Pure and mixed 

Brenner tumors of the ovary: clinicopathologic 

and histogenetic observations. 

Cancer 43: 1830-1839. 

3074. Waxman M, Vuletin JC, Urcuyo R, 

Belling CG (1979). Ovarian low-grade stromal 

sarcoma with thecomatous features: a 

critical reappraisal of the so-called "malignant 

thecoma". Cancer 44: 2206-2217. 

3075. Way S (1948). Primary carcinoma of 

the vagina. J Obstet Br Emp 55: 739. 

3076. Webb JC, Key CR, Qualls CR, Smith 

HO (2001). Population-based study of 

microinvasive adenocarcinoma of the 

uterine cervix. Obstet Gynecol 97: 701-706. 

3077. Webb LA, Young JR (1996). Case 

report: haemangioma of the breast-appearances 

on mammography and ultrasound. 

Clin Radiol 51: 523-524. 

3078. Webb MJ, Symmonds RE, Weiland 

LH (1974). Malignant fibrous histiocytoma 

of the vagina. Am J Obstet Gynecol 119: 

190-192. 

3079. Weber AM, Hewett WF, Gajewski 

WH, Curry SL (1993). Malignant mixed mullerian 

tumors of the fallopian tube. 


3080. Wei LH, Huang CY, Cheng SP, Chen 

CA, Hsieh CY (2001). Carcinosarcoma of 

ovary associated with previous radiotherapy. 


3081. Weidner N (1990). Benign breast 

lesions that mimic malignant tumors: 

analysis of five distinct lesions. S e m i n 

Diagn Pathol 7: 90-101. 

3082. Weidner N, Semple JP (1992). 

Pleomorphic variant of invasive lobular 


1167-1171. 

3083. Weigand RA, Isenberg WM, Russo J, 

Brennan MJ, Rich MA (1982). Blood vessel 

invasion and axillary lymph node involvement 

as prognostic indicators for human 


3084. Weinberg E, Hoisington S, Eastman 

AY, Rice DK, Malfetano J, Ross JS (1993). 

Uterine cervical lymphoepithelial-like carcinoma. 

Absence of Epstein-Barr virus 

genomes. Am J Clin Pathol 99: 195-199. 

3085. Weir MM, Bell DA, Young RH (1997). 

Transitional cell metaplasia of the uterine 

cervix and vagina: an underrecognized 

lesion that may be confused with highgrade 

dysplasia. A report of 59 cases. Am 


3086. Weiss SW (1994). Histological Typing 

of Soft Tissue Tumours. 2nd ed. Springer: 

Berlin Heidelberg, New York. 

3087. Weiss SW, Tavassoli FA (1988). 

Multicystic mesothelioma. An analysis of 

pathologic findings and biologic behavior 

in 37 cases. Am J Surg Pathol 12: 737-746. 

3088. Weissberg JB, Huang DD, Swift M 

(1998). Radiosensitivity of normal tissues in 

ataxia-telangiectasia heterozygotes . Int J 


3089. Weitmann HD, Knocke TH, Kucera H, 

Potter R (2001). Radiation therapy in the 

treatment of endometrial stromal sarcoma. 

Int J Radiat Oncol Biol Phys 49: 739-748. 

3090. Weitzner S, Nascimento AG, Scanlon 

LJ (1979). Intramammary granular cell 

myoblastoma. Am Surg 45: 34-37. 

3091. Wellings SR, Jensen HM, Marcum 

RG (1975). An atlas of subgross pathology 

of the human breast with special reference 

to possible precancerous lesions. J Natl 

Cancer Inst 55: 231-273. 

3092. Wells CA, Ferguson DJ (1988). 

Ultrastructural and immunocytochemical 

study of a case of invasive cribriform 

breast carcinoma. J Clin Pathol 41: 17-20. 

3093. Wells CA, McGregor IL, Makunura 

CN, Yeomans P, Davies JD (1995). 

Apocrine adenosis: a precursor of aggres - 

sive breast cancer? J Clin Pathol 48: 737- 

742. 

3094. Wells CA, Nicoll S, Ferguson DJ 


breast: a case with axillary lymph node 

metastasis. Histopathology 10: 415-424. 

3095. Wen WH, Reles A, Runnebaum IB, 

Sullivan-Halley J, Bernstein L, Jones LA, 

Felix JC, Kreienberg R, el Naggar A, Press 

MF (1999). p53 mutations and expression in 

ovarian cancers: correlation with overall 

survival. Int J Gynecol Pathol 18: 29-41. 

3096. Weng L, Brown J, Eng C (2001). PTEN 

induces apoptosis and cell cycle arrest 

through phosphoinositol-3-kinase/Aktdependent 

and -independent pathways. 


3097. Weng LP, Brown JL, Baker KM, 

Ostrowski MC, Eng C (2002). PTEN blocks 

insulin-mediated ETS-2 phosphorylation 

through MAP kinase, independently of the 

phosphoinositide 3-kinase pathway. Hum 

Mol Genet 11: 1687-1696. 

3098. Weng LP, Smith WM, Brown JL, Eng 

C (2001). PTEN inhibits insulin-stimulated 

MEK/MAPK activation and cell growth by 

blocking IRS-1 phosphorylation and IRS- 

1/Grb-2/Sos complex formation in a breast 

cancer model. Hum Mol Genet 10: 605-616. 

3099. Werling RW, Hwang H, Yaziji H, Gown 

AM (2003). Immunohistochemical distinction 

of invasive from noninvasive breast 

lesions: a comparative study of p63 versus 

calponin and smooth muscle myosin heavy 

chain. Am J Surg Pathol 27: 82-90. 

3100. Werner M, Mattis A, Aubele M, 

Cummings M, Zitzelsberger H, Hutzler P, 

Hofler H (1999). 20q13.2 amplification in 

intraductal hyperplasia adjacent to in situ 

and invasive ductal carcinoma of the 


3101. Werness BA, Dicioccio RA (2002). 

Transitional cell ovarian carcinoma in a 

BRCA1 mutation carrier. Obstet Gynecol 

100: 385. 

3102. Werness BA, Ramus SJ, Whittemore 

AS, Garlinghouse-Jones K, Oakley-Girvan 

I, Dicioccio RA, Tsukada Y, Ponder BA, 

Piver MS (2000). Histopathology of familial 

ovarian tumors in women from families 

with and without germline BRCA1 mutations. 

Hum Pathol 31: 1420-1424. 

3103. Werness BA, Ramus SJ, Whittemore 

AS, Garlinghouse-Jones K, Oakley-Girvan 

I, Dicioccio RA, Tsukada Y, Ponder BA, 

Piver MS (2000). Primary ovarian dysgerminoma 

in a patient with a germline BRCA1 

mutation. Int J Gynecol Pathol 19: 390-394. 

3104. West M, Blanchette C, Dressman H, 

Huang E, Ishida S, Spang R, Zuzan H, Olson 

JA Jr., Marks JR, Nevins JR (2001). 

Predicting the clinical status of human 

breast cancer by using gene expression 

profiles. Proc Natl Acad Sci USA 98: 11462- 

11467. 

3 1 0 4 a . Westenend PJ, Liem SJ (2001). 

Adenosis tumor of the breast containing 

ductal carcinoma in situ, a pitfall in core 

needle biopsy. Breast J 7: 200-201. 

3105. Wheeler DT, Bell KA, Kurman RJ, 

Sherman ME (2000). Minimal uterine 

serous carcinoma: diagnosis and clinicopathologic 

correlation. Am J Surg Pathol 

24: 797-806. 

3106. Wheeler JE, Enterline HT (1976). 

Lobular carcinoma of the breast in situ and 

infiltrating. Pathol Annu 11: 161-188. 

3107. Wheeler JE, Enterline HT, Roseman 

JM, Tomasulo JP, McIlvaine CH, Fitts WT 

Jr., Kirshenbaum J (1974). Lobular carcinoma 

in situ of the breast. Long-term followup. 

Cancer 34: 554-563. 

3108. Wheelock JB, Goplerud DR, Dunn LJ, 

Oates JF, III (1984). Primary carcinoma of 

the Bartholin gland: a report of ten cases. 


3109. Wheelock JB, Krebs HB, Schneider 

V, Goplerud DR (1985). Uterine sarcoma: 

analysis of prognostic variables in 71 

cases. Am J Obstet Gynecol 151: 1016- 

1022. 

3110. Whiteman DC, Murphy MF, 

Verkasalo PK, Page WF, Floderus B, 

Skytthe A, Holm NV (2000). Breast cancer 

risk in male twins: joint analyses of four 

twin cohorts in Denmark, Finland, Sweden 

and the United States. Br J Cancer 83: 

1231-1233. 

3111. WHO Technical Report Series (1983). 

WHO Scientific Group: Gestional trophoblastic 

diseases. WHO: 

3112. Wick MR, Goellner JR, Wolfe JT, III, 

Su WP (1985). Vulvar sweat gland carcinomas. 


3113. Wick MR, Lillemoe TJ, Copland GT, 

Swanson PE, Manivel JC, Kiang DT (1989). 

Gross cystic disease fluid protein-15 as a 

marker for breast cancer: immunohistochemical 

analysis of 690 human neoplasms 

and comparison with alpha-lactalbumin. 

Hum Pathol 20: 281-287. 

3114. Wijnen J, de Leeuw W, Vasen H, van 

der Klift H, Moller P, Stormorken A, 

Meijers-Heijboer H, Lindhout D, Menko F, 

Vossen S, Moslein G, Tops C, Brocker- 

Vriends A, Wu Y, Hofstra R, Sijmons R, 

Cornelisse C, Morreau H, Fodde R (1999). 

Familial endometrial cancer in female carriers 

of MSH6 germline mutations. Nat 

Genet 23: 142-144. 

3115. Wijnen J, Khan PM, Vasen H, Menko 

F, van der Klift H, van den Broek M, 

Leeuwen-Cornelisse I, Nagengast F, 

Meijers-Heijboer EJ, Lindhout D, Griffioen 

G, Cats A, Kleibeuker J, Varesco L, Bertario 

L, Bisgaard ML, Mohr J, Kolodner R, Fodde 

R (1996). Majority of hMLH1 mutations 

responsible for hereditary nonpolyposis 

colorectal cancer cluster at the exonic 

region 15-16. Am J Hum Genet 58: 300-307. 

3116. Wijnen J, van der Klift H, Vasen H, 

Khan PM, Menko F, Tops C, Meijers HH, 

Lindhout D, Moller P, Fodde R (1998). MSH2 

genomic deletions are a frequent cause of 

HNPCC. Nat Genet 20: 326-328. 

3117. Wijnen JT, Vasen HF, Khan PM, 

Zwinderman AH, van der Klift H, Mulder A, 

Tops C, Moller P, Fodde R (1998). Clinical 

findings with implications for genetic testing 

in families with clustering of colorectal 


3118. Wijnmaalen A, van Ooijen B, van Geel 

BN, Henzen-Logmans SC, Treurniet- 

Donker AD (1993). Angiosarcoma of the 

breast following lumpectomy, axillary 

lymph node dissection, and radiotherapy 

for primary breast cancer: three case 

reports and a review of the literature. Int J 


3119. Wilkinson EJ (2000). Protocol for the 

examination of specimens from patients 

with carcinomas and malignant 

melanomas of the vulva: a basis for checklists. 

Cancer Committee of the American 

College of Pathologists. Arch Pathol Lab 

Med 124: 51-56. 

3120. Wilkinson EJ (2002). Premalignant 

and Malignant Tumours of the vulva. In: 

Blaustein's Pathology of the Female 

Genital Tract. 5th ed. Springer-Verlag: 

New York. 

3121. Wilkinson EJ, Brown H (2002). Vulvar 

Paget disease of urothelial origin: a report 

of three cases and proposed classification 

of vulvar Paget disease. Hum Pathol 33: 

549-554. 

3122. Wilkinson EJ, Croker BP, Friedrich EG 

Jr., Franzini DA (1988). Two distinct pathologic 

types of giant cell tumor of the vulva. 

A report of two cases. J Reprod Med 33: 

519-522. 

3123. Wilkinson EJ, Friedrich EG Jr., Fu YS 

(1981). Multicentric nature of vulvar carcinoma 

in situ. Obstet Gynecol 58: 69-74. 

3124. Wilkinson EJ, Stone IK (1994). Atlas 

of Vulvar Disease. Williams and WIlkins: 

Baltimore, Maryland. 


3125. Willemsen W, Kruitwagen R, 

Bastiaans B, Hanselaar T, Rolland R (1993). 

Ovarian stimulation and granulosa-cell 

tumour. Lancet 341: 986-988. 

3126. Willen R, Bekassy, Carlen B, Bozoky 

B, Cajander S (1999). Cloacogenic adenocarcinoma 

of the vulva. Gynecol Oncol 74: 

298-301. 

3127. Willett GD, Kurman RJ, Reid R, 

Greenberg M, Jenson AB, Lorincz AT 

(1989). Correlation of the histologic 

appearance of intraepithelial neoplasia of 

the cervix with human papillomavirus 

types. Emphasis on low grade lesions 

including so-called flat condyloma. Int J 


3128. Williamson JD, Colome MI, Sahin A, 

Ayala AG, Medeiros LJ (2000). Pagetoid 

Bowen disease: a report of 2 cases that 

express cytokeratin 7. Arch Pathol Lab 

Med 124: 427-430. 

3129. Willsher PC, Leach IH, Ellis IO, Bell 

JA, Elston CW, Bourke JB, Blamey RW, 

Robertson JF (1997). Male breast cancer: 

pathological and immunohistochemical 

features. Anticancer Res 17: 2335-2338. 

3130. Wilson CA, Ramos L, Villasenor MR, 

Anders KH, Press MF, Clarke K, Karlan B, 

Chen JJ, Scully R, Livingston D, Zuch RH, 

Kanter MH, Cohen S, Calzone FJ, Slamon 

DJ (1999). Localization of human BRCA1 

and its loss in high-grade, non-inherited 

breast carcinomas. Nat Genet 21: 236-240. 

3131. Wilson RB, Hunter JSJ, Dockerty MB 

(1961). Chorioadenoma destruens. Am J 


3132. Wilson TM, Ewel A, Duguid JR, Eble 

JN, Lescoe MK, Fishel R, Kelley MR (1995). 

Differential cellular expression of the 

human MSH2 repair enzyme in small and 

large intestine. Cancer Res 55: 5146-5150. 

3133. Winchester DJ, Chang HR, Graves 

TA, Menck HR, Bland KI, Winchester DP 

(1998). A comparative analysis of lobular 

and ductal carcinoma of the breast: presentation, 

treatment, and outcomes. J Am 

Coll Surg 186: 416-422. 

3134. Wingren S, van den Heuvel A, Gentile 

M, Olsen K, Hatschek T, Soderkvist P 

(1997). Frequent allelic losses on chromosome 

13q in human male breast carcinomas. 

Eur J Cancer 33: 2393-2396. 

3135. Winkler B, Alvarez S, Richart RM, 

Crum CP (1984). Pitfalls in the diagnosis of 

endometrial neoplasia. Obstet Gynecol 64: 

185-194. 

3136. Wiseman C, Liao KT (1972). Primary 

lymphoma of the breast. Cancer 29: 1705- 

1712. 

3137. Wohlfahrt J, Melbye M (2001). Age at 

any birth is associated with breast cancer 

risk. Epidemiology 12: 68-73. 

3138. Wolber RA, Talerman A, Wilkinson 

EJ, Clement PB (1991). Vulvar granular cell 

tumors with pseudocarcinomatous hyperplasia: 

a comparative analysis with welldifferentiated 

squamous carcinoma. Int J 


3139. Wolfson AH, Wolfson DJ, Sittler SY, 

Breton L, Markoe AM, Schwade JG, 

Houdek PV, Averette HE, Sevin BU, 

Penalver M, Duncan RC, Ganjei P. (1994). A 

multivariate analysis of clinicopathologic 

factors for predicting outcome in uterine 

sarcomas. Gynecol Oncol 52: 56-62. 

3140. Wong JH, Kopald KH, Morton DL 

(1990). The impact of microinvasion on axillary 

node metastases and survival in 

patients with intraductal breast cancer. 

Arch Surg 125: 1298-1301. 


3141. Wong SY, Kernohan NM, Walker F 

(1990). Breast cancers with extremely high 

oestrogen receptor protein status. 


3142. Woodard BH, Brinkhous AD, 

McCarty KS, Sr., McCarty KS Jr. (1980). 

Adenosquamous differentiation in mammary 

carcinoma: an ultrastructural and 

steroid receptor study. Arch Pathol Lab 

Med 104: 130-133. 

3143. Woodman CB, Collins S, Winter H, 

Bailey A, Ellis J, Prior P, Yates M, Rollason 

TP, Young LS (2001). Natural history of cervical 

human papillomavirus infection in 

young women: a longitudinal cohort study. 

Lancet 357: 1831-1836. 

3144. Woodruff JD, Dietrich D, Genadry R, 

Parmley TH (1981). Proliferative and malig - 

nant Brenner tumors. Review of 47 cases. 


3 1 4 5 . Woodruff JD, Julian CG (1969). 

Multiple malignancy in the upper genital 

canal. Am J Obstet Gynecol 103: 810-822. 

3146. Woodruff JD, Rauh JT, Markley RL 

(1966). Ovarian struma. Obstet Gynecol 27: 

194-201. 

3 1 4 7 . Woods DB, Vousden KH (2001). 

Regulation of p53 function. Exp Cell Res 

264: 56-66. 

3148. Woods ER, Helvie MA, Ikeda DM, 

Mandell SH, Chapel KL, Adler DD (1992). 

Solitary breast papilloma: comparison of 

mammographic, galactographic, and 

pathologic findings. AJR Am J Roentgenol 

159: 487-491. 

3149. Woodward AH, Ivins JC, Soule EH 

(1972). Lymphangiosarcoma arising in 

chronic lymphedematous extremities. 

Cancer 30: 562-572. 

3150. Woolas R, Smith J, Paterson JM, 

Sharp F (1997). Fallopian tube carcinoma: 

an under-recognized primary neoplasm. 


3151. Woolcott RJ, Henry RJ, Houghton CR 

(1988). Malignant melanoma of the vulva. 

Australian experience. J Reprod Med 33: 

699-702. 

3152. Wooster R, Mangion J, Eeles R, Smith 

S, Dowsett M, Averill D, Barrett-Lee P, 

Easton DF, Ponder BA, Stratton MR (1992). 

A germline mutation in the androgen 

receptor gene in two brothers with breast 

cancer and Reifenstein syndrome. N a t 

Genet 2: 132-134. 

3153. World Cancer Research 

Fund.American Institute for Cancer 

Research (1997). Food, Nutrition and the 

Prevention of Cancer: a Global 

Perspective. American Institute for Cancer 

Research: Washington DC. 

3 1 5 4 . World Health Organization (1981). 

International Histological Classification of 

Tumours: Histologic Types of Breast 

Tumours. Geneva. 

3155. World Health Organization (2000). 

World Health Organisation 1997-1999 

World Health Statistics Annual. 

http://www who int/whosis. 

3156. Worsham MJ, Van Dyke DL, 

Grenman SE, Grenman R, Hopkins MP, 

Roberts JA, Gasser KM, Schwartz DR, 

Carey TE (1991). Consistent chromosome 

abnormalities in squamous cell carcinoma 

of the vulva. Genes Chromosomes Cancer 

3: 420-432. 

3157. Wotherspoon AC, Finn TM, Isaacson 

PG (1995). Trisomy 3 in low-grade B-cell 

lymphomas of mucosa-associated lymphoid 

tissue. Blood 85: 2000-2004. 

3158. Wrba F, Ellinger A, Reiner G, Spona J, 

Holzner JH (1988). Ultrastructural and 

immunohistochemical characteristics of 

lipid-rich carcinoma of the breast. 


413: 381-385. 

3159. Wright CV, Shier MR (2000). 

Colposcopy of Adenocarcinoma in situ and 

Adenocarcinoma of the Cervix. 

Differentiation from Other Cervical 

Lesions. Biomedical Communications: 

Houston. 

3160. Wu Y, Berends MJ, Mensink RG, 

Kempinga C, Sijmons RH, Der Zee AG, 

Hollema H, Kleibeuker JH, Buys CH, 

Hofstra RM (1999). Association of hereditary 

nonpolyposis colorectal cancer-relat - 

ed tumors displaying low microsatellite 

instability with MSH6 germline mutations. 

Am J Hum Genet 65: 1291-1298. 

3161. Wu Y, Berends MJ, Post JG, Mensink 

RG, Verlind E, Van Der Sluis T, Kempinga C, 

Sijmons RH, van der Zee AG, Hollema H, 

Kleibeuker JH, Buys CH, Hofstra RM (2001). 

Germline mutations of EXO1 gene in 

patients with hereditary nonpolyposis colorectal 

cancer (HNPCC) and atypical 

HNPCC forms. Gastroenterology 120: 1580- 

1587. 

3 1 6 2 . Wu Y, Berends MJ, Sijmons RH, 

Mensink RG, Verlind E, Kooi KA, Van Der 

Sluis T, Kempinga C, dDer Zee AG, Hollema 

H, Buys CH, Kleibeuker JH, Hofstra RM 

(2001). A role for MLH3 in hereditary nonpolyposis 

colorectal cancer. Nat Genet 29: 

137-138. 

3163. Wurdinger S, Schutz K, Fuchs D, 

Kaiser WA (2001). Two cases of metastases 

to the breast on MR mammography. 

Eur Radiol 11: 802-806. 

3164. Wyatt SW, Lancaster M, Bottorff D, 

Ross F (2001). History of tobacco use 

among Kentucky women diagnosed with 

invasive cervical cancer: 1997-1998. J Ky 

Med Assoc 99: 537-539. 

3165. Wysocka B, Serkies K, Debniak J, 

Jassem J, Limon J (1999). Sertoli cell tumor 

in androgen insensitivity syndrome--a 

case report. Gynecol Oncol 75: 480-483. 

3166. Xu B, Kim S, Kastan MB (2001). 

Involvement of Brca1 in S-phase and G(2)phase 

checkpoints after ionizing irradiation. 

Mol Cell Biol 21: 3445-3450. 

3167. Xu X, Wagner KU, Larson D, Weaver 

Z, Li C, Ried T, Hennighausen L, Wynshaw- 

Boris A, Deng CX (1999). Conditional muta - 

tion of Brca1 in mammary epithelial cells 

results in blunted ductal morphogenesis 

and tumour formation. Nat Genet 22: 37-43. 

3168. Yaghsezian H, Palazzo JP, Finkel GC, 

Carlson JA Jr., Talerman A (1992). Primary 

vaginal adenocarcinoma of the intestinal 

type associated with adenosis. Gynecol 

Oncol 45: 62-65. 

3169. Yakirevich E, Izhak OB, Rennert G, 

Kovacs ZG, Resnick MB (1999). Cytotoxic 

phenotype of tumor infiltrating lymphocytes 

in medullary carcinoma of the 

breast. Mod Pathol 12: 1050-1056. 

3170. Yakirevich E, Maroun L, Cohen O, 

Izhak OB, Rennert G, Resnick MB (2000). 

Apoptosis, proliferation, and Fas (APO-1, 

CD95)/Fas ligand expression in medullary 

carcinoma of the breast. J Pathol 192: 166- 

173. 

3171. Yamamoto Y, Akagi A, Izumi K, Kishi Y 

(1995). Carcinosarcoma of the uterine body 

of mesonephric origin. Pathol Int 45: 303- 

309. 

3172. Yamashita K, Wake N, Araki T, 

Ichinoe K, Makoto K (1979). Human lymphocyte 

antigen expression in hydatidiform 

mole: androgenesis following fertilization 

by a haploid sperm. Am J Obstet 

Gynecol 135: 597-600. 

3173. Yamauchi H, Stearns V, Hayes DF 

(2001). When is a tumor marker ready for 

prime time? A case study of c-erbB-2 as a 

predictive factor in breast cancer. J Clin 

Oncol 19: 2334-2356. 

3174. Yanai-Inbar I, Scully RE (1987). 

Relation of ovarian dermoid cysts and 

immature teratomas: an analysis of 350 

cases of immature teratoma and 10 cases 

of dermoid cyst with microscopic foci of 

immature tissue. Int J Gynecol Pathol 6: 

203-212. 

3175. Yang B, Hart WR (2000). Vulvar 

intraepithelial neoplasia of the simplex 

(differentiated) type: a clinicopathologic 

study including analysis of HPV and p53 

expression. Am J Surg Pathol 24: 429-441. 

3176. Yang WT, Suen M, Metreweli C 

(1997). Sonographic features of benign 

papillary neoplasms of the breast: review 

of 22 patients. J Ultrasound Med 16: 161- 

168. 

3177. Yannacou N, Gerolymatos A, Parissi- 

Mathiou P, Chranioti S, Perdikis T (2000). 

Carcinosarcoma of the uterine cervix composed 

of an adenoid cystic carcinoma and 

an homologous stromal sarcoma. A case 

report. Eur J Gynaecol Oncol 21: 292-294. 

3178. Yarden RI, Pardo-Reoyo S, Sgagias 

M, Cowan KH, Brody LC (2002). BRCA1 regulates 

the G2/M checkpoint by activating 

Chk1 kinase upon DNA damage. Nat Genet 

30: 285-289. 

3 1 7 9 . Yazigi R, Sandstad J, Munoz AK 

(1988). Breast cancer metastasizing to the 

uterine cervix. Cancer 61: 2558-2560. 

3180. Yaziji H, Gown AM (2001). 

Immunohistochemical analysis of gynecologic 

tumors. Int J Gynecol Pathol 20: 64- 

78. 

3181. Yaziji H, Gown AM, Sneige N (2000). 

Detection of stromal invasion in breast 

cancer: the myoepithelial markers. Adv 

Anat Pathol 7: 100-109. 

3182. Yilmaz AG, Chandler P, Hahm GK, 

O'Toole RV, Niemann TH (1999). Melanosis 

of the uterine cervix: a report of two cases 

and discussion of pigmented cervical 

lesions. Int J Gynecol Pathol 18: 73-76. 

3183. Yip CH, Wong KT, Samuel D (1997). 

Bilateral plasma cell granuloma (inflammatory 

pseudotumour) of the breast. Aust N Z 

J Surg 67: 300-302. 

3184. Yokoyama Y, Sato S, Futagami M, 

Saito Y (2000). Solitary metastasis to the 

uterine cervix from the early gastric cancer: 

a case report. Eur J Gynaecol Oncol 

21: 469-471. 

3185. Yoonessi M (1979). Carcinoma of the 

fallopian tube. Obstet Gynecol Surv 34: 

257-270. 

3186. Yoonessi M, Abell MR (1979). 

Brenner tumors of the ovary. O b s t e t 

Gynecol 54: 90-96. 

3187. Yoshino K, Enomoto T, Nakamura T, 

Nakashima R, Wada H, Saitoh J, Noda K, 

Murata Y (1998). Aberrant FHIT transcripts 

in squamous cell carcinoma of the uterine 

cervix. Int J Cancer 76: 176-181. 

3188. Yoshino K, Enomoto T, Nakamura T, 

Sun H, Ozaki K, Nakashima R, Wada H, 

Saitoh J, Watanabe Y, Noda K, Murata Y 

(2000). FHIT alterations in cancerous and 

non-cancerous cervical epithelium. Int J 

Cancer 85: 6-13.

3189. Yoshioka T, Tanaka T (2000). Mature 

solid teratoma of the fallopian tube: case 

report. Eur J Obstet Gynecol Reprod Biol 

89: 205-206. 

3190. Yoshiura K, Kanai Y, Ochiai A, 

Shimoyama Y, Sugimura T, Hirohashi S 

(1995). Silencing of the E-cadherin invasion-suppressor 

gene by CpG methylation 

in human carcinomas. Proc Natl Acad Sci 

USA 92: 7416-7419. 

3191. Young JLJr, Percy CL, Asire AJ 

(1981). Surveillance, Epidemiology and End 

results: Incidence and mortality data: 

1973-1977. NCI Monogr. 

3192. Young RH, Clement PB (1988). 

Adenomyoepithelioma of the breast. A 

report of three cases and review of the literature. 


3193. Young RH, Clement PB (2000). 

Endocervicosis involving the uterine 

cervix: a report of four cases of a benign 

process that may be confused with deeply 

invasive endocervical adenocarcinoma. 


3194. Young RH, Clement PB, Scully RE 

(1988). Calcified thecomas in young 

women. A report of four cases. Int J 


3195. Young RH, Dickersin GR, Scully RE 

(1984). Juvenile granulosa cell tumor of the 

ovary. A clinicopathological analysis of 125 


3196. Young RH, Dudley AG, Scully RE 

(1984). Granulosa cell, Sertoli-Leydig cell, 

and unclassified sex cord-stromal tumors 

associated with pregnancy: a clinicopathological 

analysis of thirty-six cases. 


3197. Young RH, Gersell DJ, Clement PB, 

Scully RE (1992). Hepatocellular carcinoma 

metastatic to the ovary: a report of three 

cases discovered during life with discussion 

of the differential diagnosis of hepatoid 

tumors of the ovary. Hum Pathol 23: 

574-580. 

3198. Young RH, Gersell DJ, Roth LM, 

Scully RE (1993). Ovarian metastases from 

cervical carcinomas other than pure adenocarcinomas. 

A report of 12 cases. 

Cancer 71: 407-418. 

3199. Young RH, Gilks CB, Scully RE (1991). 

Mucinous tumors of the appendix associated 

with mucinous tumors of the ovary 

and pseudomyxoma peritonei. A clinicopathological 

analysis of 22 cases supporting 

an origin in the appendix. Am J Surg 

Pathol 15: 415-429. 

3200. Young RH, Hart WR (1989). 

Metastases from carcinomas of the pancreas 

simulating primary mucinous tumors 

of the ovary. A report of seven cases. Am 


3201. Young RH, Kleinman GM, Scully RE 

(1981). Glioma of the uterus. Report of a 

case with comments on histogenesis. Am 


3202. Young RH, Kurman RJ, Scully RE 

(1988). Proliferations and tumors of intermediate 

trophoblast of the placental site. 

Semin Diagn Pathol 5: 223-237. 

3203. Young RH, Kurman RJ, Scully RE 

(1990). Placental site nodules and plaques. 

A clinicopathologic analysis of 20 cases. 


3204. Young RH, Oliva E, Scully RE (1994). 

Small cell carcinoma of the ovary, hypercalcemic 

type. A clinicopathological 


1102-1116. 

3205. Young RH, Prat J, Scully RE (1980). 

Epidermoid cyst of the ovary. A report of 

three cases with comments on histogenesis. 



Ovarian endometrioid carcinomas resembling 

sex cord-stromal tumors. A clinicopathological 

analysis of 13 cases. Am J 



Ovarian Sertoli-Leydig cell tumors with 

heterologous elements. I. Gastrointestinal 

epithelium and carcinoid: a clinicopathologic 

analysis of thirty-six cases. Cancer 

50: 2448-2456. 


Endometrioid stromal sarcomas of the 


cases. Cancer 53: 1143-1155. 

3209. Young RH, Scully RE (1983). Ovarian 

Sertoli-Leydig cell tumors with a retiform 

pattern: a problem in histopathologic diag - 

nosis. A report of 25 cases. Am J Surg 

Pathol 7: 755-771. 


sex cord-stromal tumors with bizarre 

nuclei: a clinicopathologic analysis of 17 



stromal tumors with minor sex cord elements: 

a report of seven cases. Int J 



tumors of probable wolffian origin. A report 

of 11 cases. Am J Surg Pathol 7: 125-135. 

3213. Young RH, Scully RE (1984). 

Endodermal sinus tumor of the vagina: a 

report of nine cases and review of the literature. 



Fibromatosis and massive edema of the 

ovary, possibly related entities: a report of 

14 cases of fibromatosis and 11 cases of 

massive edema. Int J Gynecol Pathol 3: 

153-178. 


Sertoli cell tumors: a report of 10 cases.Int 


3216. Young RH, Scully RE (1984). Well-differentiated 

ovarian Sertoli-Leydig cell 

tumors: a clinicopathological analysis of 23 



Sertoli-Leydig cell tumors. A clinicopathological 

analysis of 207 cases. Am J Surg 

Pathol 9: 543-569. 


steroid cell tumors associated with 

Cushing's syndrome: a report of three 



Mucinous ovarian tumors associated with 

mucinous adenocarcinomas of the cervix. 

A clinicopathological analysis of 16 cases. 


3220. Young RH, Scully RE (1988). Urothelial 

and ovarian carcinomas of identical cell 

types: problems in interpretation. A report 

of three cases and review of the literature. 



metastases from carcinoma of the gallbladder 

and extrahepatic bile ducts simulating 

primary tumors of the ovary. A report 

of six cases. Int J Gynecol Pathol 9: 60-72. 


Sarcomas metastatic to the ovary: a report 


252. 


Malignant melanoma metastatic to the 



3224. Young RH, Scully RE (1992). Uterine 

carcinomas simulating microglandular 

hyperplasia. A report of six cases. Am J 

Surg Pathol 16: 1092-1097. 

3225. Young RH, Scully RE (1993). Minimaldeviation 

endometrioid adenocarcinoma 

of the uterine cervix. A report of five cases 

of a distinctive neoplasm that may be misinterpreted 

as benign. Am J Surg Pathol 

17: 660-665. 

3226. Young RH, Scully RE (1994). Metastic 

tumours of the ovary. In: B l a u s t e i n ' s 

Pathology of the Female Genital Tract, 

Kurman RJ, ed., 4th ed. Springer-Verlag: 

New York , pp. 939-974. 

3227. Young RH, Scully RE, McCluskey RT 

(1985). A distinctive glomerular lesion complicating 

placental site trophoblastic 

tumor: report of two cases. Hum Pathol 16: 

35-42. 

3228. Young RH, Treger T, Scully RE (1986). 

Atypical polypoid adenomyoma of the 

uterus. A report of 27 cases. Am J Clin 

Pathol 86: 139-145. 

3 2 2 9 . Young TW, Thrasher TV (1982). 

Nonchromaffin paraganglioma of the 

uterus. A case report. Arch Pathol Lab 

Med 106: 608-609. 

3 2 3 0 . Youngs LA, Taylor HB (1967). 

Adenomatoid tumors of the uterus and fal - 

lopian tube. Am J Clin Pathol 48: 537-545. 

3231. Youngson BJ, Cranor M, Rosen PP 

(1994). Epithelial displacement in surgical 

breast specimens following needling procedures. 


3232. Yu GH, Fishman SJ, Brooks JS (1993). 

Cellular angiolipoma of the breast. Mod 

Pathol 6: 497-499. 

3233. Yuan CC, Wang PH, Lai CR, Yen MS, 

Chen CY, Juang CM (1998). Prognosis-pre - 

dicting system based on factors related to 

survival of cervical carcinoma. Int J 


3234. Zabernigg A, Muller-Holzner E, Gasc 

JM, Gattringer C (1997). An unusual case of 

a renin-producing tumour of the fallopian 

tube. Eur J Cancer 33: 1709. 

3235. Zafrani B, Aubriot MH, Mouret E, de 

Cremoux P, De Rycke Y, Nicolas A, Boudou 

E, Vincent-Salomon A, Magdelenat H, 

Sastre-Garau X (2000). High sensitivity and 

specificity of immunohistochemistry for 

the detection of hormone receptors in 

breast carcinoma: comparison with biochemical 

determination in a prospective 

study of 793 cases. Histopathology 37: 536- 

545. 

3236. Zahradka M, Zahradka W, Mach S 

(1989). [Stromal sarcoma of the vagina]. 

Zentralbl Gynakol 111: 1450-1454. 

3237. Zaidi SN, Conner MG (2001). Primary 

vulvar adenocarcinoma of cloacogenic 

origin. South Med J 94: 744-746. 

3238. Zaino RJ, Kurman RJ, Diana KL, 

Morrow CP (1995). The utility of the revised 


and Obstetrics histologic grading of 

endometrial adenocarcinoma using a 

defined nuclear grading system. A 

Gynecologic Oncology Group study. 

Cancer 75: 81-86. 

3239. Zaino RJ, Unger ER, Whitney C (1984). 

Synchronous carcinomas of the uterine 

corpus and ovary. Gynecol Oncol 19: 329- 

335. 

3240. Zaki I, Dalziel KL, Solomonsz FA, 

Stevens A (1996). The under-reporting of 

skin disease in association with squamous 

cell carcinoma of the vulva. Clin Exp 

Dermatol 21: 334-337. 

3241. Zaloudek C, Hayashi GM, Ryan IP, 

Powell CB, Miller TR (1997). Microglandular 

adenocarcinoma of the 

endometrium: a form of mucinous adenocarcinoma 

that may be confused with 

microglandular hyperplasia of the cervix. 


3242. Zaloudek C, Norris HJ (1982). 

Granulosa tumors of the ovary in children: 

a clinical and pathologic study of 32 cases. 


3243. Zaloudek C, Norris HJ (1984). Sertoli- 

Leydig tumors of the ovary. A clinicopathologic 

study of 64 intermediate and poorly 

differentiated neoplasms. Am J Surg 

Pathol 8: 405-418. 

3244. Zaloudek C, Oertel YC, Orenstein JM 


breast. Am J Clin Pathol 81: 297-307. 

3245. Zaloudek CJ, Norris HJ (1981). 

Adenofibroma and adenosarcoma of the 

uterus: a clinicopathologic study of 35 

cases. Cancer 48: 354-366. 

3246. Zaloudek CJ, Tavassoli FA, Norris HJ 

(1981). Dysgerminoma with syncytiotrophoblastic 

giant cells. A histologically and 

clinically distinctive subtype of dysgerminoma. 


3247. Zamecnik M, Michal M (1998). 

Endometrial stromal nodule with retiform 

sex-cord-like differentiation. Pathol Res 

Pract 194: 449-453. 

3248. Zamecnik M, Michal M, Curik R 


ovary. Arch Pathol Lab Med 124: 1529-1531. 

3249. Zanella M, Falconieri G, Lamovec J, 

Bittesini L (1998). Pseudoangiomatous 

hyperplasia of the mammary stroma: true 

entity or phenotype? Pathol Res Pract 194: 

535-540. 

3250. Zanetta G, Rota SM, Lissoni A, Chiari 

S, Bratina G, Mangioni C (1999). 

Conservative treatment followed by 

chemotherapy with doxorubicin and ifosfamide 

for cervical sarcoma botryoides in 

young females. Br J Cancer 80: 403-406. 

3251. Zanetta GM, Webb MJ, Li H, Keeney 

GL (2000). Hyperestrogenism: a relevant 

risk factor for the development of cancer 

from endometriosis. Gynecol Oncol 79: 18- 

22. 

3252. Zhang J, Young RH, Arseneau J, 

Scully RE (1982). Ovarian stromal tumors 

containing lutein or Leydig cells (luteinized 

thecomas and stromal Leydig cell tumors)- 

-a clinicopathological analysis of fifty 


3253. Zhao S, Kato N, Endoh Y, Jin Z, Ajioka 

Y, Motoyama T (2000). Ovarian 

gonadoblastoma with mixed germ cell 

tumor in a woman with 46, XX karyotype 

and successful pregnancies. Pathol Int 50: 

332-335. 

3254. Zhao X, Wei YQ, Kariya Y, 

Teshigawara K, Uchida A (1995). 

Accumulation of gamma/delta T cells in 

human dysgerminoma and seminoma: 

roles in autologous tumor killing and granuloma 

formation. Immunol Invest 24: 607- 

618. 

3255. Zheng L, Pan H, Li S, Flesken-Nikitin 

A, Chen PL, Boyer TG, Lee WH (2000). 

Sequence-specific transcriptional corepressor 

function for BRCA1 through a 

novel zinc finger protein, ZBRK1. Mol Cell 

6: 757-768. 


3256. Zheng W, Khurana R, Farahmand S, 

Wang Y, Zhang ZF, Felix JC (1998). p53 

immunostaining as a significant adjunct 

diagnostic method for uterine surface carcinoma: 

precursor of uterine papillary 

serous carcinoma. Am J Surg Pathol 22: 

1463-1473. 

3257. Zheng W, Wolf S, Kramer EE, Cox KA, 

Hoda SA (1996). Borderline papillary 

serous tumour of the fallopian tube. Am J 


3258. Zhong Q, Chen CF, Li S, Chen Y, Wang 

CC, Xiao J, Chen PL, Sharp ZD, Lee WH 

(1999). Association of BRCA1 with the 

hRad50-hMre11-p95 complex and the DNA 

damage response. Science 285: 747-750. 

3259. Zhou H, Kuang J, Zhong L, Kuo WL, 

Gray JW, Sahin A, Brinkley BR, Sen S 

(1998). Tumour amplified kinase 

STK15/BTAK induces centrosome amplification, 

aneuploidy and transformation. Nat 

Genet 20: 189-193. 

3260. Zhou X, Hampel H, Thiele H, Gorlin 

RJ, Hennekam RC, Parisi M, Winter RM, 

Eng C (2001). Association of germline 

mutation in the PTEN tumour suppressor 

gene and Proteus and Proteus-like syndromes. 

Lancet 358: 210-211. 


3261. Zhou XP, Kuismanen S, Nystrom- 

Lahti M, Peltomaki P, Eng C (2002). Distinct 

PTEN mutational spectra in hereditary 

non-polyposis colon cancer syndromerelated 

endometrial carcinomas compared 

to sporadic microsatellite unstable tumors. 


3262. Zhou XP, Woodford-Richens K, 

Lehtonen R, Kurose K, Aldred M, Hampel 

H, Launonen V, Virta S, Pilarski R, 

Salovaara R, Bodmer WF, Conrad BA, 

Dunlop M, Hodgson SV, Iwama T, Jarvinen 

H, Kellokumpu I, Kim JC, Leggett B, Markie 

D, Mecklin JP, Neale K, Phillips R, Piris J, 

Rozen P, Houlston RS, Aaltonen LA, 

Tomlinson IP, Eng C (2001). Germline mutations 

in BMPR1A/ALK3 cause a subset of 

cases of juvenile polyposis syndrome and 

of Cowden and Bannayan-Riley-Ruvalcaba 

syndromes. Am J Hum Genet 69: 704-711. 

3263. Zhu WY, Leonardi C, Penneys NS 

(1992). Detection of human papillomavirus 

DNA in seborrheic keratosis by polymerase 

chain reaction. J Dermatol Sci 4: 

166-171. 

3264. Zhu XL, Hartwick W, Rohan T, Kandel 

R (1998). Cyclin D1 gene amplification and 

protein expression in benign breast disease 

and breast carcinoma. Mod Pathol 

11: 1082-1088. 

3265. Zhuang Z, Merino MJ, Chuaqui R, 

Liotta LA, Emmert-Buck MR (1995). 

Identical allelic loss on chromosome 11q13 

in microdissected in situ and invasive 

human breast cancer. Cancer Res 55: 467- 

471. 

3266. Ziegler RG, Hoover RN, Pike MC, 

Hildesheim A, Nomura AM, West DW, Wu- 

Williams AH, Kolonel LN, Horn-Ross PL, 

Rosenthal JF, Hyer MB. (1993). Migration 

patterns and breast cancer risk in Asian- 

American women. J Natl Cancer Inst 85: 

1819-1827. 

3267. Zollo JD, Zeitouni NC (2000). The 

Roswell Park Cancer Institute experience 

with extramammary Paget's disease. Br J 

Dermatol 142: 59-65. 

3268. Zotalis G, Nayar R, Hicks DG (1998). 

Leiomyomatosis peritonealis disseminata, 

endometriosis, and multicystic mesothelioma: 

an unusual association. Int J 


3269. Zou A, Marschke KB, Arnold KE, 

Berger EM, Fitzgerald P, Mais DE, 

Allegretto EA (1999). Estrogen receptor 

beta activates the human retinoic acid 

receptor alpha-1 promoter in response to 

tamoxifen and other estrogen receptor 

antagonists, but not in response to estrogen. 

Mol Endocrinol 13: 418-430. 

3270. Zuntova A, Motlik K, Horejsi J, 

Eckschlager T (1992). Mixed germ cell-sex 

cord stromal tumor with heterologous 

structures. Int J Gynecol Pathol 11: 227- 

233. 

3271. Zweemer RP, van Diest PJ, Verheijen 

RH, Ryan A, Gille JJ, Sijmons RH, Jacobs 

IJ, Menko FH, Kenemans P (2000). 

Molecular evidence linking primary cancer 

of the fallopian tube to BRCA1 germline 

mutations. Gynecol Oncol 76: 45-50. 

3272. Zweemer RP, Verheijen RH, Gille JJ, 

van Diest PJ, Pals G, Menko FH (1998). 

Clinical and genetic evaluation of thirty 

ovarian cancer families. Am J Obstet 

Gynecol 178: 85-90. 

3273. Zwijsen RM, Wientjens E, 

Klompmaker R, van der Sman J, Bernards 

R, Michalides RJ (1997). CDK-independent 

activation of estrogen receptor by cyclin 

D1. Cell 88: 405-415.

References 

425

References - iarc

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?